Sentence,class,file
"ISSN 2234-3806 • eISSN 2234-3814  542  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.542Ann Lab Med 2016;36:542-549 http://dx.doi.org/10.3343/alm.2016.36.6.542Original Article Diagnostic Immunology Soluble ST2 Levels and Left Ventricular Structure and  Function in Patients With Metabolic Syndrome Vera Celic, Ph.D.1,2, Anka Majstorovic, M.D.2, Biljana Pencic-Popovic, Ph.D.1,2, Aleksandra Sljivic, M.D.2,   Natalia Lopez-Andres, Ph.D.3, Ignacio Roy, M.D.4, Elena Escribano, M.D.4, Maite Beunza, M.D.4, Amaia Melero, M.D.3,  Federico Floridi, M.D.5, Laura Magrini, M.D.5, Rossella Marino, M.D.5, Gerardo Salerno, Ph.D.5, Patrizia Cardelli, Ph.D.5,   and Salvatore Di Somma, Ph.D.5 Faculty of Medicine1, University of Belgrade, Belgrade, Serbia; University Hospital Centre “Dr DragisaMisovic-Dedinje’’2, Belgrade, Serbia; Miguel Servet  Foundation-Navarrabiomed3, Pamplona, Spain; Complejo Hospitalario de Navarra4, Pamplona, Spain; School of Medicine and Psychology5, La Sapienza  University, Sant’Andrea Hospital, Rome, Italy Background:  A biomarker that is of great interest in relation to adverse cardiovascular  events is soluble ST2 (sST2), a member of the interleukin family.",Non-OADS,/arxiv_data1/oa_pdf/14/01/alm-36-542.PMC5011107.pdf
sST2 and left ventricle in metabolic syndrome http://dx.doi.org/10.3343/alm.2016.36.6.542 www.annlabmed.org  543stolic dysfunction [4].,Non-OADS,/arxiv_data1/oa_pdf/14/01/alm-36-542.PMC5011107.pdf
"sST2 and left ventricle in metabolic syndrome 544  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.542ments (height, weight, waist circumference) were taken for all  subjects.",Non-OADS,/arxiv_data1/oa_pdf/14/01/alm-36-542.PMC5011107.pdf
"sST2 and left ventricle in metabolic syndrome http://dx.doi.org/10.3343/alm.2016.36.6.542 www.annlabmed.org  545the European and the American Society of Echocardiography  [21, 22].",Non-OADS,/arxiv_data1/oa_pdf/14/01/alm-36-542.PMC5011107.pdf
"sST2 and left ventricle in metabolic syndrome 546  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.542We performed ROC analysis for sST2, and the classification  variable was LVH.",OADS,/arxiv_data1/oa_pdf/14/01/alm-36-542.PMC5011107.pdf
sST2 and left ventricle in metabolic syndrome http://dx.doi.org/10.3343/alm.2016.36.6.542 www.annlabmed.org  547LV DD.,Non-OADS,/arxiv_data1/oa_pdf/14/01/alm-36-542.PMC5011107.pdf
"sST2 and left ventricle in metabolic syndrome 548  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.542This situation with modulated proinflammatory response  could easily be translated to other similar scenarios of increased  volume and/or pressure overload and impaired overall homeo - stasis, such as MetS.",Non-OADS,/arxiv_data1/oa_pdf/14/01/alm-36-542.PMC5011107.pdf
sST2 and left ventricle in metabolic syndrome http://dx.doi.org/10.3343/alm.2016.36.6.542 www.annlabmed.org  54915.,Non-OADS,/arxiv_data1/oa_pdf/14/01/alm-36-542.PMC5011107.pdf
"ISSN 2234-3806 • eISSN 2234-3814  550  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.550Ann Lab Med 2016;36:550-554 http://dx.doi.org/10.3343/alm.2016.36.6.550Original Article Diagnostic Immunology Evaluation of the VIDAS Anti-HCV Assay for Detection  of Hepatitis C Virus Infection Jungwon Hyun, M.D.1, Dae-Hyun Ko, M.D.1, Hee Jung Kang, M.D.1, Dong Hee Whang, M.D.2, Young Joo Cha, M.D.3,   and Hyun Soo Kim, M.D.1 Department of Laboratory Medicine1, Hallym University College of Medicine, Hwaseong; Department of Laboratory Medicine2, Inje University College of  Medicine, Seoul; Department of Laboratory Medicine3, Chung-Ang University College of Medicine, Seoul, Korea Background:  Anti-hepatitis C virus antibody (anti-HCV) assays are recommended for  screening HCV-infected persons.",Non-OADS,/arxiv_data1/oa_pdf/0c/12/alm-36-550.PMC5011108.pdf
"Evaluation of VIDAS anti-HCV assay http://dx.doi.org/10.3343/alm.2016.36.6.550 www.annlabmed.org  551France) was recently developed as a third-generation immuno - assay using antigens corresponding to the HCV Core, NS3, and  NS4 proteins for qualitative detection of anti-HCV antibodies in  human serum or plasma.",OADS,/arxiv_data1/oa_pdf/0c/12/alm-36-550.PMC5011108.pdf
"Evaluation of VIDAS anti-HCV assay 552  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.55022.56±1.24) and 997 of 1,002 HCV-negative samples were  test-negative according to the VIDAS assay.",OADS,/arxiv_data1/oa_pdf/0c/12/alm-36-550.PMC5011108.pdf
"Evaluation of VIDAS anti-HCV assay http://dx.doi.org/10.3343/alm.2016.36.6.550 www.annlabmed.org  553ples tested negative in both Architect and Procleix PCR assays,  but were weakly test-positive in the VIDAS assay (TV 1.05-6.23).",Non-OADS,/arxiv_data1/oa_pdf/0c/12/alm-36-550.PMC5011108.pdf
Evaluation of VIDAS anti-HCV assay 554  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.550and to Ji Sun Noh for the excellent technical assistance.,Non-OADS,/arxiv_data1/oa_pdf/0c/12/alm-36-550.PMC5011108.pdf
164 http://www.who.int/mediacentre/ factsheets/fs164/en (Updated on Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/0c/12/alm-36-550.PMC5011108.pdf
"WHO Press, 2014:1-222. http://www.who.int/hiv/ pub/hepatitis/hepatitis-c-guidelines/en/.",Non-OADS,/arxiv_data1/oa_pdf/0c/12/alm-36-550.PMC5011108.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.6.555 www.annlabmed.org  555Ann Lab Med 2016;36:555-560 http://dx.doi.org/10.3343/alm.2016.36.6.555Original Article Diagnostic Genetics PRSS1 , SPINK1 , CFTR , and CTRC  Pathogenic  Variants in Korean Patients With Idiopathic  Pancreatitis Sun-Mi Cho, M.D.1, Saeam Shin, M.D.2, and Kyung-A Lee, M.D.1 Department of Laboratory Medicine1, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul; Department of Laboratory Medicine2,  Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea Background:  This study aimed to identify pathogenic variants of PRSS1 , SPINK1 , CFTR ,  and CTRC  genes in Korean patients with idiopathic pancreatitis.",OADS,/arxiv_data1/oa_pdf/01/82/alm-36-555.PMC5011109.pdf
Genetic analysis of Korean idiopathic pancreatitis 556  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.555sinogen in human pancreatic juice.,Non-OADS,/arxiv_data1/oa_pdf/01/82/alm-36-555.PMC5011109.pdf
Genetic analysis of Korean idiopathic pancreatitis http://dx.doi.org/10.3343/alm.2016.36.6.555 www.annlabmed.org  5573.,Non-OADS,/arxiv_data1/oa_pdf/01/82/alm-36-555.PMC5011109.pdf
"Genetic analysis of Korean idiopathic pancreatitis 558  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.555DISCUSSION Schnur et al [16] reported that PRSS1  p.G208A pathogenic  variant was rare and predominant in Asia, and caused a moder - ate secretion defect [16].",Non-OADS,/arxiv_data1/oa_pdf/01/82/alm-36-555.PMC5011109.pdf
"Genetic analysis of Korean idiopathic pancreatitis http://dx.doi.org/10.3343/alm.2016.36.6.555 www.annlabmed.org  559without any evidence of cystic fibrosis [8, 9].",Non-OADS,/arxiv_data1/oa_pdf/01/82/alm-36-555.PMC5011109.pdf
Genetic analysis of Korean idiopathic pancreatitis 560  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.555creatitis.,Non-OADS,/arxiv_data1/oa_pdf/01/82/alm-36-555.PMC5011109.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.6.561 www.annlabmed.org  561Ann Lab Med 2016;36:561-572 http://dx.doi.org/10.3343/alm.2016.36.6.561Original Article Diagnostic Genetics A Population-Based Genomic Study of Inherited  Metabolic Diseases Detected Through Newborn  Screening Kyoung-Jin Park, M.D.1,*, Seungman Park, M.D.2, Eunhee Lee, M.D.2, Jong-Ho Park, B.S.1, June-Hee Park, B.S.3,   Hyung-Doo Park, M.D.4, Soo-Youn Lee, M.D.4, and Jong-Won Kim, M.D.1,4 Department of Health Sciences and Technology1, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul; Green  Cross Laboratories2, Yongin; Samsung Biomedical Research Institute3, Samsung Medical Center, Seoul; Department of Laboratory Medicine & Genetics4,  Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Background:  A newborn screening (NBS) program has been utilized to detect asymptom - atic newborns with inherited metabolic diseases (IMDs).",Non-OADS,/arxiv_data1/oa_pdf/69/db/alm-36-561.PMC5011110.pdf
"A population study of inherited metabolic diseases 562  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.561though the use of MS/MS has enabled cost-effective, rapid IMD  identification, there have been some bottlenecks such as false- positives and imprecision [4-6, 8].",Non-OADS,/arxiv_data1/oa_pdf/69/db/alm-36-561.PMC5011110.pdf
"A population study of inherited metabolic diseases http://dx.doi.org/10.3343/alm.2016.36.6.561 www.annlabmed.org  563(Presumptive Positive Cases, with metabolite abnormalities only)  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/69/db/alm-36-561.PMC5011110.pdf
A population study of inherited metabolic diseases 564  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.5613.,Non-OADS,/arxiv_data1/oa_pdf/69/db/alm-36-561.PMC5011110.pdf
"org/index.html), the Exome Sequencing Project (ESP6500,  http://evs.gs.washington.edu/EVS/), and the Exome Aggregation  Consortium (ExAC, http://exac.broadinstitute.org/); selection of  variants with multiple lines of evidence supporting “deleterious”  or “damaging” effects, using Sorting Intolerant From Tolerant  (SIFT), Polymorphism Phenotyping v2 (Polyphen-2), likelihood  ratio test (LRT), MutationTaster, MutationAssesor, or FATHMM;  selection of variants with a Genomic Evolutionary Rate Profiling  (GERP) score higher than 2; removal of common polymor - phisms reported in dbSNP v.138; selection of protein-impacting  mutations such as nonsense mutations, mutations in GT-AG di - nucleotides of the canonical splice sites, and frameshift muta - tions (Fig.",Non-OADS,/arxiv_data1/oa_pdf/69/db/alm-36-561.PMC5011110.pdf
A population study of inherited metabolic diseases http://dx.doi.org/10.3343/alm.2016.36.6.561 www.annlabmed.org  565of variants per sample from a median of 247 to 4 in the 27 posi - tive control samples (reduction rate of 98%).,Non-OADS,/arxiv_data1/oa_pdf/69/db/alm-36-561.PMC5011110.pdf
"A population study of inherited metabolic diseases 566  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.561ing congenital hypothyroidism (CH, n=34), galactosemia  (n=11), type II citrullinemia (CTLN2, n=3), phenylketonuria  (PKU, n=1), methylmalonic aciduria (MMA, n=2), and 3-  methylcrotonyl-CoA carboxylase deficiency (3-MCC deficiency,  n=3) (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/69/db/alm-36-561.PMC5011110.pdf
A population study of inherited metabolic diseases http://dx.doi.org/10.3343/alm.2016.36.6.561 www.annlabmed.org  567Table 2.,Non-OADS,/arxiv_data1/oa_pdf/69/db/alm-36-561.PMC5011110.pdf
"A population study of inherited metabolic diseases 568  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.561Sample ID Metabolite cut-off* NBS tests* Gene NT alteration AA alterationConventional  criteriaACMG  categoryZygosity DiseaseFrequency in APC IMD_149 TSH 12 14.2 DUOX2 DUOX2c.3616G > A c.1462G > Ap.A1206T p.G488REP KPVUS LPNA HetCH CH1/54 4/54 IMD_152 TSH 12 12.3 DUOX2 DUOXA2c.3329G > A c.738C > Gp.R1110Q p.Y246XKP KPLP PHet HetCH CH1/54 3/54 IMD_153 TSH 12 13.6 DUOXA2 PAX8c.738C > G c.739G > Ap.Y246X p.E247KKP EPP VUSHet NACH CH3/54 1/54 IMD_159 Cit 55 128.9 SLC25A13 SLC25A13c.1180+1G > A c.851delGTATNA p.M285Pfs*2KP KPP PComHet CTLN2 CTLN21/54 3/54 IMD_164 C3 5 9.126 MUT c.1228A > G p.I410V EP VUS NA MMA 1/54 IMD_186 TSH/GAL 12.0/13.0 31.3/13.5 DUOXA2 c.413dupA p.Y138X KP LP Hom CH 4/54 IMD_189 TSH/FT4 12.0/0.8 55.7/0.4 DUOX2 c.1462G > A p.G488R KP LP Het CH 4/54 IMD_191 TSH/17α- OHP/FT412/12/0.8 54.9/18.1/0.2 SLC5A5 SLC5A5c.1060A > C c.1605delp.T354P p.G535fsKP EPLP LPComHet CH CH1/54 1/54 IMD_196 TSH 12 94.1 DUOX2 c.1462G > A p.G488R KP LP Het CH 4/54 IMD_197 TSH 12 14.8 TSHR c.1349G > A p.R450H KP LP Het CH 4/54 IMD_203 TSH 12 12.4 TSHR c.1556G > A p.R519H EP VUS NA CH 1/54 IMD_206 TSH 12 54.8 DUOXA2 DUOXA2c.280C > T c.413dupAp.R94C p.Y138XEP KPVUS LPNA HetCH CH1/54 4/54 IMD_209 TSH 12 15.1 DUOX2 c.1319G > A p.S440N EP VUS NA CH 1/54 IMD_210 TSH 12 54.8 TSHR c.1449C > A p.N483K EP VUS NA CH 1/54 IMD_211 TSH 12 13 DUOX2 c.227C > T p.P76L EP VUS NA CH 1/54 IMD_221 TSH 12 25.7 TSHR c.1454C > A p.A485D EP VUS NA CH 2/54 IMD_234 Gal 13 27.7 GALK1 c.1159G > A p.A387T EP VUS NA Galactosemia 2/54 IMD_235 Gal 13 19.6 GALK1 c.1159G > A p.A387T EP VUS NA Galactosemia 2/54 IMD_237 FT4 0.8 0.2 DUOX2 c.2654G > A p.R885Q KP LP Het CH 3/54 IMD_238 FT4 0.8 0.4 TPO c.1061G > T p.W354L EP VUS NA CH 1/54 IMD_264 17α-OHP/ FT412.0/0.7 17.9/0.4 DUOXA2 c.738C > G p.Y246X KP P Het CH 3/54 Reference sequences of MUT , MCCC1 , SLC25A13 , DUOX2 , TSHR , DUOXA2 , PAX8 , GALE , GALT , GALT , PAH, SLC5A5 , GALK1 , and TPO were  NM_000255, NM_001293273, NM_001160210, NM_014080, NM_000369, NM_207581, NM_003466, NM_001127621, NM_001258332,  NM_000155, NM_000277, NM_000453, NM_000154, and NM_175722, respectively.",Non-OADS,/arxiv_data1/oa_pdf/69/db/alm-36-561.PMC5011110.pdf
A population study of inherited metabolic diseases http://dx.doi.org/10.3343/alm.2016.36.6.561 www.annlabmed.org  569Table 3.,Non-OADS,/arxiv_data1/oa_pdf/69/db/alm-36-561.PMC5011110.pdf
A population study of inherited metabolic diseases 570  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.561DISCUSSION The introduction of NGS is likely to change NBS practices.,Non-OADS,/arxiv_data1/oa_pdf/69/db/alm-36-561.PMC5011110.pdf
"A population study of inherited metabolic diseases http://dx.doi.org/10.3343/alm.2016.36.6.561 www.annlabmed.org  571Frequent heterozygote mutations might be attributable to false- negatives in the current NewbornSeq pipeline because: i) miss - ing variants due to low depth of coverage, ii) unidentified muta - tions in regulatory regions, iii) unidentified mutations in amplifi - cation-resistant gene regions, iv) allele dropout due to SNPs in  PCR primer-binding sites, or v) structural variations (SV).",Non-OADS,/arxiv_data1/oa_pdf/69/db/alm-36-561.PMC5011110.pdf
A population study of inherited metabolic diseases 572  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.561of disorders detectable through newborn screening by race/ethnicity.,Non-OADS,/arxiv_data1/oa_pdf/69/db/alm-36-561.PMC5011110.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.6.573 www.annlabmed.org  573Ann Lab Med 2016;36:573-582 http://dx.doi.org/10.3343/alm.2016.36.6.573Original Article Diagnostic Genetics Abnormalities in Chromosomes 1q and 13  Independently Correlate With Factors of Poor Prognosis  in Multiple Myeloma  Miyoung Kim, M.D.1, Young-Su Ju, M.D.2, Eun Jin Lee, M.D.1, Hee Jung Kang, M.D.1, Han-Sung Kim, M.D.1,   Hyoun Chan Cho, M.D.1, Hyo Jung Kim, M.D.3, Jung-Ah Kim, M.D.4, Dong Soon Lee, M.D.4,5, and Young Kyung Lee, M.D.1 Departments of Laboratory Medicine1, Occupational and Environmental Medicine2, and Internal Medicine3, Hallym University College of Medicine, Anyang;  Department of Laboratory Medicine4, Seoul National University College of Medicine, Seoul; Cancer Research Institute5, Seoul National University College of  Medicine, Seoul, Korea Background:  We comprehensively profiled cytogenetic abnormalities in multiple myeloma  (MM) and analyzed the relationship between cytogenetic abnormalities of undetermined  prognostic significance and established prognostic factors.",OADS,/arxiv_data1/oa_pdf/f2/ae/alm-36-573.PMC5011111.pdf
"Chromosome 1q &13 abnormality in multiple myeloma 574  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.573with t(4;14), t(14;16), or t(14;20) have a worse overall survival  rate than those with hyperdiploidy, t(11;14), or t(6;14) [2, 3, 8].",Non-OADS,/arxiv_data1/oa_pdf/f2/ae/alm-36-573.PMC5011111.pdf
Chromosome 1q &13 abnormality in multiple myeloma http://dx.doi.org/10.3343/alm.2016.36.6.573 www.annlabmed.org  575were included in the analysis of chromosomal aberrations.,OADS,/arxiv_data1/oa_pdf/f2/ae/alm-36-573.PMC5011111.pdf
Chromosome 1q &13 abnormality in multiple myeloma 576  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.573Table 1.,Non-OADS,/arxiv_data1/oa_pdf/f2/ae/alm-36-573.PMC5011111.pdf
Chromosome 1q &13 abnormality in multiple myeloma http://dx.doi.org/10.3343/alm.2016.36.6.573 www.annlabmed.org  577are depicted in Fig.,Non-OADS,/arxiv_data1/oa_pdf/f2/ae/alm-36-573.PMC5011111.pdf
Chromosome 1q &13 abnormality in multiple myeloma 578  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.573 Fig.,Non-OADS,/arxiv_data1/oa_pdf/f2/ae/alm-36-573.PMC5011111.pdf
Chromosome 1q &13 abnormality in multiple myeloma http://dx.doi.org/10.3343/alm.2016.36.6.573 www.annlabmed.org  579Table 3.,Non-OADS,/arxiv_data1/oa_pdf/f2/ae/alm-36-573.PMC5011111.pdf
"Chromosome 1q &13 abnormality in multiple myeloma 580  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.573survival duration of the patients with and without chromosome 4  abnormalities was 542 and 966 days, respectively.",OADS,/arxiv_data1/oa_pdf/f2/ae/alm-36-573.PMC5011111.pdf
"Chromosome 1q &13 abnormality in multiple myeloma http://dx.doi.org/10.3343/alm.2016.36.6.573 www.annlabmed.org  581decondensation of centromeric heterochromatin that results  from DNA hypomethylation leads to the fragility of these regions,  presumably as a part of an unknown process associated with  tumor progression.",Non-OADS,/arxiv_data1/oa_pdf/f2/ae/alm-36-573.PMC5011111.pdf
Chromosome 1q &13 abnormality in multiple myeloma 582  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.57313.,Non-OADS,/arxiv_data1/oa_pdf/f2/ae/alm-36-573.PMC5011111.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.6.583 www.annlabmed.org  583Ann Lab Med 2016;36:583-589 http://dx.doi.org/10.3343/alm.2016.36.6.583Original Article Diagnostic Genetics Relationship Between Cytogenetic Complexity and  Peritumoral Edema in High-Grade Astrocytoma Kyung-Ho Jeong, M.D.1, Young-Jin Song, M.D.1,2, Jin-Yeong Han, M.D.3, and Ki-Uk Kim, M.D.1,2 Departments of Neurosurgery1, Brain Tumor Institute2, Medical Science Research Center, Department of Laboratory Medicine3, College of Medicine, Dong-A  University, Busan, Korea Background:  The purpose of the study is to reveal the association of cytogenetic complex - ity and peritumoral edema volume (PTEV) and its prognostic significance in high-grade  astrocytoma patients by culturing patient tumor cells.",OADS,/arxiv_data1/oa_pdf/05/e1/alm-36-583.PMC5011112.pdf
"Cytogenetic complexity of high-grade astrocytoma 584  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.583let-derived growth factor receptor (PDGFR) are factors associ - ated with vascular permeability and angiogenesis, which play a  significant role in the formation of peritumoral edema (PTE) [15,  16].",Non-OADS,/arxiv_data1/oa_pdf/05/e1/alm-36-583.PMC5011112.pdf
Cytogenetic complexity of high-grade astrocytoma http://dx.doi.org/10.3343/alm.2016.36.6.583 www.annlabmed.org  585Table 1.,Non-OADS,/arxiv_data1/oa_pdf/05/e1/alm-36-583.PMC5011112.pdf
Cytogenetic complexity of high-grade astrocytoma 586  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.5836.,Non-OADS,/arxiv_data1/oa_pdf/05/e1/alm-36-583.PMC5011112.pdf
Cytogenetic complexity of high-grade astrocytoma http://dx.doi.org/10.3343/alm.2016.36.6.583 www.annlabmed.org  587The significance of the relationship between PTEV and survival  was maximized when the standard edema volume was 90 cm3.,OADS,/arxiv_data1/oa_pdf/05/e1/alm-36-583.PMC5011112.pdf
"Cytogenetic complexity of high-grade astrocytoma 588  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.583chromosomal codeletion, O6-methylguanin-DNA-methyltransfer - ase (MGMT) promoter methylation, isocitrate dehydrogenase  (IDH) mutations, and EGFR amplification [7, 12, 15, 23].",Non-OADS,/arxiv_data1/oa_pdf/05/e1/alm-36-583.PMC5011112.pdf
Cytogenetic complexity of high-grade astrocytoma http://dx.doi.org/10.3343/alm.2016.36.6.583 www.annlabmed.org  589Authors’ Disclosures of Potential Conflicts of  Interest No potential conflicts of interest relevant to this article were re - ported.,Non-OADS,/arxiv_data1/oa_pdf/05/e1/alm-36-583.PMC5011112.pdf
"ISSN 2234-3806 • eISSN 2234-3814  590  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.590Ann Lab Med 2016;36:590-594 http://dx.doi.org/10.3343/alm.2016.36.6.590Brief Communication Clinical Chemistry Soluble Suppression of Tumorigenicity 2 and  Echocardiography in Sepsis Hyun Suk Yang, M.D.1, Mina Hur, M.D.1, Hanah Kim, M.D.2, Laura Magrini, M.D.3, Rossella Marino, M.D.3,   and Salvatore Di Somma, M.D.3; on behalf of GREAT Network Departments of Cardiovascular Medicine1 and Laboratory Medicine2, Konkuk University School of Medicine, Seoul, Korea; Department of Medical-Surgery  Sciences and Translational Medicine3, University La Sapienza Rome, Sant’Andrea Hospital, Rome, Italy Soluble suppression of tumorigenicity 2 (sST2) has emerged as a biomarker of cardiac  stretch or remodeling, and has demonstrated a role in acutely decompensated heart fail - ure.",Non-OADS,/arxiv_data1/oa_pdf/af/35/alm-36-590.PMC5011113.pdf
sST2 and echocardiography in sepsis http://dx.doi.org/10.3343/alm.2016.36.6.590 www.annlabmed.org  591trauma [3-5].,Non-OADS,/arxiv_data1/oa_pdf/af/35/alm-36-590.PMC5011113.pdf
"sST2 and echocardiography in sepsis 592  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.590ages for apical ballooning, LV outflow dynamic obstruction, or  right ventricular dysfunction [12].",Non-OADS,/arxiv_data1/oa_pdf/af/35/alm-36-590.PMC5011113.pdf
"sST2 and echocardiography in sepsis http://dx.doi.org/10.3343/alm.2016.36.6.590 www.annlabmed.org  593to be higher in the systolic dysfunction group, unadjusted P val- ues did not indicate a meaningful difference.",OADS,/arxiv_data1/oa_pdf/af/35/alm-36-590.PMC5011113.pdf
sST2 and echocardiography in sepsis 594  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.590al.,Non-OADS,/arxiv_data1/oa_pdf/af/35/alm-36-590.PMC5011113.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.6.595 www.annlabmed.org  595Ann Lab Med 2016;36:595-598 http://dx.doi.org/10.3343/alm.2016.36.6.595Brief Communication Clinical Chemistry Reference Intervals for Plasma Amyloid β in Korean  Adults Without Cognitive Impairment Min-Young Kim, M.D.1, Kyu-Nam Kim, M.D.1, Hye-Min Cho, M.D.1, Duck-Joo Lee, M.D.1, and Doo-Yeoun Cho, M.D.2 Department of Family Practice & Community Health1, Ajou University School of Medicine, Suwon; Department of Clinical Pharmacology and Therapeutics2,  CHA Bundang Medical Center, CHA University, Seongnam, Korea Amyloid β (Aβ) peptides are important components of plaques in patients with Alzheimer’s  disease (AD).",OADS,/arxiv_data1/oa_pdf/63/12/alm-36-595.PMC5011114.pdf
"Reference intervals for plasma amyloid β 596  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.595Suwon, Korea.",OADS,/arxiv_data1/oa_pdf/63/12/alm-36-595.PMC5011114.pdf
"Reference intervals for plasma amyloid β http://dx.doi.org/10.3343/alm.2016.36.6.595 www.annlabmed.org  597ods, and the lower and upper limits represented the 2.5th and  97.5th percentiles.",OADS,/arxiv_data1/oa_pdf/63/12/alm-36-595.PMC5011114.pdf
"Reference intervals for plasma amyloid β 598  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.595hypertension, stroke, major depressive disorder, bipolar disor - der, schizophrenia, substance abuse disorder, and the use of  drugs that interfere with cognitive function, by establishing strict  inclusion/exclusion criteria.",Non-OADS,/arxiv_data1/oa_pdf/63/12/alm-36-595.PMC5011114.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.6.599 www.annlabmed.org  599Ann Lab Med 2016;36:599-602 http://dx.doi.org/10.3343/alm.2016.36.6.599Brief Communication Clinical Chemistry Development of a Novel Quality Improvement Indicator  Based on the Hemolysis Index Eun Jin Lee, M.D., Miyoung Kim, M.D., Han-Sung Kim, M.D., Min-Jeong Park, M.D., Young Kyung Lee, M.D.,   and Hee Jung Kang, M.D.",OADS,/arxiv_data1/oa_pdf/d1/64/alm-36-599.PMC5011115.pdf
"Hemolysis index as a quality improvement indicator 600  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.599 shaken for 0, 6, 12, 18, 24, and 30 sec, respectively, to obtain  samples with varying degrees of hemolysis.",Non-OADS,/arxiv_data1/oa_pdf/d1/64/alm-36-599.PMC5011115.pdf
Hemolysis index as a quality improvement indicator http://dx.doi.org/10.3343/alm.2016.36.6.599 www.annlabmed.org  601monthly mean H index and monthly frequency of samples with  an H index >25 were analyzed by the Mann-Whitney U test.,OADS,/arxiv_data1/oa_pdf/d1/64/alm-36-599.PMC5011115.pdf
Hemolysis index as a quality improvement indicator 602  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.599samples in a clinical laboratory to identify the time and place of  an inappropriate procedure.,Non-OADS,/arxiv_data1/oa_pdf/d1/64/alm-36-599.PMC5011115.pdf
http://www.rochediagnostics.cz/download/program/ Serum%20Indices_maly.pdf.,OADS,/arxiv_data1/oa_pdf/d1/64/alm-36-599.PMC5011115.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.6.603 www.annlabmed.org  603Ann Lab Med 2016;36:603-606 http://dx.doi.org/10.3343/alm.2016.36.6.603Brief Communication Clinical Microbiology Performance Evaluation of the Real-Q Cytomegalovirus  (CMV) Quantification Kit Using Two Real-Time PCR  Systems for Quantifying CMV DNA in Whole Blood  Jong Eun Park, M.D.1, Ji-Youn Kim, M.T.2, Sun Ae Yun, M.T.2, Myoung-Keun Lee, M.T.1, Hee Jae Huh, M.D.1,   Jong-Won Kim, M.D.1, and Chang-Seok Ki, M.D.1 Department of Laboratory Medicine and Genetics1, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; Center for Clinical  Medicine2, Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea Standardized cytomegalovirus (CMV) DNA quantification is important for managing CMV  disease.",OADS,/arxiv_data1/oa_pdf/b0/72/alm-36-603.PMC5011116.pdf
"Real-Q CMV assay in whole blood  604  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.603used (whole blood [WB] or plasma), the nucleic acid extraction  method, and test instrumentation [5].",Non-OADS,/arxiv_data1/oa_pdf/b0/72/alm-36-603.PMC5011116.pdf
Real-Q CMV assay in whole blood  http://dx.doi.org/10.3343/alm.2016.36.6.603 www.annlabmed.org  605ples had a variation of <1.0 log 10 copies/mL.,OADS,/arxiv_data1/oa_pdf/b0/72/alm-36-603.PMC5011116.pdf
Real-Q CMV assay in whole blood  606  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.603mated nucleic acid extraction.,Non-OADS,/arxiv_data1/oa_pdf/b0/72/alm-36-603.PMC5011116.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.6.607 www.annlabmed.org  607Ann Lab Med 2016;36:607-610 http://dx.doi.org/10.3343/alm.2016.36.6.607Letter to the Editor  Diagnostic Hematology Cell Population Data NE-SFL and MO-WX From  Sysmex XN-3000 Can Provide Additional Information  for Exclusion of Acute Promyelocytic Leukemia From  Other Acute Myeloid Leukemias: A Preliminary Study Sang Hyuk Park, M.D.1,2, Hyung-Hoi Kim, M.D.1,2, In-Suk Kim, M.D.3, Jongyoun Yi, M.D.1,2, Chulhun L. Chang, M.D.3,   and Eun Yup Lee, M.D.1,2 Department of Laboratory Medicine1, Pusan National University School of Medicine, Pusan National University Hospital, Busan; Biomedical Research  Institute2, Pusan National University Hospital, Busan; Department of Laboratory Medicine3, Pusan National University School of Medicine, Pusan National  University Yangsan Hospital, Yangsan, Korea Dear Editor, Acute promyelocytic leukemia (APL) is diagnosed by detection  of PML-RARA  using reverse transcriptase (RT)-PCR, but report - ing of results takes at least two days, and this situation is an ob - stacle for prompt management of patients.",Non-OADS,/arxiv_data1/oa_pdf/55/81/alm-36-607.PMC5011117.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/81/alm-36-607.PMC5011117.pdf
"NE-SFL and MO-WX in differentiating APL from AML 608  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.607ItemsResults, median (range)P valueAML (N = 21) APL (N = 10) Sex (M:F) 12: 9 5:5 0.709 Age (yr) 65.0 (19.0-83.0) 43.0 (26.0-68.0) 0.021 WBC ( × 109/L) 8.94 (0.45-204.0) 3.57 (0.44-59.86) 0.043 HGB ( × 10 g/L) 8.8 (6.6-11.7) 9.9 (7.8-11.6) 0.019 PLT ( × 109/L) 33.0 (8.0-202.0) 41.0 (13.0-377.0) 0.447 PB Blasts (%) 30.0 (10.0-80.0) 3.0 (1.0-20.0) < 0.001  PB Promyelocytes (%) 0.0 (0.0-2.0) 72.5 (50.0-90.0) < 0.001 FAB classification (M1: M2:  M3: M4: M5: M7)3:13:0:1:3:1 0:0:10:0:0:0 < 0.001 NRBC ( × 1012/L) 0.02 (0.00-2.65) 0.02 (0.00-0.23) 0.415 NRBC (%) 0.20 (0.00-11.40) 0.45 (0.00-2.30) 0.468 NEUT ( × 109/L) 2.43 (0.08-111.49) 1.43 (0.20-7.96) 0.473 LYMPH ( × 109/L) 3.05 (0.26-45.67) 0.91 (0.16-13.52) 0.056 MONO ( × 109/L) 3.16 (0.06-108.62) 0.40 (0.01-38.33) 0.051 EOSINO ( × 109/L) 0.01 (0.00-16.09) 0.01 (0.00-0.32) 0.628 BASO ( × 109/L) 0.03 (0.00-0.59) 0.01 (0.00-0.04) 0.082 NEUT (%) 21.30 (1.30-74.80) 51.75 (13.30-83.20) 0.076 LYMPH (%) 30.20 (3.40-91.90) 30.40 (12.60-58.50) 0.966 MONO (%) 27.30 (3.90-70.60) 15.20 (1.00-64.00) 0.099 EOSINO (%) 0.10 (0.00-7.90) 0.00 (0.00-4.30) 0.856 BASO (%) 0.30 (0.00-1.40) 0.15 (0.00-0.70) 0.354 IG ( × 109/L) 0.05 (0.00-34.52) 0.04 (0.00-0.24) 0.719 IG (%) 0.70 (0.00-16.90) 0.55 (0.00-25.00) 0.672 NE-SSC (ch) 148.8 (124.8-181.6) 141.0 (123.7-165.6) 0.375 NE-SFL (ch) 52.2 (42.9-89.7) 45.5 (40.7-52.4) 0.004 NE-FSC (ch) 74.8 (44.0-91.9) 74.0 (58.6-90.6) 0.673 LY-X (ch) 84.8 (74.3-97.7) 83.3 (78.5-117.9) 0.342 LY-Y (ch) 73.6 (62.9-99.6) 76.6 (64.3-108.9) 0.099 LY-Z (ch) 61.3 (54.6-65.6) 63.5 (59.8-70.7) 0.056 MO-X (ch) 120.7 (101.2-141.0) 123.2 (107.0-130.6) 0.460 MO-Y (ch) 119.3 (82.8-223.8) 113.5 (56.5-142.0) 0.291 MO-Z (ch) 65.4 (57.5-76.8) 68.6 (48.0-77.6) 0.486 NE-WX 439.0 (33.0-649.0) 362.0 (278.0-574.0) 0.499 NE-WY 998.0 (97.0-3,086.0) 780.0 (537.0-2,295.0) 0.139 NE-WZ 900.0 (91.0-1,285.0) 852.5 (685.0-1,382.0) 0.999ItemsResults, median (range)P valueAML (N = 21) APL (N = 10) LY-WX 501.0 (289.0-709.0) 502.5 (421.0-782.0) 0.833 LY-WY 915.0 (713.0-1,750.0) 767.5 (615.0-1,017.0) 0.008 LY-WZ 604.0 (503.0-845.0) 590.0 (517.0-840.0) 0.800 MO-WX 351.0 (67.0-514.0) 237.0 (56.0-375.0) 0.009 MO-WY 862.0 (33.0-1,313.0) 692.5 (32.0-904.0) 0.049 MO-WZ 675.0 (271.0-932.0) 713.5 (42.0-825.0) 0.899 WBC-N ( × 109/L) 8.94 (0.45-204.0) 3.57 (0.44-59.86) 0.053 WBC-D ( × 109/L) 8.78 (0.46-202.98) 3.40 (0.41-59.09) 0.053 TNC-N ( × 109/L ) 8.97 (0.46-204.63) 3.59 (0.45-60.09) 0.053 TNC-D ( × 109/L ) 8.81 (0.47-203.61) 3.42 (0.42-59.32) 0.053 Delta NEUT ( × 109/L) 1.26 (0.07-76.97) 1.41 (0.08-7.72) 0.512 Delta NEUT (%) 16.90 (1.30-74.30) 39.0 (5.40-82.60) 0.118 Delta LYMPH ( × 109/L) 3.00 (0.26-45.16) 0.91 (0.15-13.52) 0.051 Delta LYMPH (%) 26.90 (3.40-91.90) 29.80 (12.60-58.50) 0.866 HFLC ( × 109/L) 0.03 (0.00-0.76) 0.00 (0.00-0.01) 0.060 HFLC (%) 0.20 (0.00-7.60) 0.00 (0.00-2.30) 0.267 BASO-D ( × 109/L) 0.04 (0.00-1.69) 0.01 (0.00-0.06) 0.054 BASO-D (%) 0.40 (0.00-2.20) 0.05 (0.00-2.30) 0.165 RBC-He (pg) 31.50 (16.90-38.00) 30.05 (28.70-38.00) 0.767 Delta-He (pg) 2.30 (-6.90 to 5.80) 4.20 (-0.20 to 6.40) 0.113 RET-Y (ch) 179.2 (110.7-195.2) 184.6 (168.0-195.8) 0.272 RET-RBC-Y (ch) 174.5 (112.6-184.8) 169.5 (157.7-183.1) 0.499 IRF-Y (ch) 171.3 (145.6-196.6) 181.5 (160.4-199.3) 0.183 RPI 0.40 (0.10-2.40) 0.45 (0.00-2.40) 0.881 RET-UPP 2.00 (0.00-81.00) 4.00 (0.00-101.00) 0.913 RET_TNC 105.0 (4.0-1,883.0) 25.5 (9.0-470.0) 0.070 HYPO-He (%) 0.70 (0.10-47.90) 0.55 (0.20-3.70) 0.983 HYPER-He (%) 0.40 (0.10-3.10) 0.40 (0.20-0.90) 0.651 FRC ( × 1012/L) 0.014 (0.000-0.180) 0.011 (0.000-0.090) 0.526 FRC (%) 0.64 (0.00-5.07) 0.41 (0.01-2.67) 0.597 IPF ( × 109/L) 2.90 (0.10-15.50) 1.20 (0.50-13.90) 0.190 H-IPF 1.60 (0.30-34.10) 0.90 (0.20-9.10) 0.197 MicroR (%) 2.50 (0.40-48.10) 2.90 (0.70-5.90) 0.597 MacroR (%) 5.40 (2.50-21.10) 3.45 (2.60-10.40) 0.066Table 1.",OADS,/arxiv_data1/oa_pdf/55/81/alm-36-607.PMC5011117.pdf
NE-SFL and MO-WX in differentiating APL from AML http://dx.doi.org/10.3343/alm.2016.36.6.607 www.annlabmed.org  609patients and other AML patients.,Non-OADS,/arxiv_data1/oa_pdf/55/81/alm-36-607.PMC5011117.pdf
"NE-SFL and MO-WX in differentiating APL from AML 610  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.607trast, MO-WX showed higher specificity (90.5%), PPV (77.8%),  and accuracy (83.9%) with the cutoff ≤260.0.",OADS,/arxiv_data1/oa_pdf/55/81/alm-36-607.PMC5011117.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.6.611 www.annlabmed.org  611Ann Lab Med 2016;36:611-613 http://dx.doi.org/10.3343/alm.2016.36.6.611Letter to the Editor  Clinical Microbiology A Novel Integron Gene Cassette Harboring VIM-38  Metallo-β-lactamase in a Clinical Pseudomonas   aeruginosa  Isolate  Fatih Şaban Beri ş, Ph.D.1, Esma Akyildiz, M.S.1, Azer Özad Düzgün, Ph.D.2, Umut Safiye Say Co şkun, M.D.3,   Cemal Sandalli, Ph.D.1, and Ayşegül Çopur Çiçek, M.D.4 Department of Biology1, Faculty of Arts & Sciences, Recep Tayyip Erdo ğan University, Rize; Department of Genetics and Bioengineering2, Faculty of  Engineering and Natural Sciences, Gümü şhane University, Gümü şhane; Department of Medical Microbiology3, Faculty of Medicine, Gaziosmanpa şa  University, Tokat; Department of Medical Microbiology, Faculty of Medicine, Recep Tayyip Erdogan University4, Rize, Turkey Dear Editor, Multidrug resistance of Pseudomonas aeruginosa  has been at - tributed to both intrinsic and acquired antibiotic-resistance  mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/d9/4a/alm-36-611.PMC5011118.pdf
Forty-six variants of VIM enzymes have been  identified to date (http://www.lahey.org/Studies/other.asp).,Non-OADS,/arxiv_data1/oa_pdf/d9/4a/alm-36-611.PMC5011118.pdf
Sequencing results were analyzed by using the BLAST align - ment search tool (http://www.ncbi.nlm.nih.gov/BLAST) and the  multiple sequence alignment program CLUSTALW2 (http://www.,OADS,/arxiv_data1/oa_pdf/d9/4a/alm-36-611.PMC5011118.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/4a/alm-36-611.PMC5011118.pdf
New VIM-38 MBL-harboring P. aeruginosa  isolate 612  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.611ebi.ac.uk/Tools/msa/clustalw2/).,OADS,/arxiv_data1/oa_pdf/d9/4a/alm-36-611.PMC5011118.pdf
New VIM-38 MBL-harboring P. aeruginosa  isolate http://dx.doi.org/10.3343/alm.2016.36.6.611 www.annlabmed.org  613Acknowledgments This work was partially supported by Recep Tayyip Erdogan  University Research Fund Grants (BAP-2014.102.03.03.,Non-OADS,/arxiv_data1/oa_pdf/d9/4a/alm-36-611.PMC5011118.pdf
"ISSN 2234-3806 • eISSN 2234-3814  614  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.614Ann Lab Med 2016;36:614-616 http://dx.doi.org/10.3343/alm.2016.36.6.614Letter to the Editor  Clinical Microbiology A Case of Flavobacterium ceti  Meningitis Seung-Kyun Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/d8/fe/alm-36-614.PMC5011119.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/fe/alm-36-614.PMC5011119.pdf
"Flavobacterium ceti  meningitis http://dx.doi.org/10.3343/alm.2016.36.6.614 www.annlabmed.org  61516S rRNA gene was obtained, and compared with sequence  databases in the GenBank (http://www.ncbi.nlm.nih.gov/blast)  and the EzTaxon database (http://www.ezbiocloud.net/).",OADS,/arxiv_data1/oa_pdf/d8/fe/alm-36-614.PMC5011119.pdf
Flavobacterium ceti  meningitis 616  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.614REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d8/fe/alm-36-614.PMC5011119.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2016.36.6.617 www.annlabmed.org  617Ann Lab Med 2016;36:617-619 http://dx.doi.org/10.3343/alm.2016.36.6.617Letter to the Editor  Clinical Microbiology Identification of Pasteurella canis  in a Soft Tissue  Infection Caused by a Dog Bite: The First Report in  Korea Bongyoung Kim, M.D.1, Hyunjoo Pai, M.D.1, Kwang-hyun Lee, M.D.2, and Yangsoon Lee, M.D.3 Departments of Internal Medicine1, Orthopediatrics2, and Laboratory Medicine3, Hanyang University of College of Medicine, Seoul, Korea Dear Editor, Pasteurella canis  is a small, gram-negative coccobacillus that is  a part of the normal flora of healthy domestic animals, especially  dogs [1].",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/alm-36-617.PMC5011120.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/alm-36-617.PMC5011120.pdf
Pasteurella canis : first report in Korea 618  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.617parts of the 16S rRNA gene.,OADS,/arxiv_data1/oa_pdf/ab/b2/alm-36-617.PMC5011120.pdf
Pasteurella canis : first report in Korea http://dx.doi.org/10.3343/alm.2016.36.6.617 www.annlabmed.org  619REFERENCES 1.,OADS,/arxiv_data1/oa_pdf/ab/b2/alm-36-617.PMC5011120.pdf
"ISSN 2234-3806 • eISSN 2234-3814  620  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.620Ann Lab Med 2016;36:620-622 http://dx.doi.org/10.3343/alm.2016.36.6.620Letter to the Editor  Transfusion Medicine Identification of the ABO*cis-AB04  Allele With a  Unique Substitution C796A: The First Case in Korea  Jung Yoon, M.D.1, Hee-Jeong Youk, M.D.1, Jung Hee Chang, M.T.2, Mi-Ae Jang, M.D.3, Ji Ho Choi, M.D.4,   Myung-Hyun Nam, M.D.1, Ji Seon Choi, M.D.5, and Chae Seung Lim, M.D.1 Department of Laboratory Medicine1, Korea University College of Medicine, Seoul; Department of Laboratory Medicine2, Korea University Ansan Hospital,  Ansan; Department of Laboratory Medicine and Genetics3, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine,  Bucheon; Department of Otorhinolaryngology-Head and Neck Surgery4, Korea University College of Medicine, Seoul; Department of Laboratory Medicine5,  International St. Mary’s Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea Dear Editor, Herein, we describe a family carrying the cis-AB04  allele  through two generations; this is the first report of such a case in  the Korean population.",Non-OADS,/arxiv_data1/oa_pdf/48/1f/alm-36-620.PMC5011121.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/1f/alm-36-620.PMC5011121.pdf
A case of cis-AB04  allele in Korea  http://dx.doi.org/10.3343/alm.2016.36.6.620 www.annlabmed.org  621striction enzymes KpnI and AluI and fractionated by electropho - retic separation on agarose gels.,Non-OADS,/arxiv_data1/oa_pdf/48/1f/alm-36-620.PMC5011121.pdf
"A case of cis-AB04  allele in Korea  622  www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.6.620A101  allele, and B101  allele yielded phenotypes A 2B, AB, and  A2B, respectively.",Non-OADS,/arxiv_data1/oa_pdf/48/1f/alm-36-620.PMC5011121.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/4b/main.PMC5011123.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/4b/main.PMC5011123.pdf
http://dx.doi.org/10.1016/j.shaw.2016.01.001Safety and Health at Work 7 (2016) 218 e224,Non-OADS,/arxiv_data1/oa_pdf/bc/4b/main.PMC5011123.pdf
2015 [cited 2015 Jul 23].Available from: http://www.osha.europa.eu .,Non-OADS,/arxiv_data1/oa_pdf/bc/4b/main.PMC5011123.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/18/main.PMC5011124.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/18/main.PMC5011124.pdf
http://dx.doi.org/10.1016/j.shaw.2016.01.005Safety and Health at Work 7 (2016) 237 e243,Non-OADS,/arxiv_data1/oa_pdf/a5/18/main.PMC5011124.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/8b/main.PMC5011125.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/8b/main.PMC5011125.pdf
http://dx.doi.org/10.1016/j.shaw.2015.12.002Safety and Health at Work 7 (2016) 185 e193,Non-OADS,/arxiv_data1/oa_pdf/d9/8b/main.PMC5011125.pdf
"A more recent evaluation of the reliability of the Advanced REACH Tool ( https://www.advancedreachtool.com/ ), a more so- phisticated exposure assessment model [9], showed similar results.",Non-OADS,/arxiv_data1/oa_pdf/d9/8b/main.PMC5011125.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/98/main.PMC5011156.pdf
http://dx.doi.org/10.1016/j.idcr.2016.08.006 2214-2509/ ã  2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/fb/98/main.PMC5011156.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  6  (2016)  14–16 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locat  e/idcr,Non-OADS,/arxiv_data1/oa_pdf/fb/98/main.PMC5011156.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/31/main.PMC5011159.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.08.004 2213-0071/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/a7/31/main.PMC5011159.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 94 e97,Non-OADS,/arxiv_data1/oa_pdf/a7/31/main.PMC5011159.pdf
"a cautionary tale, BMJ Case Rep. (2013), http://dx.doi.org/10.1136/bcr-2013-200600 .",Non-OADS,/arxiv_data1/oa_pdf/a7/31/main.PMC5011159.pdf
"[10] N. Kakuoros, R. Bastiaenen, A. Kourliouros, L. Anderson, Churg-Strauss pre- senting as acute coronary syndrome: sometimes it's zebras, BMJ Case Rep. (2011), http://dx.doi.org/10.1136/bcr.01.2011.3703 .C.L.",Non-OADS,/arxiv_data1/oa_pdf/a7/31/main.PMC5011159.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/44/main.PMC5011162.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.08.002 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/e1/44/main.PMC5011162.pdf
[3]http://www.care-statement.org/ .,Non-OADS,/arxiv_data1/oa_pdf/e1/44/main.PMC5011162.pdf
http://dx.doi.org/10.1016/j.idcr.2016.07.014 2214-2509/Crown  Copyright  ã  2016  Published  by  Elsevier  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f0/26/main.PMC5011163.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).IDCases  6  (2016)  13 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/f0/26/main.PMC5011163.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/31/main.PMC5011165.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com /locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2016.08.001 2213-2244/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/31/main.PMC5011165.pdf
"International Species Information System, 2016. http://www2.isis.org/AboutUs/ Pages/Find-animals.aspx .",OADS,/arxiv_data1/oa_pdf/19/31/main.PMC5011165.pdf
http://www.smn.gov.ar/serviciosclimaticos/?,Non-OADS,/arxiv_data1/oa_pdf/19/31/main.PMC5011165.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/7a/2e/main.PMC5011166.pdf
E-mail address: sean.clouston@stonybrookmedicine.edu http://dx.doi.org/10.1016/j.dadm.2016.08.001 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/2e/main.PMC5011166.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/2e/main.PMC5011166.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.08.001 .,OADS,/arxiv_data1/oa_pdf/7a/2e/main.PMC5011166.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/d5/main.PMC5011167.pdf
"For example, in- traperitoneal injection of GSH to apolipoprotein E-de ﬁcient miceContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.08.012 2213-2317/ &2016 The Authors.",OADS,/arxiv_data1/oa_pdf/77/d5/main.PMC5011167.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: AAP, ascorbic acid phosphate; BSO, buthionine sulfoximine; BPDS, bathophenanthrolinedisulfonic acid; DCFH-DA, 2 ′,7′-dichloro ﬂuorescein diacetate; GCL, glutamate-cysteine ligase; GCLC, catalytic subunit of glutamate-cysteine li-gase; GCLM, modi ﬁer subunit of glutamate-cysteine ligase; GSH, glutathione; GSSG, glutathione disul ﬁde; HAEC, human aortic endothelial cells; IAA, iodoacetic acid; LC-MS, liquid chromatography-mass spectrometry; LPS, lipopolysaccharide; MRM, multiple reaction monitoring; MRP1, multidrug resistance protein 1; NO, nitric oxide; Nrf2, nuclear factor erythroid 2-related factor 2; p38, p38 mitogen-activatedprotein kinase; ROS, reactive oxygen species nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/77/d5/main.PMC5011167.pdf
"(2016) , http://dx.doi.org/10.1016/j.redox.2016.06.006 .",OADS,/arxiv_data1/oa_pdf/77/d5/main.PMC5011167.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/4d/main.PMC5011168.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/nuccore/JSUQ000000002.,OADS,/arxiv_data1/oa_pdf/47/4d/main.PMC5011168.pdf
http://dx.doi.org/10.1016/j.gdata.2016.08.015 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/47/4d/main.PMC5011168.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/4d/main.PMC5011168.pdf
The predicted 16S rRNA was analyzed to identify its phylogenetic af ﬁliation using the EzTaxon server (http://www.ezbiocloud.net/eztaxon )[13].,OADS,/arxiv_data1/oa_pdf/47/4d/main.PMC5011168.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d8/7c/main.PMC5011169.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d8/7c/main.PMC5011169.pdf
http://dx.doi.org/10.1016/j.eucr.2016.07.008Urology Case Reports 9 (2016) 12 e14,Non-OADS,/arxiv_data1/oa_pdf/d8/7c/main.PMC5011169.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Frontotemporal dementiaArterial spin labelingCerebral blood ﬂow PresymptomaticNeuroImage: Clinical 12 (2016) 460 –465 Abbreviations: FTD, frontotemporal dementia; MAPT ,microtubule-associated protein tau ;GRN,progranulin ; ASL, arterial spin labeling; CBF, cerebral blood ﬂow; FDG-PET, positron emission tomography with 18F- ﬂuorodeoxyglucose; MMSE, Mini-Mental State Examination; BDI-II, Beck Depression inventory II (BDI-II); RAVLT, Rey Auditory Verbal Learning Test; VAT, Visual Association Test; TMT, Trailmaking Test; WCST, Wisconsin Card Sorting Test; LDST, Letter Digit Substitution Test; BNT, Boston Naming Test; SAT, Semantic Association Test;AD, Alzheimer's disease.",Non-OADS,/arxiv_data1/oa_pdf/fd/6b/main.PMC5011170.pdf
http://dx.doi.org/10.1016/j.nicl.2016.08.001 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/6b/main.PMC5011170.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/6b/main.PMC5011170.pdf
This  is  an  open  access  article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/fc/main.PMC5011171.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.08.025 2210-2612/© 2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/9b/fc/main.PMC5011171.pdf
"(2013),  http://dx.doi.org/10.1186/2045-3329-3-16 .",Non-OADS,/arxiv_data1/oa_pdf/9b/fc/main.PMC5011171.pdf
"(2012), http://dx.doi.org/10.1186/2045-3329-2-22 .",Non-OADS,/arxiv_data1/oa_pdf/9b/fc/main.PMC5011171.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/1e/main.PMC5011172.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/1e/main.PMC5011172.pdf
http://dx.doi.org/10.1016/j.eucr.2016.07.009Urology Case Reports 9 (2016) 9 e11,Non-OADS,/arxiv_data1/oa_pdf/33/1e/main.PMC5011172.pdf
2015;65(1): 5e29.http://dx.doi.org/10.3322/caac.21254 .2.,Non-OADS,/arxiv_data1/oa_pdf/33/1e/main.PMC5011172.pdf
http://dx.doi.org/10.1056/NEJMcp065470 .,OADS,/arxiv_data1/oa_pdf/33/1e/main.PMC5011172.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/a9/main.PMC5011173.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.06.010 360,OADS,/arxiv_data1/oa_pdf/ea/a9/main.PMC5011173.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6b/8a/main.PMC5011174.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.02.002 354,OADS,/arxiv_data1/oa_pdf/6b/8a/main.PMC5011174.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/92/main.PMC5011176.pdf
The  exposure  of  the  entire  mitral  valvular  ring  and http://dx.doi.org/10.1016/j.ijscr.2016.08.024 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/15/92/main.PMC5011176.pdf
"63  (12)  (2014)  1159–1168,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/92/main.PMC5011176.pdf
"2002  (October  (347))  (2002)  1426–1432,  http://dx.doi.org/10.1056/ NEJMra020228 .",Non-OADS,/arxiv_data1/oa_pdf/15/92/main.PMC5011176.pdf
"149  (35)  (2016)  1665–1667,  http://dx.doi.org/10.1556/OH.2008.28389 .",Non-OADS,/arxiv_data1/oa_pdf/15/92/main.PMC5011176.pdf
http://dx.doi.org/10.1016/j.nicl.2016.08.0082213-1582/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/ae/92/main.PMC5011177.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/92/main.PMC5011177.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Comparative transcriptome analysisEphedra sinica High-throughput mRNA sequencing RNA-Seq 1.,Non-OADS,/arxiv_data1/oa_pdf/0b/52/main.PMC5011178.pdf
http://dx.doi.org/10.1016/j.gdata.2016.08.003 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/52/main.PMC5011178.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/52/main.PMC5011178.pdf
"A blastx search was performed against the public protein database Swiss-Prot, which consists of manually annotat- ed and reviewed proteins and amino acid sequences in the UniProt Knowledgebase (UniProtKB; http://www.uniprot.org/uniprot/ ).",OADS,/arxiv_data1/oa_pdf/0b/52/main.PMC5011178.pdf
"Mitochondrial DNA (2015), http://dx.doi.org/10.3109/19401736.2015.",Non-OADS,/arxiv_data1/oa_pdf/0b/52/main.PMC5011178.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/c3/main.PMC5011179.pdf
http://dx.doi.org/10.1016/j.nicl.2016.08.019 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/08/c3/main.PMC5011179.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/c3/main.PMC5011179.pdf
"Moreover, frontostriatal cir- cuitry, as well as parietal, insula and cerebellar activation is associatedwith WM function, as demonstrated in a term-based search ( “working memory” ) of the ‘neurosynth ’database ( http://www.neurosynth.org/ analyses/terms/ ), yielding over 900 fMRI studies of WM, which addi- tionally aided the formulation of our hypotheses.",OADS,/arxiv_data1/oa_pdf/08/c3/main.PMC5011179.pdf
Copies of the software are available upon request (http://www.drsamanthabrooks.com ).,Non-OADS,/arxiv_data1/oa_pdf/08/c3/main.PMC5011179.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Fruit and vegetablesIntention to change Community Kitchens Peru 1.,Non-OADS,/arxiv_data1/oa_pdf/97/80/main.PMC5011180.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.08.016 2211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/97/80/main.PMC5011180.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/80/main.PMC5011180.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/97/80/main.PMC5011180.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/ca/main.PMC5011181.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/ca/main.PMC5011181.pdf
http://dx.doi.org/10.1016/j.eucr.2016.07.012Urology Case Reports 9 (2016) 15 e17,Non-OADS,/arxiv_data1/oa_pdf/0e/ca/main.PMC5011181.pdf
Available from: http://www.fda.gov/Drugs/DrugSafety/ucm276119.,Non-OADS,/arxiv_data1/oa_pdf/0e/ca/main.PMC5011181.pdf
Available from: https://www.auanet.org/university/core_ topic.cfm?coreid ¼87.,Non-OADS,/arxiv_data1/oa_pdf/0e/ca/main.PMC5011181.pdf
Available from: http://www.ashp.org/ menu/DrugShortages/Current Shortages/Bulletin.aspx?id ¼861.,Non-OADS,/arxiv_data1/oa_pdf/0e/ca/main.PMC5011181.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/c9/main.PMC5011182.pdf
With  worsening  respiratory  failure http://dx.doi.org/10.1016/j.ijscr.2016.08.007 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/82/c9/main.PMC5011182.pdf
This  is  an  open access article under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/c6/main.PMC5011183.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.08.011 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/37/c6/main.PMC5011183.pdf
"39  (July  (7))  (2014) 1384–1394,  http://dx.doi.org/10.1016/j.jhsa.2014.02.024 .",OADS,/arxiv_data1/oa_pdf/37/c6/main.PMC5011183.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/6f/main.PMC5011184.pdf
250Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.08.015 2213-2317/ &2016 Published by Elsevier B.V.,OADS,/arxiv_data1/oa_pdf/51/6f/main.PMC5011184.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: AAA, abdominal aortic aneurysms; AGEs, advanced glycation end products; AKT, protein kinase B; Ang II, angiotensin II; CREB, cyclic AMP response ele ment – binding protein; eNOS, endothelial NO synthase; ERK, extracellular-regulated kinase; GPx, glutathione peroxidase; JNK, c-Jun N-terminal kinase s; MAPK, mitogen-activated protein kinases; MCP-1, monocyte chemoattractant protein-1; mmLDL, minimally oxidized low-density lipoprotein; NO, nitric oxide; NOX, NADPH oxi dases; Nrf2, nuclear factor erythroid 2-related factor 2; O-GlcNAcylation, O-linked β-N-acetylglucosamine modi ﬁcation; oxLDL, oxidized low-density lipoprotein; PASMC, pulmonary arterial smooth muscle cells; Prx, peroxiredoxin; PTEN, phosphatase and tensin homolog; ROS, reactive oxygen species; SOD, superoxide dismutases; PDGF, pl atelet-derived growth factor; PKC, protein kinase C; PI3K, phosphatidylinositol-4,5-bisphosphate 3-kinase; RANKL, receptor activator of nuclear factor kappa-B ligan d; TNF- α, tumor necrosis factor- alpha; TRAP, tartrate-resistant acid phosphatase; VEGF, vascular endothelial growth factor; VSMC, vascular smooth muscle cells nCorrespondence to: Dept.",Non-OADS,/arxiv_data1/oa_pdf/51/6f/main.PMC5011184.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/77/main.PMC5011185.pdf
"LDL receptor deﬁcient mice exhibit hypercholesterolemia with elevated cho- lesterol levels in pancreatic islets, which is associated with β-cellContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.08.007 2213-2317/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/bb/77/main.PMC5011185.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/77/main.PMC5011185.pdf
"The mean ﬂuorescence intensity was obtained using ImageJ (NIH Image, http://www.scioncorp.com , Scion Corporation, USA).",OADS,/arxiv_data1/oa_pdf/bb/77/main.PMC5011185.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2016.08.007 .,OADS,/arxiv_data1/oa_pdf/bb/77/main.PMC5011185.pdf
"129 (1) (2014)107 –119, http://dx.doi.org/10.1111/jnc.12610 , Epub 2013 Dec 2.",Non-OADS,/arxiv_data1/oa_pdf/bb/77/main.PMC5011185.pdf
"2013 (2013) 549627, http://dx.doi.org/10.1155/ 2013/549627 , Epub 2013 May 27.",Non-OADS,/arxiv_data1/oa_pdf/bb/77/main.PMC5011185.pdf
Clinical Medicine Insights: Cardiology 2014 (accepted 10th  March 2014)  [16] http://www.ncats.nih.,Non-OADS,/arxiv_data1/oa_pdf/9b/52/CCR-12-216.PMC5011189.pdf
[19] http://www.ich.org/pr oducts/guidelines.html  ?,Non-OADS,/arxiv_data1/oa_pdf/9b/52/CCR-12-216.PMC5011189.pdf
[146]  http://www.pbac.pbs.,Non-OADS,/arxiv_data1/oa_pdf/9b/52/CCR-12-216.PMC5011189.pdf
Date accessed  [147]  https://www.nhmrc.,Non-OADS,/arxiv_data1/oa_pdf/9b/52/CCR-12-216.PMC5011189.pdf
"[46] http://www.alere.com/ww/en/pr oduct-details/alere-triage-system- tests.html  [47] Glassford NJ, Eastwood GM, Young H, Peck L, Schneider AG,  Bellomo R. Rationalizing the Use of NGAL in the Intensive Care  Unit.",Non-OADS,/arxiv_data1/oa_pdf/dd/0f/CCR-12-186.PMC5011190.pdf
[34] http://www.creativespirits.info/aboriginalculture/language/   [35] Maher P. A review of ‘traditional’ aboriginal health beliefs.,Non-OADS,/arxiv_data1/oa_pdf/51/c5/CCR-12-166.PMC5011191.pdf
"Retrieved  [access date] from http://www.healthinfonet.ecu.edu.au/chronic- conditions/cvd/reviews/our-review-rhd  [85] Lawrence JG, Carapetis JR, Griffiths K, Edwards K, Condon JR.",Non-OADS,/arxiv_data1/oa_pdf/51/c5/CCR-12-166.PMC5011191.pdf
[127]  http://www.improvingchroniccare.org/index.,Non-OADS,/arxiv_data1/oa_pdf/51/c5/CCR-12-166.PMC5011191.pdf
"Canberra: Australian Institute of Health and Welfare, 2004.  http://www.aihw.",Non-OADS,/arxiv_data1/oa_pdf/51/c5/CCR-12-166.PMC5011191.pdf
"However, the absence of a signal from the recently completed Sitagliptin Cardiovascular Outcome Study (TECOS; http://www.clinicaltrials.gov; identifier, NCT00790205), study potentially allays some of these con- cerns.",Non-OADS,/arxiv_data1/oa_pdf/65/93/CCR-12-249.PMC5011193.pdf
"Byung Chul Chang and Bum Koo Cho Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea.Yonsei Med J 2016 Nov;57(6):1301-1304 http://dx.doi.org/10.3349/ymj.2016.57.6.1301Editorial pISSN: 0513-5796 · eISSN: 1976-2437 Received:  June 21, 2016 Corresponding author:  Dr. Byung Chul Chang, Department of Thoracic and Car - diovascular Surgery, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seo - daemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/42/5c/ymj-57-1301.PMC5011258.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Editorial Series: Frontiers of Medicine in Korea Fig.",Non-OADS,/arxiv_data1/oa_pdf/42/5c/ymj-57-1301.PMC5011258.pdf
1302 The First and Successful Heart Surgeries in Korea http://dx.doi.org/10.3349/ymj.2016.57.6.1301related diagnosis and treatment in clinical and academic pa - pers.,Non-OADS,/arxiv_data1/oa_pdf/42/5c/ymj-57-1301.PMC5011258.pdf
1303Byung Chul Chang and Bum Koo Cho http://dx.doi.org/10.3349/ymj.2016.57.6.1301tinued to perform basic experiments (Fig.,Non-OADS,/arxiv_data1/oa_pdf/42/5c/ymj-57-1301.PMC5011258.pdf
1304 The First and Successful Heart Surgeries in Korea http://dx.doi.org/10.3349/ymj.2016.57.6.1301He spent his remaining days in Hawaii after he resigned  from Yonsei University in July 1989.,Non-OADS,/arxiv_data1/oa_pdf/42/5c/ymj-57-1301.PMC5011258.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.The authors report on the association of non-dipole patterns  at T-peak in resting magnetocardiography (MCG) and major  adverse cardiac event (MACE), including composite of death  from any cause, reinfarction, and percutaneous coronary in - tervention, during the follow-up period (mean 6.1 years) in 124  patients with acute coronary syndromes (ACS).1 In multivariate  analysis, patients with non-dipole patterns at T-peak showed  increased hazard ratios for MACE ( p=0.02) and lower cumula - tive MACE-free survival than those with dipole patterns ( p=  0.02).",Non-OADS,/arxiv_data1/oa_pdf/0a/ef/ymj-57-1305.PMC5011259.pdf
Multicenter studies to determine the use and demon - strate the role of MCG in the context of ACS diagnosis are war - ranted.Yonsei Med J 2016 Nov;57(6):1305-1306 http://dx.doi.org/10.3349/ymj.2016.57.6.1305,Non-OADS,/arxiv_data1/oa_pdf/0a/ef/ymj-57-1305.PMC5011259.pdf
1306Magnetocardiography in Patients with Acute Myocardial Infarction http://dx.doi.org/10.3349/ymj.2016.57.6.1305REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0a/ef/ymj-57-1305.PMC5011259.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Nov;57(6):1307-1311 http://dx.doi.org/10.3349/ymj.2016.57.6.1307",Non-OADS,/arxiv_data1/oa_pdf/64/a2/ymj-57-1307.PMC5011260.pdf
"1308Target Blood Pressure in Diabetes http://dx.doi.org/10.3349/ymj.2016.57.6.1307betics, compared to non-diabetics, was increased by 1.89 to 4.40  for varying systolic blood pressure (SBP) levels.4 In a subgroup  analysis of the ONgoing Telmisartan Alone and in combination  with Ramipril Global Endpoint Trial (ONTARGET) study, dia - betic patients had a significantly higher risk for primary end - point [hazard ratio (HR): 1.48, 95% confidence interval (CI):  1.38–1.57], cardiovascular death (HR: 1.56, 95% CI: 1.42–1.71),  myocardial infarction (HR: 1.30, 95% CI: 1.17–1.46), stroke (HR:  1.39, 95% CI: 1.23–1.56), and congestive heart failure hospital - ization (HR: 2.06, 95% CI: 1.82–2.32).5 As such, adequate treat - ment of hypertension is essential to reduce the high burden of  cardiovascular disease and end-stage renal disease in diabet - ics.",Non-OADS,/arxiv_data1/oa_pdf/64/a2/ymj-57-1307.PMC5011260.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1307which showed that, in diabetic patients, the risk of stroke con - tinued to decrease to an achieved SBP value of 115 mm Hg  with no evidence of a J curve.5 Achieving SBP below 130 mm Hg, instead of 140 mm Hg, was associated with a 31.4% reduc - tion in stroke, which is in line with the results from the AC - CORD trial.",Non-OADS,/arxiv_data1/oa_pdf/64/a2/ymj-57-1307.PMC5011260.pdf
"1310Target Blood Pressure in Diabetes http://dx.doi.org/10.3349/ymj.2016.57.6.1307involving 37376 participants with either diabetes mellitus or  impaired fasting glucose, intensive SBP control (≤130 mm Hg)  was associated with a greater reduction in stroke, but not in  other major cardiovascular events.16 Also, in the normotensive  ABCD study, intensive BP lowering (mean BP: 128±0.8/75±0.3  mm Hg) was associated with a 69% reduction in stroke ( p val- ue=0.03).12 Although only a few randomized clinical outcome  studies have been performed in the Asian region, some do sup - port the application of a lower target SBP in diabetics.",Non-OADS,/arxiv_data1/oa_pdf/64/a2/ymj-57-1307.PMC5011260.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.13075.,Non-OADS,/arxiv_data1/oa_pdf/64/a2/ymj-57-1307.PMC5011260.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Nov;57(6):1312-1323 http://dx.doi.org/10.3349/ymj.2016.57.6.1312",Non-OADS,/arxiv_data1/oa_pdf/96/af/ymj-57-1312.PMC5011261.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1312metabolism and growth.,OADS,/arxiv_data1/oa_pdf/96/af/ymj-57-1312.PMC5011261.pdf
1314PKM2 in Human NSCLC Cell Lines Treatment http://dx.doi.org/10.3349/ymj.2016.57.6.1312Western blotting The levels of PKM2 protein expression in A549 and H460 cells  were examined with Western blotting (WB) analysis using a  PKM2-specific antibody at 48 h after transfection.,Non-OADS,/arxiv_data1/oa_pdf/96/af/ymj-57-1312.PMC5011261.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1312(p<0.001 vs. control) with PKM2 shRNA-946 48 h after trans - fection in A549 and H460 cells, respectively (Fig.",OADS,/arxiv_data1/oa_pdf/96/af/ymj-57-1312.PMC5011261.pdf
1316PKM2 in Human NSCLC Cell Lines Treatment http://dx.doi.org/10.3349/ymj.2016.57.6.1312ously demonstrating that PKM2 shRNA-946 was highly effi - cient for PKM2 gene knockdown in A549 and H460 cells in vitro .,Non-OADS,/arxiv_data1/oa_pdf/96/af/ymj-57-1312.PMC5011261.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1312and 72 h after incubation, cell viability in the PKM2 shRNA  group were dramatically lower than that in control group.",OADS,/arxiv_data1/oa_pdf/96/af/ymj-57-1312.PMC5011261.pdf
"1318PKM2 in Human NSCLC Cell Lines Treatment http://dx.doi.org/10.3349/ymj.2016.57.6.1312When treated with docetaxel (ranging from 0 to 25 nM for up  to 72 hrs), the viability of PKM2 rescue cells was dramatically  higher than that of knockdown cells, and was not also statisti - cally different from that of untrasfected cells at any time point.",Non-OADS,/arxiv_data1/oa_pdf/96/af/ymj-57-1312.PMC5011261.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1312p21 statistically.,OADS,/arxiv_data1/oa_pdf/96/af/ymj-57-1312.PMC5011261.pdf
1320PKM2 in Human NSCLC Cell Lines Treatment http://dx.doi.org/10.3349/ymj.2016.57.6.1312phase and docetaxel then made more cells to be blocked at G2/ M phase followed by apoptosis.,Non-OADS,/arxiv_data1/oa_pdf/96/af/ymj-57-1312.PMC5011261.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1312Based on these reports described above, we planned to study  the potential of PKM2 in influencing antitumor activity of  docetaxel in vitro  in NSCLC cell lines A549 and H460.",Non-OADS,/arxiv_data1/oa_pdf/96/af/ymj-57-1312.PMC5011261.pdf
"1322PKM2 in Human NSCLC Cell Lines Treatment http://dx.doi.org/10.3349/ymj.2016.57.6.1312transition due to activation of spindle assembly checkpoint,  subsequently resulting in apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/96/af/ymj-57-1312.PMC5011261.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1312of 274 non-small cell lung cancer patients in China.,Non-OADS,/arxiv_data1/oa_pdf/96/af/ymj-57-1312.PMC5011261.pdf
Available at: http://globocan.iarc.fr/De - fault.aspx.,Non-OADS,/arxiv_data1/oa_pdf/96/af/ymj-57-1312.PMC5011261.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Nov;57(6):1324-1328 http://dx.doi.org/10.3349/ymj.2016.57.6.1324",Non-OADS,/arxiv_data1/oa_pdf/f2/8c/ymj-57-1324.PMC5011262.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1324the effect of ENE on survival.,Non-OADS,/arxiv_data1/oa_pdf/f2/8c/ymj-57-1324.PMC5011262.pdf
"Survival rates cal - culated from Kaplan-Meier curves were read using Engauge  Digitizer version 3.0 (http://digitizer.sourceforge.net) to re - construct the HR estimate and its variance, assuming that pa - tients were censored at a constant rate during follow-up.",OADS,/arxiv_data1/oa_pdf/f2/8c/ymj-57-1324.PMC5011262.pdf
"1326ENE in PTC http://dx.doi.org/10.3349/ymj.2016.57.6.1324blinding of outcome assessment, incomplete outcome data,  and selective reporting.",Non-OADS,/arxiv_data1/oa_pdf/f2/8c/ymj-57-1324.PMC5011262.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1324with recurrent nodal disease.,Non-OADS,/arxiv_data1/oa_pdf/f2/8c/ymj-57-1324.PMC5011262.pdf
1328ENE in PTC http://dx.doi.org/10.3349/ymj.2016.57.6.1324ACKNOWLEDGEMENTS This work was supported by Dong-A University research fund.,OADS,/arxiv_data1/oa_pdf/f2/8c/ymj-57-1324.PMC5011262.pdf
"Key Words:   Peroxynitrite, arginase inhibition, endothelial nitric oxide synthase phosphorylation, endothelial dysfunction, nitric oxide,    L-arginineYonsei Med J 2016 Nov;57(6):1329-1338 http://dx.doi.org/10.3349/ymj.2016.57.6.1329Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  December 11, 2015   Revised:  April 1, 2016   Accepted:  April 7, 2016 Co-corresponding authors:  Dr. Sungwoo Ryoo, Department of Biological Sciences, Kangwon National University, 1 Gangwondaehak-gil, Chuncheon 24341, Korea.",Non-OADS,/arxiv_data1/oa_pdf/61/93/ymj-57-1329.PMC5011263.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/93/ymj-57-1329.PMC5011263.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1329 1330eNOS Phosphorylation by Arginase Inhibition INTRODUCTION The endothelium plays a pivotal role in the maintenance of vas - cular homeostasis by modulating vascular tone, leukocyte ad - hesion, platelet aggregation, smooth muscle cell proliferation,  and migration.",Non-OADS,/arxiv_data1/oa_pdf/61/93/ymj-57-1329.PMC5011263.pdf
"1331 http://dx.doi.org/10.3349/ymj.2016.57.6.1329Minh Cong Nguyen, et al.",OADS,/arxiv_data1/oa_pdf/61/93/ymj-57-1329.PMC5011263.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1329 1332eNOS Phosphorylation by Arginase Inhibition cate that SIN-1-derived peroxynitrite increased arginase activity.,Non-OADS,/arxiv_data1/oa_pdf/61/93/ymj-57-1329.PMC5011263.pdf
"1333 http://dx.doi.org/10.3349/ymj.2016.57.6.1329Minh Cong Nguyen, et al.",OADS,/arxiv_data1/oa_pdf/61/93/ymj-57-1329.PMC5011263.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1329 1334eNOS Phosphorylation by Arginase Inhibition NAME prevented a SIN-1-induced increase in ROS production,  and pretreatment with ABH or L-arginine resulted in a slope  similar to the DHE response in untreated aortas (Fig.",Non-OADS,/arxiv_data1/oa_pdf/61/93/ymj-57-1329.PMC5011263.pdf
"1335 http://dx.doi.org/10.3349/ymj.2016.57.6.1329Minh Cong Nguyen, et al.",OADS,/arxiv_data1/oa_pdf/61/93/ymj-57-1329.PMC5011263.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1329 1336eNOS Phosphorylation by Arginase Inhibition contribute to vascular injury prior to initiation of therapy due to  surgical manipulation.,Non-OADS,/arxiv_data1/oa_pdf/61/93/ymj-57-1329.PMC5011263.pdf
"1337 http://dx.doi.org/10.3349/ymj.2016.57.6.1329Minh Cong Nguyen, et al.",OADS,/arxiv_data1/oa_pdf/61/93/ymj-57-1329.PMC5011263.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1329 1338eNOS Phosphorylation by Arginase Inhibition and possible harm.,Non-OADS,/arxiv_data1/oa_pdf/61/93/ymj-57-1329.PMC5011263.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Nov;57(6):1339-1346 http://dx.doi.org/10.3349/ymj.2016.57.6.1339",Non-OADS,/arxiv_data1/oa_pdf/2f/73/ymj-57-1339.PMC5011264.pdf
1340Magnetocardiography for Long-Term Prognosis in AMI http://dx.doi.org/10.3349/ymj.2016.57.6.1339method to assess patients with acute coronary syndrome.,Non-OADS,/arxiv_data1/oa_pdf/2f/73/ymj-57-1339.PMC5011264.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1339curvature) of the signal following the inflection point after the  peak of the T wave (Tp).,OADS,/arxiv_data1/oa_pdf/2f/73/ymj-57-1339.PMC5011264.pdf
1342Magnetocardiography for Long-Term Prognosis in AMI http://dx.doi.org/10.3349/ymj.2016.57.6.1339with MACE had higher levels of serum creatinine ( p=0.04) at  the time of symptom presentation.,Non-OADS,/arxiv_data1/oa_pdf/2f/73/ymj-57-1339.PMC5011264.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1339served in patients with MACE and was associated with poor  long-term prognosis.,Non-OADS,/arxiv_data1/oa_pdf/2f/73/ymj-57-1339.PMC5011264.pdf
1344Magnetocardiography for Long-Term Prognosis in AMI http://dx.doi.org/10.3349/ymj.2016.57.6.1339Table 1.,Non-OADS,/arxiv_data1/oa_pdf/2f/73/ymj-57-1339.PMC5011264.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1339findings in ischemic heart disease patients, and these investi - gations focused on the diagnostic value of MCG modality.9-11  However, whether specific MCG findings could predict prog - nosis had not yet been elucidated.",OADS,/arxiv_data1/oa_pdf/2f/73/ymj-57-1339.PMC5011264.pdf
1346Magnetocardiography for Long-Term Prognosis in AMI http://dx.doi.org/10.3349/ymj.2016.57.6.1339mias: a review of clinical data.,OADS,/arxiv_data1/oa_pdf/2f/73/ymj-57-1339.PMC5011264.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Nov;57(6):1347-1353 http://dx.doi.org/10.3349/ymj.2016.57.6.1347",Non-OADS,/arxiv_data1/oa_pdf/e9/de/ymj-57-1347.PMC5011265.pdf
"1348Soluble ST2 and Coronary Artery Calcium Score http://dx.doi.org/10.3349/ymj.2016.57.6.1347cally seen with aging.9 Building on this study, the FHS group ex - amined the association between sST2 and subclinical athero - sclerosis in order to elucidate the underlying relationship bet- ween the ST2/IL-33 pathway and vascular biology.10 However,  no significant association between sST2 and carotid intima  medial thickness (IMT) or plaques was found.",OADS,/arxiv_data1/oa_pdf/e9/de/ymj-57-1347.PMC5011265.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1347Station, TX, USA).",Non-OADS,/arxiv_data1/oa_pdf/e9/de/ymj-57-1347.PMC5011265.pdf
1350Soluble ST2 and Coronary Artery Calcium Score http://dx.doi.org/10.3349/ymj.2016.57.6.1347and the clinical and laboratory parameters are summarized in  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/e9/de/ymj-57-1347.PMC5011265.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1347tion and risk reclassification for high risk CACS, compared to  sST2.",OADS,/arxiv_data1/oa_pdf/e9/de/ymj-57-1347.PMC5011265.pdf
"1352Soluble ST2 and Coronary Artery Calcium Score http://dx.doi.org/10.3349/ymj.2016.57.6.1347male sex was significantly correlated with sST2 levels in our  study (regression coefficient=-0.259, p<0.001).",OADS,/arxiv_data1/oa_pdf/e9/de/ymj-57-1347.PMC5011265.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1347ponectin concentration and its association with metabolic syn - drome in patients with heart failure.,Non-OADS,/arxiv_data1/oa_pdf/e9/de/ymj-57-1347.PMC5011265.pdf
"Key Words:  Trivalent influenza split vaccine, safety, immunogenicity, pre-existing HI titer, phase I influenza vaccine studyYonsei Med J 2016 Nov;57(6):1354-1360 http://dx.doi.org/10.3349/ymj.2016.57.6.1354Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  January 20, 2016   Revised:  May 3, 2016 Accepted:  May 9, 2016    Corresponding author:  Dr. Dong-Seok Yim , Department of Clinical Pharmacology  and Therapeutics, Seoul St. Mary’s Hospital, College of Medicine, The Catholic  University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea.",Non-OADS,/arxiv_data1/oa_pdf/f1/51/ymj-57-1354.PMC5011266.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/51/ymj-57-1354.PMC5011266.pdf
"1355 http://dx.doi.org/10.3349/ymj.2016.57.6.1354Kyuri Kang, et al.",OADS,/arxiv_data1/oa_pdf/f1/51/ymj-57-1354.PMC5011266.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1354 1356Phase I Study of Trivalent Split Influenza Vaccine the protocol.,Non-OADS,/arxiv_data1/oa_pdf/f1/51/ymj-57-1354.PMC5011266.pdf
"1357 http://dx.doi.org/10.3349/ymj.2016.57.6.1354Kyuri Kang, et al.",OADS,/arxiv_data1/oa_pdf/f1/51/ymj-57-1354.PMC5011266.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1354 1358Phase I Study of Trivalent Split Influenza Vaccine steps also contributed to the reduction of the manufacturing  time.,Non-OADS,/arxiv_data1/oa_pdf/f1/51/ymj-57-1354.PMC5011266.pdf
"1359 http://dx.doi.org/10.3349/ymj.2016.57.6.1354Kyuri Kang, et al.",OADS,/arxiv_data1/oa_pdf/f1/51/ymj-57-1354.PMC5011266.pdf
Available at: http://www.who.int/mediacentre/factsheets/fs211/ en.,Non-OADS,/arxiv_data1/oa_pdf/f1/51/ymj-57-1354.PMC5011266.pdf
Available at: http://www.cdc.gov/flu/keyfacts.htm.,OADS,/arxiv_data1/oa_pdf/f1/51/ymj-57-1354.PMC5011266.pdf
Available at:  http://www.fda.gov/BiologicsBloodVaccines/GuidanceCompli - anceRegulatoryInformation/Guidances/Vaccines/ucm074775.,Non-OADS,/arxiv_data1/oa_pdf/f1/51/ymj-57-1354.PMC5011266.pdf
Available at: http://www.fda.gov/Biolog - icsBloodVaccines/GuidanceComplianceRegulatoryInformation/ Guidances/Vaccines/ucm074794.htm.,Non-OADS,/arxiv_data1/oa_pdf/f1/51/ymj-57-1354.PMC5011266.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1354 1360Phase I Study of Trivalent Split Influenza Vaccine Basel: Springer; 2011.,Non-OADS,/arxiv_data1/oa_pdf/f1/51/ymj-57-1354.PMC5011266.pdf
Available at:  https://www.tga.gov.au/node/581.,OADS,/arxiv_data1/oa_pdf/f1/51/ymj-57-1354.PMC5011266.pdf
"Key Words:   Severe sepsis, septic shock, mortality, nomogramsYonsei Med J 2016 Nov;57(6):1361-1369 http://dx.doi.org/10.3349/ymj.2016.57.6.1361Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  November 19, 2015   Revised:  April 29, 2016 Accepted:  May 3, 2016 Corresponding author:  Dr. Yoo Seok Park, Department of Emergency Medicine,  Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722,  Korea.",Non-OADS,/arxiv_data1/oa_pdf/e6/fc/ymj-57-1361.PMC5011267.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/fc/ymj-57-1361.PMC5011267.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1361 1362A Nomogram to Predict Mortality in Severe Sepsis to die.,Non-OADS,/arxiv_data1/oa_pdf/e6/fc/ymj-57-1361.PMC5011267.pdf
"1363 http://dx.doi.org/10.3349/ymj.2016.57.6.1361Min Ho Seo, et al.",OADS,/arxiv_data1/oa_pdf/e6/fc/ymj-57-1361.PMC5011267.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1361 1364A Nomogram to Predict Mortality in Severe Sepsis the largest area under the receiver operating characteristic curve  (AUC).,Non-OADS,/arxiv_data1/oa_pdf/e6/fc/ymj-57-1361.PMC5011267.pdf
"1365 http://dx.doi.org/10.3349/ymj.2016.57.6.1361Min Ho Seo, et al.",OADS,/arxiv_data1/oa_pdf/e6/fc/ymj-57-1361.PMC5011267.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1361 1366A Nomogram to Predict Mortality in Severe Sepsis such as sepsis or trauma, and its levels are reduced by approxi - mately 10 –15 g/L within 1 week of the event.18 Hypoalbumin - emia can be caused by reduced hepatic synthesis, a decrease in  the supply of amino acids, increased leakage into the interstitial  space, and tissue catabolism or distributional issues.19 The re - duction in albumin synthesis during inflammation is likely as - sociated with the effect of monocytic products such as interleu - kin-6 and tumor necrosis factor- α.20 Although the precise  mechanisms have not been fully described, serum albumin has  protective effects such as maintaining physiologic homeostasis,  antioxidant activity, anti-inflammatory effects, and prevention  of apoptosis.21,22 Therefore, these protective biologic functions  may be impaired in hypoalbuminemic conditions, and in -creased morbidity and mortality can consequently develop in  severely septic patients.23,24 In patients with community-ac - quired bloodstream infection who require intensive care, hypo - albuminemia was an independent risk factor associated with  global mortality (odds ratio, 0.34; 95% CI, 0.15 –0.76).23 A previ - ous study by Vincent, et al.24 also reported that each 10 g/L de - cline in serum albumin concentration significantly raised the  odds of mortality by 137%, morbidity by 89%, prolonged ICU  stay by 28%, prolonged hospital stay by 71%, and increased re - source utilization by 66%.",Non-OADS,/arxiv_data1/oa_pdf/e6/fc/ymj-57-1361.PMC5011267.pdf
"1367 http://dx.doi.org/10.3349/ymj.2016.57.6.1361Min Ho Seo, et al.",OADS,/arxiv_data1/oa_pdf/e6/fc/ymj-57-1361.PMC5011267.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1361 1368A Nomogram to Predict Mortality in Severe Sepsis REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e6/fc/ymj-57-1361.PMC5011267.pdf
"1369 http://dx.doi.org/10.3349/ymj.2016.57.6.1361Min Ho Seo, et al.",OADS,/arxiv_data1/oa_pdf/e6/fc/ymj-57-1361.PMC5011267.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Nov;57(6):1370-1375 http://dx.doi.org/10.3349/ymj.2016.57.6.1370",Non-OADS,/arxiv_data1/oa_pdf/75/43/ymj-57-1370.PMC5011268.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1370MATERIALS AND METHODS Subjects Between January 2010 and December 2012, 23827 South Kore - ans who underwent abdominal US for health screening exami - nations at Chung-Ang University Hospital in Seoul, Korea, were  retrospectively identified.",Non-OADS,/arxiv_data1/oa_pdf/75/43/ymj-57-1370.PMC5011268.pdf
"1372Gallbladder Polypoid Lesions: Prevalence, Risk Factors http://dx.doi.org/10.3349/ymj.2016.57.6.13701.414; 95% CI 1.046 –1.912; p=0.024) were found to be risk fac - tors for multiple GB polypoid lesions when compared with  solitary GB polypoid lesions (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/75/43/ymj-57-1370.PMC5011268.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1370Table 3.,Non-OADS,/arxiv_data1/oa_pdf/75/43/ymj-57-1370.PMC5011268.pdf
"1374Gallbladder Polypoid Lesions: Prevalence, Risk Factors http://dx.doi.org/10.3349/ymj.2016.57.6.1370also be increasing due to the increasing prevalence of MS.14  However, our study evaluated only people who had more in - terest in their health.",Non-OADS,/arxiv_data1/oa_pdf/75/43/ymj-57-1370.PMC5011268.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1370REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/75/43/ymj-57-1370.PMC5011268.pdf
"Key Words:   Crohn’s disease, infliximab, tuberculosisYonsei Med J 2016 Nov;57(6):1376-1385 http://dx.doi.org/10.3349/ymj.2016.57.6.1376Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  August 11, 2015    Revised:  March 5, 2016    Accepted:  April 12, 2016 Corresponding author:  Dr. Won Ho Kim, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4d/9b/ymj-57-1376.PMC5011269.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/9b/ymj-57-1376.PMC5011269.pdf
"1377 http://dx.doi.org/10.3349/ymj.2016.57.6.1376Chang Hwan Choi, et al.",OADS,/arxiv_data1/oa_pdf/4d/9b/ymj-57-1376.PMC5011269.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1376 1378Infliximab in Korean Patients with Crohn’s Disease remission rates were evaluated at 2, 6, and 14 weeks for luminal  CD and at 14 weeks for fistulizing CD.",OADS,/arxiv_data1/oa_pdf/4d/9b/ymj-57-1376.PMC5011269.pdf
"1379 http://dx.doi.org/10.3349/ymj.2016.57.6.1376Chang Hwan Choi, et al.",OADS,/arxiv_data1/oa_pdf/4d/9b/ymj-57-1376.PMC5011269.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1376 1380Infliximab in Korean Patients with Crohn’s Disease cal response and remission were observed in 163 (71.8%) and  89 (39.2%) patients at week 2, in 177 (85.9%) and 110 (53.4%) at  week 6, and in 165 (89.2%) and 111 (60.0%) at week 14, respec - tively (Fig.",Non-OADS,/arxiv_data1/oa_pdf/4d/9b/ymj-57-1376.PMC5011269.pdf
"1381 http://dx.doi.org/10.3349/ymj.2016.57.6.1376Chang Hwan Choi, et al.",OADS,/arxiv_data1/oa_pdf/4d/9b/ymj-57-1376.PMC5011269.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1376 1382Infliximab in Korean Patients with Crohn’s Disease mission rates of 40 –73%.21-25 However, the sustained response  and remission rates in patients with luminal CD were slightly  higher than those of previous randomized, controlled trials  (RCTs) such as the ACCENT-I study, in which the clinical re - sponse and remission rates were 50% and 39% at week 30 and  39% and 30% at week 54, respectively.18 Additionally, the esti - mated response rates of maintenance treatments in patients  with fistulizing CD in our study were higher than those in the  ACCENT-II study in which the proportions of patients with re - sponse and remission were 46% and 36% at week 54, respec -tively.19 This disparity in response rates may be explained by  differences in the characteristics of the patients (ethnicity, indi - cations for infliximab, disease severity, and extension) or in the  study design (RCT or not).",Non-OADS,/arxiv_data1/oa_pdf/4d/9b/ymj-57-1376.PMC5011269.pdf
"1383 http://dx.doi.org/10.3349/ymj.2016.57.6.1376Chang Hwan Choi, et al.",OADS,/arxiv_data1/oa_pdf/4d/9b/ymj-57-1376.PMC5011269.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1376 1384Infliximab in Korean Patients with Crohn’s Disease over, we did not evaluate trough levels and antibodies to inflix - imab.",Non-OADS,/arxiv_data1/oa_pdf/4d/9b/ymj-57-1376.PMC5011269.pdf
"1385 http://dx.doi.org/10.3349/ymj.2016.57.6.1376Chang Hwan Choi, et al.",OADS,/arxiv_data1/oa_pdf/4d/9b/ymj-57-1376.PMC5011269.pdf
"Key Words:  Osteoporosis, orchiectomy, bone mineral density, spine, femurYonsei Med J 2016 Nov;57(6):1386-1394 http://dx.doi.org/10.3349/ymj.2016.57.6.1386Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  November 24, 2015   Revised:  January 3, 2016 Accepted:  January 28, 2016    Corresponding author:  Prof. Sung-Uk Kuh , Department of Neurosurgery, The  Spine and Spinal Cord Institute, Gangnam Severance Hospital, Yonsei University  College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 06273, Korea.",Non-OADS,/arxiv_data1/oa_pdf/12/e9/ymj-57-1386.PMC5011270.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/e9/ymj-57-1386.PMC5011270.pdf
"1387 http://dx.doi.org/10.3349/ymj.2016.57.6.1386Seong-Jun Ryu, et al.",OADS,/arxiv_data1/oa_pdf/12/e9/ymj-57-1386.PMC5011270.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1386 1388Osteoporosis after Orchidectomy of Young Rats were pulled through the incision using blunt forceps.,Non-OADS,/arxiv_data1/oa_pdf/12/e9/ymj-57-1386.PMC5011270.pdf
"1389 http://dx.doi.org/10.3349/ymj.2016.57.6.1386Seong-Jun Ryu, et al.",OADS,/arxiv_data1/oa_pdf/12/e9/ymj-57-1386.PMC5011270.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1386 1390Osteoporosis after Orchidectomy of Young Rats in BMD, we measured serum levels of the markers osteocal - cin, total and bone-specific ALP , P1NP as bone formation  markers, and CTX as a bone resorption marker.",OADS,/arxiv_data1/oa_pdf/12/e9/ymj-57-1386.PMC5011270.pdf
"1391 http://dx.doi.org/10.3349/ymj.2016.57.6.1386Seong-Jun Ryu, et al.",OADS,/arxiv_data1/oa_pdf/12/e9/ymj-57-1386.PMC5011270.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1386 1392Osteoporosis after Orchidectomy of Young Rats stage was determined according to the correlation of body  weight with bony changes at different postnatal phases, and  the transition from young adult to aged adult was defined as occurring between 8 and 32 weeks.13-15 Considering our results that a statistically significant reduc - tion in the BMD of femoral bones at POD 8 and 10 weeks is  2500 2000 1500 1000 500 0 n10 OCX 1 wP1NP (pg/mL) P1NP (pg/mL) OCX 4 w OCX 8 w OCX 12 w30 25 20 15 10 5 0 n10 OCX 1 wOsteocalcin (ng/mL) Osteocalcin (ng/mL) OCX 4 w OCX 8 w OCX 12 w 250 200 150 100 50 0 n10 OCX 1 wBone specific ALP isoenzyme (U/L) Bone specific ALP isoenzyme (Unit/Litter) OCX 4 w OCX 8 w OCX 12 w250 200 150 100 50 0 n10 OCX 1 wTotal ALP isoenzyme (U/L) Total ALP isoenzyme (Unit/Litter) OCX 4 w OCX 8 w OCX 12 w A 45 40 35 30 25 20 15 10 5 0 n10 OCX 1 wCTX-1 (ng/mL) CTX-1 (ng/mL) OCX 4 w OCX 8 w OCX 12 w B Fig.",Non-OADS,/arxiv_data1/oa_pdf/12/e9/ymj-57-1386.PMC5011270.pdf
"1393 http://dx.doi.org/10.3349/ymj.2016.57.6.1386Seong-Jun Ryu, et al.",OADS,/arxiv_data1/oa_pdf/12/e9/ymj-57-1386.PMC5011270.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1386 1394Osteoporosis after Orchidectomy of Young Rats of double dorso-lateral approach.,Non-OADS,/arxiv_data1/oa_pdf/12/e9/ymj-57-1386.PMC5011270.pdf
"Key Words:   Hypoglycemic agents, insulin, type 2 diabetes mellitusYonsei Med J 2016 Nov;57(6):1395-1403 http://dx.doi.org/10.3349/ymj.2016.57.6.1395Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  January 6, 2016   Revised:  March 9, 2016 Accepted:  March 14, 2016 Corresponding author:  Dr. Byung-Wan Lee, Department of Internal Medicine,  Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722,  Korea.",Non-OADS,/arxiv_data1/oa_pdf/32/80/ymj-57-1395.PMC5011271.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/80/ymj-57-1395.PMC5011271.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1395 1396Factors for Switching from Insulin to OHAs ed the stage at which both physicians and patients agreed to  start insulin therapy, and what are acceptable HbA1c levels for  Korean subjects with T2D in real practice.11 We have also tried  to answer questions regarding the characteristics of patients  who respond adequately to basal plus insulin or to insulin an - alogues (basal or biphasic insulin analogue) after sulfonylurea  failure,12,13 as well as the optimal dosing ratio of twice-daily bi - phasic insulin analogues.14,15 However, little research has been  performed on whether a change in therapeutic strategy from  insulin therapy to OHAs could be successfully applied and, if  so, which characteristics are predictive of successful mainte - nance on OHAs after switching from initial insulin therapy in  patients with T2D, especially in the Korean population.",Non-OADS,/arxiv_data1/oa_pdf/32/80/ymj-57-1395.PMC5011271.pdf
"1397 http://dx.doi.org/10.3349/ymj.2016.57.6.1395Gyuri Kim, et al.",OADS,/arxiv_data1/oa_pdf/32/80/ymj-57-1395.PMC5011271.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1395 1398Factors for Switching from Insulin to OHAs analyses were performed using PASW Statistics version 20.0  for Windows (SPSS Inc., Chicago, IL, USA).",OADS,/arxiv_data1/oa_pdf/32/80/ymj-57-1395.PMC5011271.pdf
"1399 http://dx.doi.org/10.3349/ymj.2016.57.6.1395Gyuri Kim, et al.",OADS,/arxiv_data1/oa_pdf/32/80/ymj-57-1395.PMC5011271.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1395 1400Factors for Switching from Insulin to OHAs CI 1.56 –7.31) in Model 1.,Non-OADS,/arxiv_data1/oa_pdf/32/80/ymj-57-1395.PMC5011271.pdf
"1401 http://dx.doi.org/10.3349/ymj.2016.57.6.1395Gyuri Kim, et al.",OADS,/arxiv_data1/oa_pdf/32/80/ymj-57-1395.PMC5011271.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1395 1402Factors for Switching from Insulin to OHAs function and provide better glycemic control.,Non-OADS,/arxiv_data1/oa_pdf/32/80/ymj-57-1395.PMC5011271.pdf
"1403 http://dx.doi.org/10.3349/ymj.2016.57.6.1395Gyuri Kim, et al.",OADS,/arxiv_data1/oa_pdf/32/80/ymj-57-1395.PMC5011271.pdf
"Key Words:   Triglycerides, cholesterol, HDL, insulin resistance, glucose intolerance, polycystic ovary syndromeYonsei Med J 2016 Nov;57(6):1404-1411 http://dx.doi.org/10.3349/ymj.2016.57.6.1404Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  January 7, 2016   Revised:  April 16, 2016 Accepted:  May 9, 2016 Corresponding author:  Dr. Jee-Young Oh, Department of Internal Medicine,  Ewha Womans University School of Medicine, 1071 Anyangcheon-ro, Yangcheon- gu, Seoul 07985, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b0/d2/ymj-57-1404.PMC5011272.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/d2/ymj-57-1404.PMC5011272.pdf
"1405 http://dx.doi.org/10.3349/ymj.2016.57.6.1404Do Kyeong Song, et al.",OADS,/arxiv_data1/oa_pdf/b0/d2/ymj-57-1404.PMC5011272.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1404 1406TG/HDL-C and Impaired Glucose Tolerance β-cell function (HOMA- β) was calculated using the following  formula: 20×fasting insulin (mIU/L)/fasting glucose (mmol/L) - 3.5.Statistical analyses The statistical analyses were performed using the SPSS 18.0  software package for Windows (IBM Corporation, Chicago, IL,   Fig.",OADS,/arxiv_data1/oa_pdf/b0/d2/ymj-57-1404.PMC5011272.pdf
"1407 http://dx.doi.org/10.3349/ymj.2016.57.6.1404Do Kyeong Song, et al.",OADS,/arxiv_data1/oa_pdf/b0/d2/ymj-57-1404.PMC5011272.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1404 1408TG/HDL-C and Impaired Glucose Tolerance TG/HDL-C ratio to predict IR was 1.7 (sensitivity 79%, specificity  70%) (Supplementary Fig.",OADS,/arxiv_data1/oa_pdf/b0/d2/ymj-57-1404.PMC5011272.pdf
"1409 http://dx.doi.org/10.3349/ymj.2016.57.6.1404Do Kyeong Song, et al.",OADS,/arxiv_data1/oa_pdf/b0/d2/ymj-57-1404.PMC5011272.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1404 1410TG/HDL-C and Impaired Glucose Tolerance index.30 In our study, the TG/HDL-C ratio was positively corre - lated with the percentage of fat and fat mass.",Non-OADS,/arxiv_data1/oa_pdf/b0/d2/ymj-57-1404.PMC5011272.pdf
"1411 http://dx.doi.org/10.3349/ymj.2016.57.6.1404Do Kyeong Song, et al.",OADS,/arxiv_data1/oa_pdf/b0/d2/ymj-57-1404.PMC5011272.pdf
"Key Words:    Immunoglobulin E (IgE), high-affinity IgE receptor I (Fc εRI), Fab fragment, antibody affinity,   passive cutaneous anaphylaxisYonsei Med J 2016 Nov;57(6):1412-1419 http://dx.doi.org/10.3349/ymj.2016.57.6.1412Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  February 16, 2016   Revised:  March 21, 2016 Accepted:  March 24, 2016    Corresponding author:  Dr. Myung Hyun Sohn , Department of Pediatrics and In - stitute of Allergy, Brain Korea 21 PLUS Project for Medical Science, Yonsei Univer - sity College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b7/ae/ymj-57-1412.PMC5011273.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/ae/ymj-57-1412.PMC5011273.pdf
"1413 http://dx.doi.org/10.3349/ymj.2016.57.6.1412Jung Yeon Hong, et al.",OADS,/arxiv_data1/oa_pdf/b7/ae/ymj-57-1412.PMC5011273.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1412 1414Development of Anti-Fc εRIα Antibody β-hexosaminidase activity assay and histamine  release measurement  For determination of NPB311 functional activity, IgE-induced  β-hexosaminidase and histamine release from cultured RBL- SX38 cells were measured.",OADS,/arxiv_data1/oa_pdf/b7/ae/ymj-57-1412.PMC5011273.pdf
"1415 http://dx.doi.org/10.3349/ymj.2016.57.6.1412Jung Yeon Hong, et al.",OADS,/arxiv_data1/oa_pdf/b7/ae/ymj-57-1412.PMC5011273.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1412 1416Development of Anti-Fc εRIα Antibody Fig.,Non-OADS,/arxiv_data1/oa_pdf/b7/ae/ymj-57-1412.PMC5011273.pdf
"1417 http://dx.doi.org/10.3349/ymj.2016.57.6.1412Jung Yeon Hong, et al.",OADS,/arxiv_data1/oa_pdf/b7/ae/ymj-57-1412.PMC5011273.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1412 1418Development of Anti-Fc εRIα Antibody Other possible target could be IgE-mediated atopic derma - titis (AD) and urticarial.,Non-OADS,/arxiv_data1/oa_pdf/b7/ae/ymj-57-1412.PMC5011273.pdf
"1419 http://dx.doi.org/10.3349/ymj.2016.57.6.1412Jung Yeon Hong, et al.",OADS,/arxiv_data1/oa_pdf/b7/ae/ymj-57-1412.PMC5011273.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Nov;57(6):1420-1426 http://dx.doi.org/10.3349/ymj.2016.57.6.1420",Non-OADS,/arxiv_data1/oa_pdf/e2/39/ymj-57-1420.PMC5011274.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1420method of administering gradually increasing doses of allergen  to decrease hypersensitivity to the allergen and eventually re - duce allergic symptoms resulting from exposure to the aller - gen.7 The clinical efficacy of SCIT has been proven by multiple  randomized, placebo controlled studies for the treatment of  allergic rhinitis, allergic asthma, and bee venom hypersensitivi - ty.7,8 A recent meta-analysis of randomized clinical trials on  SCIT with house dust mite (HDM) preparation in patients with  AD provided a moderate-level evidence of the efficacy for AD.9  However, the clinical usefulness of SCIT for AD is still contro - versial.",Non-OADS,/arxiv_data1/oa_pdf/e2/39/ymj-57-1420.PMC5011274.pdf
"1422Immunotherapy for Atopic Dermatitis http://dx.doi.org/10.3349/ymj.2016.57.6.1420lin and 0.15 µg of histamine dichloride, and injected subcuta - neously at monthly intervals as described in previous reports.12,13  Assessment of clinical efficacy and side effects The primary efficacy outcome was change in clinical severity  measured using standardized clinical severity scoring system  for AD (SCORAD) values at 12 months in comparison with the  values at baseline in patients with AD who received SCIT.14 In  this study, severe AD was defined as a baseline total SCORAD  value above 50 as previously described.15 A favorable clinical  response to SCIT was defined as a decrease in total SCORAD  value at 12 months greater than 50% compared to baseline  value.",Non-OADS,/arxiv_data1/oa_pdf/e2/39/ymj-57-1420.PMC5011274.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1420AD, the SCORAD value significantly decreased from 32.1±9.9  at baseline to 13.2±8.1 at 12 months ( p<0.005).",OADS,/arxiv_data1/oa_pdf/e2/39/ymj-57-1420.PMC5011274.pdf
1424Immunotherapy for Atopic Dermatitis http://dx.doi.org/10.3349/ymj.2016.57.6.1420after SCIT.,Non-OADS,/arxiv_data1/oa_pdf/e2/39/ymj-57-1420.PMC5011274.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1420tibody to D. pteronyssinus  (p=0.77) and specific IgE antibody  to D. farinae  (p=0.48) between baseline and 12 months after  SCIT (Table 5).,OADS,/arxiv_data1/oa_pdf/e2/39/ymj-57-1420.PMC5011274.pdf
"1426Immunotherapy for Atopic Dermatitis http://dx.doi.org/10.3349/ymj.2016.57.6.1420in previous studies on allergic asthma and allergic rhinitis.4,7,8  Future clinical trials of combinations of allergen immunothera - py and monoclonal antibody therapy or polyclonal immuno - globulin therapy might improve the long-term therapeutic out - comes of patients with AD.3,4,12,13,24 This study has an important limitation.",Non-OADS,/arxiv_data1/oa_pdf/e2/39/ymj-57-1420.PMC5011274.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Nov;57(6):1427-1434 http://dx.doi.org/10.3349/ymj.2016.57.6.1427",Non-OADS,/arxiv_data1/oa_pdf/7e/b3/ymj-57-1427.PMC5011275.pdf
1428Comparison of Commercial Subcutaneous Immunotherapy http://dx.doi.org/10.3349/ymj.2016.57.6.1427regulatory T cells cause B cells to produce sIgG4 instead of sIgE.,Non-OADS,/arxiv_data1/oa_pdf/7e/b3/ymj-57-1427.PMC5011275.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1427range was 0.07 mg/L to 30 mg/L.,OADS,/arxiv_data1/oa_pdf/7e/b3/ymj-57-1427.PMC5011275.pdf
1430Comparison of Commercial Subcutaneous Immunotherapy http://dx.doi.org/10.3349/ymj.2016.57.6.1427with Hollister-Stier® or Novo-Helisen®.,Non-OADS,/arxiv_data1/oa_pdf/7e/b3/ymj-57-1427.PMC5011275.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1427Changes of sIgG4 levels after SCIT using ImmunoCAP  method Contrary to the sIgE pattern, initial sIgG4 levels to D. farinae   were not different between the groups ( p=0.112).",OADS,/arxiv_data1/oa_pdf/7e/b3/ymj-57-1427.PMC5011275.pdf
1432Comparison of Commercial Subcutaneous Immunotherapy http://dx.doi.org/10.3349/ymj.2016.57.6.1427(both 21.1 kU A/L).,Non-OADS,/arxiv_data1/oa_pdf/7e/b3/ymj-57-1427.PMC5011275.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1427by different companies are difficult.,Non-OADS,/arxiv_data1/oa_pdf/7e/b3/ymj-57-1427.PMC5011275.pdf
1434Comparison of Commercial Subcutaneous Immunotherapy http://dx.doi.org/10.3349/ymj.2016.57.6.1427titis.,Non-OADS,/arxiv_data1/oa_pdf/7e/b3/ymj-57-1427.PMC5011275.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Nov;57(6):1435-1445 http://dx.doi.org/10.3349/ymj.2016.57.6.1435",Non-OADS,/arxiv_data1/oa_pdf/30/69/ymj-57-1435.PMC5011276.pdf
"1436CD47 in Atopic Dermatitis http://dx.doi.org/10.3349/ymj.2016.57.6.1435recently developed gel-free proteomic approach, which uses  isobaric labeling reagents, such as Tandem Mass Tags (TMT),  to quantitatively analyze the proteome.14 TMT labeling enables  genome-wide quantification of protein expression levels as well  as the identification and analysis of a small fraction of the pro - teins, such as membrane proteins, from the whole proteome.",Non-OADS,/arxiv_data1/oa_pdf/30/69/ymj-57-1435.PMC5011276.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1435tubing with an orifice i.d.,Non-OADS,/arxiv_data1/oa_pdf/30/69/ymj-57-1435.PMC5011276.pdf
"1438CD47 in Atopic Dermatitis http://dx.doi.org/10.3349/ymj.2016.57.6.1435RESULTS AD-like skin lesions induced by application of  D. farinae  topical ointment in mice Mild erythema was observed following a 2-week application  of D. farinae  ointment, and significant scarring and crusts  were observed after 3 weeks of topical application of D. fari - nae extracts (Fig.",Non-OADS,/arxiv_data1/oa_pdf/30/69/ymj-57-1435.PMC5011276.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1435Table 1.,Non-OADS,/arxiv_data1/oa_pdf/30/69/ymj-57-1435.PMC5011276.pdf
1440CD47 in Atopic Dermatitis http://dx.doi.org/10.3349/ymj.2016.57.6.1435Table 1.,Non-OADS,/arxiv_data1/oa_pdf/30/69/ymj-57-1435.PMC5011276.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1435ing a plateau (525.4±12.4 ng/mL after 4 weeks and 679.2±20.1  ng/mL after 6 weeks; p<0.001) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/30/69/ymj-57-1435.PMC5011276.pdf
"1442CD47 in Atopic Dermatitis http://dx.doi.org/10.3349/ymj.2016.57.6.1435these, CD47 has been reported to be associated with immune  regulation, particularly T cell costimulation16 and phagocyto - sis.17,18 Therefore, we further evaluated CD47 expression in  Treg cells.",Non-OADS,/arxiv_data1/oa_pdf/30/69/ymj-57-1435.PMC5011276.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1435ployed this method to identify differentially expressed mem - brane proteins in induced Treg cells in AD.,OADS,/arxiv_data1/oa_pdf/30/69/ymj-57-1435.PMC5011276.pdf
"1444CD47 in Atopic Dermatitis http://dx.doi.org/10.3349/ymj.2016.57.6.1435ulates activated CD103+ Treg cell homeostasis;30 however, a  deficiency of CD47 does not alter the inhibitory function of  Treg cells.30 We showed in this study that CD47 expression  was significantly higher in peripheral Treg cells in AD mice,  particularly in spleen samples.",Non-OADS,/arxiv_data1/oa_pdf/30/69/ymj-57-1435.PMC5011276.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1435Science 2000;288:2051-4.,Non-OADS,/arxiv_data1/oa_pdf/30/69/ymj-57-1435.PMC5011276.pdf
"Key Words:   Magnesium, hemodialysis, microcirculation, endotheliumYonsei Med J 2016 Nov;57(6):1446-1453 http://dx.doi.org/10.3349/ymj.2016.57.6.1446Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  August 27, 2015   Revised:  January 6, 2016 Accepted:  March 12, 2016 Corresponding author:  Dr. Kyu Bok Choi, Department of Internal Medicine,  School of Medicine, Ewha Womans University, 1071 Anyangcheon-ro, Yangcheon- gu, Seoul 07985, Korea.",Non-OADS,/arxiv_data1/oa_pdf/fa/60/ymj-57-1446.PMC5011277.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/60/ymj-57-1446.PMC5011277.pdf
"1447 http://dx.doi.org/10.3349/ymj.2016.57.6.1446Shina Lee, et al.",OADS,/arxiv_data1/oa_pdf/fa/60/ymj-57-1446.PMC5011277.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1446 1448Magnesium and Endothelial Dysfunction defined as the flow rate reached after the last drug delivery.,Non-OADS,/arxiv_data1/oa_pdf/fa/60/ymj-57-1446.PMC5011277.pdf
"1449 http://dx.doi.org/10.3349/ymj.2016.57.6.1446Shina Lee, et al.",OADS,/arxiv_data1/oa_pdf/fa/60/ymj-57-1446.PMC5011277.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1446 1450Magnesium and Endothelial Dysfunction Measurements comparisons based on the median  magnesium concentration We compared the laboratory parameters and vascular assess - ments of patients with magnesium levels above and below the  median value (3.47 mg/dL), shown in Table 3.",OADS,/arxiv_data1/oa_pdf/fa/60/ymj-57-1446.PMC5011277.pdf
"1451 http://dx.doi.org/10.3349/ymj.2016.57.6.1446Shina Lee, et al.",OADS,/arxiv_data1/oa_pdf/fa/60/ymj-57-1446.PMC5011277.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1446 1452Magnesium and Endothelial Dysfunction serum magnesium levels were associated with decreased cIMT,  although the correlation was not statistically significant.",OADS,/arxiv_data1/oa_pdf/fa/60/ymj-57-1446.PMC5011277.pdf
"1453 http://dx.doi.org/10.3349/ymj.2016.57.6.1446Shina Lee, et al.",OADS,/arxiv_data1/oa_pdf/fa/60/ymj-57-1446.PMC5011277.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Nov;57(6):1454-1460 http://dx.doi.org/10.3349/ymj.2016.57.6.1454",Non-OADS,/arxiv_data1/oa_pdf/26/30/ymj-57-1454.PMC5011278.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1454UACR below the microalbuminuria range and the risk of inci - dent hypertension.,Non-OADS,/arxiv_data1/oa_pdf/26/30/ymj-57-1454.PMC5011278.pdf
1456Urine Albumin-to-Creatinine Ratio and Hypertension http://dx.doi.org/10.3349/ymj.2016.57.6.1454Urine albumin (mg/dL) and creatinine (g/dL) were mea - sured from randomly voided urine.,Non-OADS,/arxiv_data1/oa_pdf/26/30/ymj-57-1454.PMC5011278.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1454sion than in those who did not.,Non-OADS,/arxiv_data1/oa_pdf/26/30/ymj-57-1454.PMC5011278.pdf
"1458Urine Albumin-to-Creatinine Ratio and Hypertension http://dx.doi.org/10.3349/ymj.2016.57.6.1454the progression of chronic kidney disease.20,21 Several studies  have explored the relationship between endothelial dysfunc - tion, arterial stiffness, and blood pressure.22,23 Elevation of  UACR could also be associated with loss of vasorelaxation and  vascular calcification in patients with microalbuminuria.24,25  Additionally, the development of hypertension may be due to  the upregulation of angiotensin-converting enzymes in protein - uric-conditions and the albumin-triggered activation of the  intrarenal renin-angiotensin system.26,27 Recent studies have reported that high normal ranges of  UACR are associated with the development of hypertension.13-15,28  The Framingham Offspring Study and an Indo-Asian popula -tion study reported an association between a high normal level  of albuminuria and the risk of hypertension for 2 and 2.9 years  of follow-up, respectively.13,15 However, separate analyses by  gender were not performed in these previous studies.",Non-OADS,/arxiv_data1/oa_pdf/26/30/ymj-57-1454.PMC5011278.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1454required to understand the profound pathophysiology of the  gender difference in the effects of UACR on hypertension.,Non-OADS,/arxiv_data1/oa_pdf/26/30/ymj-57-1454.PMC5011278.pdf
"1460Urine Albumin-to-Creatinine Ratio and Hypertension http://dx.doi.org/10.3349/ymj.2016.57.6.1454detection, elimination (PARADE): a position paper of the National  Kidney Foundation.",Non-OADS,/arxiv_data1/oa_pdf/26/30/ymj-57-1454.PMC5011278.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Nov;57(6):1461-1467 http://dx.doi.org/10.3349/ymj.2016.57.6.1461",Non-OADS,/arxiv_data1/oa_pdf/90/48/ymj-57-1461.PMC5011279.pdf
1462Agmatine Regulates Neural Stem Cells Differentiation  http://dx.doi.org/10.3349/ymj.2016.57.6.1461stood and are debatable.,OADS,/arxiv_data1/oa_pdf/90/48/ymj-57-1461.PMC5011279.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1461Statistical analysis All calculations were conducted using SPSS 18.0 software (IBM  Corp., Armonk, NY, USA).",OADS,/arxiv_data1/oa_pdf/90/48/ymj-57-1461.PMC5011279.pdf
"1464Agmatine Regulates Neural Stem Cells Differentiation  http://dx.doi.org/10.3349/ymj.2016.57.6.1461agmatine treatment along with let-7a  overexpression (the  same with let-7a  mimic treatment), we found that agmatine  dramatically reduced let-7a  levels in spite of let-7a  mimic  treatment (Fig.",Non-OADS,/arxiv_data1/oa_pdf/90/48/ymj-57-1461.PMC5011279.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1461was noticeably reduced in agmatine treatment group under  let-7a  mimic treatment in comparison with the let-7a  overex - pression group (Fig.,Non-OADS,/arxiv_data1/oa_pdf/90/48/ymj-57-1461.PMC5011279.pdf
"1466Agmatine Regulates Neural Stem Cells Differentiation  http://dx.doi.org/10.3349/ymj.2016.57.6.1461lating expression of let-7a  and TLX, and it may inhibit NSC pro - liferation by attenuating the increased TLX level in let-7a   overexpression conditions.38 c-Myc regulates the genes involved in self-renewal, and  proliferation39 of NSCs, and the let-7  family is known to regulate  cell proliferation by targeting c-Myc.40 In our present study,  overexpression of let-7a  upregulated the expression of c-Myc,  which is known to sustain the stemness of stem cells targeted  by the let-7  family.41 These findings imply that agmatine may  reduce c-Myc via controlling let-7a , thereby influencing self- renewal and proliferation of NSCs.",Non-OADS,/arxiv_data1/oa_pdf/90/48/ymj-57-1461.PMC5011279.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1461veloping neurons.,OADS,/arxiv_data1/oa_pdf/90/48/ymj-57-1461.PMC5011279.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Nov;57(6):1468-1474 http://dx.doi.org/10.3349/ymj.2016.57.6.1468",Non-OADS,/arxiv_data1/oa_pdf/b9/b9/ymj-57-1468.PMC5011280.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1468of the disease.9 Kao, et al.10 showed that a group of target genes  in the eutopic endometrium are normally downregulated dur - ing the window of implantation yet are significantly increased  in women with endometriosis, suggesting that progesterone  may mediate the expression of critical genes that could be al - tered in the eutopic endometrium of endometriosis patients.",Non-OADS,/arxiv_data1/oa_pdf/b9/b9/ymj-57-1468.PMC5011280.pdf
"1470Progesterone Receptor in Endometriosis  http://dx.doi.org/10.3349/ymj.2016.57.6.1468Isolation and in vitro  culture and treatment of human ESC ESCs were separated and maintained in a monolayer culture as  described previously.14 ESCs after first passage were assayed  immunocytochemically using specific cell-surface markers,  and we previously showed that the purity of isolated ESCs was  more than 95%.14 We utilized only the cells after the first pas - sage in all of the experiments using ESCs.",Non-OADS,/arxiv_data1/oa_pdf/b9/b9/ymj-57-1468.PMC5011280.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1468supermix (BIO-RAD, Hercules, CA, USA).",OADS,/arxiv_data1/oa_pdf/b9/b9/ymj-57-1468.PMC5011280.pdf
"1472Progesterone Receptor in Endometriosis  http://dx.doi.org/10.3349/ymj.2016.57.6.14686 h. The PR-B/A ratio was significantly lower in Ishikawa cells  treated with 10 ng/mL ( p=0.021) and 25 ng/mL ( p=0.011) TNF- α  at 1 h compared to those treated with vehicle, respectively (Fig.",Non-OADS,/arxiv_data1/oa_pdf/b9/b9/ymj-57-1468.PMC5011280.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1468expression in the stromal cells between the two groups.,Non-OADS,/arxiv_data1/oa_pdf/b9/b9/ymj-57-1468.PMC5011280.pdf
1474Progesterone Receptor in Endometriosis  http://dx.doi.org/10.3349/ymj.2016.57.6.1468gram through the National Research Foundation of Korea (NRF)  and funded by the Ministry of Education (2013R1A1A2008247).,Non-OADS,/arxiv_data1/oa_pdf/b9/b9/ymj-57-1468.PMC5011280.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Nov;57(6):1475-1481 http://dx.doi.org/10.3349/ymj.2016.57.6.1475",Non-OADS,/arxiv_data1/oa_pdf/e6/ef/ymj-57-1475.PMC5011281.pdf
1476Comparison of Two Astigmatism-Correction Methods http://dx.doi.org/10.3349/ymj.2016.57.6.1475what long.,Non-OADS,/arxiv_data1/oa_pdf/e6/ef/ymj-57-1475.PMC5011281.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1475and Alpins method.12-14 The power vector method aids in visu - alizing complex changes in refractive error.,Non-OADS,/arxiv_data1/oa_pdf/e6/ef/ymj-57-1475.PMC5011281.pdf
"1478Comparison of Two Astigmatism-Correction Methods http://dx.doi.org/10.3349/ymj.2016.57.6.1475The subjects in the toric group had their astigmatism over - corrected, while those in the LRI group had undercorrected as- tigmatism (Fig.",Non-OADS,/arxiv_data1/oa_pdf/e6/ef/ymj-57-1475.PMC5011281.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1475lens.,OADS,/arxiv_data1/oa_pdf/e6/ef/ymj-57-1475.PMC5011281.pdf
"1480Comparison of Two Astigmatism-Correction Methods http://dx.doi.org/10.3349/ymj.2016.57.6.1475limbus, and the far peripheral placement of incisions.10,19,20 LRIs  are associated with other important problems.",Non-OADS,/arxiv_data1/oa_pdf/e6/ef/ymj-57-1475.PMC5011281.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1475tion of toric iris-claw lenses in phakic eyes.,Non-OADS,/arxiv_data1/oa_pdf/e6/ef/ymj-57-1475.PMC5011281.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Nov;57(6):1482-1487 http://dx.doi.org/10.3349/ymj.2016.57.6.1482",Non-OADS,/arxiv_data1/oa_pdf/ad/6b/ymj-57-1482.PMC5011282.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1482alternative approach is the transmastoid approach; this ap - proach, however, provides only restricted view of the peri-ge - niculate area, which can be a “key area” for facial nerve decom - pression, and sometimes requires the performance of some  type of ossicular procedure.5,6  A few clinicians have reported new approaches to expose  the geniculate ganglion and labyrinthine segment of the facial  nerve without craniotomy, which combine the advantages of  the middle cranial fossa and transmastoid approaches.7,8 The  advantages of these new approaches include obviating the  need for craniotomy, lack of temporal lobe retraction, wide ex - posure of the peri-geniculate ganglion, and familiarity of the  approach for experienced otologists.",Non-OADS,/arxiv_data1/oa_pdf/ad/6b/ymj-57-1482.PMC5011282.pdf
1484Effective Facial Nerve Decompression Using the Transmastoid Approach http://dx.doi.org/10.3349/ymj.2016.57.6.1482pine position tilting to the contralateral side at approximately  a 45-degree angle.,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/ymj-57-1482.PMC5011282.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1482the HB grade.,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/ymj-57-1482.PMC5011282.pdf
1486Effective Facial Nerve Decompression Using the Transmastoid Approach http://dx.doi.org/10.3349/ymj.2016.57.6.1482acute onset resulting from any causes.,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/ymj-57-1482.PMC5011282.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1482ganglion in most cases, but it is very important to follow up to  the normalized neural fascicle in decompression of swollen  facial nerve.",Non-OADS,/arxiv_data1/oa_pdf/ad/6b/ymj-57-1482.PMC5011282.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Nov;57(6):1488-1493 http://dx.doi.org/10.3349/ymj.2016.57.6.1488",Non-OADS,/arxiv_data1/oa_pdf/d5/15/ymj-57-1488.PMC5011283.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1488nation with manual thrust on the improvement of PCF has  not been demonstrated in clinical practice, although several  studies compared PCF created during unassisted coughing,  during techniques involving a maximal insufflation capacity  (MIC) maneuver combined with manually assisted coughing,  by MI-E, and by MI-E combined with manual thrust.7 The aim of the present randomized controlled trial was to  investigate the ability of manual thrust assistance following an  MIC maneuver, MI-E alone, and MI-E in combination with ma- nual thrust to improve PCF in patients with NMD and respira - tory muscle dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/d5/15/ymj-57-1488.PMC5011283.pdf
"1490Effect of Various Cough Augmentation on Peak Cough Flow http://dx.doi.org/10.3349/ymj.2016.57.6.1488through the Cough Aid.8 A commercial flow analyzer test sys - tem (Certifier® FA, TSI Inc., Shoreview, MN, USA) belonging to  the Cough Aid was used to measure PCF .8 Manual-assisted PCF  following an MIC maneuver was measured by first inducing  maximal air stacking with an Ambu bag so that MIC was ach- ieved while the Ambu bag was attached to the connection part  of the Cough Aid and the pushing bar was not pressed.8 The pa - tient was then asked to cough when the pushing bar was press- ed; at the same time, manual abdominal thrust was applied (Fig.",Non-OADS,/arxiv_data1/oa_pdf/d5/15/ymj-57-1488.PMC5011283.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1488were regarded as statistically significant.,OADS,/arxiv_data1/oa_pdf/d5/15/ymj-57-1488.PMC5011283.pdf
1492Effect of Various Cough Augmentation on Peak Cough Flow http://dx.doi.org/10.3349/ymj.2016.57.6.1488was apparently not applied consistently.,Non-OADS,/arxiv_data1/oa_pdf/d5/15/ymj-57-1488.PMC5011283.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1488result, individual variations were obscured.",Non-OADS,/arxiv_data1/oa_pdf/d5/15/ymj-57-1488.PMC5011283.pdf
"Key Words:   PDT, troglitazone, apoptosisYonsei Med J 2016 Nov;57(6):1494-1499 http://dx.doi.org/10.3349/ymj.2016.57.6.1494Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  January 4, 2016   Revised:  April 5, 2016 Accepted:  April 13, 2016 Corresponding author:  Dr. Youn-Hee Choi, Department of Physiology, School of  Medicine, Ewha Womans University, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul   07985, Korea.",Non-OADS,/arxiv_data1/oa_pdf/8e/6a/ymj-57-1494.PMC5011284.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/6a/ymj-57-1494.PMC5011284.pdf
"1495 http://dx.doi.org/10.3349/ymj.2016.57.6.1494Hyunju Park, et al.",OADS,/arxiv_data1/oa_pdf/8e/6a/ymj-57-1494.PMC5011284.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1494 1496Troglitazone Enhances PDT Response in DLD-1 Cells RNA using 2 μg random hexamer (Amersham Pharmacia Bio - thech Inc., Uppsala, Sweden), 1.25 mM dNTP (Boehringer- Mannheim, Mannheim, Germany) and 200 U M-MLV reverse  transcriptase (Gibco BRL).",Non-OADS,/arxiv_data1/oa_pdf/8e/6a/ymj-57-1494.PMC5011284.pdf
"1497 http://dx.doi.org/10.3349/ymj.2016.57.6.1494Hyunju Park, et al.",OADS,/arxiv_data1/oa_pdf/8e/6a/ymj-57-1494.PMC5011284.pdf
"For  quantification, densities of procaspase-3 bands were normal - ized to the density of cytochrome C bands measured using Im - age J software (developed by Wayne Rasband, National Insti - tutes of Health, Bethesda, MD, USA; available at http://rsb.info.",OADS,/arxiv_data1/oa_pdf/8e/6a/ymj-57-1494.PMC5011284.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1494 1498Troglitazone Enhances PDT Response in DLD-1 Cells combination of PDT and troglitazone is a potent killing modali - ty in DLD-1.,Non-OADS,/arxiv_data1/oa_pdf/8e/6a/ymj-57-1494.PMC5011284.pdf
"1499 http://dx.doi.org/10.3349/ymj.2016.57.6.1494Hyunju Park, et al.",OADS,/arxiv_data1/oa_pdf/8e/6a/ymj-57-1494.PMC5011284.pdf
"Key Words:   Temporomandibular disorders (TMD), clinical sign, subjective symptom, instrumentalist, arm positionYonsei Med J 2016 Nov;57(6):1500-1507 http://dx.doi.org/10.3349/ymj.2016.57.6.1500Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  October 20, 2015   Revised:  April 5, 2016 Accepted:  April 5, 2016 Corresponding author:  Seong Taek Kim, DDS, PhD, Department of Orofacial  Pain & Oral Medicine, Yonsei University College of Dentistry, 50-1 Yonsei-ro, Seo - daemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a3/65/ymj-57-1500.PMC5011285.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/65/ymj-57-1500.PMC5011285.pdf
"1501 http://dx.doi.org/10.3349/ymj.2016.57.6.1500Jae-Young Jang, et al.",OADS,/arxiv_data1/oa_pdf/a3/65/ymj-57-1500.PMC5011285.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1500 1502TMD in Instrumentalists tion (DD w/ R); disc displacement without reduction (DD w/o  R); TMJ arthralgia, myalgia, or MFP; TMJ osteoarthritis (TMJ  OA); and TMJ osteoarthrosis (TMJ O).",Non-OADS,/arxiv_data1/oa_pdf/a3/65/ymj-57-1500.PMC5011285.pdf
"1503 http://dx.doi.org/10.3349/ymj.2016.57.6.1500Jae-Young Jang, et al.",OADS,/arxiv_data1/oa_pdf/a3/65/ymj-57-1500.PMC5011285.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1500 1504TMD in Instrumentalists 3 bassoon, 5 oboe, 3 horn, 2 trombone, 7 trumpet, and 2 tuba)  and 39 string instrumentalists (2 cello, 1 double bass, 7 viola, and  29 violin).",Non-OADS,/arxiv_data1/oa_pdf/a3/65/ymj-57-1500.PMC5011285.pdf
"1505 http://dx.doi.org/10.3349/ymj.2016.57.6.1500Jae-Young Jang, et al.",OADS,/arxiv_data1/oa_pdf/a3/65/ymj-57-1500.PMC5011285.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1500 1506TMD in Instrumentalists Heikkilä, et al.15 reported that TMJ sounds and facial pain were  more common in wind instrumentalists, due to the head and  neck muscles being involved in the production of sound with a  wind instrument.",OADS,/arxiv_data1/oa_pdf/a3/65/ymj-57-1500.PMC5011285.pdf
"1507 http://dx.doi.org/10.3349/ymj.2016.57.6.1500Jae-Young Jang, et al.",OADS,/arxiv_data1/oa_pdf/a3/65/ymj-57-1500.PMC5011285.pdf
"Key Words:  MDR, HIV , resistance, intermediate TB burdenYonsei Med J 2016 Nov;57(6):1508-1510 http://dx.doi.org/10.3349/ymj.2016.57.6.1508Brief Communication pISSN: 0513-5796 · eISSN: 1976-2437 Received:  January 13, 2016   Revised:  March 2, 2016 Accepted:  March 24, 2016    Corresponding author:  Dr. Sun Hee Lee , Department of Internal Medicine, Pu - san National University Hospital, 179 Gudeok-ro, Seo-gu, Busan 49241, Korea.",Non-OADS,/arxiv_data1/oa_pdf/43/fd/ymj-57-1508.PMC5011286.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/fd/ymj-57-1508.PMC5011286.pdf
"1509 http://dx.doi.org/10.3349/ymj.2016.57.6.1508Shinwon Lee, et al.",OADS,/arxiv_data1/oa_pdf/43/fd/ymj-57-1508.PMC5011286.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1508 1510MDR-TB and HIV in Korea MDR-TB burden of the general population in areas with low  HIV and intermediate TB burden such as South Korea, Japan,  Malaysia, Singapore, and Hong Kong.",Non-OADS,/arxiv_data1/oa_pdf/43/fd/ymj-57-1508.PMC5011286.pdf
"Key Words:  Neisseria meningitidis , serum bactericidal antibody assay, meningococcal vaccineYonsei Med J 2016 Nov;57(6):1511-1516 http://dx.doi.org/10.3349/ymj.2016.57.6.1511Brief Communication pISSN: 0513-5796 · eISSN: 1976-2437 Received:  February 3, 2016   Revised:  May 3, 2016 Accepted:  May 9, 2016    Co-corresponding authors:  Dr. Kyung-Hyo Kim, Department of Pediatrics, School  of Medicine, Ewha Womans University, 1071 Anyangcheon-ro, Yangcheon-gu,  Seoul 07985, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4a/88/ymj-57-1511.PMC5011287.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/88/ymj-57-1511.PMC5011287.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1511 1512Immunogenicity of MenACWY-CRM in the Korean Military prevalent serogroup was C. A recent outbreak at the Nonsan  Recruit Training Center in April 2011 has drawn public aware - ness to the need for meningococcal immunization in the Kore - an Army.,Non-OADS,/arxiv_data1/oa_pdf/4a/88/ymj-57-1511.PMC5011287.pdf
"1513 http://dx.doi.org/10.3349/ymj.2016.57.6.1511Han Wool Kim, et al.",OADS,/arxiv_data1/oa_pdf/4a/88/ymj-57-1511.PMC5011287.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1511 1514Immunogenicity of MenACWY-CRM in the Korean Military cal trials performed in participants aged 11 –55 years for the li - censure of MenACWY-CRM in Korea and the United States.13-15  A relatively high baseline immunity for serogroups A and  W-135 was shown in our study compared with that of Lee, et  al.14 The low incidence of invasive diseases and carriage rate  caused by meningococcal serogroups A and W-135 in Korea  might be explained by our results.8,16-18 These bactericidal an - tibodies detected in pre-immune sera might be produced by  exposure to meningococci colonized in the pharynx or by oth - er bacteria, such as N. lactamica  or E. coli  K92, that could in - duce cross-reactive antibodies.19,20 The seroprevalence of anti - bodies against serogroup A or serogroup W-135 meningococci  should be performed to confirm this finding and to identify  potentially susceptible groups in the population.",Non-OADS,/arxiv_data1/oa_pdf/4a/88/ymj-57-1511.PMC5011287.pdf
"1515 http://dx.doi.org/10.3349/ymj.2016.57.6.1511Han Wool Kim, et al.",OADS,/arxiv_data1/oa_pdf/4a/88/ymj-57-1511.PMC5011287.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1511 1516Immunogenicity of MenACWY-CRM in the Korean Military 21.,Non-OADS,/arxiv_data1/oa_pdf/4a/88/ymj-57-1511.PMC5011287.pdf
"Key Words:  Periprosthetic fractures; revision; arthroplasty, replacement; femur; kneeYonsei Med J 2016 Nov;57(6):1517-1522 http://dx.doi.org/10.3349/ymj.2016.57.6.1517Technical Report pISSN: 0513-5796 · eISSN: 1976-2437 Received:  November 24, 2015   Revised:  February 15, 2016 Accepted:  March 29, 2016    Corresponding author:  Dr. Jae-Hwi Nho , Department of Orthopaedic Surgery,  Soonchunhyang University Hospital Seoul, 59 Daesagwan-ro, Yongsan-gu, Seoul  04401, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a9/3d/ymj-57-1517.PMC5011288.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/3d/ymj-57-1517.PMC5011288.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1517 1518MUTARS® Prosthesis in Periprosthetic Fracture the total femur were -1.3 and -0.9, respectively.",OADS,/arxiv_data1/oa_pdf/a9/3d/ymj-57-1517.PMC5011288.pdf
"1519 http://dx.doi.org/10.3349/ymj.2016.57.6.1517Hyung-Suk Choi, et al.",OADS,/arxiv_data1/oa_pdf/a9/3d/ymj-57-1517.PMC5011288.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1517 1520MUTARS® Prosthesis in Periprosthetic Fracture Fig.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/ymj-57-1517.PMC5011288.pdf
"1521 http://dx.doi.org/10.3349/ymj.2016.57.6.1517Hyung-Suk Choi, et al.",OADS,/arxiv_data1/oa_pdf/a9/3d/ymj-57-1517.PMC5011288.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1517 1522MUTARS® Prosthesis in Periprosthetic Fracture 29:130-7.,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/ymj-57-1517.PMC5011288.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Nov;57(6):1523-1526 http://dx.doi.org/10.3349/ymj.2016.57.6.1523",Non-OADS,/arxiv_data1/oa_pdf/e8/a8/ymj-57-1523.PMC5011289.pdf
1524PIE Treated by Percutaneous Catheter Insertion http://dx.doi.org/10.3349/ymj.2016.57.6.1523cm H 2O.,Non-OADS,/arxiv_data1/oa_pdf/e8/a8/ymj-57-1523.PMC5011289.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.152342.,Non-OADS,/arxiv_data1/oa_pdf/e8/a8/ymj-57-1523.PMC5011289.pdf
1526PIE Treated by Percutaneous Catheter Insertion http://dx.doi.org/10.3349/ymj.2016.57.6.1523term and term neonates with respiratory distress.,Non-OADS,/arxiv_data1/oa_pdf/e8/a8/ymj-57-1523.PMC5011289.pdf
"Key Words:  Femoral head, hip dislocation, autograft transplant, fractures cartilageYonsei Med J 2016 Nov;57(6):1527-1530 http://dx.doi.org/10.3349/ymj.2016.57.6.1527Case Report pISSN: 0513-5796 · eISSN: 1976-2437 Received:  October 5, 2015   Revised:  March 8, 2016 Accepted:  April 28, 2016 Corresponding author:  Dr. Gi-Soo Lee, Department of Orthopedic Surgery, College  of Medicine, Konyang University, 158 Gwanjeodong-ro, Seo-gu, Daejeon 35365,  Korea.",Non-OADS,/arxiv_data1/oa_pdf/56/8e/ymj-57-1527.PMC5011290.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/8e/ymj-57-1527.PMC5011290.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1527 1528OATS for Femoral Head Fracture Dislocation fracture extending around the fovea in the coronal plane, with  bony fragments in the postero-superior and postero-inferior  aspects of the joint (Fig.",Non-OADS,/arxiv_data1/oa_pdf/56/8e/ymj-57-1527.PMC5011290.pdf
"1529 http://dx.doi.org/10.3349/ymj.2016.57.6.1527Yougun Won, et al.",OADS,/arxiv_data1/oa_pdf/56/8e/ymj-57-1527.PMC5011290.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1527 1530OATS for Femoral Head Fracture Dislocation can be used as a salvage procedure for defects as large as 8 to 9  cm2, although such extension of the indication can result in a  higher rate of donor-site morbidity.15 Autogenous osteochon - dral mosaicplasty is an innovative and promising treatment for  focal chondral and osteochondral articular surface defects that  are between 1 and 4 cm2 in size.",Non-OADS,/arxiv_data1/oa_pdf/56/8e/ymj-57-1527.PMC5011290.pdf
"Key Words:    Robotic surgical procedure, adenomyosis, surgery, fertility preservation, minimally invasive surgeryYonsei Med J 2016 Nov;57(6):1531-1534 http://dx.doi.org/10.3349/ymj.2016.57.6.1531Case Report pISSN: 0513-5796 · eISSN: 1976-2437 Received:  October 23, 2015   Revised:  March 10, 2016 Accepted:  March 15, 2016    Corresponding author:  Dr. Mee-Ran Kim , Department of Obstetrics and Gyne - cology, College of Medicine, The Catholic University of Korea, 222 Banpo-daero,  Seocho-gu, Seoul 06591, Korea.",Non-OADS,/arxiv_data1/oa_pdf/56/4c/ymj-57-1531.PMC5011291.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/4c/ymj-57-1531.PMC5011291.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1531 1532Robot-Assisted Laparoscopic Adenomyomectomy pain) to 10 (extremely severe pain).,Non-OADS,/arxiv_data1/oa_pdf/56/4c/ymj-57-1531.PMC5011291.pdf
"1533 http://dx.doi.org/10.3349/ymj.2016.57.6.1531Youn-Jee Chung, et al.",OADS,/arxiv_data1/oa_pdf/56/4c/ymj-57-1531.PMC5011291.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1531 1534Robot-Assisted Laparoscopic Adenomyomectomy ing inaccurate assessment of the extent of adenomyosis and  repair of a myometrial defect in a limited range of motion.,Non-OADS,/arxiv_data1/oa_pdf/56/4c/ymj-57-1531.PMC5011291.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Nov;57(6):1535-1539 http://dx.doi.org/10.3349/ymj.2016.57.6.1535",Non-OADS,/arxiv_data1/oa_pdf/03/9d/ymj-57-1535.PMC5011292.pdf
1536Simultaneous CI in VS’s http://dx.doi.org/10.3349/ymj.2016.57.6.1535Fig.,Non-OADS,/arxiv_data1/oa_pdf/03/9d/ymj-57-1535.PMC5011292.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1535charge at the left tympanic membrane.,Non-OADS,/arxiv_data1/oa_pdf/03/9d/ymj-57-1535.PMC5011292.pdf
"1538Simultaneous CI in VS’s http://dx.doi.org/10.3349/ymj.2016.57.6.1535sures the binaural hearing performance in a noisy environ - ment, are described in Table 1.",OADS,/arxiv_data1/oa_pdf/03/9d/ymj-57-1535.PMC5011292.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.6.1535Candidacy criteria for CI with tumor resection include total  tumor removal, preservation of the cochlear nerve anatomy  and function, and surgeon experience.",Non-OADS,/arxiv_data1/oa_pdf/03/9d/ymj-57-1535.PMC5011292.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Nov;57(6):1540-1541 http://dx.doi.org/10.3349/ymj.2016.57.6.1540 Postoperative Treatment of Linear Thyroidectomy  Scars with the Pinhole Method Using a 10600-nm   Carbon Dioxide Laser Jimyung Seo, Jae Won Lee, and Do Young Kim Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea.Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/3f/de/ymj-57-1540.PMC5011293.pdf
http://dx.doi.org/10.3349/ymj.2016.57.6.1540bleeding and oozing.,Non-OADS,/arxiv_data1/oa_pdf/3f/de/ymj-57-1540.PMC5011293.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/58/hepatmon-16-06-38138.PMC5011296.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 7(9) 1–4 DOI: 10.1177/2054270416649284",Non-OADS,/arxiv_data1/oa_pdf/b0/04/10.1177_2054270416649284.PMC5011299.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 7(9) 1–3 DOI: 10.1177/2054270416649285",Non-OADS,/arxiv_data1/oa_pdf/32/a3/10.1177_2054270416649285.PMC5011301.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/49/d0/10.1177_2325967116664882.PMC5011303.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 7(9) 1–3 DOI: 10.1177/2054270416640154",Non-OADS,/arxiv_data1/oa_pdf/07/7d/10.1177_2054270416640154.PMC5011304.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 7(9) 1–3 DOI: 10.1177/2054270416649286",Non-OADS,/arxiv_data1/oa_pdf/e2/3a/10.1177_2054270416649286.PMC5011307.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 7(9) 1–9 DOI: 10.1177/2054270416654859",Non-OADS,/arxiv_data1/oa_pdf/4d/51/10.1177_2054270416654859.PMC5011308.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/44/af/10.1177_2325967116664500.PMC5011310.pdf
http://espn.go.com/ college-football/stor y/_/id/6787238/ivy-league -limit-full-contact- football-workouts.,Non-OADS,/arxiv_data1/oa_pdf/44/af/10.1177_2325967116664500.PMC5011310.pdf
http://espn.go.com/ college-football/story/_/id/9338542/pac-12-limit-hits-contact- football-practice.,Non-OADS,/arxiv_data1/oa_pdf/44/af/10.1177_2325967116664500.PMC5011310.pdf
http://www.ncaa.org/health-and-safety/football-practice-guidelines.,Non-OADS,/arxiv_data1/oa_pdf/44/af/10.1177_2325967116664500.PMC5011310.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 7(9) 1–8 DOI: 10.1177/2054270416643889",Non-OADS,/arxiv_data1/oa_pdf/52/c9/10.1177_2054270416643889.PMC5011311.pdf
"Resolution ResAP (2003/3) on food and nutritional care in hospitals, https://wcd.coe.int/ViewDoc.jsp?id¼85747 (accessed 21 June 2016).",Non-OADS,/arxiv_data1/oa_pdf/52/c9/10.1177_2054270416643889.PMC5011311.pdf
"Asthma in the US: growing every year, 2011, http://www.cdc.gov/vital- signs/asthma/ (accessed 1 November 2015).",Non-OADS,/arxiv_data1/oa_pdf/49/67/10.1177_2050312116666216.PMC5011390.pdf
"The European Social Network, http://ec.europa.eu/health/mental_health/ docs/services_older.pdf (October 2008, accessed 22 June  2015).",Non-OADS,/arxiv_data1/oa_pdf/30/20/10.1177_2050312116665764.PMC5011394.pdf
"Using a targeted SNP approach together with experimental pain testing in human subjects, we exploredthe possible associations between human pain sensitivityand the previously described common SCN10A SNPs, rs6795970 and rs12632942, and additional nonsynonymousSNPs with a minor allele frequency 55% (dbSNP data- base, http://www.ncbi.nlm.nih.gov/snp/).",Non-OADS,/arxiv_data1/oa_pdf/54/05/10.1177_1744806916666083.PMC5011395.pdf
Genotyping of SCN10A SNPs was performed by Shanghai BioWing Applied Biotechnology Company (http://www.biowing.com.cn/) using ligase detectionreactions (LDRs).,OADS,/arxiv_data1/oa_pdf/54/05/10.1177_1744806916666083.PMC5011395.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/da/hepatmon-16-06-36942.PMC5011399.pdf
"The Ex- PASy translate tool (ExPASy: SIB Bioinformatics Resource Portal, http://web.expasy .org/translate/) was used to pre- dict the amino acid sequences coded in the PCR products.",OADS,/arxiv_data1/oa_pdf/2e/da/hepatmon-16-06-36942.PMC5011399.pdf
Available from: http://www.dgis.salud.gob.mx/ contenidos/sinais/estadisticas.html .,Non-OADS,/arxiv_data1/oa_pdf/2e/da/hepatmon-16-06-36942.PMC5011399.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/e4/hepatmon-16-06-36383.PMC5011400.pdf
Available from: http://www.pmrc.org.pk/ hepatitisbc.htm .,Non-OADS,/arxiv_data1/oa_pdf/db/e4/hepatmon-16-06-36383.PMC5011400.pdf
Hepatitis C factsheet Available from: http://www.who.int/mediacentre/factsheets/fs164/en/index.html .,Non-OADS,/arxiv_data1/oa_pdf/db/e4/hepatmon-16-06-36383.PMC5011400.pdf
Available from:  http://www.ncbi.nlm.nih.gov/books/NBK43749/ [Internet].,Non-OADS,/arxiv_data1/oa_pdf/87/f4/CCP-11-128.PMC5011401.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/ab/jjm-09-06-32159.PMC5011406.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/19/jjm-09-06-25246.PMC5011407.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/3e/jjm-09-06-33863.PMC5011413.pdf
E-mail: mabushhiwa@yahoo.comOriginal Article DOI: http://dx.doi.org/10.4314/ovj.v6i2.11 Submitted: 25/12/2015 Accepted: 03/08/2016 Published: 20/08/201 6 Cutaneous squamous cell carcinoma in the lateral abdominal wall  of local  Libyan ewes S.K.,Non-OADS,/arxiv_data1/oa_pdf/87/4b/OpenVetJ-6-139.PMC5011496.pdf
http://www.openveterinaryjournal.com S.K.,Non-OADS,/arxiv_data1/oa_pdf/87/4b/OpenVetJ-6-139.PMC5011496.pdf
http://www.openveterinaryjournal.com S.K.,Non-OADS,/arxiv_data1/oa_pdf/87/4b/OpenVetJ-6-139.PMC5011496.pdf
http://www.openveterinaryjournal.com S.K.,Non-OADS,/arxiv_data1/oa_pdf/87/4b/OpenVetJ-6-139.PMC5011496.pdf
"E-mail:  cezapata@uat.edu.mxOriginal Article DOI: http://dx.doi.org/10.4314/ovj.v6i2.12  Submitted: 24/04/2016 Accepted: 12/08/2016 Published: 26/08/201 6 Seroprevalence and risk factors associated with bovine herpesvi rus 1 and  bovine viral diarrhea virus in North-Eastern Mexico J.C. Segura-Correa1, C.C.",Non-OADS,/arxiv_data1/oa_pdf/d9/27/OpenVetJ-6-143.PMC5011497.pdf
http://www.openveterinaryjournal.com J.C. Segura-Correa et al.,Non-OADS,/arxiv_data1/oa_pdf/d9/27/OpenVetJ-6-143.PMC5011497.pdf
http://www.openveterinaryjournal.com J.C. Segura-Correa et al.,Non-OADS,/arxiv_data1/oa_pdf/d9/27/OpenVetJ-6-143.PMC5011497.pdf
http://www.openveterinaryjournal.com J.C. Segura-Correa et al.,Non-OADS,/arxiv_data1/oa_pdf/d9/27/OpenVetJ-6-143.PMC5011497.pdf
http://www.openveterinaryjournal.com J.C. Segura-Correa et al.,Non-OADS,/arxiv_data1/oa_pdf/d9/27/OpenVetJ-6-143.PMC5011497.pdf
http://www.openveterinaryjournal.com J.C. Segura-Correa et al.,Non-OADS,/arxiv_data1/oa_pdf/d9/27/OpenVetJ-6-143.PMC5011497.pdf
http://www.inegi.org.mx/est/contenidos/proyectos/Agro/ca2007/Resultados_Agricola/default.aspx.,OADS,/arxiv_data1/oa_pdf/d9/27/OpenVetJ-6-143.PMC5011497.pdf
Accessed 15 may 2016.  http://www.oie.int/hs2/report.asp.,Non-OADS,/arxiv_data1/oa_pdf/d9/27/OpenVetJ-6-143.PMC5011497.pdf
Accessed: 1 Sep. 2015 http://www.siap.gob.mx/exportacion-de-ganado-bovino/.,Non-OADS,/arxiv_data1/oa_pdf/d9/27/OpenVetJ-6-143.PMC5011497.pdf
http://www.openveterinaryjournal.com J.C. Segura-Correa et al.,Non-OADS,/arxiv_data1/oa_pdf/d9/27/OpenVetJ-6-143.PMC5011497.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/b5/41/jpts-28-2178.PMC5011556.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/b0/3a/jpts-28-2181.PMC5011557.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/e2/6e/jpts-28-2184.PMC5011558.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/a9/ba/jpts-28-2190.PMC5011559.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/47/2a/jpts-28-2196.PMC5011560.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/7d/5a/jpts-28-2199.PMC5011561.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/1d/8c/jpts-28-2204.PMC5011562.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/71/39/jpts-28-2211.PMC5011563.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/0e/8e/jpts-28-2214.PMC5011564.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/30/4e/jpts-28-2220.PMC5011565.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/27/93/jpts-28-2227.PMC5011566.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/0a/51/jpts-28-2232.PMC5011567.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/aa/d0/jpts-28-2238.PMC5011568.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/fe/d5/jpts-28-2241.PMC5011569.pdf
"Video sequences were digitized and examined using VirtualDub software (Avery Lee, version 1.5.10,  Cambridge, MA, USA; http://www.virtualdub.org/).",OADS,/arxiv_data1/oa_pdf/fe/d5/jpts-28-2241.PMC5011569.pdf
"The images were then analyzed using the ImageJ computer program  (National Institutes of Health, Bethesda, Maryland USA; http://rsb.info.nih.gov/nih-image) for height comparison.",OADS,/arxiv_data1/oa_pdf/fe/d5/jpts-28-2241.PMC5011569.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/67/2d/jpts-28-2245.PMC5011570.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/5e/73/jpts-28-2249.PMC5011571.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/8a/d0/jpts-28-2253.PMC5011572.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/76/1b/jpts-28-2260.PMC5011573.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/84/d3/jpts-28-2264.PMC5011574.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/b5/da/jpts-28-2268.PMC5011575.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/90/c2/jpts-28-2271.PMC5011576.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/30/95/jpts-28-2274.PMC5011577.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/85/69/jpts-28-2279.PMC5011578.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/d7/b2/jpts-28-2284.PMC5011579.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/a1/1d/jpts-28-2289.PMC5011580.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/5d/99/jpts-28-2293.PMC5011581.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/8a/cd/jpts-28-2299.PMC5011582.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/67/d7/jpts-28-2303.PMC5011583.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/20/14/jpts-28-2307.PMC5011584.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/90/85/jpts-28-2311.PMC5011585.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/0c/43/jpts-28-2316.PMC5011586.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/c9/56/jpts-28-2322.PMC5011587.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/09/ec/jpts-28-2326.PMC5011588.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/1b/0f/jpts-28-2330.PMC5011589.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/90/1f/jpts-28-2332.PMC5011590.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/d0/03/jpts-28-2337.PMC5011591.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/54/92/jpts-28-2342.PMC5011592.pdf
"http://www.idmil.org/mocap/Plug-in-Gait+Marker+Placement.pdf (Accessed Nov. 30, 2014) 16) Davis RB, Ounpuu S, Tyburski D, et al.",OADS,/arxiv_data1/oa_pdf/54/92/jpts-28-2342.PMC5011592.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/f6/b2/jpts-28-2347.PMC5011593.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/9f/67/jpts-28-2350.PMC5011594.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/fe/d2/jpts-28-2353.PMC5011595.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/23/ed/jpts-28-2358.PMC5011596.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/65/e2/jpts-28-2362.PMC5011597.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/0b/72/jpts-28-2369.PMC5011598.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/ea/9d/jpts-28-2373.PMC5011599.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/50/df/jpts-28-2376.PMC5011600.pdf
"http://www.who.int/dietphysicalactivity/factsheet_young_people/en/	 (Ac- cessed	Jan.	26,	2015) 3)	 Choi	 JY,	Chang	AK,	Choi	EJ:	Sex	differences	 in	social	cognitive	factors	and	physical	activity	in	Korean	college	students.",Non-OADS,/arxiv_data1/oa_pdf/50/df/jpts-28-2376.PMC5011600.pdf
"http://www.americanheart.org	(Accessed	Jan.	26,	2015)6)	 Kim	 JS,	Lee	DJ,	Lee	YS,	et	al.",Non-OADS,/arxiv_data1/oa_pdf/50/df/jpts-28-2376.PMC5011600.pdf
"http://www.kosso.or.kr	(Accessed	Jan.	26,	2015)19)	 Horowitz	JF:	Fatty	acid	mobilization	from	adipose	tissue	during	exercise.",Non-OADS,/arxiv_data1/oa_pdf/50/df/jpts-28-2376.PMC5011600.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/08/44/jpts-28-2379.PMC5011601.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/ff/e2/jpts-28-2381.PMC5011602.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/a2/93/jpts-28-2385.PMC5011603.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/09/86/jpts-28-2389.PMC5011604.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/10/47/jpts-28-2393.PMC5011605.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/a9/ea/jpts-28-2397.PMC5011606.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/c1/2c/jpts-28-2400.PMC5011607.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Case	Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/6b/d3/jpts-28-2404.PMC5011608.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Case Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/4e/33/jpts-28-2408.PMC5011609.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Case Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/4e/c8/jpts-28-2414.PMC5011610.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Case Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/e7/aa/jpts-28-2418.PMC5011611.pdf
"2003. http://www.dr-randoll-institut.de/wp-content/uploads/Coherent-Rhythms_Biological_Systems_MaRhyThe_Berlin2003.pdf (Accessed Sep. 14, 2015) 10) Randoll UG, Hennig FF: Vibrations and their Indication in Sport Injuries.",OADS,/arxiv_data1/oa_pdf/e7/aa/jpts-28-2418.PMC5011611.pdf
"2003. http://www.marhythe-systems.de/en/research-and-practical-experience/pub - lications (Accessed Sep. 14, 2015) 11) Taspinar F, Aslan UB, Sabir N, et al.",OADS,/arxiv_data1/oa_pdf/e7/aa/jpts-28-2418.PMC5011611.pdf
2012. http://www.lymphoedema.org.au/public/7/files/Comms/ALA_Cir - cumferential_Measurement_Guideline.pdf.,OADS,/arxiv_data1/oa_pdf/e7/aa/jpts-28-2418.PMC5011611.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and re- production in any medium, provided the original author(s) and the source are credited.JOURNAL OF NEUROTRAUMA 33:1607–1613 (September 1, 2016) Mary Ann Liebert, Inc.DOI: 10.1089/neu.2015.4127 1607",Non-OADS,/arxiv_data1/oa_pdf/52/f5/neu.2015.4127.PMC5011623.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS Volume 32, Number 7, 2016Mary Ann Liebert, Inc.DOI: 10.1089/jop.2016.0038 415",Non-OADS,/arxiv_data1/oa_pdf/a0/4b/jop.2016.0038.PMC5011631.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/5f/num-08-03-36022.PMC5011638.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/c2/hepatmon-16-06-34202.PMC5011639.pdf
"Additional Information Supplementary information accompanies this paper at http://www.nature.com/srep Competing financial interests: The authors declare no competing financial interests.How to cite this article: Zhang, C. and Ma, L. Millimetre Wave with Rotational Orbital Angular Momentum.",Non-OADS,/arxiv_data1/oa_pdf/c7/1e/srep31921.PMC5011649.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/   © The Author(s) 2016",Non-OADS,/arxiv_data1/oa_pdf/c7/1e/srep31921.PMC5011649.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Lynnette R Ferguson, Professor  of  Nutrition, Discipline of Nutrition and Dietetics and Auckland  Cancer Society Research Centre, Faculty of Medical and Health  Science, The University of Auckland, Private Bag 92019,  Auckland, New Zealand.",Non-OADS,/arxiv_data1/oa_pdf/cc/4c/WJG-22-7389.PMC5011656.pdf
"Key words:  Biomarkers; Epigenetics; Risk; Colorectal  cancer; Predisposition; MicroRNAFRONTIERSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7389 7389 September 7, 2016 |Volume 22 |Issue 33 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 September 7; 22(33): 7389-7401  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/cc/4c/WJG-22-7389.PMC5011656.pdf
World J  Gastroenterol  2016; 22(33): 7389-7401  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i33/7389.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i33.7389 INTRODUCTION Colorectal cancer (CRC) is the second most common  cancer in women and the third most common cancer in  men[1].,Non-OADS,/arxiv_data1/oa_pdf/cc/4c/WJG-22-7389.PMC5011656.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/cc/4c/WJG-22-7389.PMC5011656.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Gireesh Rajashekara, DVM, PhD,  170 Food Animal Health Research Program and Department of  Veterinary Preventive Medicine, College of Veterinary Medicine,  The Ohio State University, 1680 Madison Avenue, Wooster, OH 44691, United States.",Non-OADS,/arxiv_data1/oa_pdf/1f/9b/WJG-22-7402.PMC5011657.pdf
"Additionally, the  review article identifies potential areas for future  investigation that would enhance our understanding  of the role of poly P in C. jejuni  and other bacteria,  which ultimately would facilitate design of effective  therapeutic/preventive strategies to reduce not only the  burden of C. jejuni -caused foodborne infections but also  of other bacterial infections in humans.REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7402 7402 September 7, 2016 |Volume 22 |Issue 33 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 September 7; 22(33): 7402-7414  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/1f/9b/WJG-22-7402.PMC5011657.pdf
wjgnet.com/1007-9327/full/v22/i33/7402.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/9b/WJG-22-7402.PMC5011657.pdf
"The  genus Campylobacter  consists of 34 species and 14  subspecies, which are human and animal pathogens  (http://www.bacterio.net/campylobacter.htm l, last  accessed 17 March 2016).",Non-OADS,/arxiv_data1/oa_pdf/1f/9b/WJG-22-7402.PMC5011657.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/1f/9b/WJG-22-7402.PMC5011657.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Giuseppe Masanotti, MD, Professor,  Department of Experimental Medicine, Public Health Section,  University of Perugia, Via del Giochetto, n.6, 06126 Perugia,  Umbria, Italy.",Non-OADS,/arxiv_data1/oa_pdf/60/50/WJG-22-7415.PMC5011658.pdf
"Human  papillomavirus vaccination is the key to improving HPV- related disease control, and universal vaccination could  achieve optimal health benefits.REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7415 7415 September 7, 2016 |Volume 22 |Issue 33 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 September 7; 22(33): 7415-7430  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/60/50/WJG-22-7415.PMC5011658.pdf
"World J  Gastroenterol  2016; 22(33): 7415-7430  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i33/7415.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i33.7415 INTRODUCTION Human papillomaviruses (HPVs) are a large family of  small double-stranded DNA viruses with established  oncogenic potential, and they are recognized as a  major cause of infection-related cancer worldwide  (along with Helicobacter pylori and hepatitis viruses  B and C).",Non-OADS,/arxiv_data1/oa_pdf/60/50/WJG-22-7415.PMC5011658.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/60/50/WJG-22-7415.PMC5011658.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Atsuo Shida, MD, PhD,  Department of  Surgery, Jikei University School of Medicine, 3-25-8, Nishi- shinbashi, Minato-ku, Tokyo 105-8461,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/0e/30/WJG-22-7431.PMC5011659.pdf
"atsuoshida@ybb.ne.j p Telephone: +81-3-34331111 Fax: +81-3-54724140 Received: March 26, 2016 Peer-review started:  March 29, 2016 First decision:  May 12, 2016 Revised:  May 22, 2016 Accepted: July 6, 2016 Article in press:  July 6, 2016 Published online: September 7, 2016REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7431World J Gastroenterol   2016 September 7; 22(33): 7431-7439  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/0e/30/WJG-22-7431.PMC5011659.pdf
World J Gastroenterol  2016; 22(33): 7431-7439   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i33/7431.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/0e/30/WJG-22-7431.PMC5011659.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/0e/30/WJG-22-7431.PMC5011659.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Shunsuke Kondo, MD, PhD,  Department  of Experimental Therapeutics, National Cancer Center Hospital,  5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/cd/43/WJG-22-7440.PMC5011660.pdf
"Furthermore, the review  demonstrated that the current focus on therapeutic  strategies involving combination chemotherapy, REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7440 7440 September 7, 2016 |Volume 22 |Issue 33 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 September 7; 22(33): 7440-7452  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/cd/43/WJG-22-7440.PMC5011660.pdf
"World J  Gastroenterol  2016; 22(33): 7440-7452  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i33/7440.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i33.7440 INTRODUCTION   Currently, pancreatic adenocarcinoma (PAC) is re­ cognized as one of the most malignant neoplasms.",Non-OADS,/arxiv_data1/oa_pdf/cd/43/WJG-22-7440.PMC5011660.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/cd/43/WJG-22-7440.PMC5011660.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Si ­De Liu, MD, Professor,  Department  of Gastroenterology, Guangdong Provincial Key Laboratory  of Gastroenterology, Nanfang Hospital, Southern Medical  University, No.",Non-OADS,/arxiv_data1/oa_pdf/52/8f/WJG-22-7453.PMC5011661.pdf
"liuside2011@163.com Telephone:  +86-20-61641537  Fax:  +86-20-87280770 Received:  March 27, 2016   Peer­review started:  March 28, 2016 First decision:  May 12, 2016 Revised:  May 30, 2016   Accepted:  June 15, 2016  REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7453 7453 September 7, 2016 |Volume 22 |Issue 33 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 September 7; 22(33): 7453-7462  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/52/8f/WJG-22-7453.PMC5011661.pdf
World J Gastroenterol  2016; 22(33): 7453-7462   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i33/7453.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/52/8f/WJG-22-7453.PMC5011661.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/52/8f/WJG-22-7453.PMC5011661.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Yang-Chao Chen, PhD,  School of  Biomedical Sciences, Faculty of Medicine, the Chinese University  of Hong Kong, Shatin, NT, Hong Kong,  China.",Non-OADS,/arxiv_data1/oa_pdf/8d/74/WJG-22-7463.PMC5011662.pdf
"World J  Gastroenterol  2016; 22(33): 7463-7477  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i33/7463.htm   DOI: REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7463 7463 September 7, 2016 |Volume 22 |Issue 33 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 September 7; 22(33): 7463-7477  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/8d/74/WJG-22-7463.PMC5011662.pdf
http://dx.doi.org/10.3748/wjg.v22.i33.7463 INTRODUCTION Pancreatic cancer mortality is the fourth leading cause  of cancer deaths in males and females and accounts  for 7% of all deaths in cancer patients[1].,Non-OADS,/arxiv_data1/oa_pdf/8d/74/WJG-22-7463.PMC5011662.pdf
"Available from: URL: http://www.endocrine- abstracts.org/ea/0029/ea0029p706.htm 30 Kohli R , Kirby M, Setchell KD, Jha P, Klustaitis K, Woollett LA,  Pfluger PT, Balistreri WF, Tso P, Jandacek RJ, Woods SC, Heubi  JE, Tschoep MH, D’Alessio DA, Shroyer NF, Seeley RJ.",Non-OADS,/arxiv_data1/oa_pdf/8d/74/WJG-22-7463.PMC5011662.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/8d/74/WJG-22-7463.PMC5011662.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Bao- Rui Liu, MD, PhD,  Comprehensive  Cancer Centre of Drum Tower Hospital, Medical School  of Nanjing University, Clinical Cancer Institute of Nanjing  University, 321 Zhongshan Road, Nanjing 210008, Jiangsu  Province, China.",Non-OADS,/arxiv_data1/oa_pdf/e3/54/WJG-22-7478.PMC5011663.pdf
"In this review, we summarized REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7478 7478 September 7, 2016 |Volume 22 |Issue 33 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 September 7; 22(33): 7478-7485  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/e3/54/WJG-22-7478.PMC5011663.pdf
World J Gastroenterol  2016;  22(33): 7478-7485  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/e3/54/WJG-22-7478.PMC5011663.pdf
com/1007-9327/full/v22/i33/7478.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/54/WJG-22-7478.PMC5011663.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/e3/54/WJG-22-7478.PMC5011663.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Fan Zhu, PhD, Professor,  Department of  Medical Microbiology, School of Medicine, Wuhan University,  185 Donghu road, Wuhan 430071, Hubei Province,  China.",Non-OADS,/arxiv_data1/oa_pdf/bd/21/WJG-22-7486.PMC5011664.pdf
"Aberrant regulation from  three complexes (the cell-surface receptor complex,  the cytoplasmic destruction complex and the nuclear REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7486 7486 September 7, 2016 |Volume 22 |Issue 33 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 September 7; 22(33): 7486-7499  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/bd/21/WJG-22-7486.PMC5011664.pdf
"World  J Gastroenterol  2016; 22(33): 7486-7499  Available from: U rL:  http://www.wjgnet.com/1007-9327/full/v22/i33/7486.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i33.7486 INTRODUCTION Hepatocellular carcinoma (HCC), the fifth most  common malignancy in men and ninth among women  worldwide, is the second leading cause of cancer  deaths[1].",Non-OADS,/arxiv_data1/oa_pdf/bd/21/WJG-22-7486.PMC5011664.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/bd/21/WJG-22-7486.PMC5011664.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Koji Hashimoto, MD, PhD,  Department  of General Surgery, Digestive Disease Institute, Cleveland Clinic,  9500 Euclid Ave.",Non-OADS,/arxiv_data1/oa_pdf/30/87/WJG-22-7500.PMC5011665.pdf
"The  routine use of SLT, however, remains controversial due  to various challenges, particularly under the current  “sickest first” liver allocation policy.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7500 7500 September 7, 2016 |Volume 22 |Issue 33 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 September 7; 22(33): 7500-7506  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/30/87/WJG-22-7500.PMC5011665.pdf
World J Gastroenterol  2016; 22(33): 7500-7506   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i33/7500.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/30/87/WJG-22-7500.PMC5011665.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/30/87/WJG-22-7500.PMC5011665.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Mohammad S Khuroo, Director,  Digestive Diseases Centre, Dr. Khuroo’s Medical Clinic, Sector 1,  SK Colony, Qamarwari, Srinagar, Kashmir 190010,  India.",Non-OADS,/arxiv_data1/oa_pdf/26/9f/WJG-22-7507.PMC5011666.pdf
"Published by Baishideng Publishing  Group Inc. All rights reserved.MINIREVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7507 7507 September 7, 2016 |Volume 22 |Issue 33 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 September 7; 22(33): 7507-7517  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/26/9f/WJG-22-7507.PMC5011666.pdf
World J Gastroenterol  2016;  22(33): 7507-7517  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/26/9f/WJG-22-7507.PMC5011666.pdf
com/1007-9327/full/v22/i33/7507.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/26/9f/WJG-22-7507.PMC5011666.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/26/9f/WJG-22-7507.PMC5011666.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Niteen Tapuria, MS, MD (research),  FRCS, FRCS (Gen Surg),  Department of HPB Surgery and  Liver transplantation, Royal Free Hospital, Hampstead, London  NW32QG, United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/69/de/WJG-22-7518.PMC5011667.pdf
"PDTC (HO induction) reproduced the effects Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7518 7518 September 7, 2016 |Volume 22 |Issue 33 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 September 7; 22(33): 7518-7535  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/69/de/WJG-22-7518.PMC5011667.pdf
World J Gastroenterol  2016; 22(33): 7518-7535  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v22/i33/7518.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i33.7518 INTRODUCTION Ischemia reperfusion injury (IRI) in liver transplantation  remains a concern since the incidence of primary  nonfunction is 5%-10% in liver transplantation and the  problem is aggravated in fatty livers.,Non-OADS,/arxiv_data1/oa_pdf/69/de/WJG-22-7518.PMC5011667.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/69/de/WJG-22-7518.PMC5011667.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Magdalena Chmiela, Professor, PhD,  Department of Immunology and Infectious Biology, Institute  of Microbiology, Biotechnology and Immunology, Faculty of  Biology and Environmental Protection, University of Łódź,  Banacha 12/16, 90-237 Łódź, Poland.",Non-OADS,/arxiv_data1/oa_pdf/51/fb/WJG-22-7536.PMC5011668.pdf
"METHODS In this study, using two cellular models of gastric  epithelial cells and fibroblasts, we have focused  on exploring the effects of well defined H. pylori   soluble components such as glycine acid extract  antigenic complex (GE), subunit A of urease (UreA),  cytotoxin associated gene A protein (CagA) and  lipopolysaccharide (LPS) on cell turnover by comparing  the wound healing capacity of the cells in terms of their Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7536 7536 September 7, 2016 |Volume 22 |Issue 33 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 September 7; 22(33): 7536-7558  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/51/fb/WJG-22-7536.PMC5011668.pdf
"World J  Gastroenterol  2016; 22(33): 7536-7558  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i33/7536.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i33.7536INTRODUCTION   The gastric mucosal barrier (GMB) is composed of  a pre-epithelial layer (mucus and bicarbonate), a  tight epithelial component, the post-epithelial layer  (fibroblasts and immune cells), microcirculation (blood  flow) and nerves[1].",Non-OADS,/arxiv_data1/oa_pdf/51/fb/WJG-22-7536.PMC5011668.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/51/fb/WJG-22-7536.PMC5011668.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Young Sook Park, MD, PhD,  Department  of Gastroenterology, Eulji University School of Medicine, Eulji  Hospital, 68 Hangeulbiseok-Ro, Nowon-Gu, Seoul 139-711,  South Korea.",Non-OADS,/arxiv_data1/oa_pdf/45/af/WJG-22-7559.PMC5011669.pdf
"Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7559 7559 September 7, 2016 |Volume 22 |Issue 33 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 September 7; 22(33): 7559-7568  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/45/af/WJG-22-7559.PMC5011669.pdf
World J Gastroenterol  2016;  22(33): 7559-7568  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/45/af/WJG-22-7559.PMC5011669.pdf
com/1007-9327/full/v22/i33/7559.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/af/WJG-22-7559.PMC5011669.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/45/af/WJG-22-7559.PMC5011669.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Takuya Genda, MD, PhD, Associate  Professor,  Department of Gastroenterology and Hepatology,  Juntendo University Shizuoka Hospital, 1129 Nagaoka,  Izunokuni-shi, Shizuoka 410-2295, Japan.",Non-OADS,/arxiv_data1/oa_pdf/c5/96/WJG-22-7569.PMC5011670.pdf
"METHODS In this study, we enrolled 303 chronic hepatitis C  patients who had achieved sustained virological  response (SVR) through interferon-based antiviral ORIGINAL ARTICLESubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7569World J Gastroenterol   2016 September 7; 22(33): 7569-7578  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/c5/96/WJG-22-7569.PMC5011670.pdf
World J Gastroenterol  2016;  22(33): 7569-7578  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/c5/96/WJG-22-7569.PMC5011670.pdf
com/1007-9327/full/v22/i33/7569.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/96/WJG-22-7569.PMC5011670.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/c5/96/WJG-22-7569.PMC5011670.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript  Correspondence to: Dr. Chang-Qing Zheng, Professor,  Division II, Department of Gastroenterology, Shengjing Hospital,  China Medical University, No.",Non-OADS,/arxiv_data1/oa_pdf/87/e2/WJG-22-7579.PMC5011671.pdf
"Biochemical i ndexes (except ALB), immunological  indexes, positive rates of autoantibodies (except  SMA), and number of cases of patients with different  ANA titers (except the group at a titer of 1:10000) Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7579 7579 September 7, 2016 |Volume 22 |Issue 33 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 September 7; 22(33): 7579-7586  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/87/e2/WJG-22-7579.PMC5011671.pdf
World  J Gastroenterol  2016; 22(33): 7579-7586  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i33/7579.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i33.7579 INTRODUCTION Drug-induced liver injury (DILI) as an important  cause of acute liver failure and chronic liver injury has  increasingly been recognized.,Non-OADS,/arxiv_data1/oa_pdf/87/e2/WJG-22-7579.PMC5011671.pdf
"(20061117) Available from: URL: http://www.fda.gov/cder/ livertox/presentaions 2005/vic_Navarro.ppt 6 Watkins PB , Seeff LB.",Non-OADS,/arxiv_data1/oa_pdf/87/e2/WJG-22-7579.PMC5011671.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/87/e2/WJG-22-7579.PMC5011671.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Luiz Gonzaga Coelho, PhD, Professor  of Medicine, Department of Internal Medicine, Head of Alfa  Institute of Gastroenterology, School of Medicine, Federal  University of Minas Gerais, Belo Horizonte 30130-100, Minas  Gerais, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/46/c1/WJG-22-7587.PMC5011672.pdf
"lcoelho22@gmail.com Telephone:  +55-31-32224641 Fax:  +55-31-32262886 Received:  May 15, 2016 Peer-review started:  May 17, 2016 First decision:  June 20, 2016 Revised:  June 28, 2016Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7587 7587 September 7, 2016 |Volume 22 |Issue 33 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 September 7; 22(33): 7587-7594  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/46/c1/WJG-22-7587.PMC5011672.pdf
World J Gastroenterol  2016; 22(33): 7587-7594   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i33/7587.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/46/c1/WJG-22-7587.PMC5011672.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/46/c1/WJG-22-7587.PMC5011672.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: William Bernal, MD, FRCP,  Liver Intensive Therapy Unit,  Institute of Liver Studies, King’s College Hospital,   Denmark Hill, London SE5 9RS,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/4d/5c/WJG-22-7595.PMC5011673.pdf
"Princip les of care of patients Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7595 7595 September 7, 2016 |Volume 22 |Issue 33 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 September 7; 22(33): 7595-7603  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/4d/5c/WJG-22-7595.PMC5011673.pdf
World J Gastroenterol  2016; 22(33):  7595-7603  Available from: URL: http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/4d/5c/WJG-22-7595.PMC5011673.pdf
com/1007-9327/full/v22/i33/7595.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/5c/WJG-22-7595.PMC5011673.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/4d/5c/WJG-22-7595.PMC5011673.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Peer B Christensen, PhD, Associate  Professor,  Department of Infectious Diseases,  Odense University  Hospital,  Sdr.",Non-OADS,/arxiv_data1/oa_pdf/7a/c4/WJG-22-7604.PMC5011674.pdf
"The samples were analyzed for HBsAg, anti- HBc, anti-HBs, anti-HCV, and anti-HIV levels as well  as subjected to a combined nucleic acid test (NAT) for  HBV DNA, HCV RNA and HIV RNA.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7604 7604 September 7, 2016 |Volume 22 |Issue 33 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 September 7; 22(33): 7604-7612  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/7a/c4/WJG-22-7604.PMC5011674.pdf
"World  J Gastroenterol  2016; 22(33): 7604-7612  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i33/7604.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i33.7604 INTRODUCTION Chronic viral hepatitis B (CHB) and C (CHC) represent  a major health burden worldwide, with approximately  350 million and 170 million people infected, res­ pectively[1].",Non-OADS,/arxiv_data1/oa_pdf/7a/c4/WJG-22-7604.PMC5011674.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/7a/c4/WJG-22-7604.PMC5011674.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Demetrios Moris, MD, PhD,  Department  of Immunology, Lerner Research Institute, Cleveland Clinic  Foundation, 9500 Euclid Ave., NE60, Cleveland, O h 44195,  United States.",Non-OADS,/arxiv_data1/oa_pdf/71/87/WJG-22-7613.PMC5011675.pdf
"RESULTS Liver regeneration after Associating Liver Partition  and Portal vein ligation for Stage hepatectomy is a Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i33.7613 7613 September 7, 2016 |Volume 22 |Issue 33 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 September 7; 22(33): 7613-7624  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/71/87/WJG-22-7613.PMC5011675.pdf
World J Gastroenterol  2016;  22(33): 7613-7624  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/71/87/WJG-22-7613.PMC5011675.pdf
com/1007-9327/full/v22/i33/7613.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/87/WJG-22-7613.PMC5011675.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453  3",Non-OADS,/arxiv_data1/oa_pdf/71/87/WJG-22-7613.PMC5011675.pdf
"More information can be found at the following link: http://society-scwd.org.Figure 1 Number of manuscript submissions to the Journal of Cachexia, Sarcopenia and Muscle by year of publication.",Non-OADS,/arxiv_data1/oa_pdf/2e/60/JCSM-7-391.PMC5011813.pdf
[http://dx.doi.org/10.1007/s00415-010-5456-0] [PMID: 20352256] [3] Howard RS.,Non-OADS,/arxiv_data1/oa_pdf/e2/d0/TONEUJ-10-77.PMC5012079.pdf
"[http://dx.doi.org/10.1002/mus.20259] [PMID: 15599928] [8] Jubelt B, Agre JC.",Non-OADS,/arxiv_data1/oa_pdf/e2/d0/TONEUJ-10-77.PMC5012079.pdf
"[http://dx.doi.org/10.1001/jama.284.4.412] [PMID: 10904484] [9] Ramlow J, Alexander M, LaPorte R, Kaufmann C, Kuller L. Epidemiology of the post-polio syndrome.",Non-OADS,/arxiv_data1/oa_pdf/e2/d0/TONEUJ-10-77.PMC5012079.pdf
"[http://dx.doi.org/10.1093/aje/136.7.769] [PMID: 1442743] [10] Bertolasi L, Acler M,.",OADS,/arxiv_data1/oa_pdf/e2/d0/TONEUJ-10-77.PMC5012079.pdf
"[http://dx.doi.org/10.1007/s10072-012-0931-2] [PMID: 22246456] [11] Farbu E, Rekand T, Gilhus NE.",OADS,/arxiv_data1/oa_pdf/e2/d0/TONEUJ-10-77.PMC5012079.pdf
"[http://dx.doi.org/10.1046/j.1468-1331.2003.00613.x] [PMID: 12823493] [12] Farbu E, Gilhus NE, Barnes MP, et al.",OADS,/arxiv_data1/oa_pdf/e2/d0/TONEUJ-10-77.PMC5012079.pdf
[http://dx.doi.org/10.1111/j.1468-1331.2006.01385.x] [PMID: 16879288] [13] Post-polio  syndrome.,Non-OADS,/arxiv_data1/oa_pdf/e2/d0/TONEUJ-10-77.PMC5012079.pdf
[http://dx.doi.org/10.2340/16501977-1838] [PMID: 24941350] [15] Carlsson AM.,OADS,/arxiv_data1/oa_pdf/e2/d0/TONEUJ-10-77.PMC5012079.pdf
"[http://dx.doi.org/10.1016/0304-3959(83)90088-X] [PMID: 6602967] [16] Ivanyi B, Nollet F, Redekop WK, et al.",OADS,/arxiv_data1/oa_pdf/e2/d0/TONEUJ-10-77.PMC5012079.pdf
[http://dx.doi.org/10.1097/MRR.0000000000000052] [PMID: 24535632] [19] Dalakas MC.,Non-OADS,/arxiv_data1/oa_pdf/e2/d0/TONEUJ-10-77.PMC5012079.pdf
"[http://dx.doi.org/10.1111/j.1749-6632.1995.tb27532.x] [PMID: 7611661] [20] Kerstman E, Ahn S, Battu S, Tariq S, Grabois M. Neuropathic pain.",Non-OADS,/arxiv_data1/oa_pdf/e2/d0/TONEUJ-10-77.PMC5012079.pdf
"[http://dx.doi.org/10.1016/B978-0-444-52901-5.00015-0] [PMID: 23312640] [21] Kemp BJ, Krause JS.",OADS,/arxiv_data1/oa_pdf/e2/d0/TONEUJ-10-77.PMC5012079.pdf
"[http://dx.doi.org/10.1080/096382899297666] [PMID: 10381236] [22] Trojan  DA,  Arnold  DL,  Shapiro  S,  et  al.",OADS,/arxiv_data1/oa_pdf/e2/d0/TONEUJ-10-77.PMC5012079.pdf
"[http://dx.doi.org/10.1016/j.pmrj.2009.03.003] [PMID: 19627931] © Bertolasi et al; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/d0/TONEUJ-10-77.PMC5012079.pdf
"[http://dx.doi.org/10.1016/j.annemergmed.2012.05.025 ] [PMID: 23260687 ] [3] Hubiche T, Bes M, Roudiere L, Langlaude F, Etienne J, Del Giudice P. Mild staphylococcal scalded skin syndrome: an underdiagnosed clinical disorder.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1111/j.1365-2133.2011.10515.x ] [PMID: 21729032 ] [4] Sah P, Rijal KR, Shakya B, Tiwari BR, Ghimire P. Nasal carriage Rate of Staphylococcus aureus  in hospital personnel of National Medical College and Teaching Hospital and their susceptibility pattern.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
[http://dx.doi.org/10.1093/jb/mvh182 ] [PMID: 15671483 ] [7] Ladhani S. Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus .,Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1016/S0928-8244(03)00225-6 ] [PMID: 14625102 ] [8] Hubiche T, Bes M, Roudiere L, Langlaude F, Etienne J, Del Giudice P. Mild staphylococcal scalded skin syndrome: an underdiagnosed clinical disorder.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1111/j.1365-2133.2011.10515.x ] [PMID: 21729032 ] [9] Yamamoto T, Nishiyama A, Takano T, et al.",OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1007/s10156-010-0045-9 ] [PMID: 20336341 ] [10] Acharya KR, Passalacqua EF, Jones EY, et al.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1038/367094a0 ] [PMID: 8107781 ] [11] Alouf JE, Müller-Alouf H. Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1078/1438-4221-00232 ] [PMID: 12635926 ] [12] Adesiyun AA, Lenz W, Schaal KP.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1086/313461 ] [PMID: 10524952 ] [16] Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus : epidemiology, underlying mechanisms, and associated risks.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
[http://dx.doi.org/10.1016/j.bjid.2014.12.011 ] [PMID: 25701548 ],OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1017/S0195941700066935 ] [PMID: 3643888 ] [19] Jimenez-Truque N, Tedeschi S, Saye EJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1542/peds.2011-2308 ] [PMID: 22473373 ] [20] Aydin D, Alsbjørn B.",OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1002/ccr3.535 ] [PMID: 27099742 ] [21] Schwartz  RA,  McDonough  PH,  Lee  BW.",OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1016/j.jaad.2013.05.002 ] [PMID: 23866879 ] [22] Arbuthnott JP, Kent J, Lyell A, et al.",OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1111/j.1365-2133.1972.tb15412.x ] [23] Bailey CJ, de Azavedo J, Arbuthnott JP.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1016/0005-2795(80)90230-5 ] [PMID: 6773585 ] [24] Bailey CJ, Lockhart BP, Redpath MB, Smith TP.",OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1007/BF00221387 ] [PMID: 7500911 ] [25] Cribier B, Piemont Y, Grosshans E. Staphylococcal scalded skin syndrome in adults.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1016/S0190-9622(94)70032-X ] [PMID: 8294590 ] [26] Moss C, Gupta E. The Nikolsky sign in staphylococcal scalded skin syndrome.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1136/adc.79.3.290 ] [PMID: 9875032 ] [27] Oliveira AR, Aires S, Faria C, Santos E. Staphylococcal scalded skin syndrome.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1136/bcr-2013-009478 ] [28] Handler MZ, Schwartz RA.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
[http://dx.doi.org/10.1111/jdv.12541 ] [PMID: 24841497 ] [29] Machida K. Immunological investigations on pathogenesis of staphylococcal scalded skin syndrome.,Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1016/S0076-6879(88)65049-X ] [PMID: 3148097 ] [33] Mehrotra M, Wang G, Johnson WM.",OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1136/adc.78.1.85 ] [PMID: 9534685 ] [35] Perkin RM, Newton DA, Swift JD.",OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1016/j.amjmed.2009.09.041 ] [PMID: 20569752 ] [37] Porro AM, Caetano LdeV, Maehara LdeS, Enokihara MM.",OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1590/abd1806-4841.20142459 ] [PMID: 24626654 ] [38] Runswick SK, O’Hare MJ, Jones L, Streuli CH, Garrod DR. Desmosomal adhesion regulates epithelial morphogenesis and cell positioning.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1038/ncb0901-823 ] [PMID: 11533662 ] [39] Nishifuji  K,  Shimizu  A,  Ishiko  A,  Iwasaki  T,  Amagai  M.  Removal  of  amino-terminal  extracellular  domains  of  desmoglein  1  by",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1016/j.jdermsci.2010.07.010] [PMID: 20728315] [40] Krieg T, Bickers DR, Miyachi Y.",OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1007/978-3-540-78814-0] [41] Hanakawa Y, Schechter NM, Lin C, et al.",OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1172/JCI0215766] [PMID: 12093888] [42] Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
[http://dx.doi.org/10.1038/81385] [PMID: 11062541] [43] Johnston GA.,Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
[http://dx.doi.org/10.1586/14787210.2.3.439] [PMID: 15482208] [44] Patel GK.,Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1586/14787210.2.4.575] [PMID: 15482221] [45] Handler MZ, Schwartz RA.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1111/jdv.12541] [PMID: 24841497] [46] Kouakou K, Dainguy ME, Kassi K. Staphylococcal Scalded Skin Syndrome in Neonate.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1086/510396] [PMID: 17191165] [48] El  Helali  N,  Carbonne  A,  Naas  T,  et  al.",OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1016/j.jhin.2005.02.013] [PMID: 16009455] [49] Curran JP, Al-Salihi FL.",OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1016/S0163-4453(88)96249-4] [PMID: 3367061] [51] Lina G, Vandenesch F, Etienne J. Staphylococcal and streptococcal pediatric toxic syndrome from 1998 to 2000.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
[http://dx.doi.org/10.1016/S0929-693X(01)80195-0] [PMID: 11582926] [52] Complications of impetigo.,Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"Available at: http://www.nhs.uk/Conditions/Impetigo/Pages/Complications.aspx [Accessed February 10, 2016].",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
[http://dx.doi.org/10.1016/S0344-0338(11)80499-1] [PMID: 8065992] [54] Staphylococcal skin infections.,Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"Available at: http://www.dermnetnz.org/bacterial/staphylococci.html [Accessed February 10, 2016].",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
[http://dx.doi.org/10.1111/j.1749-6632.1974.tb41497.x] [PMID: 4278721] [56] Ladhani S. Recent developments in staphylococcal scalded skin syndrome.,Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1046/j.1198-743x.2001.00258.x] [PMID: 11442563] [57] da Silva Tatley F, Aldwell FE, Dunbier AK, Guilford PJ.",OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1128/IAI.71.3.1580-1583.2003] [PMID: 12595481] [58] Lecuit M, Dramsi S, Gottardi C, Fedor-Chaiken M, Gumbiner B, Cossart P. A single amino acid in E-cadherin responsible for host specificity towards the human pathogen Listeria monocytogenes.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1093/emboj/18.14.3956] [PMID: 10406800] [59] Shupp JW, Jett M, Pontzer CH.",OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1128/IAI.70.4.2178-2186.2002] [PMID: 11895985] reproduction in any medium, provided the work is properly cited.© Mishra et al.",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and",Non-OADS,/arxiv_data1/oa_pdf/6b/06/TOMICROJ-10-150.PMC5012080.pdf
"[http://dx.doi.org/10.1016/S0161-6420(93)31466-1 ] [PMID: 7692366 ] [2] Bai Y, Ma J-X, Guo J, et al.",OADS,/arxiv_data1/oa_pdf/95/c8/TONEUJ-10-83.PMC5012081.pdf
"[http://dx.doi.org/10.1002/path.2611 ] [PMID: 19768732 ] [3] Lu L, Hackett SF, Mincey A, Lai H, Campochiaro PA.",OADS,/arxiv_data1/oa_pdf/95/c8/TONEUJ-10-83.PMC5012081.pdf
"[http://dx.doi.org/10.1002/jcp.20439 ] [PMID: 15965958 ] [4] Mullins RF, Russell SR, Anderson DH, Hageman GS.",OADS,/arxiv_data1/oa_pdf/95/c8/TONEUJ-10-83.PMC5012081.pdf
"[http://dx.doi.org/10.1016/S0014-4835(03)00023-X ] [PMID: 12634104 ] [6] Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration.",OADS,/arxiv_data1/oa_pdf/95/c8/TONEUJ-10-83.PMC5012081.pdf
[http://dx.doi.org/10.1016/S0039-6257(00)00140-5 ] [PMID: 11033038 ] [7] Kozlowski MR.,OADS,/arxiv_data1/oa_pdf/95/c8/TONEUJ-10-83.PMC5012081.pdf
"[http://dx.doi.org/10.3109/02713683.2014.935440 ] [PMID: 24977298 ] [8] Arend N, Wertheimer C, Laubichler P, Wolf A, Kampik A, Kernt M. Idebenone prevents oxidative stress, cell death and senescence of retinal pigment epithelium cells by stabilizing BAX/Bcl-2 ratio.",Non-OADS,/arxiv_data1/oa_pdf/95/c8/TONEUJ-10-83.PMC5012081.pdf
"[http://dx.doi.org/10.1159/000381726 ] [PMID: 26044821 ] [9] Yu AL, Fuchshofer R, Kook D, Kampik A, Bloemendal H, Welge-Lüssen U. Subtoxic oxidative stress induces senescence in retinal pigment epithelial cells via TGF-beta release.",Non-OADS,/arxiv_data1/oa_pdf/95/c8/TONEUJ-10-83.PMC5012081.pdf
[http://dx.doi.org/10.1167/iovs.07-1003 ] [PMID: 19171648 ] [10] Tso MO.,OADS,/arxiv_data1/oa_pdf/95/c8/TONEUJ-10-83.PMC5012081.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/c8/TONEUJ-10-83.PMC5012081.pdf
"[http://dx.doi.org/10.1016/j.jacc.2013.10.040 ] [PMID: 24239659 ] [2] Laurent S, Kingwell B, Bank A, Weber M, Struijker-Boudier H. Clinical applications of arterial stiffness: therapeutics and pharmacology.",Non-OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1016/S0895-7061(01)02329-9 ] [PMID: 12022248 ] [3] Mackenzie IS, Wilkinson IB, Cockcroft JR. Assessment of arterial stiffness in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1093/qjmed/95.2.67 ] [PMID: 11861952 ] [4] Oliver JJ, Webb DJ.",OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1161/01.ATV.0000060460.52916.D6 ] [PMID: 12615661 ] [5] O’Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE.",OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1016/S0895-7061(01)02319-6 ] [PMID: 12022246 ] [6] Pannier BM, Avolio AP, Hoeks A, Mancia G, Takazawa K. Methods and devices for measuring arterial compliance in humans.",OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1016/S0895-7061(02)02962-X ] [PMID: 12160200 ] [7] Laurent S, Cockcroft J, Van Bortel L, et al.",OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
[http://dx.doi.org/10.1093/eurheartj/ehl254 ] [PMID: 17000623 ],Non-OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1016/j.mvr.2008.10.001 ] [PMID: 18996402 ] [9] Nürnberger  J,  Keflioglu-Scheiber  A,  Opazo  Saez  AM,  Wenzel  RR,  Philipp  T,  Schäfers  RF.",OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
[http://dx.doi.org/10.1097/00004872-200212000-00020 ] [PMID: 12473865 ] [10] Safar ME.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
[http://dx.doi.org/10.1177/1753944707086652 ] [PMID: 19124404 ] [11] World Medical Association Declaration of Helsinki.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
[http://dx.doi.org/10.1016/j.atherosclerosis.2007.06.021 ] [PMID: 17678931 ] [13] O’Rourke MF.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1097/00004872-200303000-00004 ] [PMID: 12640232 ] [15] Yasmin , Brown MJ.",OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1093/qjmed/92.10.595 ] [PMID: 10627881 ] [16] Hopkins KD, Lehmann ED, Jones RL, Turay RC, Gosling RG.",OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.2337/diacare.19.5.501 ] [PMID: 8732717 ] [17] ter Avest E, Holewijn S, Bredie SJ, van Tits LJ, Stalenhoef AF, de Graaf J. Pulse wave velocity in familial combined hyperlipidemia.",OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1016/j.amjhyper.2006.09.015 ] [PMID: 17324737 ] [18] McEleavy OD, McCallum RW, Petrie JR, et al.",OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1111/j.1464-5491.2004.01127.x ] [PMID: 15008837 ] [19] Rajzer MW, Klocek M, Kawecka-Jaszcz K, et al.",OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1097/00004872-199917121-00006 ] [PMID: 10703874 ] [20] Yan LX, Li Y, Zhao LC, et al.",OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1161/CIRCULATIONAHA.105.579342 ] [PMID: 16461839 ] [22] Noon JP, Trischuk TC, Gaucher SA, Galante S, Scott RL.",Non-OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1111/j.1365-2702.2007.02155.x ] [PMID: 18537854 ] [23] Janner JH, Godtfredsen NS, Ladelund S, Vestbo J, Prescott E. Aortic augmentation index: reference values in a large unselected population by means of the SphygmoCor device.",OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1038/ajh.2009.234 ] [PMID: 19959999 ] [24] O’Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension.",Non-OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1161/01.HYP.15.4.339 ] [PMID: 2180816 ] [25] Roman MJ, Devereux RB, Kizer JR, et al.",OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.089078 ] [PMID: 17485598 ] [26] Chirinos JA, Zambrano JP, Chakko S, et al.",Non-OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1016/j.amjcard.2005.04.036 ] [PMID: 16125487 ] [27] Nichols WW, Denardo SJ, Wilkinson IB, McEniery CM, Cockcroft J, O’Rourke MF.",OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"Pulse Wave Analysis by Applanation Tonometry The Open Cardiovascular Medicine Journal, 2016, Volume 10    195 [http://dx.doi.org/10.1111/j.1751-7176.2008.04746.x ] [PMID: 18401227 ] [28] Inzucchi SE, Zinman B, Wanner C, et al.",Non-OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1177/1479164114559852 ] [PMID: 25589482 ] [29] Boutouyrie P, Lacolley P, Briet M, et al.",OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.2165/11593790-000000000-00000 ] [PMID: 21902292 ] [30] Duvnjak L, Blaslov K. Dipeptidyl peptidase-4 inhibitors improve arterial stiffness, blood pressure, lipid profile and inflammation parameters in patients with type 2 diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1186/s13098-016-0144-6 ] [PMID: 27006706 ] [31] Papademetriou  V,  Katsiki  N,  Doumas  M,  Faselis  C.  Halting  arterial  aging  in  patients  with  cardiovascular  disease:  hypolipidemic  and antihypertensive therapy.",Non-OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.2174/1381612820666140620162157 ] [PMID: 24953392 ] [32] Doonan RJ, Hausvater A, Scallan C, Mikhailidis DP, Pilote L, Daskalopoulou SS.",Non-OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1038/hr.2010.25 ] [PMID: 20379189 ] [33] Prenner SB, Chirinos JA.",OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.1016/j.atherosclerosis.2014.12.023 ] [PMID: 25558032 ] [34] Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP.",Non-OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"[http://dx.doi.org/10.2174/1381612819666131206100750 ] [PMID: 24320038 ] [35] Seifalian AM, Filippatos TD, Joshi J, Mikhailidis DP.",Non-OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
[http://dx.doi.org/10.2174/157016110790886956 ] [PMID: 20180777 ] © Doupis et al.,Non-OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/5b/TOCMJ-10-188.PMC5012082.pdf
"EXPERIMENTAL PROCEDURES Sample Collection Bacterioplankton samples were collected during the Car153 cruise on January 13th 2009 at station A (10.30°N, 64.40°W),  the  time  series  station  for  the  CARIACO  program  (Carbon  Retention  In  A  Colored  Ocean; http://www.imars.usf.edu/CAR/ ) situated in the eastern sub-basin, with a depth of 1400 m. Two different sampling methods were employed for collection of bacterial cells for nucleic acids isolation.",Non-OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"Both samples were collected at 280 m, where the oxygen concentration was  approximately  2  μmol  kg-1,  (CTD  data),  and  the  sulfide  concentration  was  between  3.1  and  5.8  μM (http://www.imars.usf.edu/CAR/car_nodc/NODC-CAR153.txt ).",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1016/S0967-0637(00)00087-X ] [3] Taylor GT, Iabichella M, Ho TY, et al.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.4319/lo.2001.46.1.0148 ] [4] Li XN, Taylor GT, Astor Y, Varela R, Scranton MI.",Non-OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1016/j.dsr.2011.11.001 ] [5] Stevens H, Ulloa O. Bacterial diversity in the oxygen minimum zone of the eastern tropical South Pacific.",Non-OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1111/j.1462-2920.2007.01539.x ] [PMID: 18294206 ] [6] Lavik G, Stührmann T, Brüchert V, et al.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1038/nature07588 ] [PMID: 19078958 ] [7] Canfield DE, Stewart FJ, Thamdrup B, et al.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1126/science.1196889 ] [PMID: 21071631 ] [8] Rodriguez-Mora MJ, Scranton MI, Taylor GT, Chistoserdov AY.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1111/1574-6941.12094 ] [PMID: 23398056 ] [9] Griesbeck C, Günter H, Schütz M. Biological sulfide-oxidation: sulfide-quinone reductase (SQR), the primary reaction, In: Pandalai SG, Ed.",Non-OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1099/mic.0.2008/018580-0 ] [PMID: 18832317 ] [11] Schütz M, Maldener I, Griesbeck C, Hauska G. Sulfide-quinone reductase from Rhodobacter capsulatus : requirement for growth, periplasmic localization, and extension of gene sequence analysis.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1007/s002030050615 ] [PMID: 9639604 ] [13] Wagner M, Roger AJ, Flax JL, Brusseau GA, Stahl DA.",Non-OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1128/AEM.68.10.5064-5081.2002 ] [PMID: 12324358 ] [16] Neretin LN, Schippers A, Pernthaler A, Hamann K, Amann R, Jørgensen BB.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1046/j.1462-2920.2003.00452.x ] [PMID: 12871233 ] [17] Ben-Dov E, Brenner A, Kushmaro A. Quantification of sulfate-reducing bacteria in industrial wastewater, by real-time polymerase chain reaction (PCR) using dsrA and apsA genes.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1007/s00248-007-9233-2 ] [PMID: 17351812 ] [18] Dar SA, Yao L, van Dongen U, Kuenen JG, Muyzer G. Analysis of diversity and activity of sulfate-reducing bacterial communities in sulfidogenic bioreactors using 16S rRNA and dsrB genes as molecular markers.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1128/AEM.01875-06 ] [PMID: 17098925 ] [19] Blazejak A, Schippers A. Real-time PCR quantification and diversity analysis of the functional genes aprA  and dsrA  of sulfate-reducing prokaryotes in marine sediments of the Peru continental margin and the Black Sea.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.3389/fmicb.2011.00253 ] [PMID: 22203820 ] [20] Kondo R, Shigematsu K, Butani J.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.3800/pbr.3.180 ] [21] Bradley AS, Leavitt WD, Johnston DT.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1111/j.1472-4669.2011.00292.x ] [PMID: 21884365 ] [22] Taylor  CD,  Doherty  KW.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1016/0198-0149(90)90132-F ] [23] Weisburg WG, Barns SM, Pelletier DA, Lane DJ.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1093/bioinformatics/btm404 ] [PMID: 17846036 ] [25] Goujon M, McWilliam H, Li W, et al.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1093/nar/gkf436 ] [PMID: 12136088 ] [27] Tamura  K,  Peterson  D,  Peterson  N,  Stecher  G,  Nei  M,  Kumar  S.  MEGA5:  molecular  evolutionary  genetics  analysis  using  maximum likelihood, evolutionary distance, and maximum parsimony methods.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1093/molbev/msr121 ] [PMID: 21546353 ] [28] Selinger DW, Saxena RM, Cheung KJ, Church GM, Rosenow C. Global RNA half-life analysis in Escherichia coli  reveals positional patterns of transcript degradation.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1101/gr.912603 ] [PMID: 12566399 ] [29] Mutter GL, Zahrieh D, Liu C, et al.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1186/1471-2164-5-88 ] [PMID: 15537428 ] [30] Madrid V, Taylor G, Scranton M, Chistoserdov A.",Non-OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1128/AEM.67.4.1663-1674.2001 ] [PMID: 11282619 ] [31] Wakeham  SG,  Turich  C,  Taylor  GT,  et  al.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"Genes for Sulfur Metabolism in the Cariaco Basin The Open Microbiology Journal, 2016, Volume 10    149 [http://dx.doi.org/10.1016/j.orggeochem.2010.01.005 ] [32] Wakeham SG, Turich C, Schubotz F, et al.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
[http://dx.doi.org/10.1016/j.dsr.2012.01.005 ] [33] Kuykendall LD.,OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1007/0-387-29298-5_107 ] [34] Kalyuzhnaya  MG,  Khmelenina  V,  Eshinimaev  B,  et  al.",Non-OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1099/ijs.0.65317-0 ] [PMID: 18319461 ] [35] Boden R, Cunliffe M, Scanlan J, et al.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1128/JB.06267-11 ] [PMID: 22123758 ] [36] Vuilleumier S, Khmelenina VN, Bringel F, et al.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1128/JB.06392-11 ] [PMID: 22207753 ] [37] Shahak Y, Hauska G. Sulfide oxidation from cyanobacteria to humans: sulfide-quinone oxidoreductase (SQR).",Non-OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1074/jbc.274.19.13250 ] [PMID: 10224084 ] [39] Inagaki F, Takai K, Nealson KH, Horikoshi K. Sulfurovum lithotrophicum  gen. nov., sp.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1099/ijs.0.03042-0 ] [PMID: 15388698 ] [40] Nakagawa S, Takaki Y, Shimamura S, Reysenbach AL, Takai K, Horikoshi K. Deep-sea vent epsilon-proteobacterial genomes provide insights into emergence of pathogens.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1099/ijs.0.02682-0 ] [PMID: 14657107 ] [42] Sikorski J, Munk C, Lapidus A, et al.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1099/00207713-49-2-697 ] [PMID: 10319493 ] [44] Eisen JA, Nelson KE, Paulsen IT, et al.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1007/BF00290978 ] [46] Frigaard NU, Bryant DA.",Non-OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1007/0-387-29298-5_233 ] [48] Oude Elferink SJ, Akkermans-van Vliet WM, Bogte JJ, Stams AJ.",Non-OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.1099/00207713-49-2-345 ] [PMID: 10319454 ] [49] Kuever J, Rainey FA.",OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/0f/TOMICROJ-10-140.PMC5012083.pdf
"[http://dx.doi.org/10.4172/2153-2435.1000263 ] [3] Wei, G. Toxicity and estrogen effects of methyl paraben on Drosophila melanogaster .",Non-OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
"[http://dx.doi.org/10.1016/S0378-4347(00)80594-0 ] [PMID: 3235544 ] [6] Goswami, N.; Gupta, V.R.",OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
"[http://dx.doi.org/10.3797/scipharm.1301-21 ] [PMID: 23833716 ] [7] Parafitt, K. Martindale, the complete drug reference ; Pharmaceutical Press: London, 1999 .",Non-OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
"[http://dx.doi.org/10.1542/pir.17-1-12 ] [PMID: 8559710 ] [9] Sweetman, S.C. Martindale-The Complete Drug Reference .",Non-OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
"[http://dx.doi.org/10.1016/j.jchromb.2003.08.048 ] [PMID: 14630358 ] [11] Gunn, V.L.",OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
"[http://dx.doi.org/10.1542/peds.108.3.e52 ] [PMID: 11533370 ] [12] Havaldar, F.H.",OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
"[http://dx.doi.org/10.1055/s-0033-1357191 ] [PMID: 24132702 ] [17] Hadad, G.M.",Non-OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
"[http://dx.doi.org/10.1016/j.talanta.2009.06.003 ] [PMID: 19635371 ] [18] Azhagvuel, S.; Sekar, R. Method development and validation for the simultaneous determination of cetirizine dihydrochloride, paracetamol, and phenylpropanolamine hydrochloride in tablets by capillary zone electrophoresis.",Non-OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
"[http://dx.doi.org/10.1016/j.jpba.2006.08.028 ] [19] Carnevale, L. Simultaneous determination of acetaminophen, guaifenesin, pseudoephedrine, pholcodine, and paraben preservatives in cough mixture by high-performance liquid chromatography.",OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
"[http://dx.doi.org/10.1002/jps.2600720227 ] [PMID: 6834261 ] [20] Kulikov, A.U.",OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
"[http://dx.doi.org/10.1365/s10337-007-0510-5 ] [21] Jaber,  A.M.;  Al  Sherife,  H.A.",Non-OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
"[http://dx.doi.org/10.1016/j.jpba.2004.07.002 ] [PMID: 15496327 ] [22] CH-Q2B Guideline for Industry, Validation of Analytical Procedure: Methodology.",OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
"[http://dx.doi.org/10.1002/0471463728 ] [25] Hasan, N.; Chaiharn, M.; Khan, S.; Khalid, H.; Sher, N.; Siddiqui, F.A.",Non-OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
"[http://dx.doi.org/10.1155/2013/297285 ] [PMID: 24286017 ] [26] Marín, A.; Barbas, C. LC/MS for the degradation profiling of cough-cold products under forced conditions.",Non-OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
"[http://dx.doi.org/10.1016/j.jpba.2004.03.011 ] [PMID: 15336351 ] [27] Carr, G.P.",OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
"[http://dx.doi.org/10.1016/0731-7085(90)80090-C ] [PMID: 2100596 ] [28] Jenke, D.R.",OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
"[http://dx.doi.org/10.1080/10826079608005534 ] [29] Gupta, K.R.",Non-OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
[http://dx.doi.org/10.1016/j.jpha.2013.09.003 ] © Hasan et al.,OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/70/TOMCJ-10-33.PMC5012085.pdf
", 2012] (http://www.mcs.anl.gov/petsc) to obtain velocity, pr essure, and temperature ﬁelds.",OADS,/arxiv_data1/oa_pdf/2e/35/GRL-42-4770.PMC5012122.pdf
Global Ecology and Biogeography published by John Wiley & Sons LtdDOI: 10.1111/geb.12326 http://wileyonlinelibrary.com/journal/geb 973,Non-OADS,/arxiv_data1/oa_pdf/60/3d/GEB-24-973.PMC5012125.pdf
"The Global Biodiversity Information Facility (GBIF,http://www.gbif.org/) is at the moment one of the largest andmost widely used biodiversity databases (Beck et al., 2012, 2014; Jetz et al., 2012), with the objective to ‘make the world’s primary data on biodiversity freely and universally available viathe Internet’ (Chapman, 2005a; Y esson et al., 2007; GBIF, 2008; Newbold, 2010).",Non-OADS,/arxiv_data1/oa_pdf/60/3d/GEB-24-973.PMC5012125.pdf
"attempted to include all the main herbaria in South America (Appendix S1 in Supporting Information) as well as theTROPICOS database at the Missouri Botanical Garden (http://mobot.mobot.org/W3T/Search/vast.html), which is the mostcomprehensive information resource for the ﬂora of the Andeanregion (Taylor, 1999).",Non-OADS,/arxiv_data1/oa_pdf/60/3d/GEB-24-973.PMC5012125.pdf
"Biomes: They are polygons also deﬁned under WWF’s classiﬁcation, the next hierarchical level above ecoregions.Altitudinal distribution: An altitude was assigned to every occurrence based on the Shuttle Radar Topography Mission global elevation model at 90 meters resolution (http://srtm.csi.cgiar.org).",Non-OADS,/arxiv_data1/oa_pdf/60/3d/GEB-24-973.PMC5012125.pdf
"http://www.idigbio.org, http://www.ispotnature.org and http://www.inaturalist.org), but arapid change is required to advance our knowledge on biodiver-sity and distribution patterns in the era of Big Data.",Non-OADS,/arxiv_data1/oa_pdf/60/3d/GEB-24-973.PMC5012125.pdf
"Available at: http://www.R-project.org Riddle, B.R., Ladle, R.J., Lourie, S.A. & Whittaker, R.J. (2011) Basic biogeography: estimating biodiversity and mappingnature.",Non-OADS,/arxiv_data1/oa_pdf/60/3d/GEB-24-973.PMC5012125.pdf
"BIOSKETCHES The Antonelli group (http://antonelli-lab.net) focuseson understanding how biological diversity has evolvedand how it will be affected by on-going climate andhabitat changes, with a focus on the American tropics.The Rønsted group (http://snm.ku.dk/phylogenetic_prediction/) explores the evolution ofplants and the correlation between phylogeny, biologicalinteractions and natural products, to explain patternsand processes of diversity.",Non-OADS,/arxiv_data1/oa_pdf/60/3d/GEB-24-973.PMC5012125.pdf
Full details of the model are available online ( http://www.geo.uzh.ch/ en/units/h2k/services/hbv-model ).,OADS,/arxiv_data1/oa_pdf/d7/18/HYP-29-5153.PMC5012127.pdf
"Altimeter Along-Track and Gridded SLA Data, MDT, and ADT Altimeter data come from two sources: Along-track altimeter sea level anomaly (SLA) height data are obtained from the RADS (Radar Altimeter Database System, http://rads.tudelft.nl/) web site.",OADS,/arxiv_data1/oa_pdf/97/9e/JGRC-120-3391.PMC5012128.pdf
"Our primary focus is on the seasonal circulation patterns, which we investigate using gridded altimeter SLA data from the AVISO (Archiving, Validation, and Interpretation of Satellite Oceano-graphic data) site, http://www.aviso.altimetry.fr.",OADS,/arxiv_data1/oa_pdf/97/9e/JGRC-120-3391.PMC5012128.pdf
"Scatterometer Climatological Wind Stress Fields (SCOW) The Scatterometer Climatological Wind Stress Fields [ Risien and Chelton , 2008] are from the SCOW website (http://cioss.coas.oregonstate.edu/scow/).",OADS,/arxiv_data1/oa_pdf/97/9e/JGRC-120-3391.PMC5012128.pdf
"217–246, Springer, Berlin, doi:10.1007/978-3-642-12796-0_9.Acknowledgments Altimeter data were provided by the RADS system for along-track data(available from http://rads.tudelft.nl/)and by AVISO for gridded data and the mean dynamic topography (http:// www.aviso.altimetry.fr).",OADS,/arxiv_data1/oa_pdf/97/9e/JGRC-120-3391.PMC5012128.pdf
Wind data arefrom the ECMWF reanalysis (http://apps.ecmwf.int/datasets/) and from the scatterometer climatology of Risien and Chelton [2008] (http://cioss.coas.,OADS,/arxiv_data1/oa_pdf/97/9e/JGRC-120-3391.PMC5012128.pdf
"Four shelf-wide cruises (2006–2007) covered t he area very likely to develop summer bottom-water hypoxia (dissolved oxygen c oncentration less than 2 mg L21) (Figure 1), similar to the region sampled during a hypoxia study in the past 30 years (http://www.gulfhypo xia.net/).",Non-OADS,/arxiv_data1/oa_pdf/0f/53/JGRC-120-1429.PMC5012129.pdf
"Data source: U.S. Geological Survey (USGS, ‘‘Hypoxia in the Gulf of Mexico studies’’,http://toxics.usgs.gov/hypoxia/index.html).Journal of Geophysical Research: Oceans 10.1002/2014JC010498 HUANG ET AL.",OADS,/arxiv_data1/oa_pdf/0f/53/JGRC-120-1429.PMC5012129.pdf
"Monthly satellite products QuikSCAT wind data (12.5 km resolution) were adopted (from a Live Access Server provided by NOAA Coastwatch and SWFSC/Environmental Research Division, http://las.pfeg.noaa.gov/) and were interpolated to 0.1 /C14by 0.1/C14to calculate the areal-integrated air-sea CO 2ﬂuxes.",OADS,/arxiv_data1/oa_pdf/0f/53/JGRC-120-1429.PMC5012129.pdf
[Available at http://cdiac.ornl.gov/SOCCR/pdf/SAP2.2_Entire_Report_March2007.pdf.],OADS,/arxiv_data1/oa_pdf/0f/53/JGRC-120-1429.PMC5012129.pdf
The majority ofthe data have been submitted toSurface Ocean CO 2Atlas (SOCAT) and Carbon Dioxide Information Analysis Center (CDIAC) and are available atthese addresses: http://cdiac.ornl.gov/ftp/oceans/UG_GoM_UW_Data/2006.,OADS,/arxiv_data1/oa_pdf/0f/53/JGRC-120-1429.PMC5012129.pdf
"data, http://cdiac.ornl.gov/ftp/oceans/ UG_GoM_UW_Data/2007.datam,http://cdiac.esd.ornl.gov/ftp/oceans/Cape_Hatteras_GM/.Journal of Geophysical Research: Oceans 10.1002/2014JC010498 HUANG ET AL.",OADS,/arxiv_data1/oa_pdf/0f/53/JGRC-120-1429.PMC5012129.pdf
M. Webb and A.Bodas-Salcedoareacknowledged forprovidinginformationoncloud radiativeheating.Quality-controlledmodeldatafromallthreeexperimentsare archived at Earth System Grid (https://earthsystemcog.org/projects/ gass-yotc-mip/)andareavailablefordownload.,OADS,/arxiv_data1/oa_pdf/56/e1/JGRD-120-4749.PMC5012131.pdf
The MODIS data are obtained from NASA ’s Level 1 and Atmosphere Archive and Distribution System (LAADShttp://ladsweb.nascom.nasa.gov/).,OADS,/arxiv_data1/oa_pdf/9c/00/JGRD-120-4132.PMC5012132.pdf
"TheCALIOP data are obtained from NASA ’ Atmospheric Science Data Center (ASDC, https://eosweb.larc.nasa.gov/).The CloudSat data are obtained fromCloudSat data processing center (http://www.cloudsat.cira.colostate.",OADS,/arxiv_data1/oa_pdf/9c/00/JGRD-120-4132.PMC5012132.pdf
"[Available at http://modis-atmos.gsfc.nasa.gov/_docs/C6MOD06OPUserGuide.pdf, Accessed 2014.]",Non-OADS,/arxiv_data1/oa_pdf/9c/00/JGRD-120-4132.PMC5012132.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/4e/97/40266_2016_Article_389.PMC5012149.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/90/dc/40266_2016_Article_381.PMC5012150.pdf
http://www.romecriteria.org/assets/ pdf/19_RomeIII_apA_885-898.pdf .,Non-OADS,/arxiv_data1/oa_pdf/90/dc/40266_2016_Article_381.PMC5012150.pdf
Metamucil/C210.http://www.metawellness.com .,Non-OADS,/arxiv_data1/oa_pdf/90/dc/40266_2016_Article_381.PMC5012150.pdf
http://www.miralaxmd.com/product- information/miralaxsupsup-label .,Non-OADS,/arxiv_data1/oa_pdf/90/dc/40266_2016_Article_381.PMC5012150.pdf
http://www.drugs.com/cdi/constulose-solution.html .,Non-OADS,/arxiv_data1/oa_pdf/90/dc/40266_2016_Article_381.PMC5012150.pdf
Dulcolax/C210.https://www.dulcolax.com .,Non-OADS,/arxiv_data1/oa_pdf/90/dc/40266_2016_Article_381.PMC5012150.pdf
http://www.senokot.ca/en/ products/tablets .,Non-OADS,/arxiv_data1/oa_pdf/90/dc/40266_2016_Article_381.PMC5012150.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/32/jjm-09-06-34867.PMC5012192.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/6c/jjm-09-06-34701.PMC5012193.pdf
Email: alcialvagonza@yahoo.com.mx doi: http://dx.doi.org/10.14740/jocmr2668w,Non-OADS,/arxiv_data1/oa_pdf/4d/35/jocmr-08-689.PMC5012236.pdf
Email: chin-cl@jcom.zaq.ne.jp doi: http://dx.doi.org/10.14740/jocmr2672w,Non-OADS,/arxiv_data1/oa_pdf/41/ef/jocmr-08-701.PMC5012237.pdf
Email: jordanorr@uabmc.edu doi: http://dx.doi.org/10.14740/jocmr2630w,Non-OADS,/arxiv_data1/oa_pdf/de/4b/jocmr-08-705.PMC5012238.pdf
Email: ito@edogawa.or.jp doi: http://dx.doi.org/10.14740/jocmr2610w,Non-OADS,/arxiv_data1/oa_pdf/e2/e8/jocmr-08-710.PMC5012239.pdf
Email: ecarmeli@univ.haifa.ac.il doi: http://dx.doi.org/10.14740/jocmr2652w,Non-OADS,/arxiv_data1/oa_pdf/50/5f/jocmr-08-715.PMC5012240.pdf
Email: shige@hiroshima-u.ac.jp doi: http://dx.doi.org/10.14740/jocmr2545w,Non-OADS,/arxiv_data1/oa_pdf/0f/93/jocmr-08-721.PMC5012241.pdf
Email: alvaradocosme@yahoo.com doi: http://dx.doi.org/10.14740/jocmr2699w,Non-OADS,/arxiv_data1/oa_pdf/56/dd/jocmr-08-730.PMC5012242.pdf
"This illness has been recently designated as a disorder in the Diagnostic and Statistical Manual of Men-tal Disorders, Fifth Edition (DSM-5) (http://www.dsm5.org/Pages/Default.aspx).",Non-OADS,/arxiv_data1/oa_pdf/56/dd/jocmr-08-730.PMC5012242.pdf
DNA of whole blood was extracted following  a protocol describe elsewhere (http://www.protocol-online.,Non-OADS,/arxiv_data1/oa_pdf/56/dd/jocmr-08-730.PMC5012242.pdf
Email: devecchis.erre@virgilio.it doi: http://dx.doi.org/10.14740/jocmr2691w,Non-OADS,/arxiv_data1/oa_pdf/7b/54/jocmr-08-737.PMC5012243.pdf
Email: miuras@cis.fukuoka-u.ac.jp doi: http://dx.doi.org/10.14740/jocmr2675w,Non-OADS,/arxiv_data1/oa_pdf/b7/d7/jocmr-08-743.PMC5012244.pdf
"Email: k.aoki@kdu.ac.jp, terauchi@yokohama-cu.ac.jp doi: http://dx.doi.org/10.14740/jocmr2686w",Non-OADS,/arxiv_data1/oa_pdf/ad/93/jocmr-08-749.PMC5012245.pdf
Email: nzuccarini@umhs-sk.net doi: http://dx.doi.org/10.14740/jocmr2687w,Non-OADS,/arxiv_data1/oa_pdf/4f/4a/jocmr-08-753.PMC5012246.pdf
Email: drrahulanil@gmail.com doi: http://dx.doi.org/10.14740/jocmr2698w,Non-OADS,/arxiv_data1/oa_pdf/a7/64/jocmr-08-757.PMC5012247.pdf
Email: fionasan@rediffmail.com doi: http://dx.doi.org/10.14740/jocmr2674w,Non-OADS,/arxiv_data1/oa_pdf/99/be/jocmr-08-760.PMC5012248.pdf
Email: ahmadeter1@hotmail.com doi: http://dx.doi.org/10.14740/jocmr2740w,Non-OADS,/arxiv_data1/oa_pdf/4d/19/jocmr-08-764.PMC5012249.pdf
"KI Reports (2016) 1,3–9;http://dx.doi.org/10.1016/j.ekir.2016.04.003 KEYWORDS: biomarker; postoperative; prerenal azotemia; renal failureª2016 International Society of Nephrology.",Non-OADS,/arxiv_data1/oa_pdf/c9/52/main.PMC5012274.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/52/main.PMC5012274.pdf
"KI Reports (2016) 1,34–42;http://dx.doi.org/10.1016/j.ekir.2016.04.001 KEYWORDS: education; kidney transplantation; mobile health; randomized trial; staff ª2016 International Society of Nephrology.",Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC5012277.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC5012277.pdf
Available at: http://www.pewinternet.org/ ﬁles/old-media//Files/Reports /2012/PIP_MobileHealth2012_ FINAL.pdf .,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC5012277.pdf
Available at: https://rockhealth.com/reports/digital- health-2015-midyear/ .,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC5012277.pdf
Available at: http://research2guidance.com/r2g/research2 guidance-mHealth-App-Developer-Economics-2014.pdf .,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC5012277.pdf
"KI Reports (2016) 1,10–23;http://dx.doi.org/10.1016/j.ekir.2016.03.002 KEYWORDS: aging; APOL1 variants; arteriosclerosis; hypertension; race ª2016 International Society of Nephrology.",Non-OADS,/arxiv_data1/oa_pdf/47/ba/main.PMC5012291.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/ba/main.PMC5012291.pdf
Available at: http://stateofobesity.org/states/ms .,Non-OADS,/arxiv_data1/oa_pdf/47/ba/main.PMC5012291.pdf
10 March 2016. http://dx.doi.org/10.1681/ ASN.2015070763 28.,Non-OADS,/arxiv_data1/oa_pdf/47/ba/main.PMC5012291.pdf
"Tiano CNR, Institute for the Conservation and Valorization of Cultural Heritage (ICVBC), Via Madonna del Piano 10,5019 Sesto Fiorentino, Florence, Italye-mail: s.rescic@icvbc.cnr.it URL: http://www.icvbc.cnr.it P. Tiano e-mail: p.tiano@icvbc.cnr.it URL: http://www.icvbc.cnr.it Materials and Structures (2012) 45:505–520 DOI 10.1617/s11527-011-9778-x",Non-OADS,/arxiv_data1/oa_pdf/23/b7/11527_2011_Article_9778.PMC5012354.pdf
"5http://www.priorartdatabase.com/IPCOM/000152224/ .6For ﬁlm adhesion testing, the area is prepared by cross cutting in order to create a grid from the sub-squares of which the ﬁlm can be pulled off.Materials and Structures (2012) 45:505–520 507",Non-OADS,/arxiv_data1/oa_pdf/23/b7/11527_2011_Article_9778.PMC5012354.pdf
T HIS IS AN OPEN ACCESS ARTICLE UNDER THE CC BY-NC-ND LICENSE ( http://creativecommons.o rg/licenses/by-nc-nd/4.0/ ).ISSN 2452-302X http://dx.doi.org/10.1016/j.jacbts.2016.01.007,Non-OADS,/arxiv_data1/oa_pdf/74/0f/main.PMC5012372.pdf
This is an open access article under theCC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/0f/main.PMC5012372.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/77/fb/10.1177_2058460116662299.PMC5012508.pdf
Available at: http://www.drs.dk/ guidelines/ct/quality/ (accessed July 2015).,Non-OADS,/arxiv_data1/oa_pdf/77/fb/10.1177_2058460116662299.PMC5012508.pdf
"MEROPS peptidase database, http://merops.san ger.ac.uk /.",OADS,/arxiv_data1/oa_pdf/63/48/41588_2014_Article_BFng3010.PMC5012510.pdf
Genome data and the complete genome  annotation are available for download from ftp://ftp.sange r.ac.uk/ pub/pathogen s/Trichuris/GenomePa per201 4.,OADS,/arxiv_data1/oa_pdf/63/48/41588_2014_Article_BFng3010.PMC5012510.pdf
Reprints and permissions information is available online at http://www.nature.c om/ reprints/index.ht ml.,Non-OADS,/arxiv_data1/oa_pdf/63/48/41588_2014_Article_BFng3010.PMC5012510.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/52/main.PMC5012537.pdf
"http://dx.doi.org/10.1016/j.gendis.2015.10.001 2352-3042/Copyright ª2015, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/aa/52/main.PMC5012537.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2015) 2, 328e336",Non-OADS,/arxiv_data1/oa_pdf/aa/52/main.PMC5012537.pdf
"Citation: Molecular Therapy—Nucleic Acids (2016) 5, e273; doi:10.1038/mtna.2015.43 Official journal of the American Society of Gene & Cell Therapy All rights reserved 2162-2531/16 www.nature.com/mtna Introduction Cystic fibrosis (CF) is caused by mutations in the CF trans- membrane conductance regulator (CFTR) gene.1 Of the  >2,000 disease-causing mutations detected in the CFTR  gene (http://www.genet.sickkids.on.ca/cftr/), a trinucleotide  (CTT) deletion that spans codons 507 and 508 and results  in loss of a phenylalanine at amino acid 508 (F508del) of the CFTR protein is found in ~70% of all CF alleles.",Non-OADS,/arxiv_data1/oa_pdf/bb/76/mtna201543a.PMC5012545.pdf
"TALEN target- ing sequences were designed using Web-based software, TALE-NT 2.0 (https://boglab.plp.iastate.edu/).",OADS,/arxiv_data1/oa_pdf/bb/76/mtna201543a.PMC5012545.pdf
Cystic Fibrosis Mutation Database<http://www.genet.sickkids.on.ca/cftr/>.,Non-OADS,/arxiv_data1/oa_pdf/bb/76/mtna201543a.PMC5012545.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/bb/76/mtna201543a.PMC5012545.pdf
A circular plasmid map was generated using the SnapGene Viewer (http://www.snap- gene.com/products/snapgene_viewer).,OADS,/arxiv_data1/oa_pdf/cd/9a/mtna201549a.PMC5012547.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/cd/9a/mtna201549a.PMC5012547.pdf
Selected  ssDNA molecules were subjected to secondary struc- ture prediction using the mFold software  (http://mfold.rna.,OADS,/arxiv_data1/oa_pdf/d3/6b/mtna201550a.PMC5012548.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/d3/6b/mtna201550a.PMC5012548.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/48/d8/mtna201551a.PMC5012549.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/3a/3a/mtna201552a.PMC5012550.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/f4/ac/mtna201553a.PMC5012551.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/a3/f4/mtna201554a.PMC5012552.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/",Non-OADS,/arxiv_data1/oa_pdf/3a/17/mtna201556a.PMC5012553.pdf
"According to  homology models available from the eDystrophin Website  (http://edystrophin.genouest.org/), the dystrophin spectrin-like repeat predicted structures are composed of the typical triple coiled-coil structure, i.e., three α-helices (A, B, and C)  linked by two loops (AB and BC) (Figure 6 and Supplemen- tary Figure S2).",Non-OADS,/arxiv_data1/oa_pdf/64/54/mtna201558a.PMC5012554.pdf
"The nucleotide sequences targeted by the gRNAs in exons  50 and 54 were identified using the Leiden muscular dys-trophy website http://www.dmd.nl/seqs/murefDMD.html by screening for PAM (i.e., NGG sequence for S. pyogenes Cas9)  in the sense and antisense strands of each exon sequence  (Figure 1).",OADS,/arxiv_data1/oa_pdf/64/54/mtna201558a.PMC5012554.pdf
"Following clone isolation and DNA amplification, samples were sent for sequencing using the primer U6F (5′-GTCGGAACAGGAGAGCGCACGAGGGAG)  to the Genotyping Platform CHUL/CHUQ, and sequencing  results were analyzed using the NCBI BLAST platform (http://blast.ncbi.nlm.nih.gov/Blast.cgi).",OADS,/arxiv_data1/oa_pdf/64/54/mtna201558a.PMC5012554.pdf
Sequencing results were ana- lyzed with the NCBI BLAST platform (http://blast.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/64/54/mtna201558a.PMC5012554.pdf
49 Primary sequence alignment  was realized using the TM-Align64 (http://zhanglab.ccmb.,OADS,/arxiv_data1/oa_pdf/64/54/mtna201558a.PMC5012554.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/64/54/mtna201558a.PMC5012554.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/48/omw067.PMC5012583.pdf
doi:http://dx.doi.org/10.1007/ s12028-015-0162-5.,Non-OADS,/arxiv_data1/oa_pdf/9a/48/omw067.PMC5012583.pdf
doi:http://dx.doi.org/10.1016/0736- 4679(94)90011-6.,OADS,/arxiv_data1/oa_pdf/9a/48/omw067.PMC5012583.pdf
doi:http://dx.doi.org/10.1016/0736- 4679(94)90012-4.,OADS,/arxiv_data1/oa_pdf/9a/48/omw067.PMC5012583.pdf
Case Rep Med 2015;Article ID 769576. doi:http://dx.doi.org/10.1155/ 2015/769576.,Non-OADS,/arxiv_data1/oa_pdf/9a/48/omw067.PMC5012583.pdf
doi:http://dx.doi.org/10.4088/ JCP.10m06438.Diagnosis and implications in the therapeutic management of patient |231,Non-OADS,/arxiv_data1/oa_pdf/9a/48/omw067.PMC5012583.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/c4/omw064.PMC5012585.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/53/3f/dddt-10-2729.PMC5012595.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2729–2737Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2729Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11125 3 chloroquine improves left ventricle diastolic  function in streptozotocin-induced diabetic mice Xun Yuan Yi-chuan Xiao gui-Ping Zhang ning hou Xiao-Qian Wu Wen-liang chen Jian-Dong luo gen-shui Zhang Department of Pharmacology,   guangzhou Medical University,   guangzhou, People’s republic  of chinaAbstract:  Diabetes is a potent risk factor for heart failure with preserved ejection fraction  (HFpEF).",Non-OADS,/arxiv_data1/oa_pdf/53/3f/dddt-10-2729.PMC5012595.pdf
"In cultured neonatal rat cardiomyocytes,  the suppression of autophagy by 3-methyladenine and/or siRNA specific for beclin 1 or  Atg7 attenuated high glucose-induced cardiomyocyte injury.7 Xu et al8 demonstrated  that inhibition of autophagy was cardioprotective in type 1 diabetes, which was linked  to activatation of noncanonical autophagy and improvement in mitophagy.correspondence: gen-shui Zhang Department of Pharmacology, guangzhou  Medical University, Xinzao, Panyu  District, guangzhou 511436, People’s  republic of china Tel +86 20 3710 3269 email zhanggs99@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Yuan et al Running head recto: Chloroquine improves cardiac diastolic function DOI: http://dx.doi.org/10.2147/DDDT.S111253",Non-OADS,/arxiv_data1/oa_pdf/53/3f/dddt-10-2729.PMC5012595.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/53/3f/dddt-10-2729.PMC5012595.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/53/3f/dddt-10-2729.PMC5012595.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/a7/40/bctt-8-161.PMC5012596.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a7/40/bctt-8-161.PMC5012596.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a7/40/bctt-8-161.PMC5012596.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2016:8 161–172Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 161 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S97764 Reducing infection risk in implant-based   breast-reconstruction surgery: challenges  and solutions Adrian SH Ooi1,2 David H Song1 1Section of Plastic and Reconstructive  Surgery, University of Chicago  Medicine and Biological Sciences,  Chicago, IL, USA;  2Department of  Plastic, Reconstructive, and Aesthetic Surgery, Singapore General Hospital,  SingaporeAbstract: Implant-based procedures are the most commonly performed method for   postmastectomy breast reconstruction.",Non-OADS,/arxiv_data1/oa_pdf/a7/40/bctt-8-161.PMC5012596.pdf
"7 As with any foreign prosthetic material inserted into the body, infection  remains the most common and probably the most dreaded risk of implant-based Correspondence: David H Song Section of Plastic and Reconstructive Surgery, University of Chicago Medicine and Biological Sciences, Room J641, MC 6035, 5841 South Maryland Avenue, Chicago, IL 60637, USATel +1 773 834 0526Email dsong@surgery.bsd.uchicago.eduJournal name: Breast Cancer - Targets and Therapy Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: Ooi and SongRunning head recto: Reducing breast-implant reconstruction infectionDOI: http://dx.doi.org/10.2147/BCTT.S97764",Non-OADS,/arxiv_data1/oa_pdf/a7/40/bctt-8-161.PMC5012596.pdf
"Breast Cancer - Targets and Therapy 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/a7/40/bctt-8-161.PMC5012596.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 172 Ooi and Song  56.,Non-OADS,/arxiv_data1/oa_pdf/a7/40/bctt-8-161.PMC5012596.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c5/53/copd-11-2075.PMC5012597.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2075–2080International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2075OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10732 6 Mid-arm and calf circumferences are stronger  mortality predictors than body mass index for  patients with chronic obstructive pulmonary  disease shu-Chuan ho,1,2 Jiun-Yi  Wang,3,4 han-Pin Kuo,5  Chien-Da huang,5 Kang-Yun  lee,2,6 hsiao-Chi Chuang,1,2  Po-hao Feng,2,6 Tzu-Tao  Chen,2,* Min-Fang hsu7,* 1school of respiratory Therapy,   College of Medicine, 2Division of  Pulmonary Medicine, Department of  Internal Medicine, shuang ho hospital,   Taipei Medical University, new Taipei  City, 3Department of healthcare  administration, asia University,   Wufeng, 4Department of Medical  research, China Medical University  hospital, China Medical University,   Taichung, 5Department of Thoracic  Medicine, Chang gung Memorial  hospital, Chang gung University  College of Medicine, 6Department  of Internal Medicine, school of  Medicine, College of Medicine, Taipei  Medical University, 7Department of  nursing, Yuanpei University of Medical  T echnology, hsinchu City, Taiwan *These authors contributed equally  to this workBackground:  Chronic obstructive pulmonary disease (COPD) is currently the third most  common cause of death in the world.",Non-OADS,/arxiv_data1/oa_pdf/c5/53/copd-11-2075.PMC5012597.pdf
"Keywords:  anthropometric indicator, BMI, calf circumference, COPD, mid-arm circumference,  mortality Introduction Chronic obstructive pulmonary disease (COPD) is currently the third most common  cause of death in the world.1 COPD is a global health concern and a slowly progressive  inflammatory disease caused by airflow obstructions.2 COPD is not fully reversible  and can lead to progressively worsening breathlessness, which affects daily activities  and the health-related quality of life.3 Many patients with COPD experience multiple  conditions (eg, weight loss and skeletal muscle dysfunction)4 and comorbidities Correspondence: Tzu-Tao Chen Division of Pulmonary Medicine,  Department of Internal Medicine, shuang  ho hospital, Taipei Medical University,  no 291, Zhongzheng rd., Zhonghe  District, new Taipei City, 23561, Taiwan email 09330@s.tmu.edu.t w  Min-Fang hsu Department of nursing, Yuanpei  University of Medical Technology,  no 306, Yuanpei street, hsinchu City  30015, Taiwan Tel +886 3 538 1183 ext 8616 Fax +886 3 538 5353  email hsumf22@gmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ho et al Running head recto: Calf circumference can predict mortality in COPD DOI: http://dx.doi.org/10.2147/COPD.S107326",Non-OADS,/arxiv_data1/oa_pdf/c5/53/copd-11-2075.PMC5012597.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/c5/53/copd-11-2075.PMC5012597.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/53/copd-11-2075.PMC5012597.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9f/10/dddt-10-2739.PMC5012598.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2739–2744Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2739Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11476 1 The effects of the insulin resistance index on the  virologic response to entecavir in patients with  hBeag-positive chronic hepatitis B and  nonalcoholic fatty liver disease li-Yao Zhu,1,* Yu-gang  Wang,2,* li-Qing Wei,3,* Jian Zhou,1 Wei-Jie Dai,4 Xiao-Yu Zhang5,6 1Department of hepatology, The Fourth  People’s hospital of huai’an, huai’an,   Jiangsu, 2Department of gastroenterology,   shanghai Tongren hospital, shanghai Jiao  T ong University school of Medicine,   shanghai, 3Department of Medical  laboratory, The central hospital  of Wuhan, T ongji Medical college,   huazhong University of science and  T echnology, Wuhan, hubei, 4Department  of gastroenterology, huai’an First  People’s hospital, nanjing Medical  University, 5Division of gastrointestinal  surgery, Department of general surgery,   The affiliated huai’an hospital of  Xuzhou Medical college, 6Division of  gastrointestinal surgery, Department of  general surgery, The second People’s  hospital of huai’an, huai’an, Jiangsu,   People’s republic of china *These authors contributed equally  to this workPurpose:  To further observe and verify the effect of nonalcoholic fatty liver disease (NAFLD)  on the response to antiviral therapy in patients with chronic hepatitis B (CHB) and investigate  the relationship between the virologic response and insulin resistance.",Non-OADS,/arxiv_data1/oa_pdf/9f/10/dddt-10-2739.PMC5012598.pdf
"Keywords:  hepatitis B virus, chronic, fatty liver, entecavir, insulin resistance index Introduction After years of effective prevention and control, the incidence of patients with  HBsAg has been significantly reduced; however, chronic hepatitis B (CHB) is  still the primary chronic liver disease that threatens people’s health in the People’s  Republic of China.1,2 With the improvement in living standards, the morbidity of  fatty liver disease has gradually increased, and it has become the second most com - mon chronic liver disease surpassed only by hepatitis, especially for nonalcoholic  fatty liver disease (NAFLD) due to an improper diet and lifestyle.3 Definitions of  NAFLD have been proposed using biochemical criteria and hepatic imaging, such as correspondence: Xiao-Yu Zhang Division of gastrointestinal surgery,  Department of General Surgery, The Affiliated  huai’an hospital of Xuzhou Medical college,  62 south huaihai road, huai’an 223002,  Jiangsu, People’s republic of china email zhangxiaoyu_ey@163.co m  Wei-Jie Dai Department of gastroenterology, huai’an First  People’s hospital, nanjing Medical University,  6 West Beijing road, huaiyin District, huai’an  223300, Jiangsu, People’s republic of china email daiweijie_yy@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Zhu et al Running head recto: Effects of insulin resistance index on virologic response to entecavir DOI: http://dx.doi.org/10.2147/DDDT.S114761",Non-OADS,/arxiv_data1/oa_pdf/9f/10/dddt-10-2739.PMC5012598.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/9f/10/dddt-10-2739.PMC5012598.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/10/dddt-10-2739.PMC5012598.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/15/d1/ndt-12-2283.PMC5012599.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2283–2291Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2283OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10995 9 The combined effect of sleep and time of day on  emotion decoding from dynamic visual cues in  older adults Paraskevi Tsokanaki1 Despina Moraitou1 georgia Papantoniou2 1section of cognitive and  experimental Psychology, school  of Psychology, aristotle University  of Thessaloniki, Thessaloniki,   2Department of early childhood  education, University of ioannina,   ioannina, greeceAbstract:  It is well known that night sleep is a decisive factor for the effective functioning  of the human body and mind.",Non-OADS,/arxiv_data1/oa_pdf/15/d1/ndt-12-2283.PMC5012599.pdf
"Numerous correspondence: Despina Moraitou section of cognitive and experimental  Psychology, school of Psychology,  aristotle University of Thessaloniki,  Thessaloniki 541 24, greece Tel/fax +30 231 020 1372 email demorait@psy.auth.g r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Tsokanaki et al Running head recto: Effect of sleep and time of day on emotion decoding in older adults DOI: http://dx.doi.org/10.2147/NDT.S109959",Non-OADS,/arxiv_data1/oa_pdf/15/d1/ndt-12-2283.PMC5012599.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/15/d1/ndt-12-2283.PMC5012599.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/15/d1/ndt-12-2283.PMC5012599.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e5/51/ndt-12-2189.PMC5012600.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment Neuropsychiatric Disease and Treatment 2016:12 2189–2198Dove press submit your manuscript | www.dovepress.co m Dove press  OrigiNal researchopen access to scientific and medical research Open access Full T ext article 2189 http: //dx.doi.org/10.2147/NDT .S8286 4 effect of low-energy extracorporeal shock wave  on vascular regeneration after spinal cord injury  and the recovery of motor function lei Wang Yuquan Jiang Zheng Jiang lizhang  han Department of Neurosurgery, Qilu  hospital of shandong University, Jinan,   People’s republic of chinaBackground:  Latest studies show that low-energy extracorporeal shock wave therapy (ESWT)  can upregulate levels of vascular endothelial growth factor (VEGF).",Non-OADS,/arxiv_data1/oa_pdf/e5/51/ndt-12-2189.PMC5012600.pdf
"Some studies show that ESWT can increase  the expression of vascular endothelial growth factor (VEGF) in human umbilical  vein endothelial cells cultured in vitro.1,2 At the same time, in the disease model of  chronic myocardial ischemia, myocardial infarct, and peripheral vascular disease,  low-energy ESWT can increase the expression of VEGF and VEGF receptor, fms-like  tyrosine kinase 1 (Flt-1), in vivo and promote vascular regeneration and functional correspondence: lei Wang Department of Neurosurgery,  Qilu hospital of shandong University,  44 Wenhua Xilu, Jinan 250012,  People’s republic of china Tel/fax +86 531 8216 6632 email wangleijinan@yeah.ne tJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Wang et al Running head recto: Effect of ESWT on vascular regeneration in spinal cord injury DOI: http://dx.doi.org/10.2147/NDT.S82864",Non-OADS,/arxiv_data1/oa_pdf/e5/51/ndt-12-2189.PMC5012600.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e5/51/ndt-12-2189.PMC5012600.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/51/ndt-12-2189.PMC5012600.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7a/60/dddt-10-2759.PMC5012601.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2759–2770Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2759Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10514 2 T wo Phase ii randomized trials on the cr Th2  antagonist aZD1981 in adults with asthma Piotr Kuna1 leif Bjermer2 göran T ornling3,4 1Department of internal Medicine,   asthma and allergy, Barlicki University  hospital, Medical University of  Łódz, Łódz, Poland; 2Department of  respiratory Medicine and allergology,   skane University hospital, lund  University, 3astraZeneca research and  Development, Molndal, 4respiratory  Medicine Unit, Department of  Medicine solna and cMM, Karolinska  institute and Karolinska University  hospital, solna, swedenBackground:  Chemoattractant receptor-homologous molecule expressed on T helper type 2  (Th2) cell (CRTh2) receptor antagonists is being investigated for asthma.",Non-OADS,/arxiv_data1/oa_pdf/7a/60/dddt-10-2759.PMC5012601.pdf
"The  chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2)  cells (CRTh2) is present on several cell types3–5 implicated in the inflammatory cascade  in both allergic asthma and rhinitis.6 Prostaglandin D2 (PGD2) is the major ligand for this CRTh2 receptor and is  also implicated in the pathophysiology of allergic asthma, with increased levels correspondence: Piotr Kuna Department of internal Medicine, asthma  and allergy, Barlicki University hospital,  Medical University of Łódz, 90-153 Łódz,  Poland Tel +48 42 677 6834 Fax +48 42 678 1176 email piotr.kuna@umed.lodz.p l Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kuna et al Running head recto: AZD1981 in asthma DOI: http://dx.doi.org/10.2147/DDDT.S105142",Non-OADS,/arxiv_data1/oa_pdf/7a/60/dddt-10-2759.PMC5012601.pdf
Available from:  http://ginasthma.org/2016-gina-report-global-strategy-for-asthma- management-and-prevention/.,Non-OADS,/arxiv_data1/oa_pdf/7a/60/dddt-10-2759.PMC5012601.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/7a/60/dddt-10-2759.PMC5012601.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/60/dddt-10-2759.PMC5012601.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/de/62/ijn-11-4317.PMC5012604.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 4317–4325International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4317PersPectIvesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/IJN.S10994 3 Advancements in nano-enabled therapeutics for  neuroHIv management Ajeet Kaushik rahul Dev Jayant Madhavan Nair center for Personalized   NanoMedicine, Institute of  NeuroImmune Pharmacology,   Department of Immunology, Herbert  Wertheim college of Medicine,   Florida International University,   Miami, FL, UsAAbstract:  This viewpoint is a global call to promote fundamental and applied research aiming  toward designing smart nanocarriers of desired properties, novel noninvasive strategies to open  the blood–brain barrier (BBB), delivery/release of single/multiple therapeutic agents across  the BBB to eradicate neurohuman immunodeficiency virus (HIV), strategies for on-demand  site-specific release of antiretroviral therapy, developing novel nanoformulations capable  to recognize and eradicate latently infected HIV reservoirs, and developing novel smart  analytical diagnostic tools to detect and monitor HIV infection.",Non-OADS,/arxiv_data1/oa_pdf/de/62/ijn-11-4317.PMC5012604.pdf
"In the present scenario, appreci - ated efforts have been made to explore effective dual antiviral drugs and long-acting correspondence: Ajeet Kaushik center for Personalized Nanomedicine,  Institute of NeuroImmune Pharmacology,  Department of Immunology, Herbert  Wertheim college of Medicine, Florida  International University, 11200 sW, 8th  street, AHc-1, Lab 306, University Park,  Miami, FL 33199, UsA email ajeet.npl@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Perspectives Y ear: 2016 Volume: 11 Running head verso: Kaushik et al Running head recto: Nano-enabled therapeutics for neuroHIV DOI: http://dx.doi.org/10.2147/IJN.S109943",Non-OADS,/arxiv_data1/oa_pdf/de/62/ijn-11-4317.PMC5012604.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/de/62/ijn-11-4317.PMC5012604.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/62/ijn-11-4317.PMC5012604.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c9/5b/copd-11-2055.PMC5012608.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2055–2062International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2055OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10692 2 association between Helicobacter pylori   seropositivity and mild to moderate COPD:  clinical implications in an asian country with a  high prevalence of H. pylori ha Y oun lee1,2 Ji Won Kim2,3 Jung Kyu lee2,4 eun Y oung heo2,4 hee soon Chung2,4 Deog Keom Kim2,4 1Division of Pulmonary and Critical  Care Medicine, Department of  Internal Medicine, seoul national  University hospital, 2Department of  Internal Medicine, seoul national  University College of Medicine,   3Division of gastroenterology,   4Division of Pulmonary and Critical  Care Medicine, Department of  Internal Medicine, seoul national  University College of Medicine, seoul  Metropolitan government- seoul  national University Boramae Medical  Center, seoul, republic of KoreaBackground:  Helicobacter pylori  infection is a major cause of gastric diseases.",Non-OADS,/arxiv_data1/oa_pdf/c9/5b/copd-11-2055.PMC5012608.pdf
"Despite the limitations of serologic testing for H. pylori  infection,  this technique has been widely used because it is simple and noninvasive.Correspondence: Deog Keom Kim Division of Pulmonary and Critical  Care Medicine, Department of Internal  Medicine, seoul national University  College of Medicine, seoul Metropolitan  government-seoul national University  Boramae Medical Center, 20  Boramaero-5-gil, Dongjak-gu, seoul  156-707, republic of Korea Tel +82 2 870 2228 Fax +82 2 831 2826 email kimdkmd@snu.ac.k r Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Lee et al Running head recto: Association between H. pylori  and COPD DOI: http://dx.doi.org/10.2147/COPD.S106922",Non-OADS,/arxiv_data1/oa_pdf/c9/5b/copd-11-2055.PMC5012608.pdf
"Available from: http://www.diabetes.or.kr/temp/KDA_fact_sheet%20 2015.pd f. Accessed on January 6, 2016.",Non-OADS,/arxiv_data1/oa_pdf/c9/5b/copd-11-2055.PMC5012608.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/c9/5b/copd-11-2055.PMC5012608.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/5b/copd-11-2055.PMC5012608.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/50/97/ndt-12-2143.PMC5012609.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2143–2147Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2143OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11619 5 Olfactory functioning in early multiple sclerosis:  Sniffin’ Sticks T est study hale Z Batur caglayan1 Ceyla Irkec1 Bijen Nazliel1 Aslı Akyol Gurses2 irem capraz1 1Department of Neurology, Faculty  of Medicine, Gazi University, Ankara,   2Department of Neurology, Meram  Faculty of Medicine, Necmettin  Erbakan University, Konya, T urkeyIntroduction:  Previous studies have shown that olfactory functioning is affected by multiple  sclerosis (MS).",Non-OADS,/arxiv_data1/oa_pdf/50/97/ndt-12-2143.PMC5012609.pdf
"Normative data for olfaction using the Sniffin’ correspondence: hale Z Batur caglayan Department of Neurology, Faculty of  Medicine, Gazi University, C-Block 3rd  Floor, Besevler, 06500, Cankaya/Ankara,  Turkey Tel +90 312 202 5344 email halezeynep@gazi.edu.t r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Batur Caglayan et al Running head recto: Olfactory functioning in early MS DOI: http://dx.doi.org/10.2147/NDT.S116195",Non-OADS,/arxiv_data1/oa_pdf/50/97/ndt-12-2143.PMC5012609.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/50/97/ndt-12-2143.PMC5012609.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/97/ndt-12-2143.PMC5012609.pdf
Available  from: http://smelltest.eu/en/burghart-sniffin-sticks-burghart-smelltests/?,Non-OADS,/arxiv_data1/oa_pdf/50/97/ndt-12-2143.PMC5012609.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/10/8b/dddt-10-2701.PMC5012610.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2701–2711Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2701Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11380 4 nanomedical strategy to prolong survival period,  heighten cure rate, and lower systemic toxicity of  s180 mice treated with MTX/MiT ning song1 Ming Zhao1,2 Yuji Wang1 Xi hu1 Jianhui Wu1 Xueyun Jiang1 shan li1 chunying cui1 shiqi Peng1 1Beijing area Major laboratory of  Peptide and small Molecular Drugs,   engineering research center of  endogenous Prophylactic of Ministry  of education of china, Beijing  laboratory of Biomedical Materials,   college of Pharmaceutical sciences  of capital Medical University,   Beijing, People’s republic of china;   2Department of Biomedical science  and environmental Biology, Kaohsiung  Medical University, Kaohsiung, TaiwanAbstract:  In spite of the usual combination form of methotrexate (MTX)/mitoxantrone (MIT)  and various complex combination regimens of MTX/MIT with other anticancer drugs, the  survival period, cure rate, and systemic toxicity still need to be improved.",Non-OADS,/arxiv_data1/oa_pdf/10/8b/dddt-10-2701.PMC5012610.pdf
"Besides, MTX- and MIT-related combinations correspondence: Ming Zhao; shiqi Peng Beijing area Major laboratory of  Peptide and small Molecular Drugs,  engineering research center of  endogenous Prophylactic of Ministry of  education of china, Beijing laboratory  of Biomedical Materials, college of  Pharmaceutical sciences of capital  Medical University, Beijing 100069,  People’s republic of china Tel +86 10 8391 1528 Fax +86 10 8391 1533 email mingzhao@bjmu.edu.c n;   sqpeng@bjmu.edu.c nJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Song et al Running head recto: Nanomedical strategy using MTX/MIT in S180 mice DOI: http://dx.doi.org/10.2147/DDDT.S113804",Non-OADS,/arxiv_data1/oa_pdf/10/8b/dddt-10-2701.PMC5012610.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/10/8b/dddt-10-2701.PMC5012610.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/10/8b/dddt-10-2701.PMC5012610.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/67/89/ce-11-023.PMC5012611.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/67/89/ce-11-023.PMC5012611.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/67/89/ce-11-023.PMC5012611.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Core Evidence 2016:11 23–36Core Evidence Dovepress submit your manuscript | www.dovepress.com Dovepress 23 REviEw open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CE.S98687 Everolimus in the management of metastatic renal  cell carcinoma: an evidence-based review of its  place in therapy Sebastiano Buti1 Alessandro Leonetti1 Alice Dallatomasina2 Melissa Bersanelli1 1Medical Oncology Unit, University  Hospital of Parma, Parma, 2Division of  Experimental Oncology, San Raffaele  Scientific institute, Milan, italyIntroduction: Renal cell carcinoma (RCC) is the most common type of kidney cancer in  adults, and its pathogenesis is strictly related to altered cellular response to hypoxia, in which  mTOR signaling pathway is implicated.",Non-OADS,/arxiv_data1/oa_pdf/67/89/ce-11-023.PMC5012611.pdf
"The evidence about two new molecules, cabozantinib and nivolumab, successfully tested head-to-head with everolimus in recently published Phase III  trials,  will determine the shift of everolimus to the third-line setting and subsequent lines of treatment.Keywords: everolimus, afinitor, evidence-based review, renal cell carcinoma, RCC Correspondence: Sebastiano Buti Medical Oncology Unit, University Hospital of Parma, via Gramsci 14, 43100 Parma, italyTel +39 0521 702 316Email sebabuti@libero.itJournal name: Core Evidence Article Designation: REVIEwY ear: 2016V olume: 11Running head verso: Buti et alRunning head recto: Everolimus in the management of metastatic RCCDOI: http://dx.doi.org/10.2147/CE.S98687 Core evidence clinical impact summary for everolimus Outcome   measureEvidence Implications Disease-oriented evidence Clear cell renal  cell carcinomaClinical trials Everolimus consistently demonstrated efficacy in the treatment of metastatic clear cell renal cell carcinoma after previous vEGFR-tyrosine kinase inhibitor failure; therefore, it is a standard of care in second- or third-line therapy.",Non-OADS,/arxiv_data1/oa_pdf/67/89/ce-11-023.PMC5012611.pdf
"Core Evidence 2016:11submit your manuscript | www.dovepress.com Dovepress Dovepress Core Evidence Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/core-evidence-journalCore Evidence is an international, peer-reviewed open-access journal  evaluating the evidence underlying the potential place in therapy of drugs throughout their development lifecycle from preclinical to post launch.",Non-OADS,/arxiv_data1/oa_pdf/67/89/ce-11-023.PMC5012611.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 36 Buti et al  67.,Non-OADS,/arxiv_data1/oa_pdf/67/89/ce-11-023.PMC5012611.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2c/a1/cia-11-1183.PMC5012612.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1183–1192Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1183OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11071 8 A preliminary study on the effects of star fruit  consumption on antioxidant and lipid status in  elderly Thai individuals Jirakrit leelarungrayub1 Araya Yankai1 Decha Pinkaew1 rungthip Puntumetakul2 James J laskin3 richard J Bloomer4 1Department of Physical Therapy,   Faculty of Associated Medical  sciences, Chiang Mai University,   Chiang Mai, 2research Center in  Back, neck, Other Joint Pain and  human Performance (Bn OJPh),   Khon Kaen University, Khon Kaen,   Thailand; 3school of Physical  Therapy and rehabilitation sciences,   University of Montana, Missoula,   MT, 4Cardiorespiratory/Metabolic  laboratory, school of health studies,   University of Memphis, Memphis,   Tn, UsAObjective:  The aims of this preliminary study were to evaluate the antioxidant and lipid status  before and after star fruit juice consumption in healthy elderly subjects, and the vitamins in  star fruit extracts.",Non-OADS,/arxiv_data1/oa_pdf/2c/a1/cia-11-1183.PMC5012612.pdf
"Keywords:  star fruit, elderly, antioxidants, vitamins, lipid, oxidative stress Introduction It is well accepted that the aging population is growing rapidly in developed and  developing countries worldwide, and is predicted to grow in Thailand from 9.0 million  in 2015 to 15.9 million in 2035.1 In addition, there is a great deal of evidence that  demonstrates the growing prevalence of chronic diseases (eg, hypertension, stroke,  cardiac disease, type 2 diabetes, and cancer).2 Furthermore, the aging process is strongly  believed to be related to, if not caused by, oxidative stress,3 which has been linked to  many of these chronic diseases, specifically in the elderly.4 Prior work carried out on  the elderly population has shown that low concentrations of antioxidants such as glu - tathione (GSH) or increased oxidation to both lipid and protein structures increases the Correspondence: Jirakrit leelarungrayub Department of Physical Therapy, Faculty  of Associated Medical sciences, Chiang  Mai University, 110 Intawaroroj rd,  sripoom, Chiang Mai 50200, Thailand Tel +66 53 936 072 Fax +66 53 936 042 email donrawee.leela@cmu.ac.t h Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Leelarungrayub et al Running head recto: Star fruit, oxidative stress, lipid, and aging DOI: http://dx.doi.org/10.2147/CIA.S110718",Non-OADS,/arxiv_data1/oa_pdf/2c/a1/cia-11-1183.PMC5012612.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/2c/a1/cia-11-1183.PMC5012612.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/2c/a1/cia-11-1183.PMC5012612.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c2/63/ndt-12-2265.PMC5012613.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2265–2271Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2265OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11109 4 suicidality and symptoms of anxiety, irritability, and  agitation in patients experiencing manic episodes  with depressive symptoms: a naturalistic study Jonas eberhard1 emmanuelle Weiller2 1Department of clinical sciences,   lund University, lund, sweden;   2h.",Non-OADS,/arxiv_data1/oa_pdf/c2/63/ndt-12-2265.PMC5012613.pdf
"The Diagnostic and Statistical Manual of Mental Disorders , fifth  edition (DSM-5), captures mixed states using the “with mixed features” specifier, which  is added to a diagnosis of BD-I mania or depression when symptoms of the opposite  pole are present.1 The DSM-5 lists the following six depressive symptoms in its “with  mixed features” specifier for BD-I mania: prominent dysphoria or depressed mood, correspondence: Jonas eberhard h. lundbeck a/s, Ottiliavej 9, 2500 Valby,  copenhagen, Denmark Tel +45 3643 2813 Fax +45 3630 1940 email joeb@lundbeck.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Eberhard and Weiller Running head recto: Suicidality in mania with depressive symptoms DOI: http://dx.doi.org/10.2147/NDT.S111094",Non-OADS,/arxiv_data1/oa_pdf/c2/63/ndt-12-2265.PMC5012613.pdf
"Available from:  http://www.ephmra.org/user_uploads/2016%20code%20of%20con - duct%20february%202016.pd f. Accessed May 26, 2016.",Non-OADS,/arxiv_data1/oa_pdf/c2/63/ndt-12-2265.PMC5012613.pdf
"Available from: http://www.psychiatry.org/psy - chiatrists/search-directories-databases/library-and-archiv e. Accessed  February 9, 2016.",Non-OADS,/arxiv_data1/oa_pdf/c2/63/ndt-12-2265.PMC5012613.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric­disease­and­treatment­journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c2/63/ndt-12-2265.PMC5012613.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/63/ndt-12-2265.PMC5012613.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8e/ca/ndt-12-2245.PMC5012614.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2245–2253Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2245OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10932 8 construction of standardized arabic questionnaires  for screening neurological disorders (dementia,  stroke, epilepsy, movement disorders, muscle  and neuromuscular junction disorders) hamdy N el Tallawy1 Wafaa M a Farghaly1 Tarek a rageh1 ahmed O saleh2 Taha ah Mestekawy3 Manal MM Darwish4 Mohamed a abd el hamed1 anwar M ali1 Doaa M Mahmoud1 1Department of Neurology and  Psychiatry, Faculty of Medicine,   2Psychology Department, Faculty of  education, 3Psychology Department,   Faculty of arts, 4Public health  Department, Faculty of Medicine,   assiut University, assiut, egyptAbstract:  A screening questionnaire is an important tool for early diagnosis of neurological  disorders, and for epidemiological research.",Non-OADS,/arxiv_data1/oa_pdf/8e/ca/ndt-12-2245.PMC5012614.pdf
"Disorders that affect the elderly, such as  stroke, dementia, and Parkinson’s disease, will be of increasingly greater importance  as the age of the population increases.4 The estimated total population of the Arab world was around 318 million in 2005  and is projected to increase to 480 million in 2030.5 The available information on the  pattern and frequency of major neurological disorders in Arabic-speaking countries  is scanty and limited mainly to hospital-based populations who may not be totally  representative of the community.6–8 A strategy, which combines population screen - ing using a questionnaire with clinical evaluation of those identified with potential  disease by a neurologist, has been designed and found to provide accurate data on the  frequency of neurological disease in the community.9–16 This study was developed to prepare different Arabic screening questionnaires  for screening different neurological disorders, with English translation of the same  questionnaire.correspondence: Mohamed a abd   el hamed Department of Neurology and Psychiatry,  assiut University hospital, 71526, said  Marzok street, assiut, egypt Tel +20 88 210 2028 Fax +20 88 233 3327 email moh78_abdelhamed@yahoo.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: El Tallawy et al Running head recto: Standardized Arabic questionnaires for screening neurological disorders DOI: http://dx.doi.org/10.2147/NDT.S109328",Non-OADS,/arxiv_data1/oa_pdf/8e/ca/ndt-12-2245.PMC5012614.pdf
"Acknowledgment This article was presented, which includes work based  on a thesis submitted, by the authors HNEl-T, AS, and  TR to Assiut University, Egypt ( http://www.aun.edu.eg/ thesis_files /6633.pd f).",Non-OADS,/arxiv_data1/oa_pdf/8e/ca/ndt-12-2245.PMC5012614.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/8e/ca/ndt-12-2245.PMC5012614.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/ca/ndt-12-2245.PMC5012614.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/b5/96/amep-7-511.PMC5012615.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b5/96/amep-7-511.PMC5012615.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b5/96/amep-7-511.PMC5012615.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 511–516Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 511 METHODOLOGY open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S110357 Using Gagne’s instructional model in phlebotomy  education Wee Hong Woo School of Chemical & Life Sciences,   Singapore Polytechnic, SingaporeAbstract: As the role of a phlebotomist in a clinical setting involves patient interactions,  correct  patient identification, and blood specimen accessioning, it is essential that the phlebotomy  education pay attention to these procedural tasks to inculcate a culture of patient safety.",Non-OADS,/arxiv_data1/oa_pdf/b5/96/amep-7-511.PMC5012615.pdf
"To highlight some of the preanalytical variables listed in Table 2, the role play  activity (Table 3) is employed to set focus on patient variables (fasting), variables of Correspondence: Wee Hong Woo School of Chemical & Life Sciences, Singapore Polytechnic, 500 Dover Road, Singapore 139651Tel +65 6772 1899Fax +65 6772 1976Email whwoo@sp.edu.sgJournal name: Advances in Medical Education and Practice Article Designation: METHODOLOGYY ear: 2016V olume: 7Running head verso: WooRunning head recto: Gagne’ s instructional model in phlebotomy educationDOI: http://dx.doi.org/10.2147/AMEP .S110357",Non-OADS,/arxiv_data1/oa_pdf/b5/96/amep-7-511.PMC5012615.pdf
Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress 513 Gagne’s instructional model in phlebotomy education life (first 1 minute 31 seconds; https://www.youtube.com/ watch?v=Ph4H1AuvOH0).,Non-OADS,/arxiv_data1/oa_pdf/b5/96/amep-7-511.PMC5012615.pdf
Available from: http://files.eric.ed.gov/fulltext/ED084368.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/96/amep-7-511.PMC5012615.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/b5/96/amep-7-511.PMC5012615.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 516 Woo  19.,Non-OADS,/arxiv_data1/oa_pdf/b5/96/amep-7-511.PMC5012615.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8c/53/dddt-10-2745.PMC5012616.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2745–2758Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2745Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S11016 3 Anti-inflammatory drugs for Duchenne muscular  dystrophy: focus on skeletal muscle-releasing  factors Shouta Miyatake1 Yuko Shimizu-Motohashi2 Shin’ichi Takeda1 Y oshitsugu Aoki1 1Department of Molecular Therapy,   National Institute of Neuroscience,   National Center of Neurology and  Psychiatry, Kodaira, T okyo, Japan;   2Department of Child Neurology,   National Center Hospital, National  Center of Neurology and Psychiatry,   Kodaira, T okyo, JapanAbstract:  Duchenne muscular dystrophy (DMD), an incurable and a progressive muscle  wasting disease, is caused by the absence of dystrophin protein, leading to recurrent muscle  fiber damage during contraction.",Non-OADS,/arxiv_data1/oa_pdf/8c/53/dddt-10-2745.PMC5012616.pdf
"Dystrophin  acts as a bridging and anchoring protein by binding to F-actin through its cytoplasmic  N-terminal domain and to β-dystroglycan through its extracellular C-terminal domain.4,5  The loss of dystrophin disrupts the dystrophin-associated glycoprotein complex and Correspondence: Yoshitsugu Aoki Department of Molecular Therapy,  National Institute of Neuroscience,  National Center of Neurology and  Psychiatry, 4-1-1 Ogawahigashi-Cho,  Kodaira, Tokyo 187-8502, Japan Tel +81 42 346 1720 Fax +81 42 346 1750 email tsugu56@ncnp.go.j p Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Miyatake et al Running head recto: Anti-inflammatory drugs for Duchenne muscular dystrophy DOI: http://dx.doi.org/10.2147/DDDT.S110163",Non-OADS,/arxiv_data1/oa_pdf/8c/53/dddt-10-2745.PMC5012616.pdf
"ASOs have been extensively tested in  disease models and are currently being evaluated in several  clinical trials including ASO-based exon53 skipping therapy  at our institute in Japan ( http://www.ClinicalTrials.gov;  NCT0208162 5).11,12 However, each ASO has a specific antisense sequence for  single exon in the DMD  gene and is considered a new drug;  therefore, ASOs for separate exons have to undergo expen - sive and lengthy clinical trial stages.",Non-OADS,/arxiv_data1/oa_pdf/8c/53/dddt-10-2745.PMC5012616.pdf
Santhera Pharmaceuti - cals has confirmed the safety of idebenone in DMD patients  (https://ClinicalTrials.gov/ct2/show/NCT0065478 4).,Non-OADS,/arxiv_data1/oa_pdf/8c/53/dddt-10-2745.PMC5012616.pdf
"Additionally, pre - clinical studies with green tea extract and its active ingredient  epigallocatechin gallate revealed histological and functional  improvement in mdx mice.49,50 Furthermore, early treatment  with green tea extract reduced dystrophic muscle pathol - ogy, potentially by regulating NF- κB activity in regenerat - ing fibers.51 Epigallocatechin gallate for DMD patients is  now under Phase II/III trials at Charité University Hospital  Berlin, Germany ( https://www.ClinicalTrials.gov/ct2/show/ NCT0118376 7).",Non-OADS,/arxiv_data1/oa_pdf/8c/53/dddt-10-2745.PMC5012616.pdf
Flavocoxid is another antioxidant that has  been tested in a Phase I trial in DMD patients to assess its  safety ( https://www.ClinicalTrials.gov/ct2/show/CAT-100 4)  (Table 2; Figure 2).,Non-OADS,/arxiv_data1/oa_pdf/8c/53/dddt-10-2745.PMC5012616.pdf
"Drug Design, Development and Therapy 2016:10submit your manuscript | www.dovepress.co m Dove press Dove press 2751Anti-inflammatory drugs for Duchenne muscular dystrophy completed Phase I clinical trial ( https://ClinicalTrials.gov/ ct2/show/VBP1 5) (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/8c/53/dddt-10-2745.PMC5012616.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/8c/53/dddt-10-2745.PMC5012616.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/53/dddt-10-2745.PMC5012616.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9d/c9/ijn-11-4275.PMC5012617.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 4275–4285International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4275OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10903 1 The effect of ZnO nanoparticles on liver  function in rats correspondence: Ying-lun li Department of Pharmacy, sichuan  agricultural University, sichuan,  chengdu 611130, People’s  republic of china Tel +86 136 1806 7989 email liyinglun02@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Tang et al Running head recto: Nano-ZnO on liver function in rats DOI: http://dx.doi.org/10.2147/IJN.S109031 hua-Qiao Tang Min Xu Qian rong ru-Wen Jin Qi-Ji liu Ying-lun li Department of Pharmacy, sichuan  agricultural University, sichuan,   chengdu, People’s republic of chinaAbstract:  Zinc oxide (ZnO) is widely incorporated as a food additive in animal diets.",Non-OADS,/arxiv_data1/oa_pdf/9d/c9/ijn-11-4275.PMC5012617.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9d/c9/ijn-11-4275.PMC5012617.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/c9/ijn-11-4275.PMC5012617.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e4/f8/copd-11-2063.PMC5012618.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2063–2074International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2063OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10788 4 Do self-management interventions in COPD  patients work and which patients benefit most?",Non-OADS,/arxiv_data1/oa_pdf/e4/f8/copd-11-2063.PMC5012618.pdf
"Keywords:  chronic obstructive pulmonary disease, individual patient data meta-analysis,  self-management, subgroup analysis Introduction With over 60 million people affected, COPD is a major global health problem leading to  substantial morbidity and mortality.1 In addition to the disease burden, COPD requires  a major shift in patients’ daily life as they need to adhere to drug treatment, implement  lifestyle changes, monitor signs and symptoms, and apply decision making on early  treatment of exacerbations to prevent complications.2 Interventions to improve this  self-management behavior in COPD patients have been receiving increasing attention  and generally involve patient education and teaching skills to patients for monitoring Correspondence: nini h Jonkman Department of rehabilitation, nursing science & sports,  University Medical Center Utrecht, hP W01.121,  heidelberglaan 100, 3508 ga Utrecht, the netherlands Tel +31 30 613 244 760 email n.jonkman@umcutrecht.n l Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Jonkman et al Running head recto: Self-management interventions for patients with COPD DOI: http://dx.doi.org/10.2147/COPD.S107884",Non-OADS,/arxiv_data1/oa_pdf/e4/f8/copd-11-2063.PMC5012618.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/e4/f8/copd-11-2063.PMC5012618.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/f8/copd-11-2063.PMC5012618.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/14/e5/cia-11-1099.PMC5012619.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1099–1106Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1099OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10762 6 effect of pedometer use and goal setting on  walking and functional status in overweight adults  with multimorbidity: a crossover clinical trial Paul Y Takahashi1 stephanie M Quigg1 Ivana T Croghan1 Darrell r schroeder2 Jon O ebbert1 1Division of Primary Care Internal  Medicine, 2Division of Biomedical  statistics and Informatics, Mayo Clinic,   rochester, M n, UsABackground:  Walking can improve functional status, and a pedometer and goal setting can  increase walking and, potentially, gait speed.",Non-OADS,/arxiv_data1/oa_pdf/14/e5/cia-11-1099.PMC5012619.pdf
"In some  workplace studies, 70% of people will increase their activity with a 4-week pedometer  program.1 In a 2007 meta-analysis of 27 studies – both randomized controlled trials and  observational studies – participants in clinical trials increased their physical activity by  2,183 steps compared with a control group.2 Other meta-analyses have evaluated step Correspondence: Paul Y Takahashi Division of Primary Care Internal  Medicine, Mayo Clinic, 200 First st sW,  rochester, Mn 55905, UsA Tel +1 507 284 2511 Fax +1 507 266 0036 email takahashi.paul@mayo.ed u Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Takahashi et al Running head recto: Pedometers and walking with illness DOI: http://dx.doi.org/10.2147/CIA.S107626",Non-OADS,/arxiv_data1/oa_pdf/14/e5/cia-11-1099.PMC5012619.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/14/e5/cia-11-1099.PMC5012619.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/14/e5/cia-11-1099.PMC5012619.pdf
"Available from: http://www.nihtoolbox.org/ WhatAndWhy/Motor/Locomotion/Pages/NIH-Toolbox-4--Meter- Walk-Gait-Speed-Test.asp x. Accessed May 21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/14/e5/cia-11-1099.PMC5012619.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/14/e5/cia-11-1099.PMC5012619.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0c/b7/ndt-12-2255.PMC5012621.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2255–2263Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2255OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10889 9 children who screen positive for autism at  2.5 years and receive early intervention: a  prospective naturalistic 2-year outcome study Birgitta spjut Jansson1–3 carmela Miniscalco1,4 Joakim Westerlund1,5 anne-Katrin Kantzer1,6 elisabeth Fernell1 christopher gillberg1 1gillberg Neuropsychiatry centre,   sahlgrenska academy, institute  of Neuroscience and Physiology,   University of gothenburg, 2Unit of  child and adolescent habilitation,   3Department of Psychology,   University of gothenburg,   4Division of speech and language  Pathology, institute of Neuroscience  and Physiology, University  of gothenburg,  gothenburg,   5Department of Psychology,   University of stockholm, stockholm,   6Department of child and adolescent  Psychiatry, NU hospital Organization,   Trollhättan, swedenBackground:  Previous research has stressed the importance of early identification and  intervention for children with autism spectrum disorders.",Non-OADS,/arxiv_data1/oa_pdf/0c/b7/ndt-12-2255.PMC5012621.pdf
"In addition, the U.S. Preventive Services Task Force9 concludes that there correspondence: Birgitta spjut Jansson gillberg Neuropsychiatry centre,  sahlgrenska academy, University of  gothenburg, Kungsgatan 12, gothenburg  41119, sweden Tel +46 31 342 5970 email birgitta.spjut@vgregion.s e Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Spjut Jansson et al Running head recto: A follow-up of early intervention in children with autism DOI: http://dx.doi.org/10.2147/NDT.S108899",Non-OADS,/arxiv_data1/oa_pdf/0c/b7/ndt-12-2255.PMC5012621.pdf
"Available from: http://www.screening.nhs.uk/autis m. Accessed  March 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/0c/b7/ndt-12-2255.PMC5012621.pdf
Available from: http://www.habiliteringschefer.se/ebh/autism/autism.,Non-OADS,/arxiv_data1/oa_pdf/0c/b7/ndt-12-2255.PMC5012621.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/0c/b7/ndt-12-2255.PMC5012621.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/b7/ndt-12-2255.PMC5012621.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/5a/75/hmer-8-089.PMC5012622.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5a/75/hmer-8-089.PMC5012622.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5a/75/hmer-8-089.PMC5012622.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Hepatic Medicine: Evidence and Research 2016:8 89–95Hepatic Medicine: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  89 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HMER.S91709Obeticholic acid for the treatment of primary  biliary cholangitis in adult patients: clinical utility  and patient selection Christopher L Bowlus Division of Gastroenterology and  Hepatology, University of California Davis, Davis, CA, USAAbstract:  Primary biliary cholangitis (PBC), previously known as primary biliary “cirrhosis”,  is a rare autoimmune liver disease characterized by the hallmark autoantibodies to mitochon- drial antigens and immune-mediated destruction of small bile duct epithelial cells leading to  cholestasis and cirrhosis.",Non-OADS,/arxiv_data1/oa_pdf/5a/75/hmer-8-089.PMC5012622.pdf
"3 In addition to diagnosis, liver biopsy was historically used for staging  of fibrosis but has been replaced by noninvasive methods such as transient elastography.Correspondence: Christopher L Bowlus Division of Gastroenterology and Hepatology, University of California Davis, 4150 V Street, PSSB 3500, Sacramento, CA 95817, USATel +1 916 734 3751Fax +1 916 734 7908Email clbowlus@ucdavis.eduJournal name: Hepatic Medicine: Evidence and Research Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: BowlusRunning head recto: OCA for PBC in adultsDOI: http://dx.doi.org/10.2147/HMER.S91709",Non-OADS,/arxiv_data1/oa_pdf/5a/75/hmer-8-089.PMC5012622.pdf
"16,20 More recent studies  of an international cohort of over 4,500 PBC patients further characterized the relationship between levels of serum ALP and total bilirubin at 1-year of follow-up and the risk of liver transplantation or death 21 leading to the PBC GLOBE score,  which incorporates age at initiation of UDCA therapy, levels of serum ALP , total bilirubin, albumin, and platelets (http://www.globalpbc.com/globe).",Non-OADS,/arxiv_data1/oa_pdf/5a/75/hmer-8-089.PMC5012622.pdf
Calculator available at http://www.uk-pbc.com/resources/tools/riskcalculator/.,Non-OADS,/arxiv_data1/oa_pdf/5a/75/hmer-8-089.PMC5012622.pdf
Calculator available  at http://www.globalpbc.com/globe.,Non-OADS,/arxiv_data1/oa_pdf/5a/75/hmer-8-089.PMC5012622.pdf
"Hepatic Medicine: Evidence and Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Hepatic Medicine: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/hepatic-medicine-evidence-and-research-journalThe Open Access Journal of Hepatology is an international, peer- reviewed, open access journal covering all aspects of adult and pediatric hepatology in the clinic and laboratory including the following topics: Pathology, pathophysiology of hepatic disease; Investigation and treat-ment of hepatic disease; Pharmacology of drugs used for the treatment of hepatic disease.",Non-OADS,/arxiv_data1/oa_pdf/5a/75/hmer-8-089.PMC5012622.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 95 OCA for PBC in adults  9.,Non-OADS,/arxiv_data1/oa_pdf/5a/75/hmer-8-089.PMC5012622.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02308111.,Non-OADS,/arxiv_data1/oa_pdf/5a/75/hmer-8-089.PMC5012622.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/4e/72/clep-8-313.PMC5012623.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4e/72/clep-8-313.PMC5012623.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/4e/72/clep-8-313.PMC5012623.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 313–321Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 313 Original rEsEarCh open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S108761 Cholesterol testing among men and women with  disability: the role of morbidity aisha K lofters1–3,* sara JT guilcher1,3,4,* lauren Webster1 richard h glazier1–3 susan B Jaglal1 ahmed M Bayoumi1,3 1institute for Clinical Evaluative  sciences, 2Department of Family and  Community Medicine, st Michael’s  hospital, University of T oronto,   3Centre for Urban health solutions,   li Ka shing Knowledge institute, st  Michael’s hospital, 4leslie Dan Faculty  of Pharmacy, University of T oronto,   T oronto, On , Canada *These authors contributed equally to this workPurpose: Despite more frequent use of health services by people living with disability, the  quality of preventive care received may be suboptimal.",Non-OADS,/arxiv_data1/oa_pdf/4e/72/clep-8-313.PMC5012623.pdf
"9,10,12–14 In  previous work, we found an interaction between the levels of disability and morbidity Correspondence: aisha lofters Centre for research on inner City health, li Ka shing Knowledge institute, st Michael’s hospital, 30 Bond street, Toronto, On M5B 1W8, CanadaEmail aisha.lofters@utoronto.caJournal name: Clinical Epidemiology Article Designation: Original ResearchY ear: 2016V olume: 8Running head verso: Lofters et alRunning head recto: Cholesterol testing among men and women with disabilityDOI: http://dx.doi.org/10.2147/CLEP .S108761",Non-OADS,/arxiv_data1/oa_pdf/4e/72/clep-8-313.PMC5012623.pdf
Available from: http://publications.gov.sk.ca/documents/17/39966-Socio-Demographic-Profiles-Women-with-Disabilities.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4e/72/clep-8-313.PMC5012623.pdf
Available from: http://www.statcan.gc.ca/pub/89-577-x/index-eng.htm.,OADS,/arxiv_data1/oa_pdf/4e/72/clep-8-313.PMC5012623.pdf
Available from: http://www.ices.on.ca/Data-and-Privacy/ICES-data.,OADS,/arxiv_data1/oa_pdf/4e/72/clep-8-313.PMC5012623.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/4e/72/clep-8-313.PMC5012623.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3b/d1/ijn-11-4231.PMC5012625.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 4231–4246International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4231OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11057 3 Preparation and in vivo evaluation of an orally  available enteric-microencapsulated parathyroid  hormone (1-34)-deoxycholic acid nanocomplex seung rim hwang1 Dong-hyun seo2 Y oungro Byun3 Jin Woo Park4 1Department of Pharmacy, college  of Pharmacy, chosun University,   gwangju, 2Department of Biomedical  engineering, college of health  science, Y onsei University, Wonju,   gangwon, 3Department of Molecular  Medicine and Biopharmaceutical  science, graduate school of  convergence science and T echnology,   college of Pharmacy, seoul National  University, seoul, 4Department of  Pharmacy, college of Pharmacy and  Natural Medicine research Institute,   Mokpo National University, Muan-gun,   Jeonnam, republic of KoreaAbstract:  The N-terminal 34-amino-acid peptide fragment of human parathyroid hormone  PTH (1-34), is used clinically to treat osteoporosis; however, it is currently administered by a  once-daily subcutaneous injection, resulting in poor patient compliance.",Non-OADS,/arxiv_data1/oa_pdf/3b/d1/ijn-11-4231.PMC5012625.pdf
"Keywords:  oral delivery, parathyroid hormone, nanocomplex, deoxycholic acid, coaxial  ultrasonic atomization, osteoporosis Introduction Parathyroid hormone (PTH), a polypeptide consisting of 84 amino acids secreted  from the parathyroid glands, is one of the major hormones regulating the calcium ion  concentration in the blood.1 It has anabolic (ie, bone-building) and catabolic functions  in bone, and these depend on the pattern and duration of PTH exposure.2 Anabolic  functions are stimulated by intermittent exposure to PTH, resulting in differentiation  and proliferation or reduced apoptosis of osteoblasts.3–5 Catabolic functions are stimu - lated by continuous PTH exposure and associated with increased receptor activator of  nuclear factor- κB ligand expression and inhibition of osteoprotegerin expression.6 The 34 N-terminal amino acids of PTH, PTH (1-34), are indispensable for activat - ing the type 1 PTH receptor, which is highly expressed in bone and kidney.7 When  PTH (1-34) binds the type 1 PTH receptor, signaling pathways, which include the correspondence: Youngro Byun college of Pharmacy, seoul National  University, 1 gwanak-ro, gwanak-gu,  seoul 151-742, republic of Korea Tel +82 2 880 7866 Fax +82 2 872 7864 email yrbyun@snu.ac.k r  Jin Woo Park college of Pharmacy, Mokpo National  University, 1666 Youngsan-ro, Muan-gun,  Jeonnam 58554, republic of Korea Tel +82 61 450 2704 Fax +82 61 450 2689 email jwpark@mokpo.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Hwang et al Running head recto: Preparation and in vivo evaluation of an oral parathyroid hormone DOI: http://dx.doi.org/10.2147/IJN.S110573",Non-OADS,/arxiv_data1/oa_pdf/3b/d1/ijn-11-4231.PMC5012625.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/3b/d1/ijn-11-4231.PMC5012625.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/d1/ijn-11-4231.PMC5012625.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/97/f1/ndt-12-2279.PMC5012626.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2279–2281Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2279Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11668 6 adding metoclopramide to paroxetine induced  extrapyramidal symptoms and hyperprolactinemia  in a depressed woman: a case report ryohei Igata Hikaru Hori  Kiyokazu atake  asuka Katsuki Jun Nakamura Department of psychiatry, University  of occupational and environmental  Health, Kitakyushu, JapanAbstract:  A 54-year-old Japanese woman was diagnosed with major depressive disorder  and prescribed paroxetine 20 mg/day.",Non-OADS,/arxiv_data1/oa_pdf/97/f1/ndt-12-2279.PMC5012626.pdf
"In around May 2013, Correspondence: Hikaru Hori  Department of psychiatry, University of  occupational and environmental Health,  1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu,  Fukuoka 807-8555, Japan Tel +81 93 691 7253 Fax +81 93 692 4894 email hori-h@med.uoeh-u.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2016 Volume: 12 Running head verso: Igata et al Running head recto: Neuropsychiatric disease and treatment DOI: http://dx.doi.org/10.2147/NDT.S116686",Non-OADS,/arxiv_data1/oa_pdf/97/f1/ndt-12-2279.PMC5012626.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/97/f1/ndt-12-2279.PMC5012626.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/f1/ndt-12-2279.PMC5012626.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/3d/60/ccid-9-225.PMC5012627.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/3d/60/ccid-9-225.PMC5012627.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/3d/60/ccid-9-225.PMC5012627.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2016:9 225–232Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 225 EXPERT OPINION open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S92853 Volume correction in the aging hand: role of  dermal fillers Alexander Z Rivkin David Geffen/UCLA School of  Medicine Los  Angeles, CA, USAAbstract:  The hands, just like the face, are highly visible parts of the body.",Non-OADS,/arxiv_data1/oa_pdf/3d/60/ccid-9-225.PMC5012627.pdf
"These products were being used off-label, but results were found to be excellent, and hand augmentation with fillers became popular throughout Correspondence: Alexander Z Rivkin David Geffen/UCLA School of Medicine, 11645 Wilshire Blvd, Ste 800,  Los Angeles, CA 90025, USATel +1 310 443 5273Email arivkin9@gmail.comJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: EXPERT OPINIONY ear: 2016V olume: 9Running head verso: RivkinRunning head recto: V olume correction in the aging handDOI: http://dx.doi.org/10.2147/CCID.S92853",Non-OADS,/arxiv_data1/oa_pdf/3d/60/ccid-9-225.PMC5012627.pdf
"Clinical, Cosmetic and Investigational Dermatology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/3d/60/ccid-9-225.PMC5012627.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 232 Rivkin 13.,Non-OADS,/arxiv_data1/oa_pdf/3d/60/ccid-9-225.PMC5012627.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/82/09/ijn-11-4299.PMC5012628.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 4299–4316International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4299OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10995 0 systemic distribution of single-walled carbon  nanotubes in a novel model: alteration of  biochemical parameters, metabolic functions,  liver accumulation, and inflammation in vivo elisa Principi,1,* rossana  girardello,2,* antonino  Bruno,1,* Isabella Manni,3  elisabetta gini,2 arianna  Pagani,1 annalisa grimaldi,2  Federico Ivaldi,4 T erenzio  congiu,5 Daniela De  stefano,1 giulia Piaggio,3  Magda de eguileor,2  Douglas M Noonan,1,2  adriana albini1 1Vascular Biology and angiogenesis,   scientific and T echnology Pole,   Irccs MultiMedica, Milano,   2Department of Biotechnology  and life sciences, University of  Insubria, Varese, 3Department of  research, advanced Diagnosis and  Innovation, regina elena National  cancer Institute, rome, 4Department  of Neuroscience, Ophthalmology  and genetics, University of genoa,   genoa, 5Department of surgical and  Morphological sciences, University of  Insubria, Varese, Italy *These authors contributed equally  to this workAbstract:  The increasing use of carbon nanotubes (CNTs) in several industrial applications  raises concerns on their potential toxicity due to factors such as tissue penetrance, small dimen - sions, and biopersistence.",Non-OADS,/arxiv_data1/oa_pdf/82/09/ijn-11-4299.PMC5012628.pdf
"Single- walled CNTs (SWCNTs) are also of interest for their potential medical applications,1  including in vivo delivery2–4 of drugs,5 proteins, peptides,6–8 and nucleic acids8 for gene  transfer9 or gene silencing.6 In oncology, experimental studies have been focused on  SWCNTs as a new tool to target tumor cells10 for antineoplastic treatment of tumor  angiogenesis and in vivo tumor imaging.11 The small diameter, the relatively long  length, and the biopersistence of CNTs have been linked to the structure of asbestos,  suggesting extensive concerns on potential pulmonary health hazards.12–17 CNT tissue  accumulation, stability over long periods, final fate, and toxicological impact on health correspondence: Douglas M Noonan Scientific and Technology Pole, IRCCS  Multimedica, Via g. Fantoli 16/15,  Milano 20138, Italy Tel +39 025 540 6532 Fax +39 332 21 7609 email douglas.noonan@uninsubria.i t Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Principi et al Running head recto: Systemic distribution of SWCNTs DOI: http://dx.doi.org/10.2147/IJN.S109950",Non-OADS,/arxiv_data1/oa_pdf/82/09/ijn-11-4299.PMC5012628.pdf
"Statistical analyses for multiple  comparisons were tested by one-way and two-way analyses  of variance followed by Bonferroni’s multiple comparison  test ( http://www.graphpad.com/guides/prism/6/statistics/ index.htm?stat_the_bonferroni_method.ht m).30,31 Results systemic effects of sWcNTs on bone  marrow proliferation in MITO-luc mice We used a recently developed mouse model, MITO-Luc  (repTOP™ mitoIRE),23 that has a reporter gene under the control of a NF-Y-dependent cyclin B2 promoter, which  allows the determination of physiological and/or aberrant cell  proliferation in any tissue of the body, by BLI.",OADS,/arxiv_data1/oa_pdf/82/09/ijn-11-4299.PMC5012628.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/82/09/ijn-11-4299.PMC5012628.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/09/ijn-11-4299.PMC5012628.pdf
Or use: http://youtu.be/I0Yt6FbEt- oVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/82/09/ijn-11-4299.PMC5012628.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1a/f4/ijn-11-4221.PMC5012629.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 4221–4229International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4221OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11470 5 MDM2–MDM4 molecular interaction investigated  by atomic force spectroscopy and surface  plasmon resonance Ilaria Moscetti1 emanuela T everoni2,3 Fabiola Moretti3 anna rita Bizzarri1 salvatore cannistraro1 1Biophysics and Nanoscience centre,   Department D eB, Università della  T uscia, Viterbo, Italy; 2Department  of endocrinology and Metabolism,   Università cattolica di roma, roma,   Italy; 3Institute of cell Biology and  Neurobiology, consiglio Nazionale  delle ricerche (cN r), roma, ItalyAbstract:  Murine double minute 2 (MDM2) and 4 (MDM4) are known as the main negative  regulators of p53, a tumor suppressor.",Non-OADS,/arxiv_data1/oa_pdf/1a/f4/ijn-11-4221.PMC5012629.pdf
"correspondence: salvatore cannistraro Biophysics and Nanoscience centre,  Dipartimento DeB, Università della  Tuscia, largo dell’Università snc,  01100, Viterbo, Italy Tel +39 761 357 136 email cannistr@unitus.i t Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Moscetti et al Running head recto: MDM2–MDM4 molecular interaction DOI: http://dx.doi.org/10.2147/IJN.S114705",Non-OADS,/arxiv_data1/oa_pdf/1a/f4/ijn-11-4221.PMC5012629.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1a/f4/ijn-11-4221.PMC5012629.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/f4/ijn-11-4221.PMC5012629.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/38/6e/ccid-9-233.PMC5012630.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/38/6e/ccid-9-233.PMC5012630.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/38/6e/ccid-9-233.PMC5012630.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2016:9 233–239Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 233 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S110655 Assessment of a new biological complex  efficacy on dysseborrhea, inflammation, and  Propionibacterium acnes  proliferation Sandra Trompezinski1 Sophie Weber1 Benoît Cadars2 Florence Larue1 Nathalie Ardiet1 Marlène  Chavagnac-Bonneville2 Michèle Sayag2 Eric Jourdan2 1NAOS, Aix-en Provence, 2Direction  Scientifique Bioderma (NAOS),   Lyon,  FranceIntroduction: Acne vulgaris is a common chronic inflammatory disease of the pilosebaceous  unit triggered by Propionibacterium acnes.",Non-OADS,/arxiv_data1/oa_pdf/38/6e/ccid-9-233.PMC5012630.pdf
"4 The hormonal-mediated stimulation of the sebaceous gland observed in patients  with acne leads to increased sebum production and potentially changes its composition.5 Correspondence: Eric Jourdan Direction Scientifique Bioderma (NAOS), 75 cours Albert Thomas, 69447 Lyon Cedex 03, FranceTel +33 4 7211 4816Email e.jourdan@bioderma.comJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Trompezinski et alRunning head recto: A new dermocosmetic for acneDOI: http://dx.doi.org/10.2147/CCID.S110655",Non-OADS,/arxiv_data1/oa_pdf/38/6e/ccid-9-233.PMC5012630.pdf
"Clinical, Cosmetic and Investigational Dermatology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/38/6e/ccid-9-233.PMC5012630.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 239 A new dermocosmetic for acne  6.,Non-OADS,/arxiv_data1/oa_pdf/38/6e/ccid-9-233.PMC5012630.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9f/cb/ijn-11-4247.PMC5012632.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 4247–4259International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4247OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11340 7 arginine–glycine–aspartic acid–polyethylene  glycol–polyamidoamine dendrimer conjugate  improves liver-cell aggregation and function in   3-D spheroid culture Zhanfei chen1,* Fen lian1,* Xiaoqian Wang1 Yanling chen1,2 Nanhong Tang1,2 1Fujian Institute of hepatobiliary  surgery, Fujian Medical University  Union hospital, 2Key laboratory  of Ministry of education for  gastrointestinal cancer, research  center for Molecular Medicine,   Fujian Medical University, Fuzhou,   People’s republic of china *These authors contributed equally  to this workAbstract:  The polyamidoamine (PAMAM) dendrimer, a type of macromolecule material, has  been used in spheroidal cell culture and drug delivery in recent years.",Non-OADS,/arxiv_data1/oa_pdf/9f/cb/ijn-11-4247.PMC5012632.pdf
"In recent years, to correspondence: Nanhong Tang Fujian Institute of hepatobiliary surgery,  Fujian Medical University Union hospital,  29 Xinquan road, Fuzhou, Fujian 350001,  People’s republic of china Tel +86 133 6591 0895 Fax +86 591 8335 7896 email fztnh@sina.co mJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Chen et al Running head recto: RGD-PEG-PAMAM improves liver-cell function DOI: http://dx.doi.org/10.2147/IJN.S113407",Non-OADS,/arxiv_data1/oa_pdf/9f/cb/ijn-11-4247.PMC5012632.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9f/cb/ijn-11-4247.PMC5012632.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/cb/ijn-11-4247.PMC5012632.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/20/c7/copd-11-2041.PMC5012634.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2041–2053International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2041OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11456 6 The efficacy of aclidinium/formoterol on lung  function and symptoms in patients with COPD  categorized by symptom status: a pooled analysis Marc Miravitlles1 Kenneth r Chapman2 Ferran Chuecos3 Anna Ribera4 esther garcia gil3 1Department of Pneumology, Vall  d’Hebron University Hospital, CIBER  de enfermedades respiratorias  (CIBERES), Barcelona, Spain; 2asthma &  Airway Centre, University Health  Network, T oronto Western Hospital  and University of T oronto, T oronto,   ON, Canada; 3Global Medicines  Development, AstraZeneca  PLC, Barcelona, Spain; 4Global  Medical Affairs, AstraZeneca PLC,   Barcelona,  SpainBackground:  Patients with chronic obstructive pulmonary disease (COPD) experience  respiratory symptoms, which impair quality of life.",Non-OADS,/arxiv_data1/oa_pdf/20/c7/copd-11-2041.PMC5012634.pdf
"Keywords:  aclidinium, formoterol, COPD, lung function, dyspnea, symptoms Introduction Chronic obstructive pulmonary disease (COPD) is characterized by progressive loss  of lung function and a high symptom burden, including shortness of breath, chronic  cough, wheezing, and sputum production, which can impair patients’ quality of life.1 Correspondence: Marc Miravitlles Department of Pneumology, Vall  d’Hebron University Hospital, Passeig  de la Vall d’Hebron, 119-129, 08035,  Barcelona, Spain Tel +34 93 274 6083 email mmiravitlles@vhebron.ne t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Miravitlles et al Running head recto: Aclidinium/formoterol efficacy in COPD stratified by symptom burden DOI: http://dx.doi.org/10.2147/COPD.S114566",Non-OADS,/arxiv_data1/oa_pdf/20/c7/copd-11-2041.PMC5012634.pdf
Available from: http://www.ema.europa.eu/ema/index.,Non-OADS,/arxiv_data1/oa_pdf/20/c7/copd-11-2041.PMC5012634.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/20/c7/copd-11-2041.PMC5012634.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/c7/copd-11-2041.PMC5012634.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/91/86/ijn-11-4287.PMC5012635.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 4287–4298International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4287OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10832 9 Development of TIMP1 magnetic nanoformulation  for regulation of synaptic plasticity in hIV-1  infection Venkata subba rao atluri* rahul Dev Jayant* sudheesh Pilakka- Kanthikeel gabriella garcia Thangavel samikkannu adriana Yndart ajeet Kaushik Madhavan Nair center for Personalized  Nanomedicine, Department of  Immunology, herbert Wertheim  college of Medicine, Florida  International University, Miami,   Fl, Usa *These authors contributed equally  to this workAbstract:  Although the introduction of antiretroviral therapy has reduced the prevalence of  severe forms of neurocognitive disorders, human immunodeficiency virus (HIV)-1-associated  neurocognitive disorders were observed in 50% of HIV -infected patients globally.",Non-OADS,/arxiv_data1/oa_pdf/91/86/ijn-11-4287.PMC5012635.pdf
"Neuronal plasticity dysregulation can be seen at the cellular level correspondence: Madhavan Nair center for Personalized Nanomedicine,  Department of Immunology, herbert  Wertheim college of Medicine, Florida  International University, ahc-1,  418a, 11200 sW 8th street, Miami,  Fl 33199, Usa Tel +1 305 348 1493 Fax +1 305 348 6021 email nairm@fiu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Atluri et al Running head recto: Neuroprotective effect of MNP-bound TIMP1 in HIV infection DOI: http://dx.doi.org/10.2147/IJN.S108329",Non-OADS,/arxiv_data1/oa_pdf/91/86/ijn-11-4287.PMC5012635.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/91/86/ijn-11-4287.PMC5012635.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/91/86/ijn-11-4287.PMC5012635.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/f9/3b/cpaa-8-109.PMC5012636.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f9/3b/cpaa-8-109.PMC5012636.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f9/3b/cpaa-8-109.PMC5012636.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Pharmacology: Advances and Applications 2016:8 109–116Clinical Pharmacology: Advances and Applications Dovepress submit your manuscript | www.dovepress.com Dovepress  109 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S108966The effect of weight, body mass index, age,  sex, and race on plasma concentrations of  subcutaneous sumatriptan: a pooled analysis Sagar Munjal1 Anirudh Gautam2 Alan M Rapoport3 Dennis M Fisher4 1Department of Neurology Clinical  Development and Medical Affairs,   Dr. Reddy’s Laboratories Ltd,   Princeton, NJ, USA; 2Pharmacokinetics,   Modeling and Simulation & Bioanalysis,  Dr. Reddy’s Laboratories Ltd,   Hyderabad, India;  3Department of  Neurology, The David Geffen School of Medicine, University of California,  Los Angeles, Los Angeles,  4P Less Than,   San Francisco, CA, USAObjective/background: Factors such as body size (weight and body mass index [BMI]), age,  sex, and race might influence the clinical response to sumatriptan.",Non-OADS,/arxiv_data1/oa_pdf/f9/3b/cpaa-8-109.PMC5012636.pdf
"In the US, ~ 17% of women  and 6% of men experience migraine.1 Sumatriptan is one of the most commonly used Correspondence: Sagar Munjal Department of Neurology Clinical Development and Medical Affairs,   Dr. Reddy’s Laboratories Ltd, 107 College Road East, Princeton, NJ 08540, USATel +1 609 375 9083Email smunjal@drreddys.comJournal name: Clinical Pharmacology: Advances and Applications Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Munjal et alRunning head recto: Effect of covariates on sumatriptan exposureDOI: http://dx.doi.org/10.2147/CPAA.S108966",Non-OADS,/arxiv_data1/oa_pdf/f9/3b/cpaa-8-109.PMC5012636.pdf
"Clinical Pharmacology: Advances and Applications 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-pharmacology-advances-and-applications-journalClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/f9/3b/cpaa-8-109.PMC5012636.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 116 Munjal et al 6 mg (73%).,Non-OADS,/arxiv_data1/oa_pdf/f9/3b/cpaa-8-109.PMC5012636.pdf
Available from: https://gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Imitrex_Injection/pdf/IMITREX-INJECTION-PI-PPI-PIL-COMBINED.PDF .,Non-OADS,/arxiv_data1/oa_pdf/f9/3b/cpaa-8-109.PMC5012636.pdf
Available from: https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Imitrex_Tablets/pdf/IMITREX-TABLETS-PI-PIL.PDF .,Non-OADS,/arxiv_data1/oa_pdf/f9/3b/cpaa-8-109.PMC5012636.pdf
Available from: https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Imitrex_Nasal_Spray/pdf/IMITREX-NASAL-SPRA Y -PI-PIL.PDF .,Non-OADS,/arxiv_data1/oa_pdf/f9/3b/cpaa-8-109.PMC5012636.pdf
Available  from: http://www.fda.gov/downloads/drugs/developmentapprovalpro-cess/developmentresources/ucm289415.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f9/3b/cpaa-8-109.PMC5012636.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ae/88/ijn-11-4261.PMC5012637.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 4261–4273International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4261ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S10871 1 In vivo assessment of bone marrow toxicity  by gold nanoparticle-based bioconjugates  in Crl:CD1(ICR) mice Cristian Berce1,* Ciprian Lucan2,* Bobe Petrushev3,4 Sanda Boca5 Mirela Miclean6 Orsolya Sarpataki7 Simion Astilean5 Anca Buzoianu8 Ciprian T omuleasa3,9 Anca Bojan9,10 1Animal Facility, 2Department of  Surgery, 3Research Center for  Functional Genomics and Translational  Medicine, 4Department of Pathology,   Iuliu Hatieganu University of Medicine  and Pharmacy, 5Nanobiophotonics  and Laser Microscopy Center,   Interdisciplinary Research in Bio- Nano-Sciences – Faculty of Physics,   Babes-Bolyai University, 6Institute for  Research in Analytical Instruments,   7Department of Pathophysiology,   University of Veterinary Medicine,   8Department of Pharmacology, Iuliu  Hatieganu University of Medicine  and Pharmacy, 9Department  of Hematology, Ion Chiricuta  Oncology Institute, 10Department  of Hematology, Iuliu Hatieganu  University of Medicine and Pharmacy,   Cluj Napoca, Romania *These authors contributed equally  to this workIntroduction:  The present study aimed at evaluating the biodistribution of Tween® 20-gold  nanoparticle (GNP) conjugates and their potential toxicity on the bone marrow before moving  on to Phase I clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/ae/88/ijn-11-4261.PMC5012637.pdf
"This can be achieved by increas - ing the concentration of an anticancer drug in the tumor while reducing its systemic  toxicity.5–7 The US Food and Drug Administration has approved for cancer therapy  the use of doxorubicin encapsulated in liposomes (Doxil) and paclitaxel attached to  nanoparticles (Abraxane).8,9 In cancer chemotherapy, the clinician aims to achieve a  good therapeutic index, which is the ratio of the lethal dose for 50% of the population  to the minimum effective dose for 50% of the population.10 But cancer is most often Correspondence: Ciprian Tomuleasa Department of Hematology, Ion  Chiricuta Oncology Institute, Strada  Gheorghe Marinescu No 23, Cluj  Napoca 400000, Romania Tel +40 7 4133 7480 Email ciprian.tomuleasa@umfcluj.r o Journal name: International Journal of Nanomedicine Article Designation: ORIGINAL RESEARCH Y ear: 2016 Volume: 11 Running head verso: Berce et al Running head recto: Bone marrow toxicity by GNP-based bioconjugates DOI: http://dx.doi.org/10.2147/IJN.S108711",Non-OADS,/arxiv_data1/oa_pdf/ae/88/ijn-11-4261.PMC5012637.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ae/88/ijn-11-4261.PMC5012637.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/88/ijn-11-4261.PMC5012637.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c5/b9/ott-9-5427.PMC5012835.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5427–5437OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5427Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S11403 9 Clinical potential of necitumumab in non-small  cell lung carcinoma Carlo Genova1–3 Fred R Hirsch1 1Division of Medical Oncology,   Department of Medicine, University  of Colorado Cancer Center, Aurora,   CO, USA; 2Lung Cancer Unit, iRCCS  AOU San Martino iST, 3Department of  internal Medicine, School of Medicine,   University of Genoa, Genoa, italyAbstract:  Despite significant progress, new therapeutic approaches for advanced non-small  cell lung cancer (NSCLC) are highly needed, particularly for the treatment of patients with  squamous cell carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/c5/b9/ott-9-5427.PMC5012835.pdf
"Cetuximab, a chimeric  murine/human monoclonal antibody (mAB) targeting EGFR, currently registered for Correspondence: Fred R Hirsch Department of Medicine, Division  of Medical Oncology, University of  Colorado Cancer Center, 12801 e.  17th Avenue, 80045 Aurora, CO, USA Tel +1 303 807 9853 email fred.hirsch@ucdenver.ed u Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Genova and Hirsch Running head recto: Necitumumab in non-small cell lung carcinoma DOI: http://dx.doi.org/10.2147/OTT.S114039",Non-OADS,/arxiv_data1/oa_pdf/c5/b9/ott-9-5427.PMC5012835.pdf
"Available  from: http://seer.cancer.gov/csr/1975_2012 /, based on November 2014  SEER data submission, posted to the SEER website.",OADS,/arxiv_data1/oa_pdf/c5/b9/ott-9-5427.PMC5012835.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/c5/b9/ott-9-5427.PMC5012835.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c5/b9/ott-9-5427.PMC5012835.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/b9/ott-9-5427.PMC5012835.pdf
"Available from: http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements /ucm474131.ht m. Accessed March 3, 2016.",OADS,/arxiv_data1/oa_pdf/c5/b9/ott-9-5427.PMC5012835.pdf
"Available from: http://www.ema.europa.eu/docs/en_ GB/document_library/Summary_of_opinion_- _Initial_authorisation / human/003886/WC500199044.pd f. Accessed March 3, 2016.",Non-OADS,/arxiv_data1/oa_pdf/c5/b9/ott-9-5427.PMC5012835.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/003886/WC500202694.,Non-OADS,/arxiv_data1/oa_pdf/c5/b9/ott-9-5427.PMC5012835.pdf
Available from: https://www.clinicaltrials.gov/ct2/ show/NCT02496663?term =necitumumab&rank =3.,Non-OADS,/arxiv_data1/oa_pdf/c5/b9/ott-9-5427.PMC5012835.pdf
Available from: https://www.clinicaltrials.gov/ct2/show/NCT0 2392507?term =necitumumab&rank =7.,Non-OADS,/arxiv_data1/oa_pdf/c5/b9/ott-9-5427.PMC5012835.pdf
Available  from: https://www.clinicaltrials.gov/ct2/show/NCT02411591?term =ne citumumab +lung&rank =7.,Non-OADS,/arxiv_data1/oa_pdf/c5/b9/ott-9-5427.PMC5012835.pdf
Available from: https://www.clinicaltrials.,Non-OADS,/arxiv_data1/oa_pdf/c5/b9/ott-9-5427.PMC5012835.pdf
Available from: https://www.clinicaltrials.gov/ct2/show/N CT02451930?term =necitumumab +lung&rank =10.,Non-OADS,/arxiv_data1/oa_pdf/c5/b9/ott-9-5427.PMC5012835.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6d/36/opth-10-1685.PMC5012836.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1685–1689Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1685Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10666 1 risk factors for corneal endothelial cell loss by  cataract surgery in eyes with pseudoexfoliation  syndrome Yumi hasegawa1,2 ryohei nejima1 Y osai Mori1 T oshihiro sakisaka1 Keiichiro Minami1 Kazunori Miyata1 T etsuro Oshika2 1Miyata eye hospital, Miyazaki,   2Department of Ophthalmology,   Faculty of Medicine, University  of Tsukuba, ibaraki, JapanPurpose:  The aim of this study was to investigate the factors associated with decreases in  corneal endothelial cell density (ECD) resulting from cataract surgery in eyes with pseudoex - foliation syndrome (PEX).",Non-OADS,/arxiv_data1/oa_pdf/6d/36/opth-10-1685.PMC5012836.pdf
"Second is  the accuracy of the ECD assessment; variance in ECD counting is reported to be 6%, Correspondence: Yumi hasegawa Department of Ophthalmology, Faculty  of Medicine, University of Tsukuba,  1-1-1 Tennoudai, Tsukuba, ibaraki  305-8575, Japan Tel/fax +81 29 853 3148 email tam_y110@yahoo.co.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Hasegawa et al Running head recto: Endothelial cell loss in PEX eye DOI: http://dx.doi.org/10.2147/OPTH.S106661",Non-OADS,/arxiv_data1/oa_pdf/6d/36/opth-10-1685.PMC5012836.pdf
"The poster’s abstract was published in  “Poster Abstracts” in Investigative Ophthalmology & Visual  Science , Volume 55 and Issue 13: http://iovs.arvojournals.",Non-OADS,/arxiv_data1/oa_pdf/6d/36/opth-10-1685.PMC5012836.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/6d/36/opth-10-1685.PMC5012836.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/36/opth-10-1685.PMC5012836.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/64/a9/ijgm-9-311.PMC5012837.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/64/a9/ijgm-9-311.PMC5012837.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/64/a9/ijgm-9-311.PMC5012837.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2016:9 311–314International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 311 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S115393 Interstitial nephritis caused by HIV infection by  itself: a case report Asako Doi1,2  Kentaro Iwata3  Shigeo Hara4  Yukihiro Imai5  T oshikazu Hasuike1,2  Hiroaki Nishioka1,2 1Department of Infectious Diseases,   2Department of General Internal  Medicine, Kobe City Medical Center  General Hospital, 3Division of  Infectious Diseases, 4Department of  Diagnostic Pathology, Kobe University Hospital,  5Department of Pathology,   Kobe City Medical Center General Hospital, Kobe, Hyogo, JapanAbstract:  Interstitial nephritis is a common cause of renal dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/64/a9/ijgm-9-311.PMC5012837.pdf
"The patient was subsequently diagnosed Correspondence: Kentaro Iwata Division of Infectious Diseases, Kobe University Hospital, Kusunokicho 7-5-2, Chuoku, Kobe, Hyogo 650-0017, Japan   Tel +81 78 382 6296   Fax +81 78 382 6298   Email kentaroiwata1969@gmail.comJournal name: International Journal of General Medicine Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Doi et alRunning head recto: Interstitial nephritis in HIVDOI: http://dx.doi.org/10.2147/IJGM.S115393",Non-OADS,/arxiv_data1/oa_pdf/64/a9/ijgm-9-311.PMC5012837.pdf
"International Journal of General Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/64/a9/ijgm-9-311.PMC5012837.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 314 Doi et al  16.,Non-OADS,/arxiv_data1/oa_pdf/64/a9/ijgm-9-311.PMC5012837.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2e/4d/ppa-10-1679.PMC5012838.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1679–1685Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1679OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10915 7 Patient quality of life in the Mayo clinic care  Transitions program: a survey study Joshua Faucher1 Jordan rosedahl2 Dawn Finnie3 Amy glasgow3 Paul Takahashi4 1Mayo Medical school, Mayo clinic  college of Medicine, 2Division of  Biomedical statistics and informatics,   Department of health science  research, Mayo clinic, 3center for  the science of health care Delivery,   4Division of Primary care internal  Medicine, Department of Medicine,   Mayo clinic, rochester, M n, UsABackground:  Transitional care programs are common interventions aimed at reducing medical  complications and associated readmissions for patients recently discharged from the hospital.",Non-OADS,/arxiv_data1/oa_pdf/2e/4d/ppa-10-1679.PMC5012838.pdf
"These processes can include the designation of a case  manager to guide patient access to community resources during and after discharge, correspondence: Paul Takahashi Division of Primary care internal  Medicine, Department of Medicine,  Mayo clinic, 200 First street sW,  rochester, Mn 55905, UsA Tel +1 507 284 2511 Fax +1 507 266 0036 email takahashi.paul@mayo.ed u Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Faucher et al Running head recto: Quality of life in care transitions program DOI: http://dx.doi.org/10.2147/PPA.S109157",Non-OADS,/arxiv_data1/oa_pdf/2e/4d/ppa-10-1679.PMC5012838.pdf
nihpromis.org/default# 2 and http://www.promishealth.com /.,Non-OADS,/arxiv_data1/oa_pdf/2e/4d/ppa-10-1679.PMC5012838.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/2e/4d/ppa-10-1679.PMC5012838.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/18/44/mder-9-301.PMC5012839.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/18/44/mder-9-301.PMC5012839.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/18/44/mder-9-301.PMC5012839.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 301–308Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 301 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S109904 Accuracy and precision of four common  peripheral temperature measurement methods  in intensive care patients Simin Asadian1  Alireza Khatony1  Gholamreza Moradi2  Alireza Abdi1  Mansour Rezaei3 1Nursing and Midwifery School,   Kermanshah University of  Medical Sciences, 2Department of  Anesthesiology, 3Biostatistics  &  Epidemiology Department,  Kermanshah University of Medical Sciences, Kermanshah, IranIntroduction: An accurate determination of body temperature in critically ill patients is a  fundamental requirement for initiating the proper process of diagnosis, and also therapeutic  actions; therefore, the aim of the study was to assess the accuracy and precision of four nonin- vasive peripheral methods of temperature measurement compared to the central nasopharyngeal  measurement.",Non-OADS,/arxiv_data1/oa_pdf/18/44/mder-9-301.PMC5012839.pdf
"4 Correspondence: Alireza Khatony   Nursing and Midwifery School,  Kermanshah University of Medical Sciences, Ashayer St., Isar Sq., Kermanshah 67146, Iran   Email Akhatony@gmail.comJournal name: Medical Devices: Evidence and Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Asadian et alRunning head recto: Comparison of common peripheral temperature measurement methodsDOI: http://dx.doi.org/10.2147/MDER.S109904",Non-OADS,/arxiv_data1/oa_pdf/18/44/mder-9-301.PMC5012839.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/18/44/mder-9-301.PMC5012839.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/86/1f/jaa-9-155.PMC5012840.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/86/1f/jaa-9-155.PMC5012840.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/86/1f/jaa-9-155.PMC5012840.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Asthma and Allergy 2016:9 155–162Journal of Asthma and Allergy Dovepress submit your manuscript | www.dovepress.com Dovepress 155 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S94164Reslizumab in the management of poorly  controlled asthma: the data so far Diego Jose Maselli1 Maria Ines Velez1 Linda Rogers2 1Department of Medicine, Division of  Pulmonary Diseases and Critical Care,   University of T exas Health Science Center at San Antonio, San Antonio,  TX,  2Pulmonary, Critical Care, and  Sleep Division, Mount Sinai—National Jewish Health Respiratory Institute,  Icahn School of Medicine at Mount Sinai, New Y ork, NY, USAAbstract:  Interleukin-5, an important cytokine in the pathophysiology of asthma, participates  in terminal maturation and increases chemotaxis, endothelial adhesion, and activation of eosino- phils.",Non-OADS,/arxiv_data1/oa_pdf/86/1f/jaa-9-155.PMC5012840.pdf
"We also discuss other anti-IL-5 therapies and their role in treatment Correspondence: Diego Jose Maselli Department of Medicine, Division of Pulmonary Diseases and Critical Care, University of Texas Health Science Center at San Antonio, 7400 Mentor Minter MC IIIE, San Antonio, TX 78229, USATel +1 210 617 5256Fax +1 210 949 3006Email masellicacer@uthscsa.eduJournal name: Journal of Asthma and Allergy Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Maselli et alRunning head recto: Reslizumab for poorly controlled asthmaDOI: http://dx.doi.org/10.2147/JAA.S94164",Non-OADS,/arxiv_data1/oa_pdf/86/1f/jaa-9-155.PMC5012840.pdf
"Journal of Asthma and Allergy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-asthma-and-allergy-journalThe Journal of Asthma and Allergy is an international, peer-reviewed  open access journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physi-ology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/86/1f/jaa-9-155.PMC5012840.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02501629?term=NCT02501629&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/86/1f/jaa-9-155.PMC5012840.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02452190?term=NCT02452190&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/86/1f/jaa-9-155.PMC5012840.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/dc/e2/prom-7-109.PMC5012841.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/dc/e2/prom-7-109.PMC5012841.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/dc/e2/prom-7-109.PMC5012841.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Patient Related Outcome Measures 2016:7 109–125Patient Related Outcome Measures Dovepress submit your manuscript | www.dovepress.com Dovepress 109 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PROM.S104552 The Long-T erm Conditions Questionnaire:  conceptual framework and item development Michele Peters1 Caroline M Potter1 Laura Kelly1 Cheryl Hunter1 Elizabeth Gibbons1 Crispin Jenkinson1 Angela Coulter1 Julien Forder2 Ann-Marie T owers2 Christine A’Court3,4 Ray Fitzpatrick1 1Health Services Research Unit,   Nuffield Department of Population  Health, University of Oxford, Oxford,   2Personal Social Services Research  Unit, University of Kent, Canterbury,   3Nuffield Department of Primary  Health Care Sciences, University of Oxford, Oxford,  4Broadshires Health  Centre, Carterton, UKPurpose: To identify the main issues of importance when living with long-term conditions to  refine a conceptual framework for informing the item development of a patient-reported outcome  measure for long-term conditions.",Non-OADS,/arxiv_data1/oa_pdf/dc/e2/prom-7-109.PMC5012841.pdf
"5Correspondence: Michele Peters Health Services Research Unit, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Oxford OX3 7LF, UKTelephone +44 1865 289 428Email michele.peters@dph.ox.ac.ukJournal name: Patient Related Outcome Measures Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Peters et alRunning head recto: Long-Term Conditions QuestionnaireDOI: http://dx.doi.org/10.2147/PROM.S104552",Non-OADS,/arxiv_data1/oa_pdf/dc/e2/prom-7-109.PMC5012841.pdf
"To aid this process, the panel was provided with information on bodily systems, the World Health Organization Global Burden of Disease study, 19  a study on multimorbidity,7 and the LTCs included in  the Quality and Outcomes Framework (http://www.nice.org.uk/aboutnice/qof/qof.jsp).",Non-OADS,/arxiv_data1/oa_pdf/dc/e2/prom-7-109.PMC5012841.pdf
20 Participants had been recruited through an email  invitation by Rethink Mental Illness (https://www.rethink.org/about-us) and snowball sampling.,Non-OADS,/arxiv_data1/oa_pdf/dc/e2/prom-7-109.PMC5012841.pdf
"Patient Related Outcome Measures 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/patient-related-outcome-measures-journalPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/dc/e2/prom-7-109.PMC5012841.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/e2/prom-7-109.PMC5012841.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/48/be/ott-9-5405.PMC5012842.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5405–5416OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5405Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11124 0 Efficacy and safety of anti-epidermal growth factor  receptor therapy compared with anti-vascular  endothelial growth factor therapy for metastatic  colorectal cancer in first-line and second-line  therapies: a meta-analysis hongchi Wang* Bin Ma* Peng gao Y ongxi song Qingzhou Xu Yaoyuan hu cong Zhang Zhenning Wang Department of surgical Oncology and  general surgery, The First hospital of  china Medical University, shenyang,   People’s republic of china *These authors contributed equally  to this workAim:  This study aimed to compare anti-epidermal growth factor receptor (anti-EGFR) therapy  and anti-vascular endothelial growth factor therapy as first-line and second-line therapies  in patients with KRAS exon 2 codon 12/13 wild-type (KRAS-WT) metastatic colorectal  cancer (mCRC).",Non-OADS,/arxiv_data1/oa_pdf/48/be/ott-9-5405.PMC5012842.pdf
"Keywords:  colorectal cancer, anti-EGFR, anti-VEGF, chemotherapy, meta-analysis Introduction Colorectal cancer (CRC) is the third most common cancer among males and the second  most common cancer among females, with an estimated death of 600,000 individuals in  2012 worldwide owing to advanced CRC.1 Although the surgical approach has ensured correspondence: Zhenning Wang Department of surgical Oncology and  general surgery, The First hospital  of china Medical University, north  nanjing street 155, shenyang 110001,  People’s republic of china Tel +86 24 8328 3556 Fax +86 24 2270 3578 email josieon826@sina.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: Anti-EGFR for mCRC patients DOI: http://dx.doi.org/10.2147/OTT.S111240",Non-OADS,/arxiv_data1/oa_pdf/48/be/ott-9-5405.PMC5012842.pdf
"ORR was defined as the sum of partial  and complete response rates, according to the Response  Evaluation Criteria in Solid Tumors.20 Toxicity was assessed  using the National Cancer Institution Common Toxicity  Criteria (version 2.0, http://ctep.cancer.go v).",OADS,/arxiv_data1/oa_pdf/48/be/ott-9-5405.PMC5012842.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/48/be/ott-9-5405.PMC5012842.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/48/be/ott-9-5405.PMC5012842.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2016:9 303–310International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 303 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S109024Health in a fragile state: a five-year review of  mortality patterns and trends at Somalia’s Banadir  Hospital Asli Kulane1  Douglas Sematimba1  Lul M Mohamed2  Abdirashid H Ali2  Xin Lu1,3,4 1Department of Public Health  Sciences, Karolinska Institutet,   Stockholm, Sweden; 2Women  and Child Care Section, Banadir Maternity & Children Hospital,   Mogadishu, Somalia;  3College of  Information System and Management,  National University of Defense T echnology, Changsha, People’s Republic of China;  4Flowminder  Foundation, Stockholm, SwedenBackground: The recurrent civil conflict in Somalia has impeded progress toward improving  health and health care, with lack of data and poor performance of health indicators.",Non-OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
"7 The increase and continuous  influx of injured people has created conflict of interest for health care resources and Correspondence: Asli Kulane,  Department of Public Health Sciences, Karolinska Institutet, Tomtebodavägen 18A, Widerströmska huset, 171 77 Stockholm, Sweden Tel +46 8 524 833 88   Email asli.kulane@ki.seJournal name: International Journal of General Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Kulane et alRunning head recto: Health in a fragile stateDOI: http://dx.doi.org/10.2147/IJGM.S109024",Non-OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
Available from: http://www.worldatlas.com/webimage/countrys/africa/so.htm.,Non-OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
Available from: http://somalia.unfpa.org/sites/arabstates/files/pub-pdf/Population-Estima-tion-Survey-of-Somalia-PESS-2013-2014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
Available from: http://www.who.int/countries/som/en/.,OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
Available from: http://www.gapminder.org/world.,Non-OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
Available from: http://www.wsj.com/articles/SB125305726840513913.,Non-OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
Available from: http://www.childinfo.org/files/MICS3_Somalia_Fin-alReport_2006_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
Available from: http://banadirhospital.com/.,Non-OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
Available from:  http://www.who.int/topics/gender/en/.,OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
Available from: http://hdr.undp.org/en/content/gender-inequality-   index-gii.,OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
"International Journal of General Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 310 Kulane et al  14.,Non-OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs178/en/.,Non-OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
Available from: http://esa.un.org/unpd/wpp/DataQuery/.,OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
Available from: http://data.worldbank.org/country/somalia.,OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
Available from: http://www.doctorswith-outborders.org/news-stories/field-news/somalia-responding-diarrhea-kismayo.,Non-OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
Available from: http://data.worldbank.org/indicator/SH.DYN.MORT.,OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
Available from: http://www.indexmundi.com/g/g.aspx?v=2224&c=so&l=en.,Non-OADS,/arxiv_data1/oa_pdf/b0/7b/ijgm-9-303.PMC5012843.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/5f/62/tacg-9-141.PMC5012844.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5f/62/tacg-9-141.PMC5012844.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5f/62/tacg-9-141.PMC5012844.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).The Application of Clinical Genetics 2016:9 141–146The Application of Clinical Genetics Dovepress submit your manuscript | www.dovepress.com Dovepress 141 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S113828 Identification of a novel pathogenic OTOF  variant  causative of nonsyndromic hearing loss with high  frequency in the Ashkenazi Jewish population Anastasia M Fedick1 Chaim Jalas2 Ananya Swaroop1 Eric E Smouha3 Bryn D Webb1 1Department of Genetics and  Genomic Sciences, Icahn School of  Medicine at Mount Sinai,    New Y ork, NY, USA; 2Bonei Olam,   Center for Rare Jewish Genetic Disorders, Brooklyn, NY, USA;   3Department of Otolaryngology, Icahn  School of Medicine at Mount Sinai,  New Y ork, NY, USAAbstract:  Mutations in the OTOF  gene have previously been shown to cause nonsyndromic  prelingual deafness (DFNB9, OMIM 601071) as well as auditory neuropathy/dys-synchrony.",Non-OADS,/arxiv_data1/oa_pdf/5f/62/tacg-9-141.PMC5012844.pdf
"9–11 Correspondence: Bryn D Webb Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L Levy Place, Box 1498, New York, NY 10029, USATel +1 212 241 1481Fax +1 212 860 3316Email bryn.webb@mssm.eduJournal name: The Application of Clinical Genetics Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Fedick et alRunning head recto: Common OTOF  Ashkenazi mutation causes nonsyndromic hearing loss DOI: http://dx.doi.org/10.2147/TACG.S113828",Non-OADS,/arxiv_data1/oa_pdf/5f/62/tacg-9-141.PMC5012844.pdf
"The Application of Clinical Genetics 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/the-application-of-clinical-genetics-journalThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/5f/62/tacg-9-141.PMC5012844.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes   from published authors.Dovepress 146 Fedick et al,Non-OADS,/arxiv_data1/oa_pdf/5f/62/tacg-9-141.PMC5012844.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d2/77/opth-10-1691.PMC5012845.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1691–1699Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1691Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11132 8 Comparison of self-reported quality of vision  outcomes after myopic lasiK with two  femtosecond lasers: a prospective, eye-to-eye study Christopher s sáles1 edward e Manche2 1Weill Cornell Medical College, new  Y ork, nY, Usa; 2Byers eye institute,   stanford University school of  Medicine, Palo alto, C a, UsaPurpose:  To compare self-reported quality of vision (QoV) outcomes after myopic LASIK  (laser-assisted in situ keratomileusis) with two femtosecond lasers.",Non-OADS,/arxiv_data1/oa_pdf/d2/77/opth-10-1691.PMC5012845.pdf
"By comparison, the IntraLase FS 60 kHz cuts  flaps at a conventional 70 ° angle (Figure 1).Correspondence: edward e Manche Byers eye institute, stanford University  school of Medicine, 2452 Watson Court,  Palo alto, Ca 94303, Usa Tel +1 650 723 6995 Fax +1 650 565 8297 email edward.manche@stanford.ed u Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Sáles and Manche Running head recto: QoV comparison after LASIK with two femtosecond lasers DOI: http://dx.doi.org/10.2147/OPTH.S111328",Non-OADS,/arxiv_data1/oa_pdf/d2/77/opth-10-1691.PMC5012845.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d2/77/opth-10-1691.PMC5012845.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/opth-10-1691.PMC5012845.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/ca/cc/oajsm-7-099.PMC5012846.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ca/cc/oajsm-7-099.PMC5012846.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ca/cc/oajsm-7-099.PMC5012846.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Journal of Sports Medicine 2016:7 99–113Open Access Journal of Sports Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 99 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S96821The elite young athlete: strategies to ensure  physical and emotional health T odd M Sabato Tanis J Walch Dennis J Caine Department of Kinesiology and Public  Health Education, University of North Dakota, Grand Forks, ND, USAAbstract: This article presents a current review of the risk of physical and psychological injury  associated with participation in elite youth sport, and suggests strategies to ensure the physical  and emotional health of these young athletes.",Non-OADS,/arxiv_data1/oa_pdf/ca/cc/oajsm-7-099.PMC5012846.pdf
"4 These competitions also represent important Correspondence: Dennis J Caine Department of Kinesiology and Public Health Education, University of North Dakota, 2751 2nd Ave N, Stop 8235 Grand Forks, ND 58202-8235, USAEmail dennis.caine@UND.eduJournal name: Open Access Journal of Sports Medicine Article Designation: REVIEWY ear: 2016V olume: 7Running head verso: Sabato et alRunning head recto: The elite young athlete: ensuring physical and emotional healthDOI: http://dx.doi.org/10.2147/OAJSM.S96821",Non-OADS,/arxiv_data1/oa_pdf/ca/cc/oajsm-7-099.PMC5012846.pdf
Available at http://www.niams.nih.gov/Health_Info/Sports_Injuries/child_sports_injuries.asp.,Non-OADS,/arxiv_data1/oa_pdf/ca/cc/oajsm-7-099.PMC5012846.pdf
"Available at: https://www.olympic.org/youth-olympic-games.Accessed March 30, 2016.",Non-OADS,/arxiv_data1/oa_pdf/ca/cc/oajsm-7-099.PMC5012846.pdf
Available from: http://stacks.cdc.gov/view/cdc/21769.,OADS,/arxiv_data1/oa_pdf/ca/cc/oajsm-7-099.PMC5012846.pdf
Available at: http://www.anad.org/get-information/about-eating-disorders/eating-disorders-statistics/.,Non-OADS,/arxiv_data1/oa_pdf/ca/cc/oajsm-7-099.PMC5012846.pdf
Available at: http://www.zeitschrift-sportmedizin.de/fileadmin/con-tent/ Englische_Artikel/Originalia_Frank_englisch.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ca/cc/oajsm-7-099.PMC5012846.pdf
Available from: http://www.athleticinsight.com/.,Non-OADS,/arxiv_data1/oa_pdf/ca/cc/oajsm-7-099.PMC5012846.pdf
Available at: http://www.nspcc.ork/uk/Inform/research/ findings/experiences_children_sport_main_report_wdf85014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ca/cc/oajsm-7-099.PMC5012846.pdf
"Dominique Moceanu talks body image in gymnastics,  says coaches can“scar for life.” Available at: http://www.huffington-post.com/2013/07/19/dominique-moceanu-body-im_n_3625224.html.",Non-OADS,/arxiv_data1/oa_pdf/ca/cc/oajsm-7-099.PMC5012846.pdf
"Open Access Journal of Sports Medicine 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/open-access-journal-of-sports-medicine-journalThe Open Access Journal of Sports Medicine is an international,   peer-reviewed, open access journal publishing original research,   reports, reviews and commentaries on all areas of sports   medicine.",Non-OADS,/arxiv_data1/oa_pdf/ca/cc/oajsm-7-099.PMC5012846.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/cc/oajsm-7-099.PMC5012846.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9e/2b/ott-9-5399.PMC5012847.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5399–5404OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5399Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10474 8 real-time tests of multiple genome alterations  take the first steps into the clinic: a learning  example Lorenzo Gerratana1,2 Giovanna De Maglio3 alessandro De p ellegrin3 alessandro Follador1 Karim rihawi1,2 stefano pizzolitto3 Fabio puglisi1,2 Gianpiero Fasola1 1Department of Oncology, University  Hospital of Udine, 2Department  of Medical and Biological sciences,   University of Udine, 3Department  of pathology, University Hospital  of Udine, Udine, ItalyAbstract:  Molecular characterization is increasingly changing clinical practice, in both  diagnosis and treatment.",Non-OADS,/arxiv_data1/oa_pdf/9e/2b/ott-9-5399.PMC5012847.pdf
"Case presentation A 78-year-old female with a medical history of arterial hypertension, hypercholes - terolemia, and lumbar disc herniations complained of lower back pain, occasional Correspondence: Lorenzo Gerratana Department of Oncology, University  Hospital of Udine, p le santa Maria della  Misericordia, 15 – 33100 Udine, Italy email gerratana.lorenzo@spes.uniud.i t Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2016 Volume: 9 Running head verso: Gerratana et al Running head recto: Molecular diagnostics into the clinic: an example DOI: http://dx.doi.org/10.2147/OTT.S104748",Non-OADS,/arxiv_data1/oa_pdf/9e/2b/ott-9-5399.PMC5012847.pdf
Available from: https://www.nccn.org/ professionals/physician_gls/pdf/nscl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9e/2b/ott-9-5399.PMC5012847.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9e/2b/ott-9-5399.PMC5012847.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/2b/ott-9-5399.PMC5012847.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e9/8b/ott-9-5417.PMC5012848.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5417–5425OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5417Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11179 4 long noncoding rna SPRY4-IT1  promotes  malignant development of colorectal cancer by  targeting epithelial–mesenchymal transition Dong cao1 Qiong Ding1 Wubin Yu1 Ming gao1 Yilian Wang2 1Department of general surgery,   The People’s hospital of Putuo,   Zhoushan, 2Department of  cardiology, The second People’s  hospital of lianyungang, Xinpu,   People’s republic of chinaAbstract:  The clinical significance and biological functions of long noncoding RNA SPRY4  intronic transcript 1 ( SPRY4-IT1 ) in colorectal cancer (CRC) remain largely unclear.",Non-OADS,/arxiv_data1/oa_pdf/e9/8b/ott-9-5417.PMC5012848.pdf
"The  SPRY4-IT1  was first observed to be overexpressed in melanoma and modulated cell pro - liferation, invasion, and cell apoptosis.11 Subsequent studies indicated that high expression  of SPRY4-IT1  was significantly associated with worse outcomes of esophageal squamous correspondence: Yilian Wang Department of cardiology, The second  People’s hospital of lianyungang,  no 41, hailian east road, Xinpu,  lianyungang, Jiangsu 222006,  People’s republic of china email wangyilian664@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Cao et al Running head recto: The role of SPRY-IT1 in CRC DOI: http://dx.doi.org/10.2147/OTT.S111794",Non-OADS,/arxiv_data1/oa_pdf/e9/8b/ott-9-5417.PMC5012848.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e9/8b/ott-9-5417.PMC5012848.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e9/8b/ott-9-5417.PMC5012848.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/95/66/tcrm-12-1339.PMC5012849.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1339–1346Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1339ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10885 6 Does surgical treatment within 4 hours after  trauma have an influence on neurological  remission in patients with acute spinal cord injury?",Non-OADS,/arxiv_data1/oa_pdf/95/66/tcrm-12-1339.PMC5012849.pdf
"Cochrane  meta-analysis showed evidence supporting motor function recovery in the methylpred - nisolone sodium succinate group compared to the control group.3 While Hurlbert et al Correspondence: arash Moghaddam heidelberg Trauma Research group,  Center for Orthopedics, Trauma surgery  and spinal Cord injury, heidelberg  University hospital, schlierbacher  landstraße 200a, heidelberg, germany Tel +49 6221 563 5394 Fax +49 6221 562 9213 email arashmoghaddam@web.d e Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Biglari et al Running head recto: Neurological remission in patients with acute SCI DOI: http://dx.doi.org/10.2147/TCRM.S108856",Non-OADS,/arxiv_data1/oa_pdf/95/66/tcrm-12-1339.PMC5012849.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/95/66/tcrm-12-1339.PMC5012849.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/95/66/tcrm-12-1339.PMC5012849.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c7/05/tcrm-12-1329.PMC5012850.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1329–1337Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1329ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11034 0 long-term outcomes and prognostic analysis of  modified open-door laminoplasty with lateral  mass screw fusion in treatment of cervical  spondylotic myelopathy nan su Qi Fei Bingqiang Wang Dong li Jinjun li hai Meng Y ong Yang ai guo Department of Orthopedics, Beijing  Friendship hospital, Capital Medical  University, Xicheng District, Beijing,   People’s Republic of ChinaObjectives:  The purpose of the present study was to explore and analyze the long-term outcomes  and factors that affect the prognosis of expansive open-door laminoplasty with lateral mass  screw fusion in treatment of cervical spondylotic myelopathy (CSM).",Non-OADS,/arxiv_data1/oa_pdf/c7/05/tcrm-12-1329.PMC5012850.pdf
"Keywords:  cervical spondylotic myelopathy, laminoplasty, lateral mass screw, prognostic  factors, ossification of the posterior longitudinal ligament, JOA scores Introduction Cervical spine disease is a group of clinical syndromes commonly seen in the  orthopedics clinic, which is caused by degeneration of cervical disk and the surrounding Correspondence: Yong Yang; ai guo Department of Orthopedics, Beijing  Friendship hospital, Capital Medical  University, no 95, Yong’an Road,  Xicheng District 100050, Beijing,  People’s Republic of China Tel +86 10 6313 8353 Fax +86 10 8391 1029 email spineyang@126.co m;   guoaij@139.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Su et al Running head recto: Modified open-door laminoplasty in treatment of CSM DOI: http://dx.doi.org/10.2147/TCRM.S110340",Non-OADS,/arxiv_data1/oa_pdf/c7/05/tcrm-12-1329.PMC5012850.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/c7/05/tcrm-12-1329.PMC5012850.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/05/tcrm-12-1329.PMC5012850.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/f3/de/jpr-9-587.PMC5012851.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f3/de/jpr-9-587.PMC5012851.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f3/de/jpr-9-587.PMC5012851.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 587–598Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  587 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S113138A preliminary evaluation of the relationship   of cannabinoid blood concentrations with   the analgesic response to vaporized cannabis Barth L Wilsey1,2  Reena Deutsch3  Emil Samara4  Thomas D Marcotte3  Allan J Barnes5  Marilyn A Huestis5,6  Danny Le1,2 1VA Northern California Health Care  System, Mather, CA, 2Department of  Physical Medicine and Rehabilitation,   University of California, Sacramento,  CA,  3Department of Psychiatry,   University of California, San Diego, La Jolla, CA,  4PharmaPolaris International,   Davis, CA, 5Chemistry and Drug  Metabolism, IRP , National Institute on Drug Abuse, Baltimore, MD,   6University of Maryland School of  Medicine, Baltimore, MD, USAAbstract:  A randomized, placebo-controlled crossover trial utilizing vaporized cannabis con- taining placebo and 6.7% and 2.9% delta-9-tetrahydrocannabinol (THC) was performed in 42  subjects with central neuropathic pain related to spinal cord injury and disease.",Non-OADS,/arxiv_data1/oa_pdf/f3/de/jpr-9-587.PMC5012851.pdf
"4 Rigorous pharmacodynamic and pharmacokinetic studies involving THC and its  metabolites have been published.3,5–7 THC concentrations are detectable immediately Correspondence: Barth L Wilsey UC Center for Medicinal Cannabis Research, UC San Diego, 220 Dickinson Street, Suite B, San Diego, CA 92103Tel +1 (619) 543-578Email bwilsey@ucsd.eduJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Wilsey et alRunning head recto: Relationship of cannabinoid concentrations with pain descriptorsDOI: http://dx.doi.org/10.2147/JPR.S113138",Non-OADS,/arxiv_data1/oa_pdf/f3/de/jpr-9-587.PMC5012851.pdf
Available from: http://www.dru-gabuse.gov/researchers/research-resources/nida-drug-supply-program-dsp/marijuana-plant-material-available-nida-drug-supply-program.,OADS,/arxiv_data1/oa_pdf/f3/de/jpr-9-587.PMC5012851.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/f3/de/jpr-9-587.PMC5012851.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 598 Wilsey et al 31.,Non-OADS,/arxiv_data1/oa_pdf/f3/de/jpr-9-587.PMC5012851.pdf
Available from: http://www.gwpharm.com/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/f3/de/jpr-9-587.PMC5012851.pdf
Available from: http://www.marketwatch.com/story/insys-therapeutics-receives-fda-orphan-drug-designation-for-its-phar - maceutical-cannabidiol-as-a-potential-treatment-for-dravet-syndrome-a-rare-form-of-epilepsy-2014-07-02.,Non-OADS,/arxiv_data1/oa_pdf/f3/de/jpr-9-587.PMC5012851.pdf
Available from: http://www.zacks.com/stock/news/155288/insys-cannabidiol-gets-another-orphan-drug-designation#sthash.aKGjYEOn.dpuf.,Non-OADS,/arxiv_data1/oa_pdf/f3/de/jpr-9-587.PMC5012851.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5a/35/tcrm-12-1347.PMC5012852.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1347–1354Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1347CliniC al TRial Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10944 4 Safety of long-term use of linezolid: results of an  open-label study Jose a Vazquez1 anthony C arnold2 Robert n Swanson3 pinaki Biswas3 Matteo Bassetti4 1Section of infectious Diseases,   Medical College of Georgia,   Georgia Regents University, augusta,   Ga, USa; 2UCla Department  of ophthalmology, Jules Stein  eye institute, los angeles, C a,   USa; 3Clinical Research, Global  innovative pharmaceutical, pfizer  inc., new Y ork, nY, USa; 4infectious  Diseases Division, Santa Maria della  Misericordia University Hospital,   Udine, italyObjective:  The objective of this study was to assess the long-term safety of linezolid in  patients with chronic infections requiring treatment for $6 weeks.",Non-OADS,/arxiv_data1/oa_pdf/5a/35/tcrm-12-1347.PMC5012852.pdf
"In clinical practice, linezolid  has been used for a longer duration in difficult-to-treat infections.3–5 The safety and  efficacy of linezolid, when given for .28 days, have not been evaluated in controlled  clinical trials.Correspondence: pinaki Biswas Clinical Research, Global innovative  Pharmaceutical, Pfizer Inc., 235 East 42nd  Street, new York, nY 10017, USa Tel +1 212 733 8158 Fax +1 646 441 4796 email pinaki.biswas@pfizer.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Clinical Trial Report Y ear: 2016 Volume: 12 Running head verso: Vazquez et al Running head recto: Long-term use of linezolid DOI: http://dx.doi.org/10.2147/TCRM.S109444",Non-OADS,/arxiv_data1/oa_pdf/5a/35/tcrm-12-1347.PMC5012852.pdf
Available from: http://labeling.pfizer.com/ showlabeling .aspx?id=649.,Non-OADS,/arxiv_data1/oa_pdf/5a/35/tcrm-12-1347.PMC5012852.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/5a/35/tcrm-12-1347.PMC5012852.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/35/tcrm-12-1347.PMC5012852.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/79/8c/oaem-8-057.PMC5012853.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/79/8c/oaem-8-057.PMC5012853.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/79/8c/oaem-8-057.PMC5012853.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Emergency Medicine 2016:8 57–59Open Access Emergency Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 57 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S112803 Meperidine (pethidine) versus morphine in acute  pain management of opioid-dependent patients Hassan Solhi1  Hossein Sanaei-Zadeh2 Sadra Solhi1  Mohammad Ali Azizi  Nadian1  Morteza Gharibi3  Bahman Sadeghi Sedeh4  1Department of Internal Medicine,   Arak University of Medical Sciences,   Arak, 2Emergency Room, Division  of Medical T oxicology, Hazrat Ali-Asghar (p) Hospital, Shiraz University of Medical Sciences, Shiraz,   3Department of Emergency Medicine,   Arak University of Medical Sciences,   4Department of Social Medicine,   Arak University of Medical Sciences,  Arak,  IranAbstract:  The present study aimed to evaluate the effectiveness of morphine and meperidine  (pethidine) as pain relief in opioid-dependent patients with acute pain.",Non-OADS,/arxiv_data1/oa_pdf/79/8c/oaem-8-057.PMC5012853.pdf
"2 Morphine is the standard opium-based analgesic with well-known anal- gesic effects and side effects.7 Meperidine (pethidine) is another opioid, but the use Correspondence: Hossein Sanaei-Zadeh Emergency Room, Division of Medical Toxicology, Hazrat Ali-Asghar (p) Hospital, Meshkinfam Street, 7143918796, Shiraz University of Medical Sciences, Shiraz, IranTel +98 713 228 8604Fax +98 713 228 8907 Email sanaeizadeh@sums.ac.irJournal name: Open Access Emergency Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Solhi et alRunning head recto: Meperidine versus morphine in acute pain management DOI: http://dx.doi.org/10.2147/OAEM.S112803",Non-OADS,/arxiv_data1/oa_pdf/79/8c/oaem-8-057.PMC5012853.pdf
"Open Access Emergency Medicine 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-emergency-medicine-journalThe Open Access Emergency Medicine is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/79/8c/oaem-8-057.PMC5012853.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 59 Meperidine versus morphine in acute pain management doses of opioid not only undertreat the pain, but also cannot  prevent withdrawal symptoms in opioid-dependent patients.12  Therefore, pain can affect the COWS parameters and increase this score in the studied population.",Non-OADS,/arxiv_data1/oa_pdf/79/8c/oaem-8-057.PMC5012853.pdf
Available from: https://www.nhmrc.gov.au/guidelines-publications/cp104.,Non-OADS,/arxiv_data1/oa_pdf/79/8c/oaem-8-057.PMC5012853.pdf
"Key Words:  Topoisomerase II, Heat shock protein 90, Molecular docking study, Design of dual inhibitorAbstractReview Biomol  Ther 24(5), 453-468 (2016) *Corresponding Author E-mail: ykwon@ewha.ac.kr Tel: +82-2-3277-4653, Fax: +82-2-3277-3051Received  Aug 2, 2016  Revised  Aug 11, 2016  Accepted  Aug 16, 2016 Published Online  Sep 1, 2016 Copyright © 2016 The Korean Society of Applied Pharmacologyhttp://dx.doi.org/10.4062/biomolther.2016.168 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/30/bt-24-453.PMC5012869.pdf
454 http://dx.doi.org/10.4062/biomolther.2016.168using Tripos force field and Gasteiger-Hückel charges.,OADS,/arxiv_data1/oa_pdf/da/30/bt-24-453.PMC5012869.pdf
"Additionally, the  size of the ATP binding site of each protein was calculated with Computed Atlas of Surface Topography of proteins (CASTp,  http://sts.bioe.uic.edu/castp/) (Liang et al., 1998).",OADS,/arxiv_data1/oa_pdf/da/30/bt-24-453.PMC5012869.pdf
"456 http://dx.doi.org/10.4062/biomolther.2016.168Biomol  Ther 24(5), 453-468 (2016)  Table 2.",Non-OADS,/arxiv_data1/oa_pdf/da/30/bt-24-453.PMC5012869.pdf
"458 http://dx.doi.org/10.4062/biomolther.2016.168ed into 8-Cl-ATP in cells and it competed with ATP to inhibit  topo II (Yang et al., 2009).",OADS,/arxiv_data1/oa_pdf/da/30/bt-24-453.PMC5012869.pdf
"460 http://dx.doi.org/10.4062/biomolther.2016.168Biomol  Ther 24(5), 453-468 (2016)  Table 3.",Non-OADS,/arxiv_data1/oa_pdf/da/30/bt-24-453.PMC5012869.pdf
"462 http://dx.doi.org/10.4062/biomolther.2016.168Biomol  Ther 24(5), 453-468 (2016)  Table 3.",Non-OADS,/arxiv_data1/oa_pdf/da/30/bt-24-453.PMC5012869.pdf
"464 http://dx.doi.org/10.4062/biomolther.2016.168GDM or RDC, scored highest.",OADS,/arxiv_data1/oa_pdf/da/30/bt-24-453.PMC5012869.pdf
466 http://dx.doi.org/10.4062/biomolther.2016.168PU3 as the template.,Non-OADS,/arxiv_data1/oa_pdf/da/30/bt-24-453.PMC5012869.pdf
This  suggested pharmacophore model will be useful in developing  dual inhibitor of topo II and Hsp90 by constructing 3D query for virtual screening using publically available database such  as ZINC (http://zinc.docking.org/).,OADS,/arxiv_data1/oa_pdf/da/30/bt-24-453.PMC5012869.pdf
"468 http://dx.doi.org/10.4062/biomolther.2016.168Kreusch, A., Han, S., Brinker, A., Zhou, V., Choi, H. S., He, Y., Lesley,  S. A., Caldwell, J. and Gu, X. J.",OADS,/arxiv_data1/oa_pdf/da/30/bt-24-453.PMC5012869.pdf
"Considering that LR has many syn- onyms, the vernacular names are maegmundong (맥문동) in  *Corresponding Author E-mail: kimsj@khu.ac.kr Tel: +82-2-961-0868, Fax: +82-2-960-0867Received  Dec 29, 2015  Revised  Feb 19, 2016  Accepted  Mar 3, 2016 Published Online  Sep 1, 2016http://dx.doi.org/10.4062/biomolther.2015.214 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/00/bt-24-469.PMC5012870.pdf
"470 http://dx.doi.org/10.4062/biomolther.2015.214Korean, maimendong (麥 門 冬 ) in Mandarin and ryunohige (リュ ウノヒゲ ) or janohige (ジャノヒゲ ) in Japanese.",Non-OADS,/arxiv_data1/oa_pdf/b0/00/bt-24-469.PMC5012870.pdf
"472 http://dx.doi.org/10.4062/biomolther.2015.214Anti-osteoclastogenesis activities Excess osteoclastogenesis or activation of mature osteo- clasts causing the bone destruction is observed in advanced  cases of rheumatoid arthritis and the neoplastic diseases, os- teoporosis, periodontitis, multiple myeloma and bone metas- tasis.",Non-OADS,/arxiv_data1/oa_pdf/b0/00/bt-24-469.PMC5012870.pdf
474 http://dx.doi.org/10.4062/biomolther.2015.214Clin.,OADS,/arxiv_data1/oa_pdf/b0/00/bt-24-469.PMC5012870.pdf
"*Corresponding Author E-mail: kmkim@jnu.ac.kr Tel: +82-62-530-2936, Fax: +82-62-530-2949 †The first two authors contributed equally to this work.Received  Jan 21, 2016  Revised  Mar 10, 2016  Accepted  Mar 17, 2016 Published Online  Sep 1, 2016http://dx.doi.org/10.4062/biomolther.2016.015 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/bb/bt-24-475.PMC5012871.pdf
"476 http://dx.doi.org/10.4062/biomolther.2016.015MATERIALS AND METHODS Materials Human embryonic kidney cells (HEK-293) were obtained  from the American Type Culture Collection (Rockville, MD,  USA).",OADS,/arxiv_data1/oa_pdf/6b/bb/bt-24-475.PMC5012871.pdf
478 http://dx.doi.org/10.4062/biomolther.2016.015D3R (Fig.,Non-OADS,/arxiv_data1/oa_pdf/6b/bb/bt-24-475.PMC5012871.pdf
480 http://dx.doi.org/10.4062/biomolther.2016.015needed to understand their interactions.,OADS,/arxiv_data1/oa_pdf/6b/bb/bt-24-475.PMC5012871.pdf
"Key Words:  Cancer stem cells, NRF2, Colonospheres, Drug efflux transporters, ChemoresistanceAbstractOriginal Article Biomol  Ther 24(5), 482-488 (2016) *Corresponding Author E-mail: mkwak@catholic.ac.kr Tel: +82-2-2164-6532, Fax: +82-2-2164-4059Received  Jun 28, 2016  Accepted  Jul 22, 2016 Published Online  Sep 1, 2016 Copyright © 2016 The Korean Society of Applied Pharmacologyhttp://dx.doi.org/10.4062/biomolther.2016.145 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/8e/bt-24-482.PMC5012872.pdf
484 http://dx.doi.org/10.4062/biomolther.2016.145Fig.,OADS,/arxiv_data1/oa_pdf/8f/8e/bt-24-482.PMC5012872.pdf
486 http://dx.doi.org/10.4062/biomolther.2016.145monolayer-cultured cells.,OADS,/arxiv_data1/oa_pdf/8f/8e/bt-24-482.PMC5012872.pdf
"488 http://dx.doi.org/10.4062/biomolther.2016.145Calkins, M. J., Johnson, D. A., Townsend, J.",OADS,/arxiv_data1/oa_pdf/8f/8e/bt-24-482.PMC5012872.pdf
"Key Words:  Neuropathic pain, Procaine, JAK2/STAT3 signaling, CCI rat modelAbstractOriginal Article Biomol  Ther 24(5), 489-494 (2016) *Corresponding Author E-mail: yulingzhi5247@126.com Tel: +86-0531-85695150, Fax: +86-0531-85695150Received  Jan 7, 2016  Revised  Apr 25, 2016  Accepted  May 11, 2016 Published Online  Sep 1, 2016http://dx.doi.org/10.4062/biomolther.2016.006 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/ad/bt-24-489.PMC5012873.pdf
490 http://dx.doi.org/10.4062/biomolther.2016.006tions are attracting attentions and a growing number of re- searches are emerging.,Non-OADS,/arxiv_data1/oa_pdf/1b/ad/bt-24-489.PMC5012873.pdf
492 http://dx.doi.org/10.4062/biomolther.2016.006expression levels of JAK2 and STAT3 by qRT-PCR and west- ern blot on the 20th day post surgery.,Non-OADS,/arxiv_data1/oa_pdf/1b/ad/bt-24-489.PMC5012873.pdf
494 http://dx.doi.org/10.4062/biomolther.2016.006muscles.,Non-OADS,/arxiv_data1/oa_pdf/1b/ad/bt-24-489.PMC5012873.pdf
"*Corresponding Author E-mail: kongxiangang4418@126.com Tel: +86-13562788148, Fax: +86-0537-2256374Received  Dec 14, 2015  Revised  Mar 3, 2016  Accepted  May 9, 2016 Published Online  Sep 1, 2016http://dx.doi.org/10.4062/biomolther.2015.206 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/01/bt-24-495.PMC5012874.pdf
"496 http://dx.doi.org/10.4062/biomolther.2015.206Even so, the potential mechanisms in spinal cord protection  by TREK1 activation are not fully understood.",Non-OADS,/arxiv_data1/oa_pdf/2c/01/bt-24-495.PMC5012874.pdf
498 http://dx.doi.org/10.4062/biomolther.2015.206sample wells was calculated according to the NADH standard  curve.,OADS,/arxiv_data1/oa_pdf/2c/01/bt-24-495.PMC5012874.pdf
500 http://dx.doi.org/10.4062/biomolther.2015.206cated that isoflurane induced neuroprotection by up-regulation  of TREK1.,Non-OADS,/arxiv_data1/oa_pdf/2c/01/bt-24-495.PMC5012874.pdf
"Key Words:  Shikonin, p53, Nrf2, ROS, JNK, ApoptosisAbstract Copyright  © 2016 The Korean Society of Applied Pharmacology*Corresponding Authors E-mail: hichang@korea.ac.kr (Chang H), chhoonha@amc.seoul.kr (Ha CH) Tel: +82-2-3290-3421 (Chang H), +82-2-3010-2977 (Ha CH)Fax: +82-2-3290-3421 (Chang H), +82-2-3010-2977 (Ha CH) †The first two authors contributed equally to this work.Received  Jan 12, 2016  Revised  Feb 22, 2016  Accepted  Apr 5, 2016 Published Online  Sep 1, 2016http://dx.doi.org/10.4062/biomolther.2016.008 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/37/bt-24-501.PMC5012875.pdf
"502 http://dx.doi.org/10.4062/biomolther.2016.008(Shin et al., 2010).",OADS,/arxiv_data1/oa_pdf/4e/37/bt-24-501.PMC5012875.pdf
"504 http://dx.doi.org/10.4062/biomolther.2016.008especially at or higher than 35 nM of shikonin treatment, in  which the decreased cell viability was essentially not ob- served below that concentration.",Non-OADS,/arxiv_data1/oa_pdf/4e/37/bt-24-501.PMC5012875.pdf
506 http://dx.doi.org/10.4062/biomolther.2016.008by performing the immunofluorescence and luciferase assays.,Non-OADS,/arxiv_data1/oa_pdf/4e/37/bt-24-501.PMC5012875.pdf
508 http://dx.doi.org/10.4062/biomolther.2016.008carcinoma cells via caspase- and JNK-dependent apoptotic  pathways.,Non-OADS,/arxiv_data1/oa_pdf/4e/37/bt-24-501.PMC5012875.pdf
"Key Words:  Isoegomaketone, Heme oxygenase-1, p38 MAPK, ROS scavengerAbstractOriginal Article Biomol  Ther 24(5), 510-516 (2016) *Corresponding Author E-mail: jbkim74@kaeri.re.kr Tel: +82-63-570-3313, Fax: +82-63-570-3813 Received  Dec 2, 2015  Revised  Jun 16, 2016  Accepted  Jul 12, 2016 Published Online  Sep 1, 2016 Copyright © 2016 The Korean Society of Applied Pharmacologyhttp://dx.doi.org/10.4062/biomolther.2015.194 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/84/bt-24-510.PMC5012876.pdf
512 http://dx.doi.org/10.4062/biomolther.2015.194h after treatment with 15 µM IK.,Non-OADS,/arxiv_data1/oa_pdf/6c/84/bt-24-510.PMC5012876.pdf
514 http://dx.doi.org/10.4062/biomolther.2015.194lular localization of Nrf2 in IK-treated RAW264.7 cells.,Non-OADS,/arxiv_data1/oa_pdf/6c/84/bt-24-510.PMC5012876.pdf
516 http://dx.doi.org/10.4062/biomolther.2015.194ol.,Non-OADS,/arxiv_data1/oa_pdf/6c/84/bt-24-510.PMC5012876.pdf
"As an initial step toward under - standing the multifaceted roles of b-arrestins in these process- *Corresponding Author E-mail: kmkim@jnu.ac.kr  Tel: +82-62-530-2936, Fax: +82-62-530-2949Received  Dec 8, 2015  Revised  Dec 24, 2015  Accepted  Jan 5, 2016 Published Online  Sep 1, 2016http://dx.doi.org/10.4062/biomolther.2015.198 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/75/bt-24-517.PMC5012877.pdf
"518 http://dx.doi.org/10.4062/biomolther.2015.198Biomol  Ther 24(5), 517-522 (2016)  es, we determined the roles of distinct GPCR subregions in  the interactions with b-arrestins.",OADS,/arxiv_data1/oa_pdf/4f/75/bt-24-517.PMC5012877.pdf
"520 http://dx.doi.org/10.4062/biomolther.2015.198Biomol  Ther 24(5), 517-522 (2016)  when the second or third intracellular loop was replaced with  that of D 3R, while D 3R could not, as clearly, gain the ability to  translocate b-arrestin2 when both loops were replaced with  those of D 2R.",Non-OADS,/arxiv_data1/oa_pdf/4f/75/bt-24-517.PMC5012877.pdf
"522 http://dx.doi.org/10.4062/biomolther.2015.198Biomol  Ther 24(5), 517-522 (2016)  ture elucidates function.",OADS,/arxiv_data1/oa_pdf/4f/75/bt-24-517.PMC5012877.pdf
"Very recently, we have re ported  a newly synthesized UT antagonist KR-36676 (2-(6,7-dichlo - ro-3-oxo-2H-benzo[b][1,4]oxazin-4(3H)-yl)-N-methyl-N-(2- (pyrrolidin-1-yl)-1-(4-(thiophen-3-yl)phenyl) ethyl)acetamide),   *Corresponding Author E-mail: yisjung@ajou.ac.kr Tel: +82-31-219-3444, Fax: +82-31-219-3435Received  Sep 4, 2015  Revised  Sep 15, 2015  Accepted  Sep 17, 2015 Published Online  Sep 1, 2016http://dx.doi.org/10.4062/biomolther.2015.142 Copyright  © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/94/bt-24-523.PMC5012878.pdf
"524 http://dx.doi.org/10.4062/biomolther.2015.142Biomol  Ther 24(5), 523-528 (2016)  can exert anti-hypertrophic effects against pressure overload- induced cardiac hypertrophy (Oh et al., 2015).",Non-OADS,/arxiv_data1/oa_pdf/2b/94/bt-24-523.PMC5012878.pdf
"526 http://dx.doi.org/10.4062/biomolther.2015.142Biomol  Ther 24(5), 523-528 (2016) presence of decreased vessel diameter diminished the physi- ological relevance of this model for the investigation of hu- man cardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/2b/94/bt-24-523.PMC5012878.pdf
"528 http://dx.doi.org/10.4062/biomolther.2015.142Biomol  Ther 24(5), 523-528 (2016) regulation of vascular smooth muscle cell differentiation in develop - ment and disease.",Non-OADS,/arxiv_data1/oa_pdf/2b/94/bt-24-523.PMC5012878.pdf
"Both compartments are required to form an  *Corresponding Author E-mail: jshwang@khu.ac.kr Tel: +82-31-888-6173, Fax: +82-31-888-6179Received  Jan 18, 2016  Revised  Feb 16, 2016  Accepted  Feb 29, 2016 Published Online  Sep 1, 2016http://dx.doi.org/10.4062/biomolther.2016.011 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/86/bt-24-529.PMC5012879.pdf
"530 http://dx.doi.org/10.4062/biomolther.2016.011effective permeability barrier (Madison, 2003).",Non-OADS,/arxiv_data1/oa_pdf/ce/86/bt-24-529.PMC5012879.pdf
"532 http://dx.doi.org/10.4062/biomolther.2016.011TEWL with a tewameter (TM300/Courage+Khazaka electronic  GmbH, Köln, Germany), before treatment and immediately af- ter treatment and 3 and 24 hours after acute barrier disruption.",Non-OADS,/arxiv_data1/oa_pdf/ce/86/bt-24-529.PMC5012879.pdf
534 http://dx.doi.org/10.4062/biomolther.2016.011PAR-2 on keratinocyte differentiation is controversial.,Non-OADS,/arxiv_data1/oa_pdf/ce/86/bt-24-529.PMC5012879.pdf
"Key Words:  Danshensu, Paeonol, Diabetic nephropathy, Oxidative stress, Blood lipid metabolism, HistopathologyAbstractOriginal Article Biomol  Ther 24(5), 536-542 (2016) *Corresponding Author E-mail: wangsiw@fmmu.edu.cn Tel: +86-29-84772519, Fax: +86-29-84772519Received  Nov 26, 2015  Revised  Feb 22, 2016  Accepted  Jun 30, 2016 Published Online  Sep 1, 2016 Copyright © 2016 The Korean Society of Applied Pharmacologyhttp://dx.doi.org/10.4062/biomolther.2015.191 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/06/bt-24-536.PMC5012880.pdf
"538 http://dx.doi.org/10.4062/biomolther.2015.191pacity (T-AOC), nitric oxide (NO), methane dicarboxylic alde - hyde (MDA) in DN rats were measured by commercial assay  kits from Jianchen Bioengineering Company, Nanjing, China.Histopathological changes A small piece of kidney tissue was taken and fixed in 10%  formalin, embedded in paraffin wax.",OADS,/arxiv_data1/oa_pdf/a0/06/bt-24-536.PMC5012880.pdf
540 http://dx.doi.org/10.4062/biomolther.2015.191sylated hemoglobin is significant higher in model group than  the control (p<0.01).,Non-OADS,/arxiv_data1/oa_pdf/a0/06/bt-24-536.PMC5012880.pdf
"542 http://dx.doi.org/10.4062/biomolther.2015.191and Lau, C. B.",Non-OADS,/arxiv_data1/oa_pdf/a0/06/bt-24-536.PMC5012880.pdf
"The  aqueous extract of VB is used to dye rice for patients with  *Corresponding Author E-mail: jang@skku.edu Tel: +82-31-290-7780, Fax: +82-31-292-8800Received  Dec 14, 2015  Revised  Mar 3, 2016  Accepted  Mar 8, 2016 Published Online  Sep 1, 2016http://dx.doi.org/10.4062/biomolther.2015.205 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/2d/bt-24-543.PMC5012881.pdf
"544 http://dx.doi.org/10.4062/biomolther.2015.205diabetes in parts of the eastern coastal region of China so that  patients can eat more rice and avoid hunger pains (Wang et  al., 2010; Wang et al., 2013).",Non-OADS,/arxiv_data1/oa_pdf/a2/2d/bt-24-543.PMC5012881.pdf
"546 http://dx.doi.org/10.4062/biomolther.2015.205Immunocytochemistry BV-2 microglial cells (2.5×105 cells/well) were cultured on  glass coverslips (SPL Lifesciences Co., Pocheon, Korea) for  24 h. After pretreatment with VBME for 30 min, the cells were  incubated with LPS for 1 h. Immunocytochemistry was carried  out as previously described (Kwon et al., 2015b).",OADS,/arxiv_data1/oa_pdf/a2/2d/bt-24-543.PMC5012881.pdf
"548 http://dx.doi.org/10.4062/biomolther.2015.205VBME suppresses LPS-induced phosphorylation of JNK  and ERK1/2 MAPKs, PI3K/Akt, and GSK-3 b in BV-2   microglial cells To evaluate the effect of VBME on the signaling pathway  upstream of NF-κB activation, we examined changes in the  activation of intracellular signaling proteins in BV-2 cells by  Western blot analysis.",OADS,/arxiv_data1/oa_pdf/a2/2d/bt-24-543.PMC5012881.pdf
"550 http://dx.doi.org/10.4062/biomolther.2015.205regulated phosphorylation of MAPKs, PI3K/Akt, and GSK-3b  signaling proteins results in excessive production of inflamma - tory molecules, which has adverse consequences.",Non-OADS,/arxiv_data1/oa_pdf/a2/2d/bt-24-543.PMC5012881.pdf
"Key Words:  Enterovirus 71, Antiviral activity, Norwogonin, Oroxylin A, MosloflavoneAbstract Copyright  © 2016 The Korean Society of Applied Pharmacology*Corresponding Authors E-mail: hjko@kangwon.ac.kr (Ko HJ), thdwohud@naver.com (Song JH) Tel: +82-33-250-6923 (Ko HJ), +82-33-250-6923 (Song JH)Fax: +82-33-255-7865 (Ko HJ), +82-33-255-7865 (Song JH)Received  Dec 9, 2015  Revised  Feb 23, 2016  Accepted  Mar 3, 2016 Published Online  Sep 1, 2016http://dx.doi.org/10.4062/biomolther.2015.200 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/2d/bt-24-552.PMC5012882.pdf
"556 http://dx.doi.org/10.4062/biomolther.2015.200Time-course of compound addition Norwogonin, oroxylin A, and mosloflavone were added at  different time points (before, during, and after) of EV71 in- fection.",Non-OADS,/arxiv_data1/oa_pdf/fa/2d/bt-24-552.PMC5012882.pdf
558 http://dx.doi.org/10.4062/biomolther.2015.200Pediatr.,OADS,/arxiv_data1/oa_pdf/fa/2d/bt-24-552.PMC5012882.pdf
"'Erratum Biomol  Ther 24(5), 559 (2016) Copyright  © 2016 The Korean Society of Applied Pharmacology*Corresponding Author E-mail: alshatwi@ksu.edu.sa Tel: +966504236535, Fax: +96614678394DOI of original article : http://dx.doi.org/10.4062/biomolther.2016.067 http://dx.doi.org/10.4062/biomolther.2016.559 Open  Access www.biomolther.org  This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/01/bt-24-559.PMC5012883.pdf
This process requires complex  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/b2/nihms-791167.PMC5012916.pdf
Supplementary data Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.scr.2016.05.007 .,OADS,/arxiv_data1/oa_pdf/93/b2/nihms-791167.PMC5012916.pdf
Keywords Fluorescence microscopy; Stem cells; Live cell imaging; Cell therapy; Pluripotency This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/c6/nihms810724.PMC5012928.pdf
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.scr.2016.05.012 Disclaimer:  Commercial products are identified in this document in order to specify the experimental procedure adequately.,Non-OADS,/arxiv_data1/oa_pdf/9c/c6/nihms810724.PMC5012928.pdf
Access to the full size colony images and an interactive visualization of the automated  classification of hexagonal sub-regions is available at https://isg.nist.gov/deepzoomweb/ analysis .Bhadriraju et al.,OADS,/arxiv_data1/oa_pdf/9c/c6/nihms810724.PMC5012928.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):559-567 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.559 The Modulation of Neurotrophin and  Epigenetic Regulators: Implication for   Astrocyte Proliferation and Neuronal Cell  Apoptosis After Spinal Cord Injury Jong Heon Kim, MD1, Sung-Hoon Kim, MD, PhD1, Sung-Rae Cho, MD, PhD2,  Ji Yong Lee, MS3, Ji Hyun Kim, MD1, Ahreum Baek, MS3, Hong Sun Jung, MD1 1Department of Rehabilitation Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine,  Wonju; 2Department of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul; 3Department of Rehabilitation  Medicine, The Graduate School of Yonsei University Wonju College of Medicine, Wonju, Korea Objective  To investigate alterations in the expression of the main regulators of neuronal survival and death related  to astrocytes and neuronal cells in the brain in a mouse model of spinal cord injury (SCI).",OADS,/arxiv_data1/oa_pdf/75/97/arm-40-559.PMC5012966.pdf
"Tel: +82-33-741-1455, Fax: +82-33-742-1409, E-mail: hongsun.jung@gmail.comORCID: Jong Heon Kim (http://orcid.org/0000-0002-7341-3231); Sung-Hoon Kim (http://orcid.org/0000-0001-6043-7640); Sung-Rae Cho (http://orcid.org/0000-0003-1429-2684); Ji Yong Lee (http://orcid.org/0000-0002-8273-8994); Ji Hyun Kim (http://orcid.org/0000-0001-9061-3350); Ahreum Baek (http://orcid.org/0000-0002-9926-8482); Hong Sun Jung (http://orcid.org/0000-0002-2630-8674).",Non-OADS,/arxiv_data1/oa_pdf/75/97/arm-40-559.PMC5012966.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/97/arm-40-559.PMC5012966.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):568-574 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.568 Validation of Attitude and Heading Reference  System and Microsoft Kinect for Continuous  Measurement of Cervical Range of Motion  Compared to the Optical Motion Capture System Young Seop Song, MD1,2, Kyung Yong Yang, MS3, Kibum Youn, MS3, Chiyul Yoon, PhD2,   Jiwoon Yeom, MD1, Hyeoncheol Hwang, MD1,2, Jehee Lee, PhD3, Keewon Kim, MD, MS1,2 1Department of Rehabilitation Medicine, Seoul National University Hospital, Seoul National University College of Medicine,  Seoul; 2Interdisciplinary Program of Bioengineering, Graduate School, Seoul National University, Seoul;   3School of Computer Science and Engineering, Seoul National University, Seoul, Korea Objective  To compare optical motion capture system (MoCap), attitude and heading reference system (AHRS)  sensor, and Microsoft Kinect for the continuous measurement of cervical range of motion (ROM).",OADS,/arxiv_data1/oa_pdf/9d/d7/arm-40-568.PMC5012967.pdf
"Tel: +82-2-2072-0744, Fax: +82-2-743-7473, E-mail: KeewonKimM.D@gmail.comORCID: Young Seop Song (http://orcid.org/0000-0003-3503-1627); Kyung Yong Yang (http://orcid.org/0000-0003-2137-6018); Kibum Youn (http://orcid.org/0000-0002-4061-3157); Chiyul Yoon (http://orcid.org/0000-0003-0754-058X); Jiwoon Yeom (http://orcid.org/0000-0002-1431-9907); Hyeoncheol Hwang (http://orcid.org/0000-0003-4119-2742); Jehee Lee (http://orcid.org/0000-0003-1023-1868); Keewon Kim (http://orcid.org/0000-0001-6597-578X).",Non-OADS,/arxiv_data1/oa_pdf/9d/d7/arm-40-568.PMC5012967.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/d7/arm-40-568.PMC5012967.pdf
An expanded mathematical description of the conversion is provided in the Supple-mentary materials available with the full-text of this ar - ticle at http://www.e-arm.org.,Non-OADS,/arxiv_data1/oa_pdf/9d/d7/arm-40-568.PMC5012967.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):575-582 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.575 Phantom Study of a New Laser-Etched   Needle for Improving Visibility During  Ultrasonography-Guided Lumbar   Medial Branch Access With Novices Jung Wook Park, MD1, Min Woo Cheon, PhD2, Min Hong Lee, MD3 1Topteam Rehabilitation Clinic, Gwangju; 2Department of Hospital Biomedical Engineering, Dongshin University, Gwangju;  3Department of Rehabilitation Medicine, Chosun University Hospital, Gwangju, Korea Objective  To compare the visibility and procedural parameters between a standard spinal needle and a new  laser-etched needle (LEN) in real-time ultrasonography guided lumbar medial branch access in a phantom of the  lumbosacral spine Methods  We conducted a prospective single-blinded observational study at a rehabilitation medicine center.",OADS,/arxiv_data1/oa_pdf/0f/f6/arm-40-575.PMC5012968.pdf
"Tel: +82-62-974-9191, Fax: +82-62-223-0245, E-mail: hayaaaa@hanmail.netORCID: Jung Wook Park (http://orcid.org/0000-0002-2507-6111); Min Woo Cheon (http://orcid.org/0000-0002-0979-4316); Min Hong Lee (http://orcid.org/0000-0002-4457-5434).",Non-OADS,/arxiv_data1/oa_pdf/0f/f6/arm-40-575.PMC5012968.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/f6/arm-40-575.PMC5012968.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):583-591 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.583 Combined Effect of Bilateral Ovariectomy   and Anterior Cruciate Ligament Transection   With Medial Meniscectomy on the   Development of Osteoarthritis Model Jae Lim Kim, MD, Chang Won Moon, MD, Young Suk Son, MD, Sang Jun Kim, MD, PhD Department of Physical and Rehabilitation Medicine, Samsung Medical Center,   Sungkyunkwan University School of Medicine, Seoul, Korea Objective  To investigate the combined effect of bilateral ovariectomy (OVX) and anterior cruciate ligament  transection (ACLT) with medial meniscectomy (MM) on the development of osteoarthritis (OA).",OADS,/arxiv_data1/oa_pdf/43/2f/arm-40-583.PMC5012969.pdf
"Tel: +82-2-3410-6069, Fax: +82-2-3410-0052, E-mail: guitarren.kim@samsung.comORCID: Jaelim Kim (http://orcid.org/0000-0001-8267-2748); Chang Won Moon (http://orcid.org/0000-0003-4096-7470); Young Suk Son (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/43/2f/arm-40-583.PMC5012969.pdf
org/0000-0003-1328-4631); Sang Jun Kim (http://orcid.org/0000-0002-0479-7526).,Non-OADS,/arxiv_data1/oa_pdf/43/2f/arm-40-583.PMC5012969.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/2f/arm-40-583.PMC5012969.pdf
"Although the etiology of HSP is not well known, it has been suggested that multiple factors contribute to HSP , such as adhesive capsulitis, rotator cuff disorder, myofascial pain, complex regional pain syndrome, and shoulder hand syndrome Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):592-599 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.592 Botulinum Toxin A Injection into the  Subscapularis Muscle to Treat   Intractable Hemiplegic Shoulder Pain Jeong-Gue Choi, MD, Joon-Ho Shin, MD, MS, Bo-Ra Kim, MD  Department of Rehabilitation Medicine, National Rehabilitation Center, Seoul, Korea Objective  To evaluate the beneficial effect of botulinum toxin A (Botox) injection into the subscapularis muscle  on intractable hemiplegic shoulder pain.",Non-OADS,/arxiv_data1/oa_pdf/3f/51/arm-40-592.PMC5012970.pdf
"Tel: +82-2-901-1634, Fax: +82-2-901-1899, E-mail: bbora1114@naver.comORCID: Jeong-Gue Choi (http://orcid.org/0000-0002-4147-2050); Joon-Ho Shin (http://orcid.org/0000-0001-6447-8829); Bo-Ra Kim (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/3f/51/arm-40-592.PMC5012970.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/51/arm-40-592.PMC5012970.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):600-610 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.600 Effect of Laryngopharyngeal Neuromuscular  Electrical Stimulation on Dysphonia  Accompanied by Dysphagia in Post-stroke and  Traumatic Brain Injury Patients: A Pilot Study  Kyung Rok Ko, MD1, Hee Jung Park, MD1, Jung Keun Hyun, MD, PhD1,2,3,  In-Hyo Seo, PhD4, Tae Uk Kim, MD, PhD1 1Department of Rehabilitation Medicine, Dankook University College of Medicine, Cheonan; 2Department of Nanobiomedical  Science & BK21 Plus NBM Research Center for Regenerative Medicine, Dankook University, Cheonan; 3Institute of Tissue  Regeneration Engineering (ITREN), Dankook University, Cheonan; 4Voice & Speech Clinic, Department of Otorhinolaryngology- Head & Neck Surgery, Dankook University College of Medicine, Cheonan, Korea Objective  To investigate the effect of laryngopharyngeal neuromuscular electrical stimulation (NMES) on  dysphonia in patients with dysphagia caused by stroke or traumatic brain injury (TBI).",Non-OADS,/arxiv_data1/oa_pdf/e7/63/arm-40-600.PMC5012971.pdf
"Tel: +82-41-550-6640, Fax: +82-41-551-7062, E-mail: magnarbor@dankook.ac.krORCID: Kyung Rok Ko (http://orcid.org/0000-0003-3798-4878); Hee Jung Park (http://orcid.org/0000-0002-8389-1480); Jung Keun Hyun (http://orcid.org/0000-0001-9254-4424); In-Hyo Seo (http://orcid.org/0000-0002-2665-661X); Tae Uk Kim (http://orcid.org/0000-0001-9904-8781).",Non-OADS,/arxiv_data1/oa_pdf/e7/63/arm-40-600.PMC5012971.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/63/arm-40-600.PMC5012971.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):611-619 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.611 The Effect of an Upper Limb Rehabilitation  Robot on Hemispatial Neglect in Stroke Patients Yoon Sik Choi, MD, Kyeong Woo Lee, MD, Jong Hwa Lee, MD,   Sang Beom Kim, MD, Gyu Tae Park, MD, Sook Joung Lee, MD Department of Physical Medicine and Rehabilitation, Dong-A University College of Medicine & Busan-Ulsan Regional  Cardiocerebrovascular Center, Busan, Korea Objective  To investigate the effectiveness of an upper limb rehabilitation robot therapy on hemispatial neglect in  stroke patients.",Non-OADS,/arxiv_data1/oa_pdf/07/83/arm-40-611.PMC5012972.pdf
"Tel: +82-51-240-5690, Fax: +82-51-254-8511, E-mail: lsj995414@hanmail.netORCID: Yoon Sik Choi (http://orcid.org/0000-0003-2266-541X); Kyeong Woo Lee (http://orcid.org/0000-0001-8785-5535); Jong Hwa Lee (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/07/83/arm-40-611.PMC5012972.pdf
org/0000-0003-2489-358X); Sang Beom Kim (http://orcid.org/0000-0002-5622-5933); Gyu Tae Park (http://orcid.org/0000-0002-7809-2561); Sook  Joung Lee  (http://orcid.org/0000-0002-6894-445X).,Non-OADS,/arxiv_data1/oa_pdf/07/83/arm-40-611.PMC5012972.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/83/arm-40-611.PMC5012972.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):620-628 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.620 The Relationship Between Tongue Pressure   and Oral Dysphagia in Stroke Patients  Jong Ha Lee, MD, PhD1, Hee-Sang Kim, MD, PhD1, Dong Hwan Yun, MD, PhD1, Jinmann Chon, MD, PhD1,  Yoo Jin Han, MD, PhD1, Seung Don Yoo, MD, PhD2, Dong Hwan Kim, MD, PhD2, Seung Ah Lee, MD, PhD2,  Hye In Joo, MD2, Ji-su Park, MS3, Jin Chul Kim, MD1, Yunsoo Soh, MD2 1Department of Rehabilitation & Physical Medicine, Kyung-Hee Medical Center, Seoul;  2Department of Rehabilitation & Physical Medicine, Kyung-Hee University Hospital at Gangdong, Seoul;   3Department of Occupational Therapy, Inje University Busan Paik Hospital, Busan, Korea Objective  To evaluate the relationships between tongue pressure and different aspects of the oral-phase  swallowing function.",Non-OADS,/arxiv_data1/oa_pdf/62/97/arm-40-620.PMC5012973.pdf
"Tel: +82-2-440-7246, Fax: +82-2-440-7260, E-mail: soyuns@gmail.comORCID: Jong Ha Lee (http://orcid.org/0000-0002-7627-6543); Hee-Sang Kim (http://orcid.org/0000-0003-4985-0594); Dong Hwan Yun (http://orcid.org/0000-0003-1800-319x); Jinmann Chon (http://orcid.org/0000-0002-4186-6623); Yoo Jin Han (http://orcid.org/0000-0003-3256-9931); Seung Don Yoo (http://orcid.org/0000-0003-4513-2560); Dong Hwan Kim (http://orcid.org/0000-0002-3812-5509); Seung Ah Lee (http://orcid.org/0000-0002-3426-6259); Hye In Joo (http://orcid.org/0000-0002-0943-4628); Ji-su Park (http://orcid.org/0000-0001-7113-4792); Jin Chul Kim (http://orcid.org/0000-0002-4405-5463); Yunsoo Soh (http://orcid.org/0000-0001-8368-4900).",Non-OADS,/arxiv_data1/oa_pdf/62/97/arm-40-620.PMC5012973.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/97/arm-40-620.PMC5012973.pdf
"The paralyzed upper extremity, accompanied by the weakness of muscles, increased spasticity, sensory loss, Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):629-636 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.629 Efficacy of Mirror Therapy Containing  Functional Tasks in Poststroke Patients Kil-Byung Lim, MD, Hong-Jae Lee, MD, Jeehyun Yoo, MD, Hyun-Ju Yun, MD, Hye-Jung Hwang, MPH Department of Physical Medicine and Rehabilitation, Inje University Ilsan Paik Hospital, Goyang, Korea Objective  To investigate the effect of mirror therapy containing functional tasks on upper extremity function and  activities of daily living in patients with subacute stroke.",Non-OADS,/arxiv_data1/oa_pdf/c9/3c/arm-40-629.PMC5012974.pdf
"Tel: +82-31-910-7440, Fax: +82-31-910-7446, E-mail: I9581@paik.ac.krORCID: Kil-Byung Lim (http://orcid.org/0000-0001-8971-7486); Hong-Jae Lee (http://orcid.org/0000-0001-9813-4952); Jeehyun Yoo (http://orcid.org/0000-0002-1555-8029); Hyun-Ju Yun (http://orcid.org/0000-0002-4445-3680); Hye-Jung Hwang (http://orcid.org/0000-0002-5169-3033).",Non-OADS,/arxiv_data1/oa_pdf/c9/3c/arm-40-629.PMC5012974.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/3c/arm-40-629.PMC5012974.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):637-646 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.637 Association of Dysphagia With   Supratentorial Lesions in Patients With   Middle Cerebral Artery Stroke  Bo-Ram Kim, MD, PhD1, Won-Jin Moon, MD, PhD2, Hyuntae Kim, MD1,   Eunhwa Jung, OT1, Jongmin Lee, MD, PhD1 Departments of 1Rehabilitation Medicine and 2Radiology, Konkuk University School of Medicine &   Konkuk University Medical Center, Seoul, Korea Objective  To determine the supratentorial area associated with poststroke dysphagia, we assessed the diffusion  tensor images (DTI) in subacute stroke patients with supratentorial lesions.",OADS,/arxiv_data1/oa_pdf/71/dd/arm-40-637.PMC5012975.pdf
"Tel: +82-2-2030-5351, Fax: +82-2-2030-5379, E-mail: leej@kuh.ac.krORCID: Bo-Ram Kim (http://orcid.org/0000-0002-5463-1268); Won-Jin Moon (http://orcid.org/0000-0002-8925-7376); Hyuntae Kim (http://orcid.org/0000-0001-9230-9977); Eunhwa Jung (http://orcid.org/0000-0003-4331-7369); Jongmin Lee (http://orcid.org/0000-0001-8718-0099).",Non-OADS,/arxiv_data1/oa_pdf/71/dd/arm-40-637.PMC5012975.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/dd/arm-40-637.PMC5012975.pdf
"All DTI images were corrected for eddy current-induced  image distortions using FSL software (The Analysis Group, FMRIB, Oxford, UK; http://www.fmrib.ox.ac.uk/fsl).",Non-OADS,/arxiv_data1/oa_pdf/71/dd/arm-40-637.PMC5012975.pdf
DTI analyses were performed by an experienced rehabilitation medicine physician using the DTI studio (https://www.mristudio.org).,OADS,/arxiv_data1/oa_pdf/71/dd/arm-40-637.PMC5012975.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):647-656 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.647 The Effect of Cardiac Rehabilitation Exercise  Training on Cardiopulmonary Function in  Ischemic Cardiomyopathy With Reduced   Left Ventricular Ejection Fraction  Chul Kim, MD1, Hee Eun Choi, MD2, Young-Joon Lim, MD1 1Department of Rehabilitation Medicine, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul;  2Department of Rehabilitation Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea Objective  To observe the effect and safety of cardiac rehabilitation (CR) exercise in ischemic cardiomyopathy and  to compare the results between patients with preserved left ventricular ejection fraction (LVEF) and reduced LVEF .",OADS,/arxiv_data1/oa_pdf/45/d6/arm-40-647.PMC5012976.pdf
"Tel: +82-2-950-1134, Fax: +82-2-935-3076, E-mail: yjlim817@hanmail.netORCID: Chul Kim (http://orcid.org/0000-0001-8223-2945); Hee Eun Choi (http://orcid.org/0000-0002-8753-929X); Young-Joon Lim (http://orcid.org/0000-0002-5834-9905).",Non-OADS,/arxiv_data1/oa_pdf/45/d6/arm-40-647.PMC5012976.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/d6/arm-40-647.PMC5012976.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):657-665 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.657 Longitudinal Trends in Fall Accidents in  Community Dwelling Korean Adults:   The 2008–2013 Korean Community Health Survey Ickpyo Hong, PhD, OTR/L1, Annie N. Simpson, PhD2, Sarah Logan, PhD2, Hee-Soon Woo, PhD3 1Department of Health Sciences and Research, College of Health Professions, Medical University of South Carolina, Charleston,  SC, USA; 2Department of Healthcare Leadership and Management, College of Health Professions, Medical University of South  Carolina, Charleston, SC, USA; 3Department of Occupational Therapy, Wonkwang University School of Medicine, Iksan, Korea Objective  To describe the longitudinal characteristics of unintentional fall accidents using a representative  population-based sample of Korean adults.",Non-OADS,/arxiv_data1/oa_pdf/f7/03/arm-40-657.PMC5012977.pdf
"Tel: +1-412-925-2224, Fax: +1-843-792-0710, E-mail: hongi@musc.eduORCID: Ickpyo Hong  (http://orcid.org/0000-0001-5404-7646); Annie N. Simpson (http://orcid.org/0000-0002-7216-1036); Hee-Soon Woo (http:// orcid.org/0000-0003-4712-9808).",Non-OADS,/arxiv_data1/oa_pdf/f7/03/arm-40-657.PMC5012977.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/03/arm-40-657.PMC5012977.pdf
"According to a previous report [3], the incidence of falling in people aged 65 years or over was 13%, and this falling down pro-Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):666-674 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.666 Prediction of Ambulatory Status After Hip  Fracture Surgery in Patients Over 60 Years Old  Jae Lim Kim, MD, Ji Sun Jung, MD, Sang Jun Kim, MD, PhD Department of Physical and Rehabilitation Medicine, Samsung Medical Center,   Sungkyunkwan University School of Medicine, Seoul, Korea Objective  To predict ambulatory capacity, 1 month after physical therapy following hip fracture surgery.",OADS,/arxiv_data1/oa_pdf/8e/93/arm-40-666.PMC5012978.pdf
"Tel: +82-2-3410-6069, Fax: +82-2-3410-0052, E-mail: guitarren.kim@samsung.comORCID: Jae Lim Kim (http://orcid.org/0000-0001-8267-2748); Ji Sun Jung (http://orcid.org/0000-0001-8579-5794); Sang Jun Kim (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/8e/93/arm-40-666.PMC5012978.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/93/arm-40-666.PMC5012978.pdf
"The increased length of hospital  stay (LOS), which is based on socio-economic factors (such as caregiver burden) rather than medical condi - tions, could hamper home and societal reintegration and Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):675-681 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.675 Length of Hospital Stay After Stroke:   A Korean Nationwide Study Ji-Ho Kang, MD1, Hee-Joon Bae, MD2, Young-Ah Choi, MD1, Sang Heon Lee, MD3, Hyung Ik Shin, MD1 1Department of Rehabilitation Medicine, Seoul National University College of Medicine, Seoul;  2Department of Neurology, Seoul National University Bundang Hospital, Seongnam;  3Department of Physical Medicine and Rehabilitation, Korea University Anam Hospital, Seoul, Korea Objective  To investigate the length of hospital stay (LOS) after stroke using the database of the Korean Health  Insurance Review & Assessment Service.",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/arm-40-675.PMC5012979.pdf
"Tel: +82-2-2072-3218, Fax: +82-2-743-7473, E-mail: hyungik1@snu.ac.krORCID: Ji-Ho Kang (http://orcid.org/0000-0002-1108-2844); Hee-Joon Bae (http://orcid.org/0000-0003-0051-1997); Young-Ah Choi (http://orcid.org/0000-0003-0051-1997); Sang Heon Lee (http://orcid.org/0000-0002-8910-2112); Hyung Ik Shin (http://orcid.org/0000-0001-8805-3104).",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/arm-40-675.PMC5012979.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/arm-40-675.PMC5012979.pdf
"The cause of this ethnical Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):682-691 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.682 Static and Dynamic Parameters in Patients  With Degenerative Flat Back and Change After  Corrective Fusion Surgery  Jung Hwan Lee, MD, PhD1, Sang-Ho Lee, MD, PhD2 Departments of 1Physical Medicine and Rehabilitation, 2Neurosurgery, Wooridul Spine Hospital, Seoul, Korea Objective  To evaluate characteristics of static and dynamic parameters in patients with degenerative flat back  (DFB) and to compare degree of their improvement between successful and unsuccessful surgical outcome groups Methods  Forty-seven patients with DFB were included who took whole spine X-ray and three-dimensional  motion analysis before and 6 months after corrective surgery.",OADS,/arxiv_data1/oa_pdf/0c/4b/arm-40-682.PMC5012980.pdf
"Tel: +82-2-513-8151, Fax: +82-2-513-8146, E-mail: j986802@hanmail.netORCID: Jung Hwan Lee (http://orcid.org/0000-0003-2680-6953); Sang-Ho Lee (http://orcid.org/0000-0002-8526-0260).",Non-OADS,/arxiv_data1/oa_pdf/0c/4b/arm-40-682.PMC5012980.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/4b/arm-40-682.PMC5012980.pdf
"Children with feeding difficulties usually have coexist -Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):692-701 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.692 Overall Profile of a Pediatric   Multidisciplinary Feeding Clinic Ji Sun Jung, MD1, Hyun Jung Chang, MD2, Jeong-Yi Kwon, MD1 1Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University   School of Medicine, Seoul; 2Department of Physical Medicine and Rehabilitation, Samsung Changwon Hospital,   Sungkyunkwan University School of Medicine, Changwon, Korea  Objective  To evaluate the overall profile of children with feeding disorders and their relationships to medical  conditions in an outpatient feeding clinic of a tertiary hospital.",Non-OADS,/arxiv_data1/oa_pdf/97/a1/arm-40-692.PMC5012981.pdf
"Tel: +82-2-3410-2818, Fax: +82-2-3410-0052, E-mail: jeongyi.kwon@samsung.comORCID: Ji Sun Jung (http://orcid.org/0000-0001-8579-5794); Hyun Jung Chang (http://orcid.org/0000-0001-9126-4316); Jeong-Yi Kwon (http://orcid.org/0000-0003-2011-8834).",Non-OADS,/arxiv_data1/oa_pdf/97/a1/arm-40-692.PMC5012981.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/a1/arm-40-692.PMC5012981.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):702-709 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.702 Shoulder Disease Patterns of the Wheelchair  Athletes of Table-Tennis and Archery:   A Pilot Study Byung-chun You, MD, Won-Jae Lee, MD, PhD, Seung-Hwa Lee, MD, PhD,   Sol Jang, MD, Hyun-seok Lee, MD Department of Physical Medicine and Rehabilitation, Veterans Health Service Medical Center, Seoul, Korea Objective  To investigate the shoulder disease patterns for the table-tennis (TT) and archery (AR) wheelchair  athletes via ultrasonographic evaluations.",OADS,/arxiv_data1/oa_pdf/67/8a/arm-40-702.PMC5012982.pdf
"Tel: +82-2-2225-1497, Fax: +82-2-2225-1579, E-mail: braddom@nate.comORCID: Byung-chun You (http://orcid.org/0000-0003-3231-2722); Won-Jae Lee (http://orcid.org/0000-0001-6028-3565); Seung-Hwa Lee (http://orcid.org/0000-0003-3034-7980); Sol Jang (http://orcid.org/0000-0002-8534-9599); Hyun-seok Lee (http://orcid.org/0000-0003-2994-0066).",Non-OADS,/arxiv_data1/oa_pdf/67/8a/arm-40-702.PMC5012982.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/8a/arm-40-702.PMC5012982.pdf
Available from: http://kosis.kr/.,Non-OADS,/arxiv_data1/oa_pdf/67/8a/arm-40-702.PMC5012982.pdf
Available from: http://www.koreanpc.kr/.,Non-OADS,/arxiv_data1/oa_pdf/67/8a/arm-40-702.PMC5012982.pdf
Available from: http://tt.kosad.or.kr/.,Non-OADS,/arxiv_data1/oa_pdf/67/8a/arm-40-702.PMC5012982.pdf
Available from: http://archery.kosad.kr/.,Non-OADS,/arxiv_data1/oa_pdf/67/8a/arm-40-702.PMC5012982.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):710-717 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.710 Proposal and Evaluation of a Telerehabilitation  Platform Designed for Patients With Partial  Rotator Cuff Tears: A Preliminary Study  Salvador Israel Macías-Hernández, MD, MSc1, Diana Sureima Vásquez-Sotelo, MD1,   Marco Vinicio Ferruzca-Navarro, PhD2, Susana Hazel Badillo Sánchez, PhD2,   Josefina Gutiérrez-Martínez, PhD3, Marco Antonio Núñez-Gaona, MSc3, Heriberto Aguirre-Meneses, MSc3,  Oscar Benjamín Velez-Gutiérrez, BSc4, Irene Tapia-Ferrusco, BSc4,   María de los Ángeles Soria-Bastida, MD1, Roberto Coronado-Zarco, MD1, Juan Daniel Morones-Alba, MSc1  1Orthopedic Rehabilitation Division, Instituto Nacional de Rehabilitación, Mexico City;   2Department of Industrial Design, UAM-Azcapotzalco, Mexico City;   3Subdirection of Technology/Biomedical Engineering, Instituto Nacional de Rehabilitación, Mexico City;   4Physical Therapy Division, Instituto Nacional de Rehabilitación, Mexico City, Mexoco Objective  To propose and evaluate the effectiveness of a telerehabilitation platform designed for patients with  rotator cuff (RC) tears.",Non-OADS,/arxiv_data1/oa_pdf/7a/e0/arm-40-710.PMC5012983.pdf
"Tel: +52-55-59991000, Fax: +52-55-9991000, E-mail: drisraelmacias@gmail.comORCID: Salvador Israel Macías-Hernández (http://orcid.org/0000-0003-1469-6128); Diana Sureima Vásquez-Sotelo (http://orcid.org/0000-0001-5479-9290); Marco Vinicio Ferruzca-Navarro (http://orcid.org/0000-0003-2415-586X); Susana Hazel Badillo Sánchez (http://orcid.org/0000-0002-3658-244X); Josefina Gutiérrez-Martínez (http://orcid.org/0000-0002-2022-5835); Marco Antonio Núñez-Gaona (http://orcid.org/0000-0002-8450-6003); Heriberto Aguirre-Meneses (http://orcid.org/0000-0002-2655-1367); Oscar Benjamín Velez-Gutiérrez (http://orcid.org/0000-0002-1700-9488); Irene Tapia-Ferrusco (http://orcid.org/0000-0001-9891-2005); María de los Ángeles Soria-Bastida (http://orcid.org/0000-0002-7842-4247); Roberto Coronado-Zarco (http://orcid.org/0000-0002-8268-9686); Juan Daniel Morones-Alba (http://orcid.org/0000-0002-3961-5243).",Non-OADS,/arxiv_data1/oa_pdf/7a/e0/arm-40-710.PMC5012983.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/e0/arm-40-710.PMC5012983.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):718-724 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.718 Factors Related to the Occurrence of Urinary  Tract Infection Following a Urodynamic   Study in Patients With Spinal Cord Injury Sung-Il Hwang, MD1, Bum-Suk Lee, MD, MPH2, Zee-A Han, MD2, Hye-Jin Lee, MD2,   Sang-Hoon Han, MD2, Myeong-Ok Kim, MD, PhD3 1Department of Rehabilitation Medicine, Soonchunhyang University Gumi Hospital, Gumi;   2Department of Rehabilitation Medicine, National Rehabilitation Center, Seoul;   3Department of Physical and Rehabilitation Medicine, Inha University Hospital, Incheon, Korea Objective  To analyze the factors related to urinary tract infection (UTI) occurrence after an urodynamic study  (UDS) in patients with spinal cord injury (SCI).",OADS,/arxiv_data1/oa_pdf/70/76/arm-40-718.PMC5012984.pdf
"Tel: +82-32-890-2480, Fax: +82-32-890-2486, E-mail: rmkmo@inha.ac.krORCID: Sung-Il Hwang (http://orcid.org/0000-0002-7080-2549); Bum-Suk Lee (http://orcid.org/0000-0002-0506-0403); Zee-A Han (http://orcid.org/0000-0002-8070-2218); Hye-Jin Lee (http://orcid.org/0000-0001-9400-6283); Sang-Hoon Han (http://orcid.org/0000-0003-4184-4747); Myeong-Ok Kim (http://orcid.org/0000-0002-5584-7714).",Non-OADS,/arxiv_data1/oa_pdf/70/76/arm-40-718.PMC5012984.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/76/arm-40-718.PMC5012984.pdf
Available from: http://uroweb.org/wp-content/uploads/17_Urologi - cal-infections_LR-II.pdf.,Non-OADS,/arxiv_data1/oa_pdf/70/76/arm-40-718.PMC5012984.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(4):725-733 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.725 Energy Expenditures for Activities of   Daily Living in Korean Young Adults:   A Preliminary Study  Kye Hee Cho, MD1,2, Woojin Song, MS2, Jungsoo Kim, MPH2, Eun Ji Jung, MS2,   Joonyoung Jang, MD1, Sang Hee Im, MD, PhD1,2, MinYoung Kim, MD, PhD1,2 1Department of Rehabilitation Medicine, CHA Bundang Medical Center, CHA University, Seongnam;  2Rehabilitation and Regeneration Research Center, CHA University, Seongnam, Korea Objective  To investigate the energy expenditure (EE) of Korean young adults based on activities refined to a  deskbound lifestyle.",Non-OADS,/arxiv_data1/oa_pdf/39/09/arm-40-725.PMC5012985.pdf
"Tel: +82-31-780-6281, Fax: +82-31-780-6206, E-mail: kmin@cha.ac.krORCID: Kye Hee Cho (http://orcid.org/0000-0003-3818-9403); Woojin Song (http://orcid.org/0000-0002-0190-2319); Jungsoo Kim (http://orcid.org/0000-0002-3190-1165); Eun Ji Jung (http://orcid.org/0000-0002-9987-0529); Jun Young Jang (http://orcid.org/0000-0002-4646-6354); Sang Hee Im (http://orcid.org/0000-0001-5128-5526); MinYoung Kim (http://orcid.org/0000-0001-5481-2985).",Non-OADS,/arxiv_data1/oa_pdf/39/09/arm-40-725.PMC5012985.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/09/arm-40-725.PMC5012985.pdf
Available from: http://www.cosmed.it/en/products/cardio-pulmonary-exercise-testing/k4-b2-mobile-cpet.,Non-OADS,/arxiv_data1/oa_pdf/39/09/arm-40-725.PMC5012985.pdf
"CASE REPORT A 40-year male was referred to the Department of Oto-Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2016;40(4):734-740 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.734 Progressive Bilateral Facial Palsy as a  Manifestation of Granulomatosis With  Polyangiitis: A Case Report Sang Mee Jeong, MD, Joo Hyun Park, MD, PhD, Jong In Lee, MD, PhD,   Kyung Eun Nam, MD, Jung Soo Lee, MD, PhD, Joo Hee Kim, MD Department of Rehabilitation Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea Bilateral facial palsy, which is usually combined with other diseases, occurs infrequently.",Non-OADS,/arxiv_data1/oa_pdf/ec/8c/arm-40-734.PMC5012986.pdf
"Tel: +82-31-820-3178, Fax: +82-31-847-7776, E-mail: drlee71@naver.com ORCID: Sang Mee Jeong (http://orcid.org/0000-0002-9247-0995); Joo Hyun Park (http://orcid.org/0000-0001-9257-8704); Jong In Lee (http://orcid.org/0000-0002-8844-4807); Kyung Eun Nam (http://orcid.org/0000-0001-5195-4320); Jung Soo Lee (http://orcid.org/0000-0002-3807-4377); Joo Hee Kim (http://orcid.org/0000-0001-5543-121X).",Non-OADS,/arxiv_data1/oa_pdf/ec/8c/arm-40-734.PMC5012986.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/8c/arm-40-734.PMC5012986.pdf
"Therefore, a detailed pain history and physical examination are Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2016;40(4):741-744 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.741 Pudendal Nerve Entrapment Syndrome due to   a Ganglion Cyst: A Case Report Jae Wook Lee, MD1, Sung-Moon Lee, MD2, Dong Gyu Lee, MD1 Departments of 1Rehabilitation Medicine and 2Diagnostic Radiology, Keimyung University School of Medicine, Daegu, Korea Pudendal nerve entrapment syndrome is an unusual cause of chronic pelvic pain.",Non-OADS,/arxiv_data1/oa_pdf/9e/5d/arm-40-741.PMC5012987.pdf
"Tel: +82-53-250-7980, Fax: +82-53-250-7268, E-mail: hikkali@hanmail.netORCID: Jae Wook Lee (http://orcid.org/0000-0001-5641-2870); Sung-Moon Lee (http://orcid.org/0000-0002-2675-3209); Dong Gyu Lee (http://orcid.org/0000-0002-4787-4448).",Non-OADS,/arxiv_data1/oa_pdf/9e/5d/arm-40-741.PMC5012987.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/5d/arm-40-741.PMC5012987.pdf
"We evaluated Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2016;40(4):745-750 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.745 A Comprehensive Rehabilitation Approach in   a Patient With Serious Neuropsychiatric  Systemic Lupus Erythematosus Yong Jae Ko, MD, Yang Gyun Lee, MD, PhD, Ji Woong Park, MD, PhD,   Sung Ho Ahn, MD, Jin Myoung Kwak, MD, Yoon-Hee Choi, MD Department of Physical Medicine and Rehabilitation, Soonchunhyang University Hospital, Seoul, Korea Neuropsychiatric systemic lupus erythematosus (NPSLE) involves the central and peripheral nervous system  in patients with systemic lupus erythematosus (SLE).",Non-OADS,/arxiv_data1/oa_pdf/46/0b/arm-40-745.PMC5012988.pdf
"Tel: +82-2-710-3240, Fax: +82-2-709-9265, E-mail: yoonhee.choi83@gmail.comORCID: Yong Jae Ko (http://orcid.org/0000-0001-7045-1577); Yang Gyun Lee (http://orcid.org/0000-0003-2425-2870); Ji Woong Park (http://orcid.org/0000-0001-7987-3581); Sung Ho Ahn (http://orcid.org/0000-0003-1867-0320); Jin Myoung Kwak (http://orcid.org/0000-0003-3606-755X); Yoon-Hee Choi (http://orcid.org/0000-0001-6651-7908).",Non-OADS,/arxiv_data1/oa_pdf/46/0b/arm-40-745.PMC5012988.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/0b/arm-40-745.PMC5012988.pdf
"The patient presented with weak - ness in the muscles regulating swallowing, speech, and chewing because of an anatomical variation, the artery of Percheron, which resulted in bilateral paramedian tha-lamic infarct.Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2016;40(4):751-756 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.4.751 Acute Pseudobulbar Palsy After Bilateral  Paramedian Thalamic Infarction: A Case Report Hye Yeon Lee, MD1, Min Jeong Kim, MD1, Bo-Ram Kim, MD1, Seong-Eun Koh, MD, PhD1,   In-Sik Lee, MD, PhD1, Jongmin Lee, MD, PhD1,2 1Department of Rehabilitation Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul;  2International Healthcare Research Institute, Konkuk University, Seoul, Korea Bilateral paramedian thalamic infarction is a rare subtype of stroke caused by occlusion of the artery of Percheron,  an uncommon variant originating from one of the posterior cerebral arteries.",Non-OADS,/arxiv_data1/oa_pdf/5a/c6/arm-40-751.PMC5012989.pdf
"Tel: +82-2-2030-5345, Fax: +82-2-2030-5379, E-mail: leej@kuh.ac.krORCID: Hye Yeon Lee (http://orcid.org/0000-0001-6625-3471); Min Jeong Kim (http://orcid.org/0000-0003-3213-0697); Bo-Ram Kim (http://orcid.org/0000-0002-5463-1268); Seong-Eun Koh (http://orcid.org/0000-0002-0446-1889); In-Sik Lee (http://orcid.org/0000-0001-8167-7168); Jongmin Lee (http://orcid.org/0000-0001-8718-0099).",Non-OADS,/arxiv_data1/oa_pdf/5a/c6/arm-40-751.PMC5012989.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/c6/arm-40-751.PMC5012989.pdf
"tendon, distal aponeurosis, tendinous inscription) were identiﬁed by visual inspection in three dimensions within the voxel array using open source software Chimera 1.9 (http://www.cgl.ucsf.edu/chimera; Pettersen et al.",OADS,/arxiv_data1/oa_pdf/3c/60/JOA-229-591.PMC5013067.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/annrheumdis-2016-209481).,Non-OADS,/arxiv_data1/oa_pdf/50/b8/annrheumdis-2016-209481.PMC5013077.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ To cite Allanore Y, Denton CP, Krieg T, et al.Ann Rheum Dis 2016; 75:1736 – 1740.",Non-OADS,/arxiv_data1/oa_pdf/50/b8/annrheumdis-2016-209481.PMC5013077.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2015-207838).,OADS,/arxiv_data1/oa_pdf/3d/40/annrheumdis-2015-207838.PMC5013078.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Cohen J.,Non-OADS,/arxiv_data1/oa_pdf/3d/40/annrheumdis-2015-207838.PMC5013078.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Prakken B, Albani S, Martini A.",Non-OADS,/arxiv_data1/oa_pdf/25/35/annrheumdis-2015-207818.PMC5013079.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/annrheumdis-2015-207900).,Non-OADS,/arxiv_data1/oa_pdf/08/45/annrheumdis-2015-207900.PMC5013080.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis.",Non-OADS,/arxiv_data1/oa_pdf/08/45/annrheumdis-2015-207900.PMC5013080.pdf
"To view,please visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2015-207923).",Non-OADS,/arxiv_data1/oa_pdf/89/52/annrheumdis-2015-207923.PMC5013081.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/REFERENCES 1 Brooks PM.,Non-OADS,/arxiv_data1/oa_pdf/89/52/annrheumdis-2015-207923.PMC5013081.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ To cite Asavarut P, Norsworthy PJ, Cook J, et al.Med Humanit 2016; 42:181 –183.",Non-OADS,/arxiv_data1/oa_pdf/c2/e1/medhum-2016-010893.PMC5013082.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Sperstad JB, et al.Br J Sports Med 2016; 50:1092 –1096.",Non-OADS,/arxiv_data1/oa_pdf/13/73/bjsports-2016-096065.PMC5013086.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/bjsports-2016-096572).,Non-OADS,/arxiv_data1/oa_pdf/58/c4/bjsports-2016-096572.PMC5013087.pdf
Olympiadreview August 2009 (personal communication; EIS website:http://www.uksport.gov.uk/news/2012/07/25/battle-against-injury-and-illness).,Non-OADS,/arxiv_data1/oa_pdf/58/c4/bjsports-2016-096572.PMC5013087.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Walsh NP, Gleeson M, Shephard RJ, et al .",Non-OADS,/arxiv_data1/oa_pdf/58/c4/bjsports-2016-096572.PMC5013087.pdf
http://www.oxforddictionaries.,Non-OADS,/arxiv_data1/oa_pdf/58/c4/bjsports-2016-096572.PMC5013087.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/thoraxjnl-2016-208279).,Non-OADS,/arxiv_data1/oa_pdf/69/d8/thoraxjnl-2016-208279.PMC5013088.pdf
"Correspondence to Bernie Bissett, Department ofPhysiotherapy Department, Building 15, Canberra Hospital, Yamba Drive, Garran,Canberra ACT 2605, Australia;Bernie.Bissett@act.gov.au Received 5 January 2016 Revised 29 April 2016Accepted 8 May 2016Published Online First 2 June 2016 ▸http://dx.doi.org/10.1136/ thoraxjnl-2016-208835 To cite: Bissett BM, Leditschke IA, Neeman T, et al.Thorax 2016; 71: 812–819.ABSTRACT Background In patients who have been mechanically ventilated, inspiratory muscles remain weak and fatigablefollowing ventilatory weaning, which may contribute todyspnoea and limited functional recovery.",Non-OADS,/arxiv_data1/oa_pdf/69/d8/thoraxjnl-2016-208279.PMC5013088.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Levine S, Nguyen T, Taylor N, et al.",Non-OADS,/arxiv_data1/oa_pdf/69/d8/thoraxjnl-2016-208279.PMC5013088.pdf
To view please visit the journal online (http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e3/7d/postgradmedj-2016-134271.PMC5013091.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ heartjnl-2015-309230).,Non-OADS,/arxiv_data1/oa_pdf/7a/e9/heartjnl-2015-309230.PMC5013094.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/REFERENCES 1 Feinstein JA, Goldhaber SZ, Lock JE, et al.",Non-OADS,/arxiv_data1/oa_pdf/7a/e9/heartjnl-2015-309230.PMC5013094.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 [No authors listed].,Non-OADS,/arxiv_data1/oa_pdf/82/0c/heartjnl-2014-306775.PMC5013095.pdf
"http://www.fda.gov/downloads/Drugs/ …/Guidances/ ucm078749.pdf 30 Pocock SJ, McMurray JJV, Collier TJ.",Non-OADS,/arxiv_data1/oa_pdf/82/0c/heartjnl-2014-306775.PMC5013095.pdf
http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/82/0c/heartjnl-2014-306775.PMC5013095.pdf
http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/82/0c/heartjnl-2014-306775.PMC5013095.pdf
https://www.nice.org.uk/guidance/GID-TAG516/documents/appraisal-consultation-document 39 Scottish Medicines Consortium.,Non-OADS,/arxiv_data1/oa_pdf/82/0c/heartjnl-2014-306775.PMC5013095.pdf
"2016. http://www.sign.ac.uk/guidelines/fulltext/147/index.html Jhund PS, McMurray JJV.",Non-OADS,/arxiv_data1/oa_pdf/82/0c/heartjnl-2014-306775.PMC5013095.pdf
"See: http://creativecommons.org/licenses/ by-nc/4.0/ To cite Askew I, Chaiban T, Kalasa B, et al.J Med Ethics 2016; 42:619–620.",Non-OADS,/arxiv_data1/oa_pdf/b6/6e/medethics-2016-103553.PMC5013096.pdf
Accepted 21 March 2016 Published Online First 8 April 2016 ▸http://dx.doi.org/10.1136/medethics-2014-102375 ▸http://dx.doi.org/10.1136/medethics-2016-103606 J Med Ethics 2016; 42:619–620.,Non-OADS,/arxiv_data1/oa_pdf/b6/6e/medethics-2016-103553.PMC5013096.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Moulton AD, Mercer SL, Popovic T, et al.",Non-OADS,/arxiv_data1/oa_pdf/37/c2/oemed-2016-103672.PMC5013097.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/oemed-2016-103652).,Non-OADS,/arxiv_data1/oa_pdf/11/ef/oemed-2016-103652.PMC5013098.pdf
"Actual (2000 –2015) and estimated (2016 –2029, inter- mediate scenario) population data, by year, gender and age weredownloaded from the National Institute of Statistics website(http://demo.istat.it/index_e.html).",OADS,/arxiv_data1/oa_pdf/11/ef/oemed-2016-103652.PMC5013098.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 IARC.,Non-OADS,/arxiv_data1/oa_pdf/11/ef/oemed-2016-103652.PMC5013098.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ sextrans-2015-052285).,Non-OADS,/arxiv_data1/oa_pdf/07/dc/sextrans-2015-052285.PMC5013099.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Westrom L, Joesoef R, Reynolds G, et al.",Non-OADS,/arxiv_data1/oa_pdf/07/dc/sextrans-2015-052285.PMC5013099.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/heartjnl-2015-309209).,Non-OADS,/arxiv_data1/oa_pdf/dd/c8/heartjnl-2015-309209.PMC5013107.pdf
"Received 23 December 2015 Accepted 13 April 2016Published Online First 16 May 2016 ▸http://dx.doi.org/10.1136/ heartjnl-2016-309804 To cite: Grace SL, Turk- Adawi KI, Contractor A, et al.",Non-OADS,/arxiv_data1/oa_pdf/dd/c8/heartjnl-2015-309209.PMC5013107.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/dd/c8/heartjnl-2015-309209.PMC5013107.pdf
2007. http://www.who.int/choice/ costs/CER_thresholds/en/ (accessed 27 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/dd/c8/heartjnl-2015-309209.PMC5013107.pdf
http://wdi.worldbank.,Non-OADS,/arxiv_data1/oa_pdf/dd/c8/heartjnl-2015-309209.PMC5013107.pdf
"The BACPR Standards and Core Components for Cardiovascular Disease Prevention and Rehabilitation, 2012. http://www.bacpr.com/resources/46C_BACPR_Standards_and_ Core_Components_2012.pdf (accessed 13 Feb 2015).",Non-OADS,/arxiv_data1/oa_pdf/dd/c8/heartjnl-2015-309209.PMC5013107.pdf
"Received 23 December 2015 Revised 12 May 2016 Accepted 11 June 2016Published Online First11 July 2016 ▸http://dx.doi.org/10.1136/ heartjnl-2016-309760 To cite: Gijsberts CM, Benson L, Dahlström U, et al.Heart 2016; 102:1464 –1471.ABSTRACT Background QRS duration (QRSd) criteria for device therapy in heart failure (HF) were derived frompredominantly white populations and ethnic differencesare poorly understood.Methods We compared the association of QRSd with ejection fraction (EF) and outcomes between 839 Singaporean Asian and 11 221 Swedish white patientswith HF having preserved EF (HFPEF)and HF havingreduced EF (HFREF) were followed in prospectivepopulation-based HF studies.Results Compared with whites, Asian patients with HF were younger (62 vs 74 years, p<0.001), had smallerbody size (height 163 vs 171 cm, weight 70 vs 80 kg,both p<0.001) and had more severely impaired EF(EF was <30% in 47% of Asians vs 28% of whites).Overall, unadjusted QRSd was shorter in Asians thanwhites (101 vs 104 ms, p<0.001).",Non-OADS,/arxiv_data1/oa_pdf/96/49/heartjnl-2015-309212.PMC5013108.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Kashani A, Barold SS.",Non-OADS,/arxiv_data1/oa_pdf/96/49/heartjnl-2015-309212.PMC5013108.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Porter KM.,Non-OADS,/arxiv_data1/oa_pdf/1f/54/emermed-2015-204881.PMC5013110.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/REFERENCES 1 Olsen T. Calculation of intraocular lens power: a review.,Non-OADS,/arxiv_data1/oa_pdf/5f/ca/bjophthalmol-2015-307779.PMC5013111.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Behin A, Hoang-Xuan K, Carpentier AF, et al .",Non-OADS,/arxiv_data1/oa_pdf/60/c1/jnnp-2015-311516.PMC5013113.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Cotter JM, Rosenthal P. Scleral contact lenses.",Non-OADS,/arxiv_data1/oa_pdf/37/67/bjophthalmol-2015-307483.PMC5013114.pdf
2000. http://www.nei.nih.gov/resources/visionfunction/manual_cm2000.pdf (accessed 31Dec 2013).,OADS,/arxiv_data1/oa_pdf/37/67/bjophthalmol-2015-307483.PMC5013114.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/jnnp-2015-312283).,Non-OADS,/arxiv_data1/oa_pdf/e5/84/jnnp-2015-312283.PMC5013115.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Rocca WA, Mielke MM, Vemuri P, et al.",Non-OADS,/arxiv_data1/oa_pdf/e5/84/jnnp-2015-312283.PMC5013115.pdf
http://www.insee.fr.,Non-OADS,/arxiv_data1/oa_pdf/e5/84/jnnp-2015-312283.PMC5013115.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Arroyo R, Vila C, Clissold S. Retrospective observational study of the management of multiple sclerosis patients with resistant spasticity in Spain: the ‘5E’study.",Non-OADS,/arxiv_data1/oa_pdf/86/fa/jnnp-2015-312591.PMC5013116.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ jnnp-2015-312383).,OADS,/arxiv_data1/oa_pdf/d4/43/jnnp-2015-312383.PMC5013117.pdf
Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (http://www.fnih.org).,Non-OADS,/arxiv_data1/oa_pdf/d4/43/jnnp-2015-312383.PMC5013117.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Sperling RA, Aisen PS, Beckett LA, et al.",Non-OADS,/arxiv_data1/oa_pdf/d4/43/jnnp-2015-312383.PMC5013117.pdf
"1School of Health Policy & Management, York University, Toronto, Ontario, Canada 2Department of Psychology, Saint Mary ’s University, Halifax, Nova Scotia, Canada Correspondence to Dr Liane Ginsburg, School of Health Policy & Management, York University, Toronto, Ontario, Canada M3J 1P3; lgins@yorku.ca Received 4 March 2015 Revised 21 July 2015 Accepted 16 September 2015 Published Online First 9 October 2015 ▸http://dx.doi.org/10.1136/ bmjqs-2015-004847 To cite: Ginsburg L, Gilin Oore D. BMJ Qual Saf 2016; 25:680 –687.ABSTRACT Background When patient safety climate (PSC) surveys are used in healthcare, reporting typicallyfocuses on PSC level (mean or per cent positive scores).",Non-OADS,/arxiv_data1/oa_pdf/a5/d1/bmjqs-2015-004150.PMC5013122.pdf
"See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 Shojania KG, Catchpole K. ‘The problem with …’: a new series on problematic improvements and problematic problems inhealthcare quality and patient safety.",Non-OADS,/arxiv_data1/oa_pdf/a5/d1/bmjqs-2015-004150.PMC5013122.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ jnnp-2015-312601).,OADS,/arxiv_data1/oa_pdf/04/ae/jnnp-2015-312601.PMC5013123.pdf
The heatmap was generated using GENE-E V.3.0.204 (http://www.broadinstitute.org/cancer/software/GENE-E/).,OADS,/arxiv_data1/oa_pdf/04/ae/jnnp-2015-312601.PMC5013123.pdf
Funding This study was funded by the Eugene Devic European Network (EDEN) project (ERA-Net ERARE 2: http://www.erare.eu/ ﬁnanced –projects/eden).,Non-OADS,/arxiv_data1/oa_pdf/04/ae/jnnp-2015-312601.PMC5013123.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Lennon VA, Kryzer TJ, Pittock SJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/04/ae/jnnp-2015-312601.PMC5013123.pdf
"Correspondence to Dr Evangelos Kontopantelis, Institute of Population Health, University of Manchester, 5th Floor, Williamson Building, Manchester M13 9PL, UK; e.kontopantelis@manchester.ac.uk Received 14 July 2015 Revised 20 October 2015 Accepted 1 November 2015 Published Online First1 December 2015 ▸http://dx.doi.org/10.1136/ bmjqs-2015-005003 To cite: Kontopantelis E, Springate DA, Ashcroft DM, et al.BMJ Qual Saf 2016; 25:657–670.ABSTRACT Objectives The UK ’s Quality and Outcomes Framework permits practices to exempt patientsfrom financially-incentivised performance targets.",Non-OADS,/arxiv_data1/oa_pdf/35/37/bmjqs-2015-004602.PMC5013124.pdf
All codes used in the study are available at http://www.clinicalcodes.org.,Non-OADS,/arxiv_data1/oa_pdf/35/37/bmjqs-2015-004602.PMC5013124.pdf
"Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others todistribute, remix, adapt, build upon this work non-commercially , and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.See: http://creativecommons.org/licenses/by-nc/4.0/Original research 668 Kontopantelis E, et al.BMJ Qual Saf 2016; 25:657–670.",Non-OADS,/arxiv_data1/oa_pdf/35/37/bmjqs-2015-004602.PMC5013124.pdf
"Health & Social Care Information Centre, 2014:63. http://www.hscic.gov.uk/catalogue/PUB15751/qof-1314-report.pdf 23 NHS Employers.",Non-OADS,/arxiv_data1/oa_pdf/35/37/bmjqs-2015-004602.PMC5013124.pdf
"http://www.communities.gov.uk/documents/statistics/pdf/1870718.pdf 26 McLean G, Guthrie B, W att G, et al.",Non-OADS,/arxiv_data1/oa_pdf/35/37/bmjqs-2015-004602.PMC5013124.pdf
"2In our articulation of the term, medical performanceincludes but goes beyond conventional theatre pro-ductions with medical subject matter (eg, MargretEdsom ’sWit (1995)), encompassing autobio- graphical performances of illness (the subject ofthis paper); those that incorporate medical practicesinto performance (most famously, Orlan ’s surgery performances); as well as the use of performance tech-niques within medical educa tion (eg, the Performing Medicine project (http://www.clodensemble.com/medicine.htm).",Non-OADS,/arxiv_data1/oa_pdf/ae/4b/medhum-2016-010959.PMC5013131.pdf
"PhD thesis submitted to University of Surrey, September 2014. http://epubs.surrey.ac.uk/808305/).",Non-OADS,/arxiv_data1/oa_pdf/ae/4b/medhum-2016-010959.PMC5013131.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Bates V, Bleakley A, Goodman S. Medicine, health and the arts: approaches to the medical humanities .",Non-OADS,/arxiv_data1/oa_pdf/ae/4b/medhum-2016-010959.PMC5013131.pdf
http://www.performance-research.org/past-issue-detail.php?issue_id=73.,OADS,/arxiv_data1/oa_pdf/ae/4b/medhum-2016-010959.PMC5013131.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Hat ﬁeld I. Self-employment in Europe .,Non-OADS,/arxiv_data1/oa_pdf/f4/4e/oemed-2015-103472.PMC5013135.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/jnnp-2015-312185).,Non-OADS,/arxiv_data1/oa_pdf/4b/48/jnnp-2015-312185.PMC5013137.pdf
Funding This project is supported by the german Bundesministerium für Bildung und Forschung (BMBF) grant SOPHIA to JG under the aegis of the EU JointProgramme —Neurodegenerative Disease Research ( JPND —http://www.jpnd.eu) and a BMBF grant PYRAMID to JG in the framework of the ERANET E-RARE programme (http://www.e-rare.eu).,Non-OADS,/arxiv_data1/oa_pdf/4b/48/jnnp-2015-312185.PMC5013137.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Ambrosino N, Carpenè N, Gherardi M. Chronic respiratory care for neuromuscular diseases in adults.",Non-OADS,/arxiv_data1/oa_pdf/4b/48/jnnp-2015-312185.PMC5013137.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/jech- 2015-206502).,OADS,/arxiv_data1/oa_pdf/81/75/jech-2015-206502.PMC5013153.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Burt BA, Eklund SA.",Non-OADS,/arxiv_data1/oa_pdf/81/75/jech-2015-206502.PMC5013153.pdf
http://handbook.cochrane.org/ (accessed 24 Mar 2016).,OADS,/arxiv_data1/oa_pdf/81/75/jech-2015-206502.PMC5013153.pdf
"BiostatXL, 2011. http://www.meta-analysis-made-easy.com 12 Borenstein M, Hedges LV, Higgins JPT, et al .Introduction to meta-analysis .",OADS,/arxiv_data1/oa_pdf/81/75/jech-2015-206502.PMC5013153.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/jech-2015-206926).,Non-OADS,/arxiv_data1/oa_pdf/b6/d4/jech-2015-206926.PMC5013158.pdf
"19 All analyses were undertaken using Stata V .12.1 software (StataCorp, College Station, T exas, USA; http://www.stata.com).Ethical approval was not sought since the study used aggregateddata.",OADS,/arxiv_data1/oa_pdf/b6/d4/jech-2015-206926.PMC5013158.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Eikemo TA, Mackenbach JP.",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/jech-2015-206926.PMC5013158.pdf
"14 http://www.scotland.gov.uk/topics/statistics/SIMD/ 15 McCain LJ, McCleary R. The statistical analysis of the simple interrupted time –series quasi-experiment.",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/jech-2015-206926.PMC5013158.pdf
"The NEoLCIN also provides area level data, available to download fromtheir website (http://www.endoflifecare-intelligence.",OADS,/arxiv_data1/oa_pdf/32/04/bmjspcare-2015-000994.PMC5013160.pdf
"Another useful source of open access aggregate data is the UK Data Service (http://ukdataservice.ac.uk/), a gateway for researcherswanting to access Census derived data, administrative data from social services, education, tax, and socialsecurity systems and large health and social survey data.",OADS,/arxiv_data1/oa_pdf/32/04/bmjspcare-2015-000994.PMC5013160.pdf
In recent years in England there has been a concerted effort via the introduction of trusted third parties (TTP) and the Administrative DataResearch Network (ADRN) (previously the Administrative Data Liaison Service (ADLS)) to improve access to linked data (http://adrn.ac.uk/).There are also developments in technology that can aid safe data linking; DataSHIELD is one approach in development that allows remote data pooling.,Non-OADS,/arxiv_data1/oa_pdf/32/04/bmjspcare-2015-000994.PMC5013160.pdf
See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 WHO.,Non-OADS,/arxiv_data1/oa_pdf/32/04/bmjspcare-2015-000994.PMC5013160.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/ bmjspcare-2015-000956).,Non-OADS,/arxiv_data1/oa_pdf/66/c3/bmjspcare-2015-000956.PMC5013161.pdf
See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 Gold standards framework for end of life care.,Non-OADS,/arxiv_data1/oa_pdf/66/c3/bmjspcare-2015-000956.PMC5013161.pdf
2008. http://www.nao.org.uk/wp-content/uploads/ 2008/11/07081043_alternatives.pd (accessed 18 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/66/c3/bmjspcare-2015-000956.PMC5013161.pdf
http://prisma-statement.org (accessed 18 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/66/c3/bmjspcare-2015-000956.PMC5013161.pdf
http://media.wix.com/ugd/dded87_40b9ff0bf538404783 31915a8ed8b2fb.pdfhttp://media.wix.com/ugd/dded87_ 40b9ff0bf53840478331915a8ed8b2fb.pdf (accessed 20 Jan2016).,Non-OADS,/arxiv_data1/oa_pdf/66/c3/bmjspcare-2015-000956.PMC5013161.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/ bmjspcare-2015-000958).,Non-OADS,/arxiv_data1/oa_pdf/ef/5d/bmjspcare-2015-000958.PMC5013162.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Morris SM, King C, T urner M, et al.",Non-OADS,/arxiv_data1/oa_pdf/ef/5d/bmjspcare-2015-000958.PMC5013162.pdf
BMC Palliat Care 2014;13:22. http://www.biomedcentral.com/1472 –684X/ 13/22 (accessed 20 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/ef/5d/bmjspcare-2015-000958.PMC5013162.pdf
Working Pap Health Sci 2014;1:8. http://www.southampton.ac.uk/wphs/ previous_issues/2014/summer.page (accessed 20 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/ef/5d/bmjspcare-2015-000958.PMC5013162.pdf
http://www.jmir.org/2010/2/e23/ (accessed 2 Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/ef/5d/bmjspcare-2015-000958.PMC5013162.pdf
BMC Med 2013;11:111. http://www.biomedcentral.,Non-OADS,/arxiv_data1/oa_pdf/ef/5d/bmjspcare-2015-000958.PMC5013162.pdf
"http://www.mrc.ac.uk/complexinterventionsguidance (accessed 20 May 2015).Review Latter S, et al.BMJ Supportive & Palliative Care 2016; 6:263 –275.",Non-OADS,/arxiv_data1/oa_pdf/ef/5d/bmjspcare-2015-000958.PMC5013162.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/jech- 2015-206640).,OADS,/arxiv_data1/oa_pdf/ed/c4/jech-2015-206640.PMC5013163.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ 860 Santosa A, et al.J Epidemiol Community Health 2016; 70:855–861.",Non-OADS,/arxiv_data1/oa_pdf/ed/c4/jech-2015-206640.PMC5013163.pdf
"http://www.who.int/healthinfo/global_burden_disease/en/ 17 Basu S, King AC.",Non-OADS,/arxiv_data1/oa_pdf/ed/c4/jech-2015-206640.PMC5013163.pdf
http://pubs.niaaa.nih.gov/publications/Social/Module10IDisabilities/ Module10I.html 21 The Finnish Center for Interdisciplinary Gerontology.,Non-OADS,/arxiv_data1/oa_pdf/ed/c4/jech-2015-206640.PMC5013163.pdf
"The impairments that writer’s cramp patients experience often intrude on their abilities to complete professional work,3a factor that may relate to the higher incidence of depression and anxiety in this population.4Therefore, effective treatment is essential to improve quality of life and to allow patients to re-enter the work force.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/11/7d/tre-06-410-7522-1.PMC5013165.pdf
Predicting Improvement in Writer’s Cramp Symptoms Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/11/7d/tre-06-410-7522-1.PMC5013165.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/11/7d/tre-06-410-7522-1.PMC5013165.pdf
Predicting Improvement in Writer’s Cramp Symptoms Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/11/7d/tre-06-410-7522-1.PMC5013165.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/11/7d/tre-06-410-7522-1.PMC5013165.pdf
Predicting Improvement in Writer’s Cramp Symptoms Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/11/7d/tre-06-410-7522-1.PMC5013165.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/11/7d/tre-06-410-7522-1.PMC5013165.pdf
Predicting Improvement in Writer’s Cramp Symptoms Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services8,Non-OADS,/arxiv_data1/oa_pdf/11/7d/tre-06-410-7522-1.PMC5013165.pdf
"Highlights of prescribing information: Botox (onabotulinumtoxinA) 2010. http://www.allergan.com/assets/pdf/botox_pi.pdf, Accessed Online: 30 Aug. 2016.",Non-OADS,/arxiv_data1/oa_pdf/11/7d/tre-06-410-7522-1.PMC5013165.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services9,Non-OADS,/arxiv_data1/oa_pdf/11/7d/tre-06-410-7522-1.PMC5013165.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/22/jjm-09-06-33498.PMC5013237.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/c4/jjm-09-06-33529.PMC5013238.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/1c/main.PMC5013246.pdf
"After  pre-oxygenation, 100  mcg  of  IV  fentanyl  was  administered  and  a  preliminary  awake http://dx.doi.org/10.1016/j.ijscr.2016.06.018 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/b4/1c/main.PMC5013246.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/48/main.PMC5013247.pdf
"Epidemiolog- ically,  myiasis secondary to  C.  rodhaini  is  most  common  in  those with  recent  travel  to  central  and  sub-Saharan  Africa:  Cameroon http://dx.doi.org/10.1016/j.ijscr.2016.07.018 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/4f/48/main.PMC5013247.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/39/main.PMC5013248.pdf
"In addition, it was also plated in CHROMagar media forContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2016.06.001 2211-7539/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/52/39/main.PMC5013248.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/39/main.PMC5013248.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/7e/main.PMC5013249.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.07.051 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/6e/7e/main.PMC5013249.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cleft lipCleft palateGenome-wide association studySingle nucleotide polymorphismCancer 1.,Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
http://dx.doi.org/10.1016/j.gdata.2016.08.017 2213-5960/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"Cancer GWAS search strategy In a second step, a search of the “NHGRI GWAS Online Catalog ”([29], http://www.genome.gov/gwastudies ) was performed to identify GWAS of those cancer entities for which an association with NSCL/P had been reported (cancer entities of interest listed in Supplementary Table S1).",OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
The prostate and PanScan study datasets were accessed with appropri- ate approval through the dbGaP online resource ( http://cgems.cancer.,OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"gov/data/ ) accession numbers phs000207.v1.p1 and phs000206.v3.p2, respectively, and the lung datasets were accessed from the dbGaP website ( http://www.ncbi.nlm.nih.gov/gap ) through accession number phs000093.v2.p2.",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"A full listing of WHI investigators can be found at: http://www.whi.org/ researchers/Documents%20%20Write%20a%20Paper/ WHI%20Investigator%20Short%20List.pdf Acknowledgements We thank all affected individuals and their families for their partici- pation in this study, as well as the German support group for persons with cleft lip and/or palate (Deutsche Selbsthilfevereinigung für Lippen-Gaumen-Fehlbildungen e.V.",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"44 (4) (2012) 426 –429, S421 http://dx.doi.org/10.1038/ ng.1104 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"Oncogene 32 (12) (2013) 1497 –1507, http://dx.doi.org/10.1038/onc.",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"161 (11) (2005) 1047 –1055, http://dx.doi.org/10.1093/aje/kwi132 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"41 (4) (2009) 473 –477, http://dx.doi.org/10.1038/ng.333 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"Feldkamp, et al., Cancer risk in children and adolescents with birth defects: a population-based cohort study.PLoS One 8 (7) (2013), e69077, http://dx.doi.org/10.1371/journal.pone.0069077 PONE-D-13-06176 .",OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"36 (11) (2015)1029 –1033, http://dx.doi.org/10.1002/humu.22827 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"41 (6) (2009) 718 –723, http://dx.doi.org/10.1038/ng.374 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"PLoS One 7 (4) (2012), e35347, http://dx.doi.org/10.1371/journal.pone.0035347 PONE-D-12-01653 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"130 (1) (2011) 59 –78,http://dx.doi.org/10.1007/s00439- 011-1030-9 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"Blood 119 (2) (2012) 469 –475, http://dx.doi.org/10.1182/ blood-2011-03-343921 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"42 (2) (2010) 132 –136, http://dx.doi.org/10.1038/ng.510 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"44 (7) (2012) 770 –776, http://dx.doi.org/10.1038/ng.2293 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"Nature 447 (7148) (2007) 1087 –1093, http://dx.doi.org/10.1038/nature05887 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"41 (10) (2009) 1116 –1121, http://dx.doi.org/10.1038/ng.",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"Leukemia 26 (5) (2012) 902 –909, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"42 (12) (2010) 1126 –1130, http://dx.doi.org/10.1038/ng.696 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"43 (2) (2006) 138 –142, http://dx.doi.org/10.1136/jmg.2005.",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"51 (2) (2012) 165 –173, http://dx.doi.org/10.1002/mc.20773 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"J. N a t l .C a n c e rI n s t .1 0 0( 1 3 )( 2 0 0 8 )9 6 2 –966, http://dx.doi.org/10.1093/jnci/djn190 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"155 (6) (2009) 909 –913, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"41 (10) (2009) 1122 –1126, http://dx.doi.org/10.1038/ng.448 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"39 (5) (2007) 631 –637, http://dx.doi.org/ 10.1038/ng1999 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"40 (12) (2008) 1426 –1435, http://dx.doi.org/ 10.1038/ng.262 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"43 (8) (2011) 792 –796, http://dx.doi.org/10.1038/ng.875 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"Nature 437 (7063) (2005) 1299 –1320, http://dx.doi.org/10.1038/nature04226 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"Cancer 131 (2) (2012) 367 –376, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"43 (5) (2011) 455 –458, http://dx.doi.org/10.1038/ng.809 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"85 (5) (2009)679 –691, http://dx.doi.org/10.1016/j.ajhg.2009.09.012 .",OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"8 (7) (2012), e1002791 http://dx.doi.org/10.1371/ journal.pgen.1002791 (PGENETICS-D-11-02735).",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"Genes Cancer 1 (9) (2010) 908 –916, http://dx.doi.org/10.1177/1947601910388271 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
(2015) http://dx.doi.org/10.1093/hmg/ddv614 .,Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"Cell 32 (6) (2015) 693 –706, http://dx.doi.org/10.1016/j.devcel.2015.01.028 .28 E. Dunkhase et al.",OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"44 (9) (2012) 968 –971, http://dx.doi.org/10.1038/ng.",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"42 (1) (2010) 24 –26,http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"17 (12) (2011) 725 –733, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"131 (2) (2012) 217 –234, http://dx.doi.org/10.1007/s00439-011-1055-0 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"Nature 460 (7256) (2009) 748 –752, http://dx.doi.org/10.1038/nature08185 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"41 (8) (2009) 899 –904, http://dx.doi.org/10.1038/ng.407 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"Oncogene 25 (22) (2006) 3219 –3224, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"41 (8) (2009) 873 –875, http://dx.doi.org/10.1038/ng.419 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"41 (8) (2009) 909 –914, http://dx.doi.org/10.1038/ng.412 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"Stem Cells 30 (1) (2012) 15 –21,http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"12 (2011) 163, http://dx.doi.org/10.1186/1471-2350-12-163 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"84 (3) (2009) 406 –411, http://dx.doi.org/10.1016/j.ajhg.2009.02.002 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"40 (5) (2008) 631 –637, http://dx.doi.org/10.1038/ng.133 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"40 (3) (2008) 310 –315, http://dx.doi.org/10.1038/ng.91 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"39 (8) (2007) 984 –988, http://dx.doi.org/ 10.1038/ng2085 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"42 (6) (2010) 504 –507, http://dx.doi.org/10.1038/ng.586 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"46 (7) (2014) 753 –758, http://dx.doi.org/10.1038/ng.2971 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"40 (12) (2008) 1407 –1409, http://dx.doi.org/10.1038/ng.273 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"Cell Stem Cell 10 (4) (2012) 440 –454, http://dx.doi.org/10.1016/j.stem.2012.02.016 .",OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"Rep. 28 (1) (2012) 186 –192, http://dx.doi.org/10.3892/or.2012.1765 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"39 (5) (2007) 645 –649, http://dx.doi.org/10.1038/ng2022 .",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"42 (9) (2010) 755 –758, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
"Cancer 87 (5) (2002) 524 –528, http://dx.doi.org/10.1038/sj.bjc.",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5013250.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/63/main.PMC5013253.pdf
"Among C57BL/6 mice exposed via inhalation (5 mg/m3,5h / day, 4 days) to single-walled CNTs (SWCNTs) contaminated with 17.7% iron, exposure was associated with approximately a 50% de- crease in the lung's total GSH content [55].D e c r e a s e so f4 0 –50% inContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.08.009 2213-2317/ &2016 Published by Elsevier B.V.",Non-OADS,/arxiv_data1/oa_pdf/31/63/main.PMC5013253.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/63/main.PMC5013253.pdf
Antenatal and Postnatal Mental Health :Clinical Management and Service Guidance (https://www.nice.org.uk/ guidance/cg192).,Non-OADS,/arxiv_data1/oa_pdf/de/9c/bjporcpsych003079.PMC5013258.pdf
Drug Safety Update 17 Feb 2016 (https://www.gov.uk/drug-safety-update/valproate-and-of- risk-of-abnormal-pregnancy-outcomes-new-communication-materials).,Non-OADS,/arxiv_data1/oa_pdf/de/9c/bjporcpsych003079.PMC5013258.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/d0/jjm-09-06-32163.PMC5013289.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/10/jjm-09-06-33264.PMC5013290.pdf
This  is  an  open  access  article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/29/main.PMC5013291.pdf
"Findings  of  laparoscopy:  the  introduction  of  the  ﬁrst  trocar  with open  technique  throught  the  umbelica  allows  the  discovering  of distended  small  bowel  loops,  herniated  small  bowel  loop  through  a http://dx.doi.org/10.1016/j.ijscr.2016.05.003 2210-2612/© 2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.",Non-OADS,/arxiv_data1/oa_pdf/0d/29/main.PMC5013291.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/90/2f/main.PMC5013329.pdf
"On  the  other  hand,  during  the  ﬁrst  24  h  after  IV  rt-PA administration,  the  risk  of  intracranial  hemorrhage  associated  with early  reperfusion  might  be  increased  because  of  hyperperfusion http://dx.doi.org/10.1016/j.ijscr.2016.07.027 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/90/2f/main.PMC5013329.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/bmjgast-2016-000095.PMC5013330.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/79/a4/bmjgast-2016-000106.PMC5013331.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011640).,Non-OADS,/arxiv_data1/oa_pdf/b6/13/bmjopen-2016-011640.PMC5013334.pdf
03 November 2015. http://healthitboard.health.govt.nz/ health-it-programme-2015-2020-0/next-phase-health-it-programme-announced 2.,Non-OADS,/arxiv_data1/oa_pdf/b6/13/bmjopen-2016-011640.PMC5013334.pdf
ISBN: 978-0-947491-87-1.http://www.health.govt.nz/system/files/documents/publications/new-zealand-health-strategy-future-direction-apr16_1.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/b6/13/bmjopen-2016-011640.PMC5013334.pdf
ISBN: 978-0-478-41555-1.http://healthitboard.health.govt.nz/our-programmes/national-health-it-plan 4.,Non-OADS,/arxiv_data1/oa_pdf/b6/13/bmjopen-2016-011640.PMC5013334.pdf
2008 https://www.health.gov.au/internet/main/publishing.nsf/Content/69B9E01747B836DCCA257BF0001DC5CC/$File/Summary% 20National%20E-Health%20Strategy%20final.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/b6/13/bmjopen-2016-011640.PMC5013334.pdf
05 April 2016. http://healthitboard.health.govt.nz/ health-it-programme-2015-2020-0/design-workshop-progresses-consumer-centric-ehr 10.,Non-OADS,/arxiv_data1/oa_pdf/b6/13/bmjopen-2016-011640.PMC5013334.pdf
"World Health Organization, 2006.http://www.who.int/hrh/documents/reassessing_relationship.pdf 13.",Non-OADS,/arxiv_data1/oa_pdf/b6/13/bmjopen-2016-011640.PMC5013334.pdf
"London: Department of Health, 2004. http://www.connectingforhealth.nhs.uk 20.",Non-OADS,/arxiv_data1/oa_pdf/b6/13/bmjopen-2016-011640.PMC5013334.pdf
http://www.elections.org.nz/research-statistics/enrolment-statistics-electorate 22.,Non-OADS,/arxiv_data1/oa_pdf/b6/13/bmjopen-2016-011640.PMC5013334.pdf
http://www.stats.govt.nz/ Census/2013-census/data-tables/total-by-topic.aspx 23.,OADS,/arxiv_data1/oa_pdf/b6/13/bmjopen-2016-011640.PMC5013334.pdf
"London: Department of Health, 2002. http://webarchive.nationalarchives.gov.uk/20130502102046/http://www.connectingforhealth.nhs.uk/resources/archive/share_with_care.pdf (accessed online August 2016).",Non-OADS,/arxiv_data1/oa_pdf/b6/13/bmjopen-2016-011640.PMC5013334.pdf
"Pollock M. Better Information for better care —New Zealand ’s approach to efficient and affordable health care, White paper .N e w Zealand Trade and Enterprise (NZTE), April 2012. https://www.nzte.govt.nz/media/553044/final_nzte_europe_whitepaper_low.pdf 27.",Non-OADS,/arxiv_data1/oa_pdf/b6/13/bmjopen-2016-011640.PMC5013334.pdf
10 May 2015. https://www.health.gov.au/internet/ ministers/publishing.nsf/Content/health-mediarel-yr2015-ley050.htm 30.,Non-OADS,/arxiv_data1/oa_pdf/b6/13/bmjopen-2016-011640.PMC5013334.pdf
As of 30 December 2015. https://www.gov.uk/ government/uploads/system/uploads/attachment_data/file/265869/2901668_G8_DementiaSummitDeclaration_acc.pdf 5.,OADS,/arxiv_data1/oa_pdf/c1/9c/bmjopen-2016-012052.PMC5013335.pdf
As of19 January 2016: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/215101/dh_133176.pdf 6.,OADS,/arxiv_data1/oa_pdf/c1/9c/bmjopen-2016-012052.PMC5013335.pdf
Asof 30 December 2015: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/414344/pm-dementia2020.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/c1/9c/bmjopen-2016-012052.PMC5013335.pdf
As of 30 December 2015. http://www.alzheimers.org.uk/site/scripts/documents_info.php?documentID=429 12.,Non-OADS,/arxiv_data1/oa_pdf/c1/9c/bmjopen-2016-012052.PMC5013335.pdf
2015. http://EThOS.bl.uk (accessed19 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/c1/9c/bmjopen-2016-012052.PMC5013335.pdf
As of 4 February 2016: http://www.esf.org/fileadmin/Public_documents/Publications/Career_Tracking.pdf 17.,OADS,/arxiv_data1/oa_pdf/c1/9c/bmjopen-2016-012052.PMC5013335.pdf
"The Wellcome Trust, 2013. http://www.wellcome.ac.",Non-OADS,/arxiv_data1/oa_pdf/c1/9c/bmjopen-2016-012052.PMC5013335.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjdrc-2016- 000243).,Non-OADS,/arxiv_data1/oa_pdf/6e/22/bmjdrc-2016-000243.PMC5013337.pdf
2006. http://www.who.int/bmi/index.jsp?introPage=intro_3.html(accessed 2 Feb 2014) 11.,OADS,/arxiv_data1/oa_pdf/6e/22/bmjdrc-2016-000243.PMC5013337.pdf
2012. https://www.andrew.cmu.edu/user/bjones/ 18.,Non-OADS,/arxiv_data1/oa_pdf/6e/22/bmjdrc-2016-000243.PMC5013337.pdf
http://www.diabetes.org.nz/about_diabetes/are_you_at_risk 40.,Non-OADS,/arxiv_data1/oa_pdf/6e/22/bmjdrc-2016-000243.PMC5013337.pdf
http://www.nccmerp.org/about-medication-errors 3.,Non-OADS,/arxiv_data1/oa_pdf/17/fb/bmjopen-2015-010675.PMC5013338.pdf
http://www.casp-uk.net/wp-content/uploads/ 2011/11/CASP_Cohort_Appraisal_Checklist_14oct10.pdfwebcite 19.,Non-OADS,/arxiv_data1/oa_pdf/17/fb/bmjopen-2015-010675.PMC5013338.pdf
http://joannabriggs.org/assets/docs/jbc/operations/criticalAppraisalForms/JBC_Form_CritAp_DescCase.pdf 20.,OADS,/arxiv_data1/oa_pdf/17/fb/bmjopen-2015-010675.PMC5013338.pdf
"http://www.fda.gov/AboutFDA/Transparency/Basics/ucm194951.htm 4 Assiri GA, et al.BMJ Open 2016; 6:e010675.",Non-OADS,/arxiv_data1/oa_pdf/17/fb/bmjopen-2015-010675.PMC5013338.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011559).,Non-OADS,/arxiv_data1/oa_pdf/2a/9e/bmjopen-2016-011559.PMC5013339.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e9/15/bmjopen-2016-011697.PMC5013340.pdf
2014. http://cot.food.gov.uk/sites/ default/files/cot/cotpapotas.pdf (accessed 19 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/91/41/bmjopen-2016-011716.PMC5013341.pdf
http://cot.food.gov.uk/sites/default/files/TOX-2015 –11_0.,Non-OADS,/arxiv_data1/oa_pdf/91/41/bmjopen-2016-011716.PMC5013341.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011278).,Non-OADS,/arxiv_data1/oa_pdf/d1/ce/bmjopen-2016-011278.PMC5013345.pdf
Authorship eligibility guide- lines of publications arising from the OPAL trial will align with those outlined by the International Committee ofMedical Journal Editors (http://www.icmje.org/).,Non-OADS,/arxiv_data1/oa_pdf/d1/ce/bmjopen-2016-011278.PMC5013345.pdf
http://www.acc.,Non-OADS,/arxiv_data1/oa_pdf/74/b9/bmjdrc-2016-000275.PMC5013346.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011209).,Non-OADS,/arxiv_data1/oa_pdf/22/bf/bmjopen-2016-011209.PMC5013347.pdf
http://www.bccdc.ca/NR/rdonlyres/069B2104-03E5-4C49-BFBC-064F1DAF62D7/0/STI_Annual_Report_2013FINAL.PDF (accessed 18 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/22/bf/bmjopen-2016-011209.PMC5013347.pdf
https://www12.statcan.gc.ca/census-recensement/2011/as-sa/fogs-spg/Index-eng.cfm (accessed 25 Feb 2016) 13.,OADS,/arxiv_data1/oa_pdf/22/bf/bmjopen-2016-011209.PMC5013347.pdf
http://www.phac-aspc.gc.ca/std-mts/sti-its/ cgsti-ldcits/index-eng.php (accessed 18 Jul 2015).,OADS,/arxiv_data1/oa_pdf/22/bf/bmjopen-2016-011209.PMC5013347.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011371).,Non-OADS,/arxiv_data1/oa_pdf/f8/94/bmjopen-2016-011371.PMC5013348.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011861).,Non-OADS,/arxiv_data1/oa_pdf/d2/d6/bmjopen-2016-011861.PMC5013349.pdf
Funding This study is funded by the Consortium Stronger On Your Own Feet (http://www.sterkeropeigenbenen.nl).,Non-OADS,/arxiv_data1/oa_pdf/d2/d6/bmjopen-2016-011861.PMC5013349.pdf
"Secondary Definition ofIntellectual Disability, 2013. http://aaidd.org/intellectual-disability/definition 10.",Non-OADS,/arxiv_data1/oa_pdf/d2/d6/bmjopen-2016-011861.PMC5013349.pdf
Secondary LimeSurvey —the most popular Free Open Source Software survey tool on the web 2016.https://http://www.limesurvey.org/en/ 24.,OADS,/arxiv_data1/oa_pdf/d2/d6/bmjopen-2016-011861.PMC5013349.pdf
"Secondary Briefing note seven: approaches to publicinvolvement in research, 2014. http://www.invo.org.uk/posttyperesource/approaches-to-public-involvement/ 27.",Non-OADS,/arxiv_data1/oa_pdf/d2/d6/bmjopen-2016-011861.PMC5013349.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011368).,Non-OADS,/arxiv_data1/oa_pdf/76/01/bmjopen-2016-011368.PMC5013350.pdf
http://www.webmm.ahrq.gov/glossary.aspx (28 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/76/01/bmjopen-2016-011368.PMC5013350.pdf
"Eindhoven, The Netherlands: University of Technology, August, 2005. http://www.who.int/patientsafety/taxonomy/PRISMA_Medical.pdf (28 Aug 2015).",Non-OADS,/arxiv_data1/oa_pdf/76/01/bmjopen-2016-011368.PMC5013350.pdf
http://www.nccmerp.org/sites/default/files/indexBW2001-06-12.pdf (28 Aug2015).,Non-OADS,/arxiv_data1/oa_pdf/76/01/bmjopen-2016-011368.PMC5013350.pdf
"Geneva, Switzerland: World Health Organization, 2006. http://www.who.int/patientsafety/taxonomy/icps_full_report.pdf (28 Aug 2015).",Non-OADS,/arxiv_data1/oa_pdf/76/01/bmjopen-2016-011368.PMC5013350.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012091).,Non-OADS,/arxiv_data1/oa_pdf/bc/07/bmjopen-2016-012091.PMC5013351.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/bc/07/bmjopen-2016-012091.PMC5013351.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010490).,Non-OADS,/arxiv_data1/oa_pdf/a1/d9/bmjopen-2015-010490.PMC5013352.pdf
2014. http://apps.who.int/iris/bitstream/10665/112697/1/WHO_RHR_14.13_eng.pdf?ua=1 5.,OADS,/arxiv_data1/oa_pdf/a1/d9/bmjopen-2015-010490.PMC5013352.pdf
http://www.searo.who.int/maldives/documents/Maternal_Deaths_in_the_Maldives_2009-2011_-_short_report_edit_3.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/a1/d9/bmjopen-2015-010490.PMC5013352.pdf
http://www.who.int/maternal_child_adolescent/epidemiology/maternal-death-surveillance/case-studies/bangladesh-study/en/ 29.,Non-OADS,/arxiv_data1/oa_pdf/a1/d9/bmjopen-2015-010490.PMC5013352.pdf
http://www.scielosp.,Non-OADS,/arxiv_data1/oa_pdf/a1/d9/bmjopen-2015-010490.PMC5013352.pdf
http://sustainabledevelopment.un.org 34.,Non-OADS,/arxiv_data1/oa_pdf/a1/d9/bmjopen-2015-010490.PMC5013352.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011668).,Non-OADS,/arxiv_data1/oa_pdf/de/55/bmjopen-2016-011668.PMC5013353.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/de/55/bmjopen-2016-011668.PMC5013353.pdf
http://statline.cbs.nl/ StatWeb/publication/?VW=T&DM=SLNL&PA=80386NED&LA=NL 2.,Non-OADS,/arxiv_data1/oa_pdf/de/55/bmjopen-2016-011668.PMC5013353.pdf
2006. http://www.nvgic.nl/richtlijnen/Best%20Practice%20Laparoscopische%20Cholecystectomie.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/de/55/bmjopen-2016-011668.PMC5013353.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0c/a2/openhrt-2016-000433.PMC5013354.pdf
2012. http://www.who.int/healthinfo/global_burden_disease/metrics_daly/en/ (accessed 8 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/0c/a2/openhrt-2016-000433.PMC5013354.pdf
2013. http://www.abep.org (accessed 07 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/0c/a2/openhrt-2016-000433.PMC5013354.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013645).,Non-OADS,/arxiv_data1/oa_pdf/a0/20/bmjopen-2016-013645.PMC5013355.pdf
2013. https://www.england.nhs.uk/ wp-content/uploads/2013/11/nqb-how-to-guid.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/bmjopen-2016-013645.PMC5013355.pdf
"The Shelford Group, 2013. http://www.nhsiq.nhs.uk/ media/2760784/130719_shelford_safer_nursing_final.pdf 4.",Non-OADS,/arxiv_data1/oa_pdf/a0/20/bmjopen-2016-013645.PMC5013355.pdf
"Great Britain: National Assembly for Wales, 2016. http://legislation.data.gov.uk/anaw/2016/5/body/data.htm?wrap=true (accessed 22 Aug 2016).",Non-OADS,/arxiv_data1/oa_pdf/a0/20/bmjopen-2016-013645.PMC5013355.pdf
2014. https://www.nice.org.uk/guidance/sg1 13.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/bmjopen-2016-013645.PMC5013355.pdf
2016. http://www.nuffieldtrust.org.uk/node/4651 18.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/bmjopen-2016-013645.PMC5013355.pdf
2014. http://programme.exordo.com/cares2014/delegates/presentation/14/ 48.,Non-OADS,/arxiv_data1/oa_pdf/a0/20/bmjopen-2016-013645.PMC5013355.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011049).,Non-OADS,/arxiv_data1/oa_pdf/fa/9c/bmjopen-2016-011049.PMC5013357.pdf
2006.http://www.rcpsych.ac.uk/PDF/Self-Harm%20Quality%20Standards.,Non-OADS,/arxiv_data1/oa_pdf/fa/9c/bmjopen-2016-011049.PMC5013357.pdf
http://gov.wales/docs/statistics/2011/111222wimd11techen.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fa/9c/bmjopen-2016-011049.PMC5013357.pdf
2004. http://webarchive.nationalarchives.gov.uk/20110215111010/http:/defra.gov.uk/evidence/statistics/rural/documents/rural-defn/Rural_Urban_Introductory_Guide.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fa/9c/bmjopen-2016-011049.PMC5013357.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012193).,Non-OADS,/arxiv_data1/oa_pdf/c5/d0/bmjopen-2016-012193.PMC5013359.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ BMJ Open Diabetes Research and Care 2016; 4:e000232corr1.,Non-OADS,/arxiv_data1/oa_pdf/99/2b/bmjdrc-2016-000232corr1.PMC5013360.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6b/1a/bmjopen-2016-011269.PMC5013361.pdf
April 2013. http://www.publications.parliament.uk/pa/cm201314/cmselect/cmhealth/171/171vw25.htm (accessed 10 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/6b/1a/bmjopen-2016-011269.PMC5013361.pdf
BBC News 16 December 2014. http://www.bbc.co.uk/news/health- 30507649 (accessed 1 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/6b/1a/bmjopen-2016-011269.PMC5013361.pdf
2014. http://www.england.nhs.uk/ wp-content/uploads/2014/11/comm-pharm-better-quality-resilient-urgent-care.pdf (accessed 10 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/6b/1a/bmjopen-2016-011269.PMC5013361.pdf
2015. https://www.england.nhs.uk/commissioning/ wp-content/uploads/sites/12/2015/11/quick-guid-comm-pharm-urgent-care.pdf (accessed 4 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/6b/1a/bmjopen-2016-011269.PMC5013361.pdf
2014. https://www.england.,Non-OADS,/arxiv_data1/oa_pdf/6b/1a/bmjopen-2016-011269.PMC5013361.pdf
2014. http://www.rpharms.com/policy-pdfs/ urgent-and-emergency-care.pdf (accessed 13 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/6b/1a/bmjopen-2016-011269.PMC5013361.pdf
http://psnc.org.uk/services-commissioning/ pharmoutcomes/ (accessed 3 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/6b/1a/bmjopen-2016-011269.PMC5013361.pdf
2014. http://psnc.org.uk/ sunderland-lpc/wp-content/uploads/sites/89/2014/12/PERMSS-SLA-Final.pdf (accessed 1 Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/6b/1a/bmjopen-2016-011269.PMC5013361.pdf
2008. http://www.patientsafetyfirst.nhs.uk/ashx/Asset.,Non-OADS,/arxiv_data1/oa_pdf/6b/1a/bmjopen-2016-011269.PMC5013361.pdf
2013. http://www.england.nhs.uk/wp-content/uploads/2013/12/winter- pressures_community-pharmacy-services.pdf (accessed 10 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/6b/1a/bmjopen-2016-011269.PMC5013361.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012227).,Non-OADS,/arxiv_data1/oa_pdf/b9/4f/bmjopen-2016-012227.PMC5013362.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012180).,Non-OADS,/arxiv_data1/oa_pdf/47/8e/bmjopen-2016-012180.PMC5013363.pdf
2015. http://abs.gov.au/ AUSSTATS/abs@.nsf/DetailsPage/3101.0Dec%202015?OpenDocument (accessed online Aug 2016).,Non-OADS,/arxiv_data1/oa_pdf/47/8e/bmjopen-2016-012180.PMC5013363.pdf
doi:10.1136/rmdopen-2016- 000279 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ rmdopen-2016-000279).,Non-OADS,/arxiv_data1/oa_pdf/1d/b4/rmdopen-2016-000279.PMC5013366.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0c/af/bmjopen-2016-011967.PMC5013367.pdf
http://statline.cbs.nl/Statweb/publication/?,Non-OADS,/arxiv_data1/oa_pdf/0c/af/bmjopen-2016-011967.PMC5013367.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011757).,Non-OADS,/arxiv_data1/oa_pdf/f6/64/bmjopen-2016-011757.PMC5013369.pdf
"Toronto, ON, 2015:26. http://parachutecanada.org/downloads/research/Cost_of_Injury-2015.pdf (accessed 28 Feb 2016).",Non-OADS,/arxiv_data1/oa_pdf/f6/64/bmjopen-2016-011757.PMC5013369.pdf
"Ottawa, ON, 2014. http://www.phac-aspc.gc.ca/seniors-aines/ Lachance CC, et al.BMJ Open 2016; 6:e011757.",Non-OADS,/arxiv_data1/oa_pdf/f6/64/bmjopen-2016-011757.PMC5013369.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010689).,Non-OADS,/arxiv_data1/oa_pdf/f1/a2/bmjopen-2015-010689.PMC5013370.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011620).,Non-OADS,/arxiv_data1/oa_pdf/8a/72/bmjopen-2016-011620.PMC5013371.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012048).,Non-OADS,/arxiv_data1/oa_pdf/d8/46/bmjopen-2016-012048.PMC5013375.pdf
"56 69Aiming to derive guidance documents for key issues of the analysis of observational studies, the STRengthening Analytical Thinking for ObservationalStudies (STRATOS) initiative (http://www.stratos-initiative.",Non-OADS,/arxiv_data1/oa_pdf/ef/e1/bmjopen-2015-009972.PMC5013379.pdf
"To view, please visit the journal online (http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/25/9d/lupus-2015-000144.PMC5013381.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011926).,Non-OADS,/arxiv_data1/oa_pdf/70/e9/bmjopen-2016-011926.PMC5013382.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjdrc-2016- 000229).,Non-OADS,/arxiv_data1/oa_pdf/ee/5a/bmjdrc-2016-000229.PMC5013384.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011644).,Non-OADS,/arxiv_data1/oa_pdf/c3/df/bmjopen-2016-011644.PMC5013385.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c3/df/bmjopen-2016-011644.PMC5013385.pdf
"Rockville, MD: Agency for Healthcare Research and Quality, 2008.http://www.ncbi.nlm.nih.gov/books/NBK43618/6.",Non-OADS,/arxiv_data1/oa_pdf/c3/df/bmjopen-2016-011644.PMC5013385.pdf
These concentrations were con- verted to NGSP concentrations by adding 0.4 (%) toJDS concentrations 7and converted to International Federation of Clinical Chemistry and Laboratory Medicine mmol/mol units using the NGSP converterfor HbA1c (http://www.ngsp.org/convert1.asp).,OADS,/arxiv_data1/oa_pdf/2b/4a/bmjdrc-2016-000223.PMC5013397.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2b/4a/bmjdrc-2016-000223.PMC5013397.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011390).,Non-OADS,/arxiv_data1/oa_pdf/d5/a8/bmjopen-2016-011390.PMC5013398.pdf
2016. http://data.worldbank.org/indicator/SH.DYN.AIDS.ZS.,OADS,/arxiv_data1/oa_pdf/d5/a8/bmjopen-2016-011390.PMC5013398.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/46/61/bmjdrc-2016-000228.PMC5013402.pdf
2015. http://pi.lilly.com/us/humalog-pen-pi.pdf (accessed 8 Jan 2016).5.,Non-OADS,/arxiv_data1/oa_pdf/46/61/bmjdrc-2016-000228.PMC5013402.pdf
2015. http://products.sanofi.,Non-OADS,/arxiv_data1/oa_pdf/46/61/bmjdrc-2016-000228.PMC5013402.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010809).,Non-OADS,/arxiv_data1/oa_pdf/22/b7/bmjopen-2015-010809.PMC5013403.pdf
2015. http://www.ginasthma.org/(accessed 15 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/22/b7/bmjopen-2015-010809.PMC5013403.pdf
http://www.cbs.nl/en-GB/menu/themas/ vrije-tijd cultuur/publicaties/artikelen/archief/2015/tablet-verdringt-bord-van-schoot.htm (accessed 15 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/22/b7/bmjopen-2015-010809.PMC5013403.pdf
http://hum.sagepub.com/content/45/7/659.abstract 32.,Non-OADS,/arxiv_data1/oa_pdf/22/b7/bmjopen-2015-010809.PMC5013403.pdf
http://www.cbs.nl/en-GB/menu/themas/dossiers/eu/publicaties/archief/2013/2013-3851-wm.htm (accessed 15 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/22/b7/bmjopen-2015-010809.PMC5013403.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011319).,Non-OADS,/arxiv_data1/oa_pdf/cb/b9/bmjopen-2016-011319.PMC5013410.pdf
Secondary Korea NationalHealth and Nutrition Examination Survey 2013. https://knhanes.cdc.go.kr/knhanes/eng/ (accessed online August 2016).,Non-OADS,/arxiv_data1/oa_pdf/cb/b9/bmjopen-2016-011319.PMC5013410.pdf
http://www.hira.or.kr/eng/index.html (accessed online August 2016).,OADS,/arxiv_data1/oa_pdf/cb/b9/bmjopen-2016-011319.PMC5013410.pdf
To view please visit the journal (http://dx.doi.org/10.1136/openhrt-2016- 000462).,Non-OADS,/arxiv_data1/oa_pdf/3b/67/openhrt-2016-000462.PMC5013412.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010845).,Non-OADS,/arxiv_data1/oa_pdf/6b/90/bmjopen-2015-010845.PMC5013413.pdf
"National Library of Medicine, 2016. https://clinicaltrials.gov/ct2/show/NCT00759746/ (accessed 14 Mar 2016).",Non-OADS,/arxiv_data1/oa_pdf/6b/90/bmjopen-2015-010845.PMC5013413.pdf
"Helsinki, 2013. http://www.wma.net/en/30publications/10policies/b3/(accessed 02 Sep 2015).",Non-OADS,/arxiv_data1/oa_pdf/6b/90/bmjopen-2015-010845.PMC5013413.pdf
"ICH Harmonized Tripartite Guideline, “Guideline for Good Clinical Practice ”; 1996. http://www.ich.org/fileadmin/Public_Web_Site/ICH_ Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf (accessed 2Sep 2015).",Non-OADS,/arxiv_data1/oa_pdf/6b/90/bmjopen-2015-010845.PMC5013413.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a8/fd/bmjopen-2016-011387.PMC5013414.pdf
http://www.immi.gov.au/refugee/index.htm (accessed Jun2016).,Non-OADS,/arxiv_data1/oa_pdf/a8/fd/bmjopen-2016-011387.PMC5013414.pdf
"The Forgotten Children: National Inquiry into Children in Immigration Detention 2014.Australian Human Rights Commission 2015, Sydney, Australia.https://www.humanrights.gov.au/our-work/asylum-seekers-and-refugees/projects/national-inquiry-children-immigration-detention-index(accessed Jun 2016).",Non-OADS,/arxiv_data1/oa_pdf/a8/fd/bmjopen-2016-011387.PMC5013414.pdf
https://www.asid.net.au/documents/item/1225 (accessed Jul 2016).,OADS,/arxiv_data1/oa_pdf/a8/fd/bmjopen-2016-011387.PMC5013414.pdf
http://www.growingupinaustralia.gov.au/pubs/discussion/dp1/#ch2 (accessed Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/a8/fd/bmjopen-2016-011387.PMC5013414.pdf
"Canberra, ACT: Commonwealth of Australia, 2010. https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/r47.pdf(accessed Jun 2016).",Non-OADS,/arxiv_data1/oa_pdf/a8/fd/bmjopen-2016-011387.PMC5013414.pdf
ISBN Print: 1864962933. https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/e73_challenging_ethical_issues_contemporary_ research_human_beings.pdf (accessed Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/a8/fd/bmjopen-2016-011387.PMC5013414.pdf
http://www.growingupinaustralia.gov.au/ pubs/asr/2014/asr2014a.pdf (accessed Jun 2016).,OADS,/arxiv_data1/oa_pdf/a8/fd/bmjopen-2016-011387.PMC5013414.pdf
http://www.immi.gov.au/media/research/lsia/ (accessed Jun 2016).,OADS,/arxiv_data1/oa_pdf/a8/fd/bmjopen-2016-011387.PMC5013414.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010983).,Non-OADS,/arxiv_data1/oa_pdf/6f/8b/bmjopen-2015-010983.PMC5013416.pdf
http://handbook.cochrane.org/chapter_9/9_4_4_meta_analysis_of_dichotomous_outcomes.htm 3.,OADS,/arxiv_data1/oa_pdf/6f/8b/bmjopen-2015-010983.PMC5013416.pdf
2012. http://www.who.int/mental_health/publications/dementia_report_2012/en/ (accessed 14 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/61/75/bmjopen-2015-010948.PMC5013417.pdf
2003. http://www.who.int/whr/ 2003/en/Chapter1-en.pdf?ua=1 (accessed 14 Dec 2015).,OADS,/arxiv_data1/oa_pdf/61/75/bmjopen-2015-010948.PMC5013417.pdf
https://www.alz.co.uk/ research/WorldAlzheimerReport2015.pdf (accessed online August 2015).,Non-OADS,/arxiv_data1/oa_pdf/61/75/bmjopen-2015-010948.PMC5013417.pdf
http://www.ihe.ca/documents/HTA-FR13.pdf (accessed 28 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/61/75/bmjopen-2015-010948.PMC5013417.pdf
http://www.alz.co.uk/research/WorldAlzheimerReport2013.,Non-OADS,/arxiv_data1/oa_pdf/61/75/bmjopen-2015-010948.PMC5013417.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/rmdopen-2016- 000289).,Non-OADS,/arxiv_data1/oa_pdf/9b/19/rmdopen-2016-000289.PMC5013418.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012081).,Non-OADS,/arxiv_data1/oa_pdf/2c/b9/bmjopen-2016-012081.PMC5013419.pdf
"The web-based system With the support of the FSP/USP Informatics Center, a dedicated web-based online self-administered system (http://www.fsp.usp.br/nutrihs/index.html) was devel-oped, named e-NutriHS, to collect health-related data based on previously validated printed questionnaires.",OADS,/arxiv_data1/oa_pdf/2c/b9/bmjopen-2016-012081.PMC5013419.pdf
"In order to increase awareness of NutriHS, a social network page on the internet was created (https://http://www.facebook.com/nutrihs) with a direct link to the e-NutriHS homepage.",Non-OADS,/arxiv_data1/oa_pdf/2c/b9/bmjopen-2016-012081.PMC5013419.pdf
"Cohorts of health professionals, like the Nurses ’Health Study I and II (http://www.channing.",Non-OADS,/arxiv_data1/oa_pdf/2c/b9/bmjopen-2016-012081.PMC5013419.pdf
"harvard.edu/nhs/) and the Health Professionals Follow-up Study (https://http://www.hsph.harvard.edu/ hpfs/), which included thousands of participants inNorth America, brought remarkable scienti ﬁc contribu- tions for identifying and intervening in major risk factors for NCCDs.",Non-OADS,/arxiv_data1/oa_pdf/2c/b9/bmjopen-2016-012081.PMC5013419.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/05/22/bmjopen-2016-011367.PMC5013421.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ vetreco-2016-000187).,Non-OADS,/arxiv_data1/oa_pdf/1e/57/vetreco-2016-000187.PMC5013422.pdf
"Data regarding the prevalence of strangles in these countries are very limitedwith only occasional outbreaks of strangles being reported by the Kimron Veterinary Institute in their annual reports (none in2010; ﬁve in 2011; eight in 2012 and none in 2013) (http://www.vetserv.moag.gov.il/Vet/ all_Publications/dochot-shnatiim/default.htm, last accessed January 2016).",Non-OADS,/arxiv_data1/oa_pdf/1e/57/vetreco-2016-000187.PMC5013422.pdf
"All PCR products were sequenced and compared with the SeM strains in the MLST database (http://pubmlst.org/ szooepidemicus/seM/, last accessed January 2016).",OADS,/arxiv_data1/oa_pdf/1e/57/vetreco-2016-000187.PMC5013422.pdf
"SeM-28 isolates were recovered from the USA ( Waller and Jolley 2007 ), the UK (Ivens and others 2011 ) and Dubai (http://pubmlst.org/ szooepidemicus/seM/, last accessed January 2016).",OADS,/arxiv_data1/oa_pdf/1e/57/vetreco-2016-000187.PMC5013422.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011094).,Non-OADS,/arxiv_data1/oa_pdf/09/ca/bmjopen-2016-011094.PMC5013424.pdf
"Funding This study was a component of the project titled Interrupting Pathways to Maternal, Newborn and Early Childhood Sepsis (IPSI) (Project # S065353 –001) that was funded by the Canadian Department of Foreign Affairs, Trade and Development ’s MUSKOKA Initiative on Maternal, Newborn and Child Health (MNCH), received by CL, http://www.international.gc.ca/.",Non-OADS,/arxiv_data1/oa_pdf/09/ca/bmjopen-2016-011094.PMC5013424.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/09/ca/bmjopen-2016-011094.PMC5013424.pdf
"UNICEF Progress Report, 2012. http://www.un.org/ru/publications/ pdfs/renewed_%20progress%20report%202012.pdf 3.",Non-OADS,/arxiv_data1/oa_pdf/09/ca/bmjopen-2016-011094.PMC5013424.pdf
"Pocket book of hospital care for children: guidelines for the management of common childhood illnesses – 2nd ed, 2013. http://apps.who.int/iris/bitstream/10665/81170/1/9789241548373_eng.pdf 10.",Non-OADS,/arxiv_data1/oa_pdf/09/ca/bmjopen-2016-011094.PMC5013424.pdf
"Recommendations for management of common childhood conditions, 2012. http://apps.who.int/iris/bitstream/10665/44774/1/9789241502825_eng.pdf 11.",Non-OADS,/arxiv_data1/oa_pdf/09/ca/bmjopen-2016-011094.PMC5013424.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010548).,Non-OADS,/arxiv_data1/oa_pdf/70/8b/bmjopen-2015-010548.PMC5013427.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/70/8b/bmjopen-2015-010548.PMC5013427.pdf
To view please visit the journal (http://dx.doi.org/10.1136/openhrt-2016- 000439).,Non-OADS,/arxiv_data1/oa_pdf/67/d9/openhrt-2016-000439.PMC5013428.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Acknowledgements An abstract of this paper was presented as a poster presentation at The ESC (European Society of Cardiology) Congress in Rome, Italy, in 2016.",Non-OADS,/arxiv_data1/oa_pdf/67/d9/openhrt-2016-000439.PMC5013428.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011523).,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/bmjopen-2016-011523.PMC5013429.pdf
Project partners are listed on the websitehttp://www.DD2.nu.,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/bmjopen-2016-011523.PMC5013429.pdf
2015. http://pro.medicin.dk/Specielleemner/Emner/318019 (accessed 21 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/d3/c9/bmjopen-2016-011523.PMC5013429.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013377).,Non-OADS,/arxiv_data1/oa_pdf/14/20/bmjopen-2016-013377.PMC5013430.pdf
2014. http://www.transport.govt.nz/ourwork/tmif/travelpatterns/tp007/ 15.,Non-OADS,/arxiv_data1/oa_pdf/14/20/bmjopen-2016-013377.PMC5013430.pdf
2016. http://www.education.govt.nz/school/running-a-school/resourcing/operational-funding/school-decile-ratings/ 48.,Non-OADS,/arxiv_data1/oa_pdf/14/20/bmjopen-2016-013377.PMC5013430.pdf
2013.http://www.ipenproject.org/methods_accelerometers.html 52.,Non-OADS,/arxiv_data1/oa_pdf/14/20/bmjopen-2016-013377.PMC5013430.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011475).,Non-OADS,/arxiv_data1/oa_pdf/77/8c/bmjopen-2016-011475.PMC5013437.pdf
The searches will be conducted in the following databases:▸MEDLINE and MEDLINE in process (via OvidSP); ▸PubMed; ▸EMBASE (via OvidSP); ▸PsycINFO (via OvidSP);▸NEXIS (media database useful for commercial/ market reports on over the counter sales of interven- tions such as gripe water); ▸Database of Abstracts of Reviews of Effects (DARE) in the Cochrane Library; ▸Health T echnology Assessment Database (HTA Database) in the Cochrane Library; ▸NHS Economic Evaluation Database (NHS EED) in the Cochrane Library; ▸CEA Registry (via https://research.tufts-nemc.org/ cear4/); ▸Evidence Search (https://www.evidence.nhs.uk/); ▸OAISTER (http://www.oclc.org/oaister.en.html); ▸RePEc (http://repec.org/).,OADS,/arxiv_data1/oa_pdf/77/8c/bmjopen-2016-011475.PMC5013437.pdf
The search and recordselection process will be presented in a PRISMA ﬂow diagram (http://www.prisma-statement.org/statement.,OADS,/arxiv_data1/oa_pdf/77/8c/bmjopen-2016-011475.PMC5013437.pdf
https://www.covidence.org.),Non-OADS,/arxiv_data1/oa_pdf/77/8c/bmjopen-2016-011475.PMC5013437.pdf
2014. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp 41.,Non-OADS,/arxiv_data1/oa_pdf/77/8c/bmjopen-2016-011475.PMC5013437.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/rmdopen-2016-000305).,Non-OADS,/arxiv_data1/oa_pdf/98/56/rmdopen-2016-000305.PMC5013443.pdf
"39. http://www.wearewvproud.com/story/32150336/phase-iii-study- shows-genentechs-actemra-tocilizumab-maintained-steroid-free-remission-in-people-with-giant-cell-arteritis-gca 6 Toussirot É, et al.RMD Open 2016; 2:e000305.",Non-OADS,/arxiv_data1/oa_pdf/98/56/rmdopen-2016-000305.PMC5013443.pdf
"During the recruitment period, 5 244 individuals visited the clinic and of those 3 500 received the questionnaire(published earlier: http://www.biomedcentral.com/content/supplementary/ 1471-2458-9-198-S1.doc).",Non-OADS,/arxiv_data1/oa_pdf/b3/e6/bmjopen-2016-011312.PMC5013445.pdf
"http://www.lafa.nu/Documents/Styrdokument/Nationell%20handlingsplan%20f%C3%B6r%20klamydiaprevention.pdf (accessed Aug 19, 2016).",Non-OADS,/arxiv_data1/oa_pdf/b3/e6/bmjopen-2016-011312.PMC5013445.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011649).,Non-OADS,/arxiv_data1/oa_pdf/b6/cd/bmjopen-2016-011649.PMC5013453.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b6/cd/bmjopen-2016-011649.PMC5013453.pdf
"http://web.worldbank.org/WBSITE/ EXTERNAL/TOPICS/EXTPOVERTY/EXTPA/0,,menuPK:430373~pagePK:149018~piPK:149093~theSitePK:430367,00.html (accessed 23Jun 2015).",Non-OADS,/arxiv_data1/oa_pdf/b6/cd/bmjopen-2016-011649.PMC5013453.pdf
2016. http://www.dartmouthatlas.org 12.,Non-OADS,/arxiv_data1/oa_pdf/21/73/bmjopen-2016-011739.PMC5013457.pdf
"Department of Health and Human Services, 2003. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/CMS-Statistics-Reference-Booklet/Downloads/2003CMSStatistics.pdf#table41 (accessed Aug 2016).",OADS,/arxiv_data1/oa_pdf/21/73/bmjopen-2016-011739.PMC5013457.pdf
https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCS_Coding_Questions.html 15.,Non-OADS,/arxiv_data1/oa_pdf/21/73/bmjopen-2016-011739.PMC5013457.pdf
2016. http://www.cms.gov/ Research-Statistics-Data-and-Systems/Files-for-Order/LimitedDataSets/StandardAnalyticalFiles.html 18.,OADS,/arxiv_data1/oa_pdf/21/73/bmjopen-2016-011739.PMC5013457.pdf
To view please visit the journal (http://dx.doi.org/10.1136/rmdopen-2016- 000323).,Non-OADS,/arxiv_data1/oa_pdf/7e/2e/rmdopen-2016-000323.PMC5013458.pdf
"METHODS This study was developed according to the Cochrane col-laboration guidelines (http://www.cochrane.org) and followed a protocol that prespeci ﬁed study selection, eli- gibility criteria, quality assessment, data abstraction andstatistical analysis.",OADS,/arxiv_data1/oa_pdf/7e/2e/rmdopen-2016-000323.PMC5013458.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fa/24/bmjdrc-2016-000237.PMC5013461.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010554).,Non-OADS,/arxiv_data1/oa_pdf/e9/d3/bmjopen-2015-010554.PMC5013462.pdf
"HarvardMedical School, Diversity Inclusion & Community Partnership, 2010. https://catalyst.harvard.edu/pdf/diversity/CCR-annotated-bibliography-10-12-10ver2-FINAL.pdf5.",Non-OADS,/arxiv_data1/oa_pdf/e9/d3/bmjopen-2015-010554.PMC5013462.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011999).,Non-OADS,/arxiv_data1/oa_pdf/81/5e/bmjopen-2016-011999.PMC5013465.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/81/5e/bmjopen-2016-011999.PMC5013465.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011362).,Non-OADS,/arxiv_data1/oa_pdf/e7/e9/bmjopen-2016-011362.PMC5013466.pdf
"Recuperado de: Catálogo general publicaciones oficiales, 2008.http://www.060.es 24.",Non-OADS,/arxiv_data1/oa_pdf/e7/e9/bmjopen-2016-011362.PMC5013466.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010935).,Non-OADS,/arxiv_data1/oa_pdf/f4/71/bmjopen-2015-010935.PMC5013473.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f4/71/bmjopen-2015-010935.PMC5013473.pdf
"REFERENCES [1] HIV/AIDS  Surveillance  Technical  Report  20021(1)  [Accessed:  May  23,  2016];  Available  from:  http://www.cdc.gov/hiv/ pdf/statistics_2000_HIV_  Surveillance_technichal_Report_vol1_no_1.pdf [2] HIV Surveillance Supported by the Division of HIV/AIDS Prevention 2014 May; [Accessed: May 23, 2016]; [Fact sheet] Available from http://www.cdc.gov/hiv/pdf/prevention_ongoing_surveillance_systems.pdf [3] Centers  for  Disease  Control  and  Prevention.",OADS,/arxiv_data1/oa_pdf/67/87/TOAIDJ-10-164.PMC5013474.pdf
"24  [Accessed:  May  23,  2016];  Available  from: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/ [4] Samji H, Cescon A, Hogg RS, et al.",OADS,/arxiv_data1/oa_pdf/67/87/TOAIDJ-10-164.PMC5013474.pdf
"[http://dx.doi.org/10.1371/journal.pone.0081355 ] [PMID: 24367482 ] [5] Shapiro MF, Morton SC, McCaffrey DF, et al.",OADS,/arxiv_data1/oa_pdf/67/87/TOAIDJ-10-164.PMC5013474.pdf
"[http://dx.doi.org/10.1001/jama.281.24.2305 ] [PMID: 10386555 ] [6] Measuring What Matters: Allocation, Planning, and Quality Assessment for the Ryan White CARE Act.",Non-OADS,/arxiv_data1/oa_pdf/67/87/TOAIDJ-10-164.PMC5013474.pdf
"[http://dx.doi.org/10.17226/10855 ] [7] Blair JM, McNaghten AD, Frazier EL, Skarbinski J, Huang P, Heffelfinger JD.",OADS,/arxiv_data1/oa_pdf/67/87/TOAIDJ-10-164.PMC5013474.pdf
"[http://dx.doi.org/10.1371/journal.pone.0000550 ] [PMID: 17579722 ] [9] Hansen M, Hurwitz W, Madow W. Sample Survey Methods and Theory.",OADS,/arxiv_data1/oa_pdf/67/87/TOAIDJ-10-164.PMC5013474.pdf
"[http://dx.doi.org/10.1001/jama.1992.03480130114035 ] [PMID: 1347573 ] [13] Buehler JW, Diaz T, Hersh BS, Chu SY.",OADS,/arxiv_data1/oa_pdf/67/87/TOAIDJ-10-164.PMC5013474.pdf
"[PMID: 8862169 ] [14] Distinguishing  public  health  research  and  public  health  nonresearch  2010  [Accessed:  May  23,  2016];  Available  from: http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf [15] US Federal Code Title 45 Part 46 2009 [Accessed: May 23, 2016]; Available from: http://www.hhs.gov/ohrp/humansubjects/guidance/ 45cfr46.html .",Non-OADS,/arxiv_data1/oa_pdf/67/87/TOAIDJ-10-164.PMC5013474.pdf
"[16] Behavioral and Clinical Characteristics of Persons Receiving Medical Care for HIV Infection-Medical Monitoring Project, United States, 2010,  HIV  Surveillance  Special  Report  9  2014  [Accessed:  May  23,  2016];  Available  from:  http://www.cdc.gov/hiv/pdf/MMP_2010_ surveillancesummary.pdf [17] Frankel MR, McNaghten A, Shapiro MF, et al.",OADS,/arxiv_data1/oa_pdf/67/87/TOAIDJ-10-164.PMC5013474.pdf
"[http://dx.doi.org/10.2174/1874613601206010067 ] [PMID: 23049655 ] [18] Valliant R, Dever JE, Kreuter F. Practical Tools for Designing and Weighting Survey Samples.",OADS,/arxiv_data1/oa_pdf/67/87/TOAIDJ-10-164.PMC5013474.pdf
"[http://dx.doi.org/10.1007/978-1-4614-6449-5 ] [19] Standard  definitions:  final  dispositions  of  case  codes  and  outcome  rates  for  surveys  2011  [Accessed:  June  9,  2016];  Available  from: http://www.aapor.org/AAPOR_Main/media/publications/Standard-Definitions20169theditionfinal.pdf [20] Lessler JT, Kalsbeek WD.",Non-OADS,/arxiv_data1/oa_pdf/67/87/TOAIDJ-10-164.PMC5013474.pdf
[http://dx.doi.org/10.1002/0470011351 ] [22] Kalton G. Methods for oversampling rare subpopulations in social surveys.,Non-OADS,/arxiv_data1/oa_pdf/67/87/TOAIDJ-10-164.PMC5013474.pdf
"[24] Behavioral  Risk  Factor  Surveillance  System  2009  summary  data  quality  report  2011  [Accessed:  May  23,  2016];  Available  from: http://www.cdc.gov/brfss/annual_data/2009/pdf/2009_Summary_Data_Quality_Report.pdf [25] 2005–2010  NAMCS  Physician  Trend  File  Documentation  2016  [Accessed  May  23,  2016];  Available  from: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/  Dataset_Documentation/NAMCS/namphydoc0510.pdf  Public  use  data  file  documentation [26] Kanuk L, Berenson C. Mail surveys and response rates: a literature review.",OADS,/arxiv_data1/oa_pdf/67/87/TOAIDJ-10-164.PMC5013474.pdf
"[http://dx.doi.org/10.2307/3151093 ] [27] Skalland BJ, Blumberg SJ.",OADS,/arxiv_data1/oa_pdf/67/87/TOAIDJ-10-164.PMC5013474.pdf
"[http://dx.doi.org/10.1093/poq/nfl033 ] [29] Harding  L,  Iachan  R,  Johnson  C,  Skarbinski  J.  Weighting  procedures  for  the  2011  MMP  Study  of  HIV  patients.",Non-OADS,/arxiv_data1/oa_pdf/67/87/TOAIDJ-10-164.PMC5013474.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/87/TOAIDJ-10-164.PMC5013474.pdf
"Data sharing statement Information about accessing the 45 and Up Study data and related costs is avilable at: https://www.saxinstitute.org.au/our-work/ 45-up-study/for-researchers/ Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license,which permits others to distribute, remix, adapt, build upon this work non- commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.",Non-OADS,/arxiv_data1/oa_pdf/98/cc/bmjopen-2016-012386.PMC5013478.pdf
2006. http://www.aihw.gov.au/publication-detail/?id=6442467872(accessed 17 December 2015).,Non-OADS,/arxiv_data1/oa_pdf/98/cc/bmjopen-2016-012386.PMC5013478.pdf
doi:10.1136/bmjopen-2016- 011998 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011998).,Non-OADS,/arxiv_data1/oa_pdf/5b/1e/bmjopen-2016-011998.PMC5013479.pdf
"15In addition, the N. gonorrhoeae strains were tested for production of β-lactamase using the nitroce ﬁn test.15 N. gonorrhoeae multiantigen sequence typing (NG-MAST) DNA strain typing16was performed accord- ing to the standard protocol with minor modi ﬁcations (use of a Hot-start Taq-DNA polymerase and a touch- down PCR), and sequence types (STs) were assignedusing the http://www.ng-mast.net website.",OADS,/arxiv_data1/oa_pdf/5b/1e/bmjopen-2016-011998.PMC5013479.pdf
"This enabled early detection of the introduction of a new cipro ﬂoxacin-resistant strain and Table 1 MIC in mg/L and susceptibility according to the EUCAST (http://www.eucast.org/clinical_breakpoints) for selected antimicrobial agents among 102 ciprofloxacin susceptible Neisseria gonorrhoeae strains isolated in Nuuk, Greenland Antimicrobial MIC 50 MIC 90MIC rangeSusceptible NBreakpoint mg/LIntermediate NResistant NBreakpoint (mg/L) Ceftriaxone 0.003 0.004 <0.002 –0.006 102 (100%) ≤0.125 0 0 >0.125 Benzylpenicillin 0.125 0.19 0.064 –1.5 8 (8%) ≤0.06 92 (90%) 2 (2%) >1 Spectinomycin 12.0 12 4 –12 102 (100%) ≤64 0 0 >64 Azithromycin 0.064 0.125 0.023 –0.125 102 (100%) ≤0.25 0 0 >0.5 Tetracycline 0.38 0.75 0.064 –0.75 81 (79%) ≤0.5 21 (21%) 0 >1 Gentamicin* 2.0 3.0 1.5 –4.0 102 (100%) ≤400 > 4 *US GISP MIC breakpoint.",Non-OADS,/arxiv_data1/oa_pdf/5b/1e/bmjopen-2016-011998.PMC5013479.pdf
EPI-NEWS 2013. http://www.ssi.dk/English/News/EPI-NEWS/2013/ No%2035%20-%202013.aspx 5.,Non-OADS,/arxiv_data1/oa_pdf/5b/1e/bmjopen-2016-011998.PMC5013479.pdf
EPI-NEWS 2013; http://www.ssi.dk/ English/News/EPI-NEWS/2013/No%2036%20-%202013.aspx 19.,Non-OADS,/arxiv_data1/oa_pdf/5b/1e/bmjopen-2016-011998.PMC5013479.pdf
"To maintainpractice-change post workshop, pharmacies were pro- vided a DVD of all workshop content (including the video material), notepads of checklists ready to imple-ment and a link to a web page containing PDF docu- ments of the guidelines and checklist that could be printed (http://www.asthma-pharmacy.org).",Non-OADS,/arxiv_data1/oa_pdf/d2/16/bmjopen-2016-012369.PMC5013480.pdf
"Pharmacies received, as part of the academic detailing visit, a copyof the SABA guidelines, a DVD of all workshop content (including the video material), notepads of checklists ready to implement and a link to the asthma-pharmacyweb page (http://www.asthma-pharmacy.org).",Non-OADS,/arxiv_data1/oa_pdf/d2/16/bmjopen-2016-012369.PMC5013480.pdf
Updated 2015. http://www.ginasthma.org 2.,Non-OADS,/arxiv_data1/oa_pdf/d2/16/bmjopen-2016-012369.PMC5013480.pdf
http://www.tga.gov.au/industry/scheduling-poisons-standard.htm 8.,Non-OADS,/arxiv_data1/oa_pdf/d2/16/bmjopen-2016-012369.PMC5013480.pdf
2012. http://www.psa.org.au/download/guidelines/Short-acting-beta-antagonist-protocol.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/d2/16/bmjopen-2016-012369.PMC5013480.pdf
"2014. http://www.guild.org.au/docs/ 12 Watkins K, et al.BMJ Open 2016; 6:e012369.",Non-OADS,/arxiv_data1/oa_pdf/d2/16/bmjopen-2016-012369.PMC5013480.pdf
2015. http://www.qcpp.,Non-OADS,/arxiv_data1/oa_pdf/d2/16/bmjopen-2016-012369.PMC5013480.pdf
"Amendment, 2007. http://www.slp.wa.gov.au/gazette/gg.nsf/act2?OpenView&Start=1&Count=300&Expand=100&RestrictToCategory=Poisons Act 1964 —100 20.",Non-OADS,/arxiv_data1/oa_pdf/d2/16/bmjopen-2016-012369.PMC5013480.pdf
28 Nov 2012. http://www.slp.wa.gov.au/legislation/statutes.nsf/main_mrtitle_1920_homepage.html 21.,Non-OADS,/arxiv_data1/oa_pdf/d2/16/bmjopen-2016-012369.PMC5013480.pdf
Short on Air Report 2010. https://www.nationalasthma.org.au/living-with-asthma/resources/health-professionals/reports-and-statistics/short-on-air (accessed online Aug 2016).,Non-OADS,/arxiv_data1/oa_pdf/d2/16/bmjopen-2016-012369.PMC5013480.pdf
2013. https://http://www.psa.org.au/download/guidelines/3744 Emergency contraception checklist_V3.pdf 35.,Non-OADS,/arxiv_data1/oa_pdf/d2/16/bmjopen-2016-012369.PMC5013480.pdf
2015. http://www.pharmacyboardwa.com.au/?n=Main.Register 38.,Non-OADS,/arxiv_data1/oa_pdf/d2/16/bmjopen-2016-012369.PMC5013480.pdf
"Guidelines for the Diagnosis and Management of Asthma: Expert Panel Report(EPR-3), 2007. http://www.nhlbi.nih.gov/files/docs/guidelines/asthsumm.pdf 54.",Non-OADS,/arxiv_data1/oa_pdf/d2/16/bmjopen-2016-012369.PMC5013480.pdf
All com- munication directed interested participants to the project website (http://www.projectmove.ca) for moredetailed information about the grants and the submis- sion process.,Non-OADS,/arxiv_data1/oa_pdf/bd/1c/bmjopen-2016-012533.PMC5013483.pdf
http://www.cancer.ca/en/cancer-information/cancer-type/breast/breast-cancer/?region=on 3.,Non-OADS,/arxiv_data1/oa_pdf/bd/1c/bmjopen-2016-012533.PMC5013483.pdf
http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer 4.,Non-OADS,/arxiv_data1/oa_pdf/bd/1c/bmjopen-2016-012533.PMC5013483.pdf
http://www.canceradvocacy.org/news/defining-cancer-survivorship/2014 35.,Non-OADS,/arxiv_data1/oa_pdf/bd/1c/bmjopen-2016-012533.PMC5013483.pdf
1996. http://www.ssc.wisc.edu/nsfh/home.htm 58.,Non-OADS,/arxiv_data1/oa_pdf/bd/1c/bmjopen-2016-012533.PMC5013483.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011380).,Non-OADS,/arxiv_data1/oa_pdf/74/4f/bmjopen-2016-011380.PMC5013486.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/74/4f/bmjopen-2016-011380.PMC5013486.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012233).,Non-OADS,/arxiv_data1/oa_pdf/0a/48/bmjopen-2016-012233.PMC5013487.pdf
"18All statistical analyses were performed with R (R CoreT eam 2016, http://www.R-project.org/).",OADS,/arxiv_data1/oa_pdf/61/c8/openhrt-2016-000490.PMC5013488.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/c1/jjm-09-06-29978.PMC5013492.pdf
doi:10.1136/bmjopen-2014- 005148 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005148).,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/bmjopen-2014-005148.PMC5013494.pdf
2014. http://www.who.int/diabetes/facts/world_figures/en/ 15.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/bmjopen-2014-005148.PMC5013494.pdf
2015. http://www.ccn.on.ca/ccn_public/uploadfiles/files/CCN_Annual_Report_2014_15.pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/4c/a2/openhrt-2016-000468.PMC5013496.pdf
"IDF Diabetes Atlas Sixth Edition, update 2014. http://www.idf.org/ atlasmap/atlasmap?indicator=i1&date=2014 (accessed 28 May2015).",Non-OADS,/arxiv_data1/oa_pdf/8d/7a/bmjopen-2015-010352.PMC5013497.pdf
Summary of the HIPAA Privacy Rule May 2003. http://www.hhs.gov/sites/default/files/ privacysummary.pdf (accessed 21 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/8d/7a/bmjopen-2015-010352.PMC5013497.pdf
20 Dec 2012. http://www.hscic.gov.uk/catalogue/PUB09300 (accessed 28 May2015).,Non-OADS,/arxiv_data1/oa_pdf/8d/7a/bmjopen-2015-010352.PMC5013497.pdf
Version 1. http://doc.ukdataservice.ac.uk/doc/7260/mrdoc/pdf/7260datadocs.pdf (accessed 28 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/8d/7a/bmjopen-2015-010352.PMC5013497.pdf
2010. http://webarchive.nationalarchives.gov.uk/20130513172055/http:/www.diabetes.nhs.uk/document.php?o=238 (accessed 28 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/8d/7a/bmjopen-2015-010352.PMC5013497.pdf
"NICE guidelines [CG64] Published date:March 2008. https://www.nice.org.uk/guidance/cg64/ 13. van der Meer JT, Thompson J, Valkenburg HA, et al.",Non-OADS,/arxiv_data1/oa_pdf/96/ae/openhrt-2016-000498.PMC5013500.pdf
http://www.equator-network.org/ reporting-guidelines/strobe/ 16.,Non-OADS,/arxiv_data1/oa_pdf/96/ae/openhrt-2016-000498.PMC5013500.pdf
NICE guideline CG64 update 2015. https://www.nice.org.uk/ guidance/cg64/evidence/full-guideline-addendum-196759982 28.,Non-OADS,/arxiv_data1/oa_pdf/96/ae/openhrt-2016-000498.PMC5013500.pdf
We used one source of data:the patient materials section of Choosing Wisely Canada ’s ofﬁcial website (http://www.choosingwiselycanada.org/ materials/).,Non-OADS,/arxiv_data1/oa_pdf/80/00/bmjopen-2016-011918.PMC5013503.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/80/00/bmjopen-2016-011918.PMC5013503.pdf
"Protectingresources, promoting value: a doctor ’s guide to cutting waste in clinical care, 2014. http://www.aomrc.org.uk/dmdocuments/Promoting%20value%20FINAL.pdf (accessed 13 Jul 2016).",Non-OADS,/arxiv_data1/oa_pdf/80/00/bmjopen-2016-011918.PMC5013503.pdf
"Medical Specialities, 2013. https://www.fmsq.org/en/profession/medecine-specialisee/specialites-medicales (accessed 13Jul 2016).",Non-OADS,/arxiv_data1/oa_pdf/80/00/bmjopen-2016-011918.PMC5013503.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011921).,Non-OADS,/arxiv_data1/oa_pdf/33/a2/bmjopen-2016-011921.PMC5013504.pdf
Secondary HIV/AIDS: Fact sheet N°360 2015 July 2015. http://www.who.int/mediacentre/factsheets/fs360/en/ 2.,Non-OADS,/arxiv_data1/oa_pdf/33/a2/bmjopen-2016-011921.PMC5013504.pdf
Secondary 2014 Global Statistics 2014. http://www.unaids.org/sites/default/files/media_asset/20150714_FS_MDG6_Report_en.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/33/a2/bmjopen-2016-011921.PMC5013504.pdf
Secondary guideline on when to start antiretroviral therapy and on pre-exposureprophylaxis for HIV 2015. http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf 31.,Non-OADS,/arxiv_data1/oa_pdf/33/a2/bmjopen-2016-011921.PMC5013504.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012137).,Non-OADS,/arxiv_data1/oa_pdf/88/31/bmjopen-2016-012137.PMC5013505.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/88/31/bmjopen-2016-012137.PMC5013505.pdf
http://data.worldbank.org/about/ country-and-lending-groups.,Non-OADS,/arxiv_data1/oa_pdf/88/31/bmjopen-2016-012137.PMC5013505.pdf
http://www.ser.es/investigacion/Proyectos/Episer/Episer.php 41.,Non-OADS,/arxiv_data1/oa_pdf/c7/6f/lupus-2016-000163.PMC5013507.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011078).,Non-OADS,/arxiv_data1/oa_pdf/88/38/bmjopen-2016-011078.PMC5013509.pdf
http://www.cosmin.nl/ (accessed 4 Dec 2015).21.,Non-OADS,/arxiv_data1/oa_pdf/88/38/bmjopen-2016-011078.PMC5013509.pdf
http://www.heart.org/idc/groups/heart-public/@wcm/@adv/documents/downloadable/ucm_432451.,Non-OADS,/arxiv_data1/oa_pdf/88/38/bmjopen-2016-011078.PMC5013509.pdf
doi:10.1136/rmdopen-2016- 000293 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ rmdopen-2016-000293).,Non-OADS,/arxiv_data1/oa_pdf/66/78/rmdopen-2016-000293.PMC5013510.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010996).,Non-OADS,/arxiv_data1/oa_pdf/82/65/bmjopen-2015-010996.PMC5013511.pdf
2010. https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_55.pdf (accessed Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/82/65/bmjopen-2015-010996.PMC5013511.pdf
Recorded delivery: a national survey of women ’s experience of maternity care 2006: National Perinatal Epidemiology Unit NPEU; 2007. https://www.npeu.ox.ac.uk/downloads/files/reports/Maternity-Survey-Report.pdf(accessed Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/82/65/bmjopen-2015-010996.PMC5013511.pdf
"Oxford: The National Perinatal Epidemiology Unit, 2014. https://www.npeu.ox.ac.uk/maternity-surveys 30.",Non-OADS,/arxiv_data1/oa_pdf/82/65/bmjopen-2015-010996.PMC5013511.pdf
"Cambridge, MA: Institute for Healthcare Improvement 2011. http://www.IHI.org.",Non-OADS,/arxiv_data1/oa_pdf/ee/f2/bmjopen-2016-011403.PMC5013512.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012540).,Non-OADS,/arxiv_data1/oa_pdf/be/79/bmjopen-2016-012540.PMC5013513.pdf
To view please visit the journal (http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b6/c3/rmdopen-2015-000202.PMC5013514.pdf
METHODS Consensus-based Standards for the selection of health Measurement Instruments (COSMIN http://www.cosmin.nl) were applied in this systematic review.,Non-OADS,/arxiv_data1/oa_pdf/b6/c3/rmdopen-2015-000202.PMC5013514.pdf
"All the information gathered in this review will be taken up in the European League Against Rheumatism (EULAR) OutcomesMeasures Library (OML; http://oml.eular.org/) in order to create an openly accessible database of PROM-based measures, which can be updated with newinformation as it becomes available.",Non-OADS,/arxiv_data1/oa_pdf/b6/c3/rmdopen-2015-000202.PMC5013514.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b6/c3/rmdopen-2015-000202.PMC5013514.pdf
"http://www.cosmin.nl/images/upload/files/COSMIN% 20checklist%20manual%20v9.pdf Hendrikx J, et al.RMD Open 2016; 2:e000202.",Non-OADS,/arxiv_data1/oa_pdf/b6/c3/rmdopen-2015-000202.PMC5013514.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9f/f9/bmjopen-2016-011657.PMC5013515.pdf
"NHS England, 2014. https://www.england.nhs.uk/wp-content/uploads/2014/02/rm-fs-6.pdf (accessed online Aug 2016).",Non-OADS,/arxiv_data1/oa_pdf/9f/f9/bmjopen-2016-011657.PMC5013515.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011615).,Non-OADS,/arxiv_data1/oa_pdf/e0/e5/bmjopen-2016-011615.PMC5013516.pdf
"2015. http://dx.doi.org/10.1016/j.jhep.2014.12.005 ,  in press 4.",OADS,/arxiv_data1/oa_pdf/86/41/nihms813774.PMC5013530.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012803).,Non-OADS,/arxiv_data1/oa_pdf/3d/33/bmjopen-2016-012803.PMC5013531.pdf
CDC .http://www.cdc.gov/measles/cases-outbreaks.,Non-OADS,/arxiv_data1/oa_pdf/3d/33/bmjopen-2016-012803.PMC5013531.pdf
